<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
	<title>Aesclepius</title>
	<link>https://www.aesclepius.com.br/tags/documentos/</link>
	<description>Recent content in documentos on Aesclepius</description>
	<generator>Hugo -- gohugo.io</generator>
	<language>en-us</language>
	<lastBuildDate>Wed, 12 Jun 2024 19:15:57 -0300</lastBuildDate>
    
        <atom:link href="https://www.aesclepius.com.br/tags/documentos/index.xml" rel="self" type="application/rss+xml" />
	
	
	<item>
		<title>0001</title>
		<link>https://www.aesclepius.com.br/pericias/0001/</link>
		<pubDate>Sun, 28 Sep 2025 07:09:07 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/pericias/0001/</guid>
		<description>&lt;h2 id=&#34;parecer-pericial&#34;&gt;Parecer pericial&lt;/h2&gt;
&lt;h3 id=&#34;preâmbulo&#34;&gt;Preâmbulo&lt;/h3&gt;
&lt;p&gt;Dr. Jefferson Torres da Silva, CRM-DF 33.612, intimado aos autos na condição de auxiliar da justiça como perito, conhece deste processo 0718321-73.2024.8.07.0020 que trata de questão cível de obrigação de fazer na qual se questiona aspectos técnicos da doença de base &lt;strong&gt;obesidade&lt;/strong&gt; assinalada à &lt;strong&gt;RAQUEL OLIVEIRA FREIRE&lt;/strong&gt;, sexo feminino, atualmente com 39 anos incompletos, neste parecer tratada doravante como paciente.&lt;/p&gt;
&lt;h3 id=&#34;dos-quesitos&#34;&gt;Dos quesitos&lt;/h3&gt;
&lt;p&gt;As partes não explicitaram quesitos, mas implicitamente restou questionado conhecer se a condição de obesidade aludida à paciente é pretérita a adesão ao plano de saúde, que presume-se ter ocorrido em 20/06/2023, tendo em vista o documento &lt;code&gt;209140576 - Petição Inicial&lt;/code&gt; deste processo.&lt;/p&gt;
&lt;div class=&#34;page-break&#34;&gt;&lt;/div&gt;
&lt;h3 id=&#34;discussão&#34;&gt;Discussão&lt;/h3&gt;
&lt;p&gt;Na petição inicial alude-se ao peso, estatura e ao conhecido índice de massa corpórea (IMC), como sinônimo diagnóstico de &lt;strong&gt;obesidade&lt;/strong&gt; da paciente. Ocorre que &amp;ldquo;&lt;em&gt;o IMC é um bom apontador, mas não totalmente correlacionado com a gordura corporal&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/em&gt;&amp;rdquo;, apesar de ser capaz de indicar, &lt;em&gt;per si&lt;/em&gt; a condição de &lt;strong&gt;sobrepeso&lt;/strong&gt;, entidade diversa mas fundamental no diagnóstico de obesidade.&lt;/p&gt;
&lt;p&gt;Explico: a doença obesidade se faz pela soma dos achados de sobrepeso e sua origem adipócita cumulativa, isto é, de excessivo tecido adiposo, um mecanismo evolutivo de diversas espécies inclusive a humana para armazenamento energético na forma lipídica, i.e. gordurosa.&lt;/p&gt;
&lt;p&gt;Há indivíduos com IMC elevado e baixíssimo percentual de gordura ou quase nenhum acúmulo de adipócitos, casos em que o mero índice alto não se traduz em obesidade. &amp;ldquo;&lt;em&gt;Além disso, o IMC não é indicador do mesmo grau de gordura em populações diversas, particularmente por causa das diferentes proporções corporais&lt;sup id=&#34;fnref1:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/em&gt;&amp;rdquo;.&lt;/p&gt;
&lt;p&gt;Ou seja, conhece-se o diagnóstico de obesidade primeiro pelo IMC elevado e, depois, por sua causa gordurosa, &lt;strong&gt;normalmente crônica&lt;/strong&gt;, desenvolvida de forma paulatina. O famoso artigo da The Lancet &lt;strong&gt;Obesidade, uma bomba-relógio&lt;/strong&gt;&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt; de 1998 bem aludia: &lt;em&gt;&amp;ldquo;Tanto a genética como os fatores ambientais modificam o peso corporal [&amp;hellip;]&amp;rdquo;&lt;/em&gt; e &lt;em&gt;&amp;ldquo;a obesidade é amplamente ambiental, por causa do descompasso entre os antigos genes humanos e o ambiente moderno é o que vai direcionar estratégias terapêuticas e preventivas&amp;rdquo; (grifo e tradução livre nossa)&lt;/em&gt;.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Assim, firma-se um primeiro posicionamento pericial de que a paciente apresenta, de forma documentada, a condição de &lt;u&gt;sobrepeso&lt;/u&gt; desde 18/10/2023, data do mais antigo exame da série fornecida, um ecocardiograma, com IMC de 47.9Kg/m&lt;sup&gt;2&lt;/sup&gt;&lt;/strong&gt;. A classificação quanto ao grau de obesidade de acordo com IMC é atualmente alvo de debates científicos controversos, razão pela qual desqualifico neste parecer sua importância mas &lt;strong&gt;destaco que resta consensual a relação entre gravidade da doença e o valor do índice&lt;sup id=&#34;fnref:3&#34;&gt;&lt;a href=&#34;#fn:3&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;3&lt;/a&gt;&lt;/sup&gt;&lt;/strong&gt;. O valor de 47.9kg/m&lt;sup&gt;2&lt;/sup&gt; certamente se traduz em quadro grave de sobrepeso, agravador da suspeita de obesidade. A literatura médica é incapaz de ilustrar um caso de obesidade com progressão a tal índice em menos de uma década a não ser por obesidade hipotalâmica&lt;sup id=&#34;fnref:4&#34;&gt;&lt;a href=&#34;#fn:4&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;4&lt;/a&gt;&lt;/sup&gt; ou por reativação alimentar inadequada após anorexia&lt;sup id=&#34;fnref:5&#34;&gt;&lt;a href=&#34;#fn:5&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;5&lt;/a&gt;&lt;/sup&gt;, ambas situações excluídas para a ilustração do caso da paciente, pois ná registro de tais síndromes, exceto se documento superveniente prove contrário.&lt;/p&gt;
&lt;p&gt;Tendo em vista a cronicidade típica da doença em tela, sua instalação, início ou primeiros sintomas são sempre discretos, normalmente detectados por distúrbios nos padrões de consumo alimentar com preferência por palatáveis, polifagia e polidipsia, bem como sono irregular, estresse, ansiedade etc. &lt;strong&gt;Desta forma, é difícil firmar precisamente um momento de aquisição da moléstia. Porém, é possível dizê-la recente ou antiga com facilidade&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Constata-se que as repercussões da obesidade se dão em diversos órgãos e podem ser observados, como consequência do convívio com a doença, o surgimento de lesões articulares, infecções de pele e tecidos moles, &lt;em&gt;acantose nigricans&lt;/em&gt;, &lt;strong&gt;distúrbios do sono&lt;/strong&gt;, depressão, gastroenterites diversas infecciosas ou não, refluxo gástrico com ou sem repercussão esofágica, déficit neurológico sensorial, principalmente de visão, disautonomias como hipertensão e síncopes, má perfusão tecidual distal em membros, queda na qualidade de vida e aumento de índice de causas externas com impacto na saúde (acidentes e incidentes).&lt;/p&gt;
&lt;div class=&#34;page-break&#34;&gt;&lt;/div&gt;
&lt;h4 id=&#34;distúrbios-do-sono&#34;&gt;Distúrbios do sono&lt;/h4&gt;
&lt;p&gt;No caso em baila, dispõe-se de uma polissonografia realizada em 28/02/2024 com 13 eventos respiratórios, &lt;strong&gt;todos obstrutivos&lt;/strong&gt; sem causa central, ou seja, &lt;strong&gt;um clássico achado da obesidade desenvolvida, já instalada, mantida e não curada&lt;/strong&gt;. A recomendação dos neurofisiologistas responsáveis pelo laudo de uso de dispositivo respiratório de pressão continuada (CPAP) e a completa ausência de registros centrais (causas neurológicas) corroboram para que assinalemos com segurança que &lt;strong&gt;as apneias de sono da paciente decorrem de complicação do excesso de tecido adiposo ou ainda, em última análise, da obesidade&lt;/strong&gt;. Nos casos congênitos de déficit de sono por apneia, o diagnóstico é infantil e costumam terminar em operações otorrinolaringologistas como remoção de tecidos ou correção de desvios, o que não parece ser o caso da paciente.&lt;/p&gt;
&lt;p&gt;Apud Zimberg et al&lt;sup id=&#34;fnref:6&#34;&gt;&lt;a href=&#34;#fn:6&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;6&lt;/a&gt;&lt;/sup&gt;, &lt;em&gt;&amp;ldquo;atualmente &lt;strong&gt;a síndrome da apneia obstrutiva do sono é reconhecida como um preditor independente para a obesidade&lt;/strong&gt; (Steiropoulos e colaboradores, 2010; Ge e colaboradores, 2013; Kim e colaboradores, 2013), e esta, por sua vez, caracteriza-se como o principal fator de risco para a síndrome, estando presente em aproximadamente 70% dos indivíduos apneicos (Ho e Brass, 2011) [&amp;hellip;] em obesos mórbidos, por exemplo, a prevalência pode chegar a 80% nos homens e 50% nas mulheres (Salvador e colaboradores, 2004). Isso estabelece um link bidirecional entre a síndrome apneica e obesidade&amp;rdquo;&lt;/em&gt;. Por link bidirecional, entende-se desenvolvimento de gravidade de uma comorbidade de acordo a outra, ou seja, associação temporal e de intensidade sobrepostas, sendo este tempo &lt;strong&gt;normalmente medido em anos&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Ainda de acordo com Zimberg et al&lt;sup id=&#34;fnref1:6&#34;&gt;&lt;a href=&#34;#fn:6&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;6&lt;/a&gt;&lt;/sup&gt;, &amp;ldquo;&lt;em&gt;Tuomilheto e colaboradores (2012) avaliaram os resultados de 2 anos de follow-up em 71 indivíduos obesos apneicos. Após a intervenção inicial de 12 semanas e 1 ano de aconselhamento nutricional, não foi realizada nenhuma intervenção ao longo do segundo ano.&lt;/em&gt;&amp;rdquo;. O aludido estudo&lt;sup id=&#34;fnref:7&#34;&gt;&lt;a href=&#34;#fn:7&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;7&lt;/a&gt;&lt;/sup&gt; traz reversão parcial dos quadros de apneia obstrutiva ao longo de pelo menos dois anos, sendo um de intervenção na obesidade. É notório que a desinstalação do quadro, mesmo que parcialmente, reflita seu tempo de instalação, &lt;strong&gt;isto é, pode se afirmar, com alguma segurança, que um exame polissonográfico revelando apneia do sono em obeso trata-se de um quadro de obesidade instalada há também pelo menos dois anos ou, na hipótese mais segura, há mais de um ano&lt;/strong&gt;.&lt;/p&gt;
&lt;div class=&#34;page-break&#34;&gt;&lt;/div&gt;
&lt;h4 id=&#34;dislipidemia&#34;&gt;Dislipidemia&lt;/h4&gt;
&lt;p&gt;Noutra frente, como apontado por Gusmão et. al &lt;sup id=&#34;fnref:8&#34;&gt;&lt;a href=&#34;#fn:8&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;8&lt;/a&gt;&lt;/sup&gt;, a esteatose hepática é paripasso da obesidade no que tange a aquisição dos quadros. É sabido que o metabolismo lipídico disfuncional é o grande precursor do comprometimento de hepatócitos. O quadro normalmente decorre de anos de exposição a dislipidemia e resistência insulínica que provoca errôneo acúmulo de reservas energéticas no fígado.&lt;/p&gt;
&lt;p&gt;Nesta lide, a paciente apresentou como mais antigo exame laboratorial aquele realizado em 17/07/2024, onde &lt;strong&gt;não apresentou dislipidemia&lt;/strong&gt;, isto é, seus níveis de HDL, LDL e colesterol totais não eram os típicos do obeso. Confrontando tal achado com uma ecografia abdominal realizada em 06/12/23 apontando esteatose hepática, surgem três caminhos lógicos:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;a paciente apresentanva dislipidemia e esteatose por hábito alimentar ou de etiologia alcoólica e, no interstício de mais de 6 meses cessou por completo o abuso dietético com absoluta cura, o que é improvável; &lt;strong&gt;ou&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;a paciente nunca foi dislipidêmica e a esteatose se instalou por causas a investigar, quadro também improvável uma vez que passou por cirurgia abdominal e, neste cenário foi investigada pela equipe de anestesiologistas que alertariam tal anormalidade&lt;sup&gt;a&lt;/sup&gt;; &lt;strong&gt;ou&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;apresentou melhora significativa dos níveis lipídicos e de triglicerídeos após a intervenção cirúrgica, &lt;strong&gt;hipótese de maior sentido&lt;/strong&gt;.&lt;/li&gt;
&lt;/ol&gt;
&lt;h4 id=&#34;resistência-insulínica&#34;&gt;Resistência insulínica&lt;/h4&gt;
&lt;p&gt;Apesar de adequada para comparação diagnóstica com outras doenças que tem a obesidade como consequência, a resistência insulínica deveria estar documentada como série de exames para ter valor correlatio temporal, motivo pelo qual não evoco esta entidade especificamente neste parecer.&lt;/p&gt;
&lt;!-- 


&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/pericias/0001/criterios.png&#34;&gt;
  &lt;figcaption&gt;Critérios segundo a Associação Brasileira de Obesidade - 2016.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt; --&gt;
&lt;div class=&#34;page-break&#34;&gt;&lt;/div&gt;
&lt;h4 id=&#34;bioimpedância&#34;&gt;Bioimpedância&lt;/h4&gt;
&lt;p&gt;Exame peculiar do diagnóstico discutido, a bioimpedância isolada no tempo é incapaz de tecer uma história da aquisição do sobrepeso, mas tem papel crucial em determinar se sua natureza atual é muscular ou gordurosa. A paciente se submeteu a bioimpedância em 25/03/2024 com resultado apontando 71% de gordura na composição de massa corpórea. Novamente, inferir o momento de aquisição diagnóstica é impossível apenas com tal exame, porém este vem corroborar com a qualidade do sobrepeso por obesidade grave.&lt;/p&gt;
&lt;h3 id=&#34;conclusão&#34;&gt;Conclusão&lt;/h3&gt;
&lt;p&gt;Este parecer é uma análise médica em caráter especializado sobre endocrinologia a partir de retrospecção lógica dedutiva onde, para fins jurídicos, se tenta esclarecer uma condição diagnóstica no tempo.&lt;/p&gt;
&lt;p&gt;Os documentos apresentados são escassos nos principais achados marcadores do estabelecimento inicial da doença, sejam eles a medida de circunferência abdominal&lt;sup id=&#34;fnref2:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;, das coxas, insulinemia sérica seriada, triglicerídeos e frações de colesterol da primeira década de vida versus atuais e exame físico detalhado do abdome e de dobras cutâneas.&lt;/p&gt;
&lt;p&gt;Porém, os mesmos documentos são ricos na descrição de complicações da obesidade, contando com bioimpedância, ultrassonografia abdominal e polissonografia, todos realizados sob a indicação de investigar colaterais da patologia. Estas complicações demonstram uma idade ao diagnóstico, conforme discorrido.&lt;/p&gt;
&lt;p&gt;Assim, &lt;strong&gt;concluo por afirmar que é seguro dizer que a paciente portava o diagnóstico de obesidade há pelo menos um ano antes da data de 20/06/2023&lt;/strong&gt;, com algum manejo insuficiente no ínterim e com possível melhora dos achados laboratoriais e de imagem tanto em momentos de dieta tanto como após a intervenção cirúrgica, como a realização de um Y de Roux, objeto desta lide.&lt;/p&gt;
&lt;div class=&#34;page-break&#34;&gt;&lt;/div&gt;
&lt;h3 id=&#34;respostas-aos-quesitos&#34;&gt;Respostas aos quesitos&lt;/h3&gt;
&lt;p&gt;A obesidade da paciente é pretérita a adesão ao plano de saúde em 20/06/2023 porque suas complicações são achados &lt;strong&gt;desenvolvidos com métrica temporal anual&lt;/strong&gt; e, dado o grau dos achados, pode se concluir por no mínimo mais de um ano de condição de obesidade prévia &lt;strong&gt;instalada ou em desenvolvilmento&lt;/strong&gt;.&lt;/p&gt;
&lt;br&gt;
&lt;br&gt;
&lt;br&gt;
&lt;br&gt;
Brasília, 03 de outubro de 2025.
&lt;div class=center&gt;
&lt;p&gt;CRM-DF 33.612&lt;/p&gt;
&lt;p&gt;Dr. Jefferson T.&lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;page-break&#34;&gt;&lt;/div&gt;
&lt;br&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;p&gt;a) Normalmente, a avaliação de risco cardiovascular pré-operatória demanda correlação entre achados de exames de imagem prévios, como a esteatose, e exames de marcadores, como colesterol e suas frações.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;ABESO. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. Diretrizes brasileiras de obesidade 2016 / ABESO - Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica. – 4.ed. - São Paulo, SP.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref1:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref2:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;BRAY, G. A. Obesity: a time bomb to be defused. Lancet (London, England), v. 352, n. 9123, p. 160-161, 1998.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:3&#34;&gt;
&lt;p&gt;KRAL, John G. Morbidity of severe obesity. Surgical Clinics, v. 81, n. 5, p. 1039-1061, 2001.&amp;#160;&lt;a href=&#34;#fnref:3&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:4&#34;&gt;
&lt;p&gt;Lustig RH. Hypothalamic obesity after craniopharyngioma: mechanisms, diagnosis, and treatment. Front Endocrinol (Lausanne). 2011 Nov 3;2:60. doi: 10.3389/fendo.2011.00060. PMID: 22654817; PMCID: PMC3356006.&amp;#160;&lt;a href=&#34;#fnref:4&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:5&#34;&gt;
&lt;p&gt;Madden, S., Miskovic-Wheatley, J., Clarke, S. et al. Outcomes of a rapid refeeding protocol in Adolescent Anorexia Nervosa. J Eat Disord 3, 8 (2015). &lt;a href=&#34;https://doi.org/10.1186/s40337-015-0047-1&#34;&gt;https://doi.org/10.1186/s40337-015-0047-1&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref:5&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:6&#34;&gt;
&lt;p&gt;ZIMBERG, Ioná Zalcman et al. Relação entre apneia obstrutiva do sono e obesidade: uma revisão sobre aspectos endócrinos, metabólicos e nutricionais. RBONE-Revista Brasileira de Obesidade, Nutrição e Emagrecimento, v. 11, n. 64, p. 250-260, 2017.&amp;#160;&lt;a href=&#34;#fnref:6&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref1:6&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:7&#34;&gt;
&lt;p&gt;Tuomilehto, H.; Gylling, H.; Peltonen, M.; Martikainen, T.; Sahlman, J.; Kokkarinen, J.; Randell, J.; Tukiainen, H.; Vanninen, E.; Partinen, M. Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up. Am J Clin Nutr. Vol. 92. Núm. 4. p. 688-96. 2010.&amp;#160;&lt;a href=&#34;#fnref:7&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:8&#34;&gt;
&lt;p&gt;GUSMAO, L. V.; RAMOS, A. C. R.; REMIGIO, G. C. B.; BAIARDI, V. C. S.; GONÇALVES, B. P. Doença Hepática Esteatótica associada à disfunção metabólica. Brazilian Journal of Health Review, [S. l.], v. 7, n. 4, p. e71622 , 2024. DOI: 10.34119/bjhrv7n4-173. Disponível em: &lt;a href=&#34;https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/71622&#34;&gt;https://ojs.brazilianjournals.com.br/ojs/index.php/BJHR/article/view/71622&lt;/a&gt;. Acesso em: 28 sep. 2025.&amp;#160;&lt;a href=&#34;#fnref:8&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>O prescritor inteligente AesclepiusRx</title>
		<link>https://www.aesclepius.com.br/medicina/aesclepiusrx/</link>
		<pubDate>Tue, 06 May 2025 14:46:30 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/medicina/aesclepiusrx/</guid>
		<description>&lt;h1 id=&#34;asclepiusrx&#34;&gt;AsclepiusRx&lt;/h1&gt;
&lt;p&gt;O prescritor padrão de Asclepius!&lt;/p&gt;
&lt;p&gt;Acesse em &lt;a href=&#34;https://aesclepius.com.br/aesclepiusrx&#34;&gt;https://aesclepius.com.br/aesclepiusrx&lt;/a&gt;.&lt;/p&gt;
&lt;h2 id=&#34;sobre&#34;&gt;Sobre&lt;/h2&gt;
&lt;p&gt;O projeto AesclepiusRx oferece uma forma de prescrição de medicações segura, eliminando a necessidade de cálculos por parte do médico.&lt;/p&gt;
&lt;p&gt;O desenvolvimento se baseia na definição de tipos sólidos em Rust, segurança na conversão de unidades e na comparação de valores. Exemplo simples:&lt;/p&gt;
&lt;div class=&#34;highlight&#34;&gt;&lt;pre tabindex=&#34;0&#34; style=&#34;color:#f8f8f2;background-color:#272822;-moz-tab-size:4;-o-tab-size:4;tab-size:4;&#34;&gt;&lt;code class=&#34;language-rust&#34; data-lang=&#34;rust&#34;&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#66d9ef&#34;&gt;pub&lt;/span&gt; &lt;span style=&#34;color:#66d9ef&#34;&gt;struct&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;Idade&lt;/span&gt; {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    tipo: &lt;span style=&#34;color:#a6e22e&#34;&gt;IdadeTipo&lt;/span&gt;,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    valor: &lt;span style=&#34;color:#66d9ef&#34;&gt;i32&lt;/span&gt;,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;}
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#66d9ef&#34;&gt;enum&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;IdadeTipo&lt;/span&gt; {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    Meses,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    Anos,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;}
&lt;/span&gt;&lt;/span&gt;&lt;/code&gt;&lt;/pre&gt;&lt;/div&gt;&lt;p&gt;Exemplo mais complexo:&lt;/p&gt;
&lt;div class=&#34;highlight&#34;&gt;&lt;pre tabindex=&#34;0&#34; style=&#34;color:#f8f8f2;background-color:#272822;-moz-tab-size:4;-o-tab-size:4;tab-size:4;&#34;&gt;&lt;code class=&#34;language-rust&#34; data-lang=&#34;rust&#34;&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#75715e&#34;&gt;#[derive(Clone, Debug, PartialEq, Eq, Copy)]&lt;/span&gt;
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#66d9ef&#34;&gt;pub&lt;/span&gt; &lt;span style=&#34;color:#66d9ef&#34;&gt;enum&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;Volume&lt;/span&gt; {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    Ml(Float),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    L(Float),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    Dl(Float),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;}
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#66d9ef&#34;&gt;impl&lt;/span&gt; Volume {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    &lt;span style=&#34;color:#e6db74&#34;&gt;/// entrega o valor em `mL`
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#e6db74&#34;&gt;&lt;/span&gt;    &lt;span style=&#34;color:#66d9ef&#34;&gt;fn&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;valor&lt;/span&gt;(self) -&amp;gt; &lt;span style=&#34;color:#66d9ef&#34;&gt;f32&lt;/span&gt; {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;        &lt;span style=&#34;color:#66d9ef&#34;&gt;match&lt;/span&gt; self {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::Ml(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt;  valor.&lt;span style=&#34;color:#ae81ff&#34;&gt;0&lt;/span&gt;,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::L(valor) &lt;span style=&#34;color:#f92672&#34;&gt;|&lt;/span&gt; Volume::Dl(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; valor.&lt;span style=&#34;color:#ae81ff&#34;&gt;0&lt;/span&gt; &lt;span style=&#34;color:#f92672&#34;&gt;*&lt;/span&gt; &lt;span style=&#34;color:#ae81ff&#34;&gt;1000.0&lt;/span&gt;,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::&lt;span style=&#34;color:#66d9ef&#34;&gt;DL&lt;/span&gt;(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; valor.&lt;span style=&#34;color:#ae81ff&#34;&gt;0&lt;/span&gt; &lt;span style=&#34;color:#f92672&#34;&gt;*&lt;/span&gt; &lt;span style=&#34;color:#ae81ff&#34;&gt;100.0&lt;/span&gt;,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;        }
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    }
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    &lt;span style=&#34;color:#e6db74&#34;&gt;/// escreve em `&amp;amp;&amp;#39;static str` a unidade do volume
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#e6db74&#34;&gt;&lt;/span&gt;    &lt;span style=&#34;color:#66d9ef&#34;&gt;fn&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;unidade&lt;/span&gt;(self) -&amp;gt; &lt;span style=&#34;color:#66d9ef&#34;&gt;&amp;amp;&lt;/span&gt;&amp;#39;static &lt;span style=&#34;color:#66d9ef&#34;&gt;str&lt;/span&gt; {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;        &lt;span style=&#34;color:#66d9ef&#34;&gt;match&lt;/span&gt; self {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::Ml(_) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; &lt;span style=&#34;color:#e6db74&#34;&gt;&amp;#34;mL&amp;#34;&lt;/span&gt;,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::L(_) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; &lt;span style=&#34;color:#e6db74&#34;&gt;&amp;#34;L&amp;#34;&lt;/span&gt;,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::Dl(_) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; &lt;span style=&#34;color:#e6db74&#34;&gt;&amp;#34;dL&amp;#34;&lt;/span&gt;,
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;        }
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    }
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    &lt;span style=&#34;color:#e6db74&#34;&gt;/// Devolve o tipo `Volume` em `mL`, independente do seu tipo original
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#e6db74&#34;&gt;&lt;/span&gt;    &lt;span style=&#34;color:#66d9ef&#34;&gt;pub&lt;/span&gt; &lt;span style=&#34;color:#66d9ef&#34;&gt;fn&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;normalizar&lt;/span&gt;(&lt;span style=&#34;color:#f92672&#34;&gt;&amp;amp;&lt;/span&gt;self) -&amp;gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;Self&lt;/span&gt; {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;        &lt;span style=&#34;color:#66d9ef&#34;&gt;match&lt;/span&gt; self {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::Ml(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; Volume::Ml(Float(valor.&lt;span style=&#34;color:#ae81ff&#34;&gt;0&lt;/span&gt;)),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::L(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; Volume::Ml(Float(valor.&lt;span style=&#34;color:#ae81ff&#34;&gt;0&lt;/span&gt; &lt;span style=&#34;color:#f92672&#34;&gt;*&lt;/span&gt; &lt;span style=&#34;color:#ae81ff&#34;&gt;1000.0&lt;/span&gt;)),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::Dl(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; Volume::Ml(Float(valor.&lt;span style=&#34;color:#ae81ff&#34;&gt;0&lt;/span&gt; &lt;span style=&#34;color:#f92672&#34;&gt;/&lt;/span&gt; &lt;span style=&#34;color:#ae81ff&#34;&gt;100.0&lt;/span&gt;)),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;        }
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    }
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;}
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#e6db74&#34;&gt;/// Permite uso idiomático do tipo
&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;&lt;span style=&#34;color:#e6db74&#34;&gt;&lt;/span&gt;&lt;span style=&#34;color:#66d9ef&#34;&gt;impl&lt;/span&gt; std::fmt::Display &lt;span style=&#34;color:#66d9ef&#34;&gt;for&lt;/span&gt; Volume {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    &lt;span style=&#34;color:#66d9ef&#34;&gt;fn&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;fmt&lt;/span&gt;(&lt;span style=&#34;color:#f92672&#34;&gt;&amp;amp;&lt;/span&gt;self, f: &lt;span style=&#34;color:#66d9ef&#34;&gt;&amp;amp;&lt;/span&gt;&lt;span style=&#34;color:#a6e22e&#34;&gt;mut&lt;/span&gt; std::fmt::Formatter&lt;span style=&#34;color:#f92672&#34;&gt;&amp;lt;&lt;/span&gt;&amp;#39;_&lt;span style=&#34;color:#f92672&#34;&gt;&amp;gt;&lt;/span&gt;) -&amp;gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;std&lt;/span&gt;::fmt::Result {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;        &lt;span style=&#34;color:#66d9ef&#34;&gt;match&lt;/span&gt; self {
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::Ml(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;write!&lt;/span&gt;(f, &lt;span style=&#34;color:#e6db74&#34;&gt;&amp;#34;{}mL&amp;#34;&lt;/span&gt;, valor),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::L(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;write!&lt;/span&gt;(f, &lt;span style=&#34;color:#e6db74&#34;&gt;&amp;#34;{}L&amp;#34;&lt;/span&gt;, valor),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;            Volume::Dl(valor) &lt;span style=&#34;color:#f92672&#34;&gt;=&amp;gt;&lt;/span&gt; &lt;span style=&#34;color:#a6e22e&#34;&gt;write!&lt;/span&gt;(f, &lt;span style=&#34;color:#e6db74&#34;&gt;&amp;#34;{}dL&amp;#34;&lt;/span&gt;, valor),
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;        }
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;    }
&lt;/span&gt;&lt;/span&gt;&lt;span style=&#34;display:flex;&#34;&gt;&lt;span&gt;}
&lt;/span&gt;&lt;/span&gt;&lt;/code&gt;&lt;/pre&gt;&lt;/div&gt;&lt;p&gt;Note-se a segurança de tipos, o uso de unidades internacionais e o caráter idiomático.&lt;/p&gt;
&lt;h2 id=&#34;desenvolvimento-e-contribuição&#34;&gt;Desenvolvimento e contribuição&lt;/h2&gt;
&lt;p&gt;Se você é desenvolvedor web ou Rust interessado no projeto, entre em contato por &lt;a href=&#34;https://t.me/fatiservae&#34;&gt;Telegram&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Consulte &lt;code&gt;LICENCE.md&lt;/code&gt; e &lt;code&gt;CONTRIBUTING.md&lt;/code&gt; (em breve).&lt;/p&gt;
&lt;h2 id=&#34;aviso-legal&#34;&gt;Aviso legal&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Este software não substitui o julgamento médico sobre a administração, uso, suspensão, recomendação, aplicação, medida, comparação e dispensação de quaisquer drogas ou medicamentos.&lt;/strong&gt;&lt;/p&gt;
</description>
	</item>
	
	<item>
		<title>Linfonodomegalias</title>
		<link>https://www.aesclepius.com.br/linfonodomegalia/</link>
		<pubDate>Wed, 26 Mar 2025 22:53:30 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/linfonodomegalia/</guid>
		<description>&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
1(Linfonodos maiores que 1cm;&lt;br&gt;Quanto maior pior;&lt;br&gt;Acima dos 40 anos;&lt;br&gt;Aderidos ou profundos;&lt;br&gt;Supraclavicular; e&lt;br&gt;Cronicidade ou fatores de risco para neoplasias.) --&gt; 2(Fator explicativo&lt;br&gt;encontrado);
2 --&gt; 3(Tratar doença de base);
1 -- Generalizado --&gt; 5(Mononucleose;&lt;br&gt;Hepatite B;&lt;br&gt;HIV;&lt;br&gt;Dengue;&lt;br&gt;Rubéola;&lt;br&gt;Sífilis;&lt;br&gt;Citomegalovírus;&lt;br&gt;Toxoplasmose; etc);
1 -- Localziado --&gt; 6(Examinar e solicitar imagem&lt;br&gt;do linfonodo e da região a montante&lt;br&gt;que drenam para o grupo);
6 -- Observar&lt;br&gt;2 a 3 semanas --&gt; 7(Biopsar com aspiração&lt;br&gt;por agulha fina&lt;br&gt;caso persista.);
1 -- Forte predisposição&lt;br&gt;a neoplasias --&gt; 8(Biopsar imediatamente.);
&lt;/pre&gt;

</description>
	</item>
	
	<item>
		<title>Testosterona</title>
		<link>https://www.aesclepius.com.br/testosterona/</link>
		<pubDate>Wed, 26 Feb 2025 16:11:43 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/testosterona/</guid>
		<description>&lt;h2 id=&#34;calculadora&#34;&gt;Calculadora&lt;/h2&gt;
&lt;div class=calculadoras&gt;
  &lt;h2&gt;Calculadora de testosterona livre&lt;/h2&gt;
  &lt;label for=albumina&gt;Albumina&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=number id=albumina placeholder=&#34;g/dL&#34;&gt;&lt;/input&gt;
&lt;p&gt;&lt;label for=testosterona&gt;Testosterona&lt;/label&gt;
&lt;br&gt;
&lt;input type=number id=testosterona placeholder=&#34;nmol/L&#34;&gt;&lt;/input&gt;&lt;/p&gt;
&lt;p&gt;&lt;label for=shgb&gt;Globulina ligante a hormônio sexual (SHGB)&lt;/label&gt;
&lt;br&gt;
&lt;input type=number id=shgb placeholder=&#34;nmol/L&#34;&gt;&lt;/input&gt;
&lt;br&gt;
&lt;br&gt;
&lt;button onclick=testo()&gt;Calcular!&lt;/button&gt;
&lt;br&gt;&lt;/p&gt;
  &lt;p id=resultadoTesto&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script&gt;
function testo(){
  let testosterona = document.getElementById(&#34;testosterona&#34;).value;
  let shgb = document.getElementById(&#34;shgb&#34;).value;
  let albumina = document.getElementById(&#34;albumina&#34;).value;

  let freeT = 0.0;

  let kat = 3.6 * 10000;
  let kt = 10 * 100000000;

  a = kat + kt + (kat*kt)*(shgb + albumina - testosterona);

  b = 1 + kt*shgb + kat*albumina - (kat + kt)*testosterona;

  freeT = ((Math.sqrt(2*b*b + 4*a*testosterona) - b)/2*a)*((2.88*1.6*0.003448)/10000000000000);

  console.log(((2.88*1.6*0.003448)/10000000000000));

  if (!freeT == 0 || !isNaN(freeT)) {
    document.getElementById(&#34;resultadoTesto&#34;).innerHTML = &#34;Testosterona livre estimada pela fórmula de Vermeulen em &#34;+freeT.toFixed(2)+&#34;mol/L&#34;;
  } else {
    document.getElementById(&#34;resultadoTesto&#34;).innerHTML = &#34;Verifique valores informados!&#34;;
  }
}
  // Free Testosterone (mol/L) = [-b + sqrt (b 2 +4a x T)]
  // Where:
  // a = kat + kt + (kat x kt) x (SHBG + Albumin – T)
  // b = 1 + kt x SHBG + kat x Albumin – (kat + kt) x T
  // kat = 3.6 x 104 L/mol; kt = 10 x 108 L/mol
  // T = testosterone in nmol/L; SHBG – in nmol/L; Albumin – in mg/dL;
  // Free Testosterone from mol/L to nmol/L, multiply by: 2.88 x 10-13 x 1.6 x 0.003448
&lt;/script&gt;
&lt;br&gt;
&lt;h2 id=&#34;valores-normais&#34;&gt;Valores normais&lt;/h2&gt;
&lt;h3 id=&#34;testosterona-livre&#34;&gt;Testosterona livre&lt;/h3&gt;
&lt;table&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Age&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Adult male &lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Adult female&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;20 – &amp;lt;25&lt;/td&gt;
&lt;td&gt;5.25-20.7&lt;/td&gt;
&lt;td&gt;0.06-1.08&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;25 – &amp;lt;30&lt;/td&gt;
&lt;td&gt;5.05-19.8&lt;/td&gt;
&lt;td&gt;0.06-1.06&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;30 – &amp;lt;35&lt;/td&gt;
&lt;td&gt;4.85-19.0&lt;/td&gt;
&lt;td&gt;0.06-1.03&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;35 – &amp;lt;40&lt;/td&gt;
&lt;td&gt;4.65-18.1&lt;/td&gt;
&lt;td&gt;0.06-1.00&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;40 – &amp;lt;45&lt;/td&gt;
&lt;td&gt;4.46-17.1&lt;/td&gt;
&lt;td&gt;0.06-0.98&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;45 – &amp;lt;50&lt;/td&gt;
&lt;td&gt;4.26-16.4&lt;/td&gt;
&lt;td&gt;0.06-0.95&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;50 – &amp;lt;55&lt;/td&gt;
&lt;td&gt;4.06-15.6&lt;/td&gt;
&lt;td&gt;0.06-0.92&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;55 – &amp;lt;60&lt;/td&gt;
&lt;td&gt;3.87-14.7&lt;/td&gt;
&lt;td&gt;0.06-0.90&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;60 – &amp;lt;65&lt;/td&gt;
&lt;td&gt;3.67-13.9&lt;/td&gt;
&lt;td&gt;0.06-0.87&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;65 – &amp;lt;70&lt;/td&gt;
&lt;td&gt;3.47-13.0&lt;/td&gt;
&lt;td&gt;0.06-0.84&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;70 – &amp;lt;75&lt;/td&gt;
&lt;td&gt;3.28-12.2&lt;/td&gt;
&lt;td&gt;0.06-0.82&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;75 – &amp;lt;80&lt;/td&gt;
&lt;td&gt;3.08-11.3&lt;/td&gt;
&lt;td&gt;0.06-0.79&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;80 – &amp;lt;85&lt;/td&gt;
&lt;td&gt;2.88-10.5&lt;/td&gt;
&lt;td&gt;0.06-0.76&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;85 – &amp;lt;90&lt;/td&gt;
&lt;td&gt;2.69-9.61&lt;/td&gt;
&lt;td&gt;0.06-0.73&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;h3 id=&#34;testosterona-biodisponível&#34;&gt;Testosterona biodisponível&lt;/h3&gt;
&lt;table&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Age&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Adult male&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;20 – &amp;lt;30&lt;/td&gt;
&lt;td&gt;83-257&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;30 – &amp;lt;40&lt;/td&gt;
&lt;td&gt;72-235&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;40 – &amp;lt;50&lt;/td&gt;
&lt;td&gt;61-213&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;50 – &amp;lt;60&lt;/td&gt;
&lt;td&gt;50-190&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;60 – &amp;lt;70&lt;/td&gt;
&lt;td&gt;40-168&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
</description>
	</item>
	
	<item>
		<title>Asma</title>
		<link>https://www.aesclepius.com.br/asma/</link>
		<pubDate>Thu, 20 Feb 2025 09:13:01 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/asma/</guid>
		<description>&lt;p&gt;Este guia simplificado é uma adaptacão das recomendações da Global Strategy for Asthma Management and Prevention (GINA)&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt; e o guia de rotinas assistenciais de pediatria do Hospital Materno-Infantil de Brasília (HMIB)&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;h2 id=&#34;definições&#34;&gt;Definições&lt;/h2&gt;
&lt;p&gt;A primeira sibilância da criança é por definição &lt;strong&gt;bronquiolite viral aguda&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Até os cinco anos de idade, o diagnóstico de asma é difícil. As sibilâncias desta fase da vida são tratadas como nova bronquiolite viral ou episódio de sibilância idiopático. &lt;strong&gt;Como exceção, independente da idade, aceita-se como boa probabilidade pré-teste diagnóstica:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Os sibilos se iniciam por exercício físico, riso, choro, sustos etc;&lt;/li&gt;
&lt;li&gt;Ocorrem na ausência de outros sinais de infecção respiratória;&lt;/li&gt;
&lt;li&gt;Há história de outras atopias como eczema, rinite etc;&lt;/li&gt;
&lt;li&gt;Há história familiar forte, como pais asmáticos, irmão mais velho com diagnóstico precoce fechado; e&lt;/li&gt;
&lt;li&gt;Foi iniciado manejo empírico com corticoide inalatório e/ou broncodilatador por dois ou três meses e houve melhora &lt;strong&gt;indiscutível&lt;/strong&gt; dos episódios.
Fora estes casos, o diagnóstico deve ser reservado para a idade de seis anos incompletos com espirometria e avaliação do pneumologista.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;exacerbação&#34;&gt;Exacerbação&lt;/h2&gt;
&lt;h3 id=&#34;avaliação-da-gravidade&#34;&gt;Avaliação da gravidade&lt;/h3&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Sintomas&lt;/th&gt;
          &lt;th&gt;Leve&lt;/th&gt;
          &lt;th&gt;Severa*&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Alteração no nível de consciência?&lt;/td&gt;
          &lt;td&gt;Não&lt;/td&gt;
          &lt;td&gt;Agitada, confusa ou sonolenta&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Oximetria na chegada&lt;/td&gt;
          &lt;td&gt;&amp;gt; 95%&lt;/td&gt;
          &lt;td&gt;&amp;lt; 92%&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Fala&lt;/td&gt;
          &lt;td&gt;Frases&lt;/td&gt;
          &lt;td&gt;Palavras&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Pulso&lt;/td&gt;
          &lt;td&gt;&amp;lt; 100 bpm&lt;/td&gt;
          &lt;td&gt;&amp;gt; 180 bpm (0-3 anos) &lt;br&gt; &amp;gt; 150 bpm (4-7 anos)&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Frequência respiratória&lt;/td&gt;
          &lt;td&gt;&amp;lt; 40 irpm&lt;/td&gt;
          &lt;td&gt;&amp;gt; 40 irpm&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Cianose central&lt;/td&gt;
          &lt;td&gt;Ausente&lt;/td&gt;
          &lt;td&gt;Presente&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Intensidade dos sibilos&lt;/td&gt;
          &lt;td&gt;Variável&lt;/td&gt;
          &lt;td&gt;Tórax silencioso&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;blockquote&gt;
&lt;p&gt;&lt;strong&gt;&lt;sup&gt;*&lt;/sup&gt; &lt;mark&gt;Exacerbação severa:&lt;/mark&gt;&lt;/strong&gt; basta que qualquer um dos itens da coluna &lt;strong&gt;Severa&lt;/strong&gt; na tabela acima ou &lt;strong&gt;história de exacerbação grave anterior com anafilaxia ou necessidade de UTI/intubação&lt;/strong&gt;.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h3 id=&#34;manejo&#34;&gt;Manejo&lt;/h3&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
1(Leve ou moderada) --&gt; 2(Salbutamol 100mcg: 2 jatos; ou&lt;br&gt;Salbutamol 2.5mcg: nebulização.&lt;br&gt;Repetir a cada 20min na primeira hora.&lt;br&gt;Ajustar oxigênio até saturação de O&lt;sub&gt;2&lt;/sub&gt; de 94-98%.);
8(Grave) -- Iniciar corticoide&lt;br&gt;se ainda não feito --&gt; 5;
2 -- Monitore por 2h!&lt;br&gt;Considere ipratrópio 1 ou 2 jatos --&gt; 3(Recorrência: 2 ou 3 jatos extras de salbutamol por hora;&lt;br&gt;Predinisolona&lt;sup&gt;1&lt;/sup&gt; 2mg/Kg);
3 -- Melhora! --&gt; 4(&lt;b&gt;Alta com&lt;br&gt;orientações&lt;/b&gt;);
3 -- Piora! --&gt; 5(Idade);
5 -- Até 5 anos --&gt; z(Realizar até 6 jatos de salbutamol;&lt;br&gt;Ajuste oxigênio para saturar 94-98%;&lt;br&gt;Brometo de ipratrópio 250mcg nebulizado) --&gt; y(Considere dobrar dose de ipratrópio);
5 -- Acima de 5 anos --&gt; n(Realizar até 10 jatos de salbutamol;&lt;br&gt;Ajuste oxigênio para saturar 93-95%;&lt;br&gt;Brometo de ipratrópio 500mcg nebulizado);
y --&gt; 6(Box ou transferência);
n --&gt; 6;
3 -- Urgência ou&lt;br&gt;Anafilaxia!--&gt; 7(Intubação orotraqueal;&lt;br&gt;Considere epinefrina 0.01mg/kg via intramuscular&lt;br&gt;no vasto lateral da coxa) --&gt; 6;
6 --&gt; 11(Terapia intensiva)
&lt;/pre&gt;

&lt;blockquote&gt;
&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt; &lt;mark&gt;Predinisolona:&lt;/mark&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Via oral&lt;/strong&gt;:
Máximo de 20mg para até dois anos, 30mg para até cinco anos e 40mg se acima de cinco anos. Adultos, 50mg.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Uso intravenoso&lt;/strong&gt;: mesma dose por quilo de metilpredinisolona.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;blockquote&gt;
&lt;p&gt;&lt;sup&gt;*&lt;/sup&gt; &lt;mark&gt;Ipratróprio:&lt;/mark&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;Pode ser feito em jatos durante 1h como alternativa a nebulização, sendo 4 jatos a cada 20min para menores de seis anos e até 8 jatos a cada 20min para maiores.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;blockquote&gt;
&lt;p&gt;&lt;sup&gt;*&lt;/sup&gt; &lt;mark&gt;Epinefrina/adrenalina prática:&lt;/mark&gt;&lt;br&gt;&lt;/p&gt;
&lt;p&gt;0,1ml IM até 10kg;&lt;/p&gt;
&lt;p&gt;0,2ml IM entre 10 a 20kg;&lt;/p&gt;
&lt;p&gt;0,3ml IM acima de 20kg.&lt;/p&gt;
&lt;p&gt;Dose máxima (0,3ml IM)&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h3 id=&#34;alta&#34;&gt;Alta&lt;/h3&gt;
&lt;p&gt;A alta está condicionada ao desmame completo da oxigenoterapia, total independência do paciente para uso da prescrição domiciliar, domínio dos inaladores, ausência de sibilância e melhora radiográfica&lt;sup id=&#34;fnref:3&#34;&gt;&lt;a href=&#34;#fn:3&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;3&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;p&gt;A prescrição de alta deve conter um plano de terapia continuada e um plano de alívio pré-hospitalar.&lt;/p&gt;
&lt;h4 id=&#34;prescrição-de-alta&#34;&gt;Prescrição de alta&lt;/h4&gt;
&lt;p&gt;&lt;strong&gt;Sugestão de corticoide&lt;/strong&gt;: beclometasona aeressól 250mcg/jato, dois jatos a cada 12h.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Sugestão de broncodilatador de curta duração&lt;/strong&gt;: salbutamol 100mcg/jato, dois jatos a cada 20min sempre que necessitar.&lt;/p&gt;
&lt;p&gt;Orientar retorno ao pronto-socorro se não houver melhora.&lt;/p&gt;
&lt;h2 id=&#34;manejo-continuado&#34;&gt;Manejo continuado&lt;/h2&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;2024 GINA Main Report, Global Strategy for Asthma Management and Prevention. Fontana, USA.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;Costa, SUZANA et al. &lt;strong&gt;Rotinas assistenciais da pediatria - Hospital materno-infantil Dr. Antônio Lisboa&lt;/strong&gt;. Brasília-DF. 2022.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:3&#34;&gt;
&lt;p&gt;Caso a radiografia tenha sido feita durante a internação, com indicação ou inadivertida.&amp;#160;&lt;a href=&#34;#fnref:3&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Calculadoras de doses, diluições e preparos</title>
		<link>https://www.aesclepius.com.br/doses-diluicoes-preparos/</link>
		<pubDate>Wed, 29 Jan 2025 15:29:00 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/doses-diluicoes-preparos/</guid>
		<description>&lt;div class=calculadoras&gt;
  &lt;h2&gt;Calculadora diluente&lt;/h2&gt;
  &lt;select id=substancia&gt;
    &lt;option value=glicose&gt;Glicose&lt;/option&gt;
    &lt;option value=sodio&gt;Sódio&lt;/option&gt;
    &lt;option value=potassio&gt;Potássio&lt;/option&gt;
  &lt;/select&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;select id=substancia&gt;
    &lt;option value=perct&gt;Percentual&lt;/option&gt;
    &lt;option value=mEq&gt;Miliequivalente por litro (mEq/L)&lt;/option&gt;
    &lt;option value=mgl&gt;Miligrama por litro (mg/L)&lt;/option&gt;
    &lt;option value=mgml&gt;Miligrama por mililitro (mg/mL)&lt;/option&gt;
    &lt;option value=gl&gt;Grama por litro (g/L)&lt;/option&gt;
    &lt;option value=gml&gt;Grama por mililitro (g/mL)&lt;/option&gt;
  &lt;/select&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;label for=concI&gt;Concentração inicial&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=number id=concI &gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;label for=concF&gt;Concentração desejada&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=number id=concF &gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;label for=volF&gt;Volume desejado&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=number id=volF &gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;button onclick=diluir()&gt;Diluir!&lt;/button&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;p id=resultadoDil&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;br&gt;
&lt;br&gt;
&lt;br&gt;
&lt;div class=calculadoras&gt;
  &lt;h2&gt;Dose por massa corporal diária&lt;br&gt;Drogas diluídas&lt;/h2&gt;
  &lt;br&gt;
  &lt;label for=intervalo&gt;Intervalo entre doses&lt;/label&gt;
  &lt;br&gt;
  &lt;select id=intervalo&gt;
    &lt;option value=4&gt;seis vezes ao dia&lt;/option&gt;
    &lt;option value=6&gt;quatro vezes ao dia&lt;/option&gt;
    &lt;option value=8&gt;&lt;i&gt;ter in die&lt;/i&gt;&lt;/option&gt;
    &lt;option value=12&gt;&lt;i&gt;bis in die&lt;/i&gt;&lt;/option&gt;
    &lt;option value=24&gt;uma vez ao dia&lt;/option&gt;
  &lt;/select&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;label for=massaDose&gt;Massa corporal&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=number id=massaDose placeholder=&#34;Kg&#34;&gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;label for=dose&gt;Dose por Kg desejada&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=number id=dose placeholder=&#34;mg&#34;&gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;label for=apresentacaoQtd&gt;Apresentação&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=number id=apresentacaoQtd placeholder=mg&gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;label for=apresentacaoVol&gt;Volume da apresentação&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=number placeholder=ml id=apresentacaoVol&gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;button onclick=dosar()&gt;Calcular!&lt;/button&gt;
  &lt;br&gt;
  &lt;p id=resultadoDosar&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script src=&#34;../../doses-diluicoes-preparos.js&#34;&gt;&lt;/script&gt;
</description>
	</item>
	
	<item>
		<title>Insuficiência respiratória</title>
		<link>https://www.aesclepius.com.br/insuficiencia-respiratoria/</link>
		<pubDate>Mon, 27 Jan 2025 10:34:02 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/insuficiencia-respiratoria/</guid>
		<description>&lt;h2 id=&#34;definições&#34;&gt;Definições&lt;/h2&gt;
&lt;p&gt;Tipo I ou hipoxêmica: quando a paO2 &amp;lt; 60mmHg.&lt;/p&gt;
&lt;p&gt;A fisiologia respiratória pode ser desarranjada de duas maneiras:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Incapacidade de movimentar a massa de ar necessária para diluição do CO2 na atmosfera e/ou promover a saturação da hemoglobina passante pelo capilar;&lt;/li&gt;
&lt;li&gt;Redução da permeabilidade gasosa da membrana alveolar.
Na prevalência do primeiro mecanismo, diz-se da insuficiência respiratória hipercápnica ou do tipo II. Trata-se, sempre, de hipoventilação. Na prevalência do segundo mecanismo, diz-se da insuficiência respiratória hipoxêmica ou do tipo I.&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;Na insuficiência hipoxêmica, a larga oferta de O2 da atmosfera é impedida de alcançar a corrente sanguínea pelo espessamento da membrana basal alveolar, pelo excesso de líquido no lúmem alveolar, pela inflamação parenquimatosa e edema ou por quaisquer outras causas de diminuição da permeabilidade membranar.&lt;/p&gt;
&lt;p&gt;Na insuficiência hipercápnica, o ar rico em CO2 contido no pulmão ao fim de um ciclo inspiratório e do tempo de troca é impedido de ser diluído na atmosfera pela incapacidade musculatória torácica (seja pela fadiga muscular, seja por comprometimento neurológico, i.e. Guillain Barré),&lt;/p&gt;
&lt;h2 id=&#34;pediatria&#34;&gt;Pediatria&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
    ImpressaoInicial(&#34;Impressão inicial: Consciência, Cor, Respiração&#34;) --&gt; |Algum presente?| SalaEmergencia
    SalaEmergencia(&#34;Sala de emergência: Chamar ajuda, Monitorização&#34;) --&gt; A
    A(&#34;A: Via aérea&lt;br&gt;Checar obstrução&lt;br&gt;Aspirar/remover corpo estranho&lt;br&gt;Posicionar (cheirar ou neutro)&#34;) --&gt; AirwayDecision{Via aérea pérvia?}
    AirwayDecision --&gt;|Sim| B
    AirwayDecision --&gt;|Não| ConsiderarCannula(&#34;Considerar cânula orofaríngea ou intubação&#34;)
    B(&#34;B: Ventilação&lt;br&gt;Verificar trabalho ventilatório eficaz&#34;) --&gt; VentilationDecision{Ventilação eficaz?}
    VentilationDecision --&gt;|Sim| O2(&#34;Oferecer O₂&lt;br&gt;Tratar causa primária&#34;)
    O2 --&gt; C
    VentilationDecision --&gt;|Não| VentilacaoPressao(&#34;Ventilação com pressão positiva + O₂&lt;br&gt;Considerar via aérea avançada&#34;)
    C(&#34;C: Avaliar outras disfunções&lt;br&gt;Circulação, metabólica, neurológica&lt;br&gt;Glicemia, temperatura&lt;br&gt;Lesões de pele, sinais de choque&#34;) --&gt; AirwayCheckAgain{Via aérea mantém pérvia?}
    AirwayCheckAgain --&gt;|Sim| B
    AirwayCheckAgain --&gt;|Não| ConsiderarCannula
&lt;/pre&gt;

&lt;h3 id=&#34;bronquiolite-viral-aguda&#34;&gt;Bronquiolite viral aguda &lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Oxigenoterapia se satO&lt;sub&gt;2&lt;/sub&gt; menor que 90%;&lt;/li&gt;
&lt;li&gt;Nebulização com soluçã́o salina hipertônica de 5 a 7%; e&lt;/li&gt;
&lt;li&gt;Hidratação isotônica (~140mEq/L de Na).&lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Tratado de pediatria 2025.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Vitaminas e suplementos dietéticos</title>
		<link>https://www.aesclepius.com.br/suplementacao/</link>
		<pubDate>Sat, 25 Jan 2025 07:05:38 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/suplementacao/</guid>
		<description>&lt;h2 id=&#34;história&#34;&gt;História&lt;/h2&gt;
&lt;p&gt;Os termos históricos referentes a vitaminas como &lt;em&gt;sistemas de letras&lt;/em&gt;, &lt;em&gt;&amp;ldquo;complexo&amp;rdquo;&lt;/em&gt; e &lt;em&gt;&amp;ldquo;grupos&amp;rdquo;&lt;/em&gt; são um reflexo da forma de descoberta das substâncias essenciais.&lt;/p&gt;
&lt;p&gt;Por exemplo, estudos dietéticos da década de 1930 perceberam a presença do retinol, substância que correspondeu a um prêmio Nobel que foi chamada de vitamina A e, por ser a primeira, foi posta em contraste com a riboflavina, uma outra substância identificada pela sua ausência no consumo de arroz polido, chamada então de vitamina B por ser a segunda.&lt;/p&gt;
&lt;p&gt;Assim, iniciou-se uma tradição de duas classificações das substâncias essenciais por grupos (de descoberta, de fonte alimentar etc) e por solubilidade. Atualmente, &lt;strong&gt;estas classificações não são tão importantes.&lt;/strong&gt;&lt;/p&gt;
&lt;h2 id=&#34;vitaminas&#34;&gt;Vitaminas&lt;/h2&gt;
&lt;h3 id=&#34;lipossolúveis&#34;&gt;Lipossolúveis&lt;/h3&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;&lt;/th&gt;
          &lt;th&gt;Dose diária&lt;/th&gt;
          &lt;th&gt;Horário ideal&lt;/th&gt;
          &lt;th&gt;Justificativa&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Acetato de retinol (A)&lt;/td&gt;
          &lt;td&gt;800mcg&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Calciferol (D)&lt;/td&gt;
          &lt;td&gt;15mcg&lt;sup id=&#34;fnref1:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Acetato DL-alfa-tocoferol (E)&lt;/td&gt;
          &lt;td&gt;15mg&lt;sup id=&#34;fnref2:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h3 id=&#34;hidrossolúveis&#34;&gt;Hidrossolúveis&lt;/h3&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;&lt;/th&gt;
          &lt;th&gt;Dose diária&lt;/th&gt;
          &lt;th&gt;Horário ideal&lt;/th&gt;
          &lt;th&gt;Justificativa&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Riboflavina (B2)&lt;/td&gt;
          &lt;td&gt;1.5mg&lt;/td&gt;
          &lt;td&gt;Durante principal refeição&lt;/td&gt;
          &lt;td&gt;Absorção melhorada pelo processo digestivo ácido.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Vitamina C&lt;/td&gt;
          &lt;td&gt;100mg&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Cianocobalamina (B12)&lt;/td&gt;
          &lt;td&gt;1.5mcg&lt;sup id=&#34;fnref3:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Nicotinamida (B3)&lt;/td&gt;
          &lt;td&gt;16mg&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;oligoelementos&#34;&gt;Oligoelementos&lt;/h2&gt;
&lt;h3 id=&#34;metais&#34;&gt;Metais&lt;/h3&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;&lt;/th&gt;
          &lt;th&gt;Dose diária&lt;/th&gt;
          &lt;th&gt;Horário ideal&lt;/th&gt;
          &lt;th&gt;Justificativa&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Zinco&lt;/td&gt;
          &lt;td&gt;10mg&lt;sup id=&#34;fnref:3&#34;&gt;&lt;a href=&#34;#fn:3&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;3&lt;/a&gt;&lt;/sup&gt;&lt;/td&gt;
          &lt;td&gt;Durante principal refeição, por absorção melhorada pelo processo digestivo ácido.&lt;/td&gt;
          &lt;td&gt;Participa de diversos processos enzimáticos. Melhora produção de testosterona, apesar de impactar pouco na espermatogênese&lt;sup id=&#34;fnref:4&#34;&gt;&lt;a href=&#34;#fn:4&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;4&lt;/a&gt;&lt;/sup&gt;.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;10mg&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h3 id=&#34;ametais&#34;&gt;Ametais&lt;/h3&gt;
&lt;h3 id=&#34;outros-pró-enzimáticos&#34;&gt;Outros pró-enzimáticos&lt;/h3&gt;
&lt;h2 id=&#34;pró-hormônios&#34;&gt;Pró-hormônios&lt;/h2&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Dan Benardot. &lt;strong&gt;Advanced Sports Nutrition 3rd edition&lt;/strong&gt;. Human Kinetics. ISBN: 978-1-4925-9309-6. 2021.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref1:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref2:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref3:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;Formulação do Centrum A-Z, disponível em forma de bula.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:3&#34;&gt;
&lt;p&gt;APA Style. Hall, John E., Hall, Michael E.. (2021). &lt;strong&gt;Guyton and Hall : Textbook of Medical Physiology 14th ed&lt;/strong&gt;. (14th ed.). China: Elsevier.&amp;#160;&lt;a href=&#34;#fnref:3&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:4&#34;&gt;
&lt;p&gt;Liu YL, Zhang MN, Tong GY, Sun SY, Zhu YH, Cao Y, Zhang J, Huang H, Niu B, Li H, Guo QH, Gao Y, Zhu DL, Li XY; Hypogonadotropic Hypogonadism Intervention Study (HHIS) Group. &lt;strong&gt;The effectiveness of zinc supplementation in men with isolated hypogonadotropic hypogonadism&lt;/strong&gt;. Asian J Androl. 2017 May-Jun;19(3):280-285. doi: 10.4103/1008-682X.189621. PMID: 27768007; PMCID: PMC5427781.&amp;#160;&lt;a href=&#34;#fnref:4&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Valores de referência para sinais vitais</title>
		<link>https://www.aesclepius.com.br/sinais-vitais/</link>
		<pubDate>Sat, 14 Dec 2024 11:13:49 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/sinais-vitais/</guid>
		<description>&lt;!-- Frequências Cardíacas Normais --&gt;
&lt;table border=&#34;1&#34;&gt;
  &lt;caption&gt;&lt;strong&gt;Frequências Cardíacas Normais&lt;/strong&gt;&lt;/caption&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th&gt;Idade&lt;/th&gt;
      &lt;th&gt;Vigília (batimentos/min)&lt;/th&gt;
      &lt;th&gt;Sono (batimentos/min)&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td&gt;Neonatos&lt;/td&gt;
      &lt;td&gt;100-205&lt;/td&gt;
      &lt;td&gt;90-160&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Bebê&lt;/td&gt;
      &lt;td&gt;100-180&lt;/td&gt;
      &lt;td&gt;90-160&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;1ª infância&lt;/td&gt;
      &lt;td&gt;98-140&lt;/td&gt;
      &lt;td&gt;80-120&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Idade pré-escolar&lt;/td&gt;
      &lt;td&gt;80-120&lt;/td&gt;
      &lt;td&gt;65-100&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Idade escolar&lt;/td&gt;
      &lt;td&gt;75-118&lt;/td&gt;
      &lt;td&gt;58-90&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Adolescente&lt;/td&gt;
      &lt;td&gt;60-100&lt;/td&gt;
      &lt;td&gt;50-90&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;br&gt;
&lt;br&gt;
&lt;table border=&#34;1&#34;&gt;
  &lt;caption&gt;&lt;strong&gt;Frequências Respiratórias Normais&lt;/strong&gt;&lt;/caption&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th&gt;Idade&lt;/th&gt;
      &lt;th&gt;Frequência (respirações/min)&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td&gt;Bebê&lt;/td&gt;
      &lt;td&gt;30-53&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;1ª infância&lt;/td&gt;
      &lt;td&gt;22-37&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Idade pré-escolar&lt;/td&gt;
      &lt;td&gt;20-28&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Idade escolar&lt;/td&gt;
      &lt;td&gt;18-25&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Adolescente&lt;/td&gt;
      &lt;td&gt;12-20&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;br&gt;
&lt;br&gt;
&lt;table border=&#34;1&#34;&gt;
  &lt;caption&gt;&lt;strong&gt;Pressões Arteriais Normais&lt;/strong&gt;&lt;/caption&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th&gt;Idade&lt;/th&gt;
      &lt;th&gt;Pressão sistólica (mmHg)&lt;/th&gt;
      &lt;th&gt;Pressão diastólica (mmHg)&lt;/th&gt;
      &lt;th&gt;Pressão arterial média (mmHg)&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td&gt;Nascimento (12 h, &amp;lt; 1.000 g)&lt;/td&gt;
      &lt;td&gt;39-59&lt;/td&gt;
      &lt;td&gt;16-36&lt;/td&gt;
      &lt;td&gt;28-42&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Nascimento (12 h, 3 kg)&lt;/td&gt;
      &lt;td&gt;60-76&lt;/td&gt;
      &lt;td&gt;31-45&lt;/td&gt;
      &lt;td&gt;48-57&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Neonato (96 h)&lt;/td&gt;
      &lt;td&gt;67-84&lt;/td&gt;
      &lt;td&gt;35-53&lt;/td&gt;
      &lt;td&gt;45-60&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Bebê (1 a 12 meses)&lt;/td&gt;
      &lt;td&gt;72-104&lt;/td&gt;
      &lt;td&gt;37-56&lt;/td&gt;
      &lt;td&gt;50-62&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;1ª infância (1 a 2 anos)&lt;/td&gt;
      &lt;td&gt;86-106&lt;/td&gt;
      &lt;td&gt;42-63&lt;/td&gt;
      &lt;td&gt;49-62&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Idade pré-escolar (3 a 5 anos)&lt;/td&gt;
      &lt;td&gt;89-112&lt;/td&gt;
      &lt;td&gt;46-72&lt;/td&gt;
      &lt;td&gt;58-69&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Criança em idade escolar (6 a 9 anos)&lt;/td&gt;
      &lt;td&gt;97-115&lt;/td&gt;
      &lt;td&gt;57-76&lt;/td&gt;
      &lt;td&gt;66-72&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Pré-adolescente (10 a 12 anos)&lt;/td&gt;
      &lt;td&gt;102-120&lt;/td&gt;
      &lt;td&gt;61-80&lt;/td&gt;
      &lt;td&gt;71-79&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;Adolescente (12 a 15 anos)&lt;/td&gt;
      &lt;td&gt;110-131&lt;/td&gt;
      &lt;td&gt;64-83&lt;/td&gt;
      &lt;td&gt;73-84&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;hr&gt;
&lt;h2 id=&#34;bibliografia&#34;&gt;Bibliografia&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Mosby. &lt;strong&gt;Children are different. In: Nursing Care of the Critically Ill Child. 3ª ed&lt;/strong&gt;. 2013:1-18, copyright Elsevier.&lt;/li&gt;
&lt;li&gt;Fleming S et al. Lancet. 2011;377(9770):1011-1018.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Síndrome infecciosa sistêmica: sepse</title>
		<link>https://www.aesclepius.com.br/sepse/</link>
		<pubDate>Mon, 09 Dec 2024 21:12:44 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/sepse/</guid>
		<description>&lt;h2 id=&#34;o-que-é-sepse&#34;&gt;O que é sepse&lt;/h2&gt;
&lt;h2 id=&#34;choque-séptico&#34;&gt;Choque séptico&lt;/h2&gt;
&lt;h3 id=&#34;diagnóstico&#34;&gt;Diagnóstico&lt;/h3&gt;
&lt;p&gt;qSOFA = FR &amp;gt;= 22irpm; rebaixamento de consciência; PA &amp;lt;= 100mmHg. Se preencher pelo menos dois, provável sepse.
SIRS = temp &amp;gt; 38.3°C ou &amp;lt; 36°; FC &amp;gt; 90bpm; FR &amp;gt; 20irpm ou paCO2 &amp;lt; 32mmHg; Leucocitose.&lt;/p&gt;
&lt;h4 id=&#34;procalcitonina&#34;&gt;Procalcitonina&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Inferior a 0,5 ng/mL
• Baixo risco de progressão para septicemia.Caso seja clinicamente indicado, considerar nova dosagem depois de 6 a 24 horas.&lt;/li&gt;
&lt;li&gt;De 0,5 a &amp;lt;2,0 ng/mL
• Risco moderado de progressão para septicemia.Recomenda-se repetição do exame depois de 6 a 24 horas.&lt;/li&gt;
&lt;li&gt;De 2,0 a &amp;lt;10,0 ng/mL
• Alto risco de progressão para septicemia.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;abordagem-imediata&#34;&gt;Abordagem imediata&lt;/h3&gt;
&lt;h4 id=&#34;hipovolemia-ou-colapso-distributivo&#34;&gt;Hipovolemia ou colapso distributivo&lt;/h4&gt;
&lt;h4 id=&#34;vasoplegia&#34;&gt;Vasoplegia&lt;/h4&gt;
&lt;h4 id=&#34;inflamação&#34;&gt;Inflamação&lt;/h4&gt;
&lt;h4 id=&#34;infecção&#34;&gt;Infecção&lt;/h4&gt;
&lt;h5 id=&#34;antibioticoterapia&#34;&gt;Antibioticoterapia&lt;/h5&gt;
&lt;h6 id=&#34;biomarcadores-de-tempo-de-terapia&#34;&gt;Biomarcadores de tempo de terapia&lt;/h6&gt;
&lt;ul&gt;
&lt;li&gt;O uso de procalcitonina como controle do tempo de antibioticoterapia na sepse mostrou redução de 0.88 dia no tempo total do tratamento sem afetar mortalidade [1].&lt;/li&gt;
&lt;li&gt;O uso de proteína C reativa como controle não mostrou mudança no tempo de tratamento [1].&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li&gt;Dark P, Hossain A, McAuley DF, et al. &lt;strong&gt;Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial&lt;/strong&gt;. JAMA. Published online December 09, 2024. doi:10.1001/jama.2024.26458&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Pneumopatias</title>
		<link>https://www.aesclepius.com.br/doencas-pulmonares/</link>
		<pubDate>Mon, 09 Dec 2024 10:33:45 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/doencas-pulmonares/</guid>
		<description>&lt;h2 id=&#34;padrões-obstrutivos-versus-restritivos&#34;&gt;Padrões obstrutivos versus restritivos&lt;/h2&gt;


&lt;div class=&#34;scalidraw&#34;&gt;
&lt;svg version=&#34;1.1&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34; viewBox=&#34;0 0 673.6194817433693 515.2782507974655&#34; width=&#34;673.6194817433693&#34; height=&#34;515.2782507974655&#34;&gt;
  &lt;!-- svg-source:excalidraw --&gt;
  
  &lt;defs&gt;
    &lt;style class=&#34;style-fonts&#34;&gt;
      @font-face { font-family: Excalifont; src: url(data:font/woff2;base64,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); }
      @font-face { font-family: Comic Shanns; src: url(data:font/woff2;base64,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); }
      @font-face { font-family: Comic Shanns; src: url(data:font/woff2;base64,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); }
    &lt;/style&gt;
    
  &lt;/defs&gt;
  &lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(82.5 465.27825079746543) rotate(0 2.5 -227.5)&#34;&gt;&lt;path d=&#34;M0.65 0.21 C1.47 -75.83, 5.43 -379.49, 5.98 -455.28 M-0.47 -0.73 C0.19 -76.67, 4.42 -377.91, 5.55 -453.89&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(82.5 465.27825079746543) rotate(0 2.5 -227.5)&#34;&gt;&lt;path d=&#34;M13.76 -430.27 C10.75 -437.71, 6.77 -450.2, 5.55 -453.89 M13.76 -430.27 C11.97 -439.31, 8.42 -447.03, 5.55 -453.89&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(82.5 465.27825079746543) rotate(0 2.5 -227.5)&#34;&gt;&lt;path d=&#34;M-3.34 -430.52 C0.25 -437.95, 2.87 -450.34, 5.55 -453.89 M-3.34 -430.52 C0.68 -439.38, 2.93 -447.01, 5.55 -453.89&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(74.5 465.27825079746543) rotate(0 294 1)&#34;&gt;&lt;path d=&#34;M0.98 -0.28 C98.7 0.1, 489.3 2.21, 586.96 2.48 M0.04 -1.47 C98.06 -1.47, 490.92 -0.02, 589.12 0.6&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(74.5 465.27825079746543) rotate(0 294 1)&#34;&gt;&lt;path d=&#34;M565.59 9.04 C573.44 4.12, 583.02 1.06, 589.12 0.6 M565.59 9.04 C571.27 6.55, 577.62 5.85, 589.12 0.6&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(74.5 465.27825079746543) rotate(0 294 1)&#34;&gt;&lt;path d=&#34;M565.67 -8.06 C573.52 -6.93, 583.08 -3.93, 589.12 0.6 M565.67 -8.06 C571.47 -6.39, 577.8 -2.93, 589.12 0.6&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(138.5 452.27825079746543) rotate(0 -0.5 12.5)&#34;&gt;&lt;path d=&#34;M-0.48 0.22 C-0.8 4.35, -1.48 20.65, -1.5 24.69 M0.28 -0.15 C0.08 4.07, -0.36 21.07, -0.52 25.23&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(125.5 476.27825079746543) rotate(0 9.766666666666652 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;1s&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(70.5 78.27825079746538) rotate(0 16.5 0)&#34;&gt;&lt;path d=&#34;M0.43 -0.53 C6.02 -0.54, 27.53 -0.52, 33.01 -0.37 M-0.01 0.38 C5.55 0.46, 27.06 0.29, 32.59 0.14&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(7.5 58.278250797465375) rotate(270.22442415123083 48 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;4 a 5 (L)&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(78.5 466.27825079746543) rotate(0 236.99059670401653 -212.5)&#34;&gt;&lt;path d=&#34;M0.78 0.82 C26.82 -62.7, 77.34 -310.84, 156.25 -381.93 C235.16 -453.03, 421.39 -418.66, 474.24 -425.75 M-0.27 0.21 C25.59 -63.55, 76.2 -312.65, 155.18 -383.49 C234.16 -454.33, 420.6 -417.62, 473.61 -424.83&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(38.5 249.27825079746538) rotate(0 16.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;~1L&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(62.99894472137089 278.4912068886801) rotate(0 16.5 0)&#34;&gt;&lt;path d=&#34;M0.12 -0.34 C5.59 -0.39, 27.2 0.23, 32.72 0.24 M-0.48 0.67 C5.18 0.7, 28.23 -0.52, 33.8 -0.6&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(137.5 443.27825079746543) rotate(0 1 -83)&#34;&gt;&lt;path d=&#34;M-0.62 0.53 C-0.26 -27.11, 1.98 -138.9, 2.42 -166.62&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2.5&#34; fill=&#34;none&#34; stroke-dasharray=&#34;1.5 8&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(107.5 278.27825079746543) rotate(0 15 0)&#34;&gt;&lt;path d=&#34;M0.19 -0.28 C5.24 -0.31, 25 -0.01, 29.99 0.11&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2.5&#34; fill=&#34;none&#34; stroke-dasharray=&#34;1.5 8&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(252.5 15.278250797465375) rotate(0 157.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Normal ou predito por z-score&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(13.5 269.27825079746543) rotate(0 22 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;FEV1&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(80.5 461.27825079746543) rotate(0 238.5000220049663 -182.5)&#34;&gt;&lt;path d=&#34;M-1.14 -0.87 C31.38 -48.79, 115.66 -226.02, 195.42 -286.57 C275.17 -347.13, 430.47 -350.97, 477.41 -364.21 M0.47 1.29 C32.85 -46.57, 115.39 -224.1, 194.79 -285.34 C274.19 -346.57, 429.77 -352.79, 476.87 -366.13&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(402.5 80.27825079746538) rotate(0 55 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Obstrutivo&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(595.5 142.27825079746538) rotate(0 22.850000381469727 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;ΔCVF&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(81.5 464.27825079746543) rotate(0 236 -105.5)&#34;&gt;&lt;path d=&#34;M0.08 -0.97 C16.75 -27.88, 21.92 -125.65, 100.41 -160.7 C178.91 -195.75, 409.24 -202.84, 471.05 -211.26 M-1.33 1.14 C15.18 -26.22, 20.55 -127.46, 99.68 -162.67 C178.81 -197.87, 411.54 -202.15, 473.45 -210.08&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(560.5 40.278250797465375) rotate(0 14 104.5)&#34; stroke=&#34;none&#34;&gt;&lt;path fill=&#34;var(--fonte)&#34; d=&#34;M -0.34,-1.59 Q -0.34,-1.59 1.94,-1.68 4.23,-1.77 7.93,3.46 11.63,8.71 13.13,25.30 14.64,41.89 16.26,59.68 17.88,77.48 20.39,88.15 22.90,98.83 24.61,104.32 26.32,109.82 27.17,112.14 28.01,114.47 28.40,115.53 28.78,116.60 28.19,118.18 27.60,119.76 26.09,120.56 24.57,121.36 23.47,121.57 22.36,121.78 21.95,130.94 21.53,140.10 21.47,148.59 21.42,157.09 21.63,163.25 21.85,169.42 21.92,175.92 22.00,182.43 21.75,187.48 21.51,192.53 20.45,196.10 19.38,199.67 18.86,201.47 18.33,203.27 17.72,204.55 17.11,205.83 15.74,207.62 14.37,209.41 13.41,209.92 12.44,210.43 10.01,211.62 7.57,212.82 5.58,213.10 3.60,213.38 3.21,213.35 2.82,213.31 2.46,213.16 2.11,213.00 1.82,212.74 1.53,212.47 1.34,212.13 1.15,211.79 1.08,211.41 1.01,211.02 1.07,210.64 1.12,210.25 1.30,209.91 1.48,209.56 1.75,209.28 2.03,209.01 2.38,208.84 2.73,208.67 3.12,208.62 3.51,208.57 3.89,208.65 4.27,208.73 4.61,208.92 4.95,209.11 5.20,209.41 5.46,209.70 5.61,210.06 5.76,210.42 5.79,210.81 5.82,211.19 5.72,211.57 5.63,211.95 5.41,212.28 5.20,212.60 4.89,212.84 4.59,213.09 4.22,213.22 3.85,213.35 3.47,213.36 3.08,213.36 2.70,213.25 2.33,213.13 2.02,212.90 1.70,212.67 1.48,212.35 1.25,212.03 1.14,211.66 1.03,211.28 1.05,210.90 1.06,210.51 1.20,210.14 1.33,209.78 1.58,209.47 1.83,209.17 2.16,208.97 2.49,208.76 2.87,208.67 3.25,208.58 3.25,208.58 3.24,208.58 5.79,208.29 8.33,208.01 10.02,207.10 11.72,206.20 12.93,205.13 14.14,204.07 14.80,203.20 15.46,202.34 16.06,200.60 16.66,198.86 17.63,195.62 18.59,192.38 18.78,187.43 18.96,182.48 18.81,176.02 18.66,169.56 18.34,163.32 18.02,157.09 17.94,148.48 17.86,139.87 18.64,129.90 19.42,119.93 21.12,118.89 22.82,117.85 24.10,116.64 25.39,115.44 24.49,113.06 23.59,110.68 21.81,105.09 20.03,99.51 17.43,88.64 14.83,77.77 13.12,59.97 11.42,42.17 10.06,26.30 8.69,10.44 5.66,5.69 2.62,0.95 1.48,1.50 0.34,2.05 0.11,2.06 -0.10,2.08 -0.32,2.04 -0.54,2.00 -0.74,1.91 -0.95,1.82 -1.13,1.68 -1.30,1.54 -1.44,1.37 -1.58,1.19 -1.67,0.99 -1.76,0.78 -1.80,0.56 -1.85,0.34 -1.83,0.12 -1.82,-0.09 -1.75,-0.31 -1.69,-0.52 -1.57,-0.71 -1.46,-0.90 -1.30,-1.06 -1.14,-1.22 -0.95,-1.34 -0.76,-1.45 -0.55,-1.52 -0.34,-1.59 -0.34,-1.59 L -0.34,-1.59 Z&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(641.4999999999999 146.77825079746538) rotate(0 4.5 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;r&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(598.0999999046326 58.778250797465375) rotate(0 22.850000381469727 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;ΔCVF&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(641.0999999046325 68.27825079746538) rotate(0 4.400000095367432 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;o&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(579.5 43.778250797465375) rotate(0 5.5 24.5)&#34; stroke=&#34;none&#34;&gt;&lt;path fill=&#34;var(--fonte)&#34; d=&#34;M 1.17,-3.12 Q 1.17,-3.12 2.94,-1.67 4.71,-0.23 5.64,4.22 6.56,8.67 7.24,13.11 7.91,17.55 8.86,20.09 9.81,22.62 10.55,23.89 11.29,25.16 11.90,26.07 12.52,26.99 11.87,28.39 11.22,29.78 10.49,31.65 9.77,33.52 9.68,35.55 9.59,37.58 9.74,39.06 9.89,40.53 9.96,42.19 10.04,43.84 10.01,45.21 9.98,46.58 9.55,47.81 9.12,49.04 8.53,50.10 7.93,51.17 6.56,52.04 5.20,52.91 3.33,53.28 1.46,53.65 1.04,53.60 0.61,53.55 0.22,53.37 -0.16,53.18 -0.47,52.88 -0.78,52.59 -0.98,52.20 -1.18,51.82 -1.25,51.40 -1.31,50.97 -1.24,50.55 -1.17,50.12 -0.96,49.74 -0.76,49.36 -0.44,49.07 -0.13,48.77 0.26,48.60 0.65,48.42 1.08,48.38 1.51,48.33 1.93,48.43 2.35,48.52 2.71,48.75 3.08,48.98 3.36,49.31 3.63,49.64 3.79,50.04 3.95,50.44 3.97,50.87 3.99,51.30 3.87,51.71 3.75,52.13 3.50,52.48 3.26,52.84 2.91,53.10 2.57,53.35 2.16,53.49 1.75,53.62 1.32,53.62 0.89,53.62 0.48,53.47 0.07,53.33 -0.26,53.07 -0.60,52.81 -0.84,52.45 -1.08,52.09 -1.19,51.67 -1.30,51.26 -1.27,50.83 -1.25,50.40 -1.08,50.00 -0.92,49.60 -0.64,49.27 -0.36,48.95 0.00,48.73 0.38,48.51 0.80,48.42 1.22,48.33 1.22,48.33 1.22,48.33 2.78,48.07 4.34,47.81 5.06,47.00 5.77,46.19 5.91,45.07 6.05,43.95 6.03,42.37 6.02,40.80 5.95,39.19 5.89,37.59 5.80,35.36 5.70,33.13 6.99,29.91 8.28,26.69 7.62,25.21 6.96,23.73 5.84,20.91 4.73,18.09 3.95,13.69 3.18,9.29 2.65,5.71 2.12,2.13 0.47,1.18 -1.17,0.23 -1.35,0.06 -1.54,-0.09 -1.67,-0.30 -1.81,-0.50 -1.90,-0.73 -1.98,-0.96 -2.01,-1.21 -2.04,-1.45 -2.01,-1.70 -1.98,-1.94 -1.89,-2.17 -1.80,-2.40 -1.66,-2.60 -1.52,-2.81 -1.33,-2.97 -1.15,-3.13 -0.93,-3.24 -0.71,-3.36 -0.47,-3.42 -0.23,-3.47 0.01,-3.47 0.25,-3.47 0.49,-3.41 0.73,-3.35 0.95,-3.23 1.17,-3.12 1.17,-3.12 L 1.17,-3.12 Z&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(352.09999990463257 161.77825079746538) rotate(0 22.850000381469727 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;ΔCVF&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(398.09999990463257 166.27825079746538) rotate(0 4.5 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;r&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(444.09999990463257 162.77825079746538) rotate(0 22.850000381469727 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;ΔCVF&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(490.09999990463257 167.27825079746538) rotate(0 4.400000095367432 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;o&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(418.5 166.27825079746538) rotate(0 8.899999999999977 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;&amp;gt;&amp;gt;&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(400.5 232.77825079746538) rotate(0 55 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Restritivo&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(557.5 455.27825079746543) rotate(0 -1 12)&#34;&gt;&lt;path d=&#34;M0.1 0.21 C-0.17 4.24, -1.07 20.06, -1.5 23.98 M-0.51 -0.16 C-0.82 3.98, -1.53 20.62, -1.67 24.67&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(543.5 480.27825079746543) rotate(0 11 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;5s&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(10 318.77825079746543) rotate(0 27.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;FEV1r&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(10 358.77825079746543) rotate(0 27.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;FEV1o&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(80.5 369.27825079746543) rotate(0 28 -1)&#34;&gt;&lt;path d=&#34;M-0.16 0.17 C9.26 -0.16, 46.99 -0.68, 56.24 -1.16&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2.5&#34; fill=&#34;none&#34; stroke-dasharray=&#34;1.5 8&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(80.5 335.27825079746543) rotate(0 26.5 0)&#34;&gt;&lt;path d=&#34;M0.24 0.84 C8.99 0.71, 43.66 -0.33, 52.33 -0.66&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2.5&#34; fill=&#34;none&#34; stroke-dasharray=&#34;1.5 8&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(66.09485733044914 334.3387324306811) rotate(0 16.5 0)&#34;&gt;&lt;path d=&#34;M-0.31 -0.3 C5.12 -0.46, 27.18 -0.57, 32.68 -0.53 M0.54 0.73 C6.14 0.59, 28.48 -0.07, 33.76 -0.11&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(67.09485733044914 368.3387324306811) rotate(0 16.5 0)&#34;&gt;&lt;path d=&#34;M-0.32 -0.53 C5.18 -0.49, 27.18 -0.1, 32.69 -0.06 M0.52 0.38 C6.23 0.54, 28.48 0.65, 33.77 0.6&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(331.5 321.27825079746543) rotate(0 17 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;0.7&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(308 321.77825079746543) rotate(0 6 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;&amp;lt;&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(244 314.02825079746543) rotate(0 27.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;FEV1o&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(247 337.02825079746543) rotate(0 16.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;CVF&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(282 342.52825079746543) rotate(0 4.400000095367432 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;o&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(399 313.02825079746543) rotate(0 27.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;FEV1r&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(402 336.02825079746543) rotate(0 16.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;CVF&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(437 341.52825079746543) rotate(0 4.5 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;1&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(373 321.77825079746543) rotate(0 5.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.5&#34; font-family=&#34;Comic Shanns, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;≤&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(246.5 337.27825079746543) rotate(0 22.5 -0.5)&#34;&gt;&lt;path d=&#34;M0 0 C7.5 -0.17, 37.5 -0.83, 45 -1 M0 0 C7.5 -0.17, 37.5 -0.83, 45 -1&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(400 335.77825079746543) rotate(0 22.5 -0.5)&#34;&gt;&lt;path d=&#34;M0 0 C7.5 -0.17, 37.5 -0.83, 45 -1 M0 0 C7.5 -0.17, 37.5 -0.83, 45 -1&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;/svg&gt;
&lt;/div&gt;

  &lt;p style=&#34;font-size: 80%&#34;&gt;Tradicionais relações da espirometria.&lt;/p&gt;


</description>
	</item>
	
	<item>
		<title>Traumatismo craniencefálico</title>
		<link>https://www.aesclepius.com.br/traumantismo-cranioencefalcio/</link>
		<pubDate>Tue, 12 Nov 2024 07:55:39 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/traumantismo-cranioencefalcio/</guid>
		<description>&lt;!-- TODO: adicionar artigo The Mantle --&gt;
&lt;h2 id=&#34;conduta-pediátrica1&#34;&gt;Conduta pediátrica[1]&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
a(Glasgow menor que 15&lt;br&gt;Alteração de consciência&lt;br&gt;Fratura palpável) -- sim --&gt; tc(Realizar tomografia);
a --&gt; c(Hematoma subgaleal não frontal&lt;br&gt;Perda de consciência por mais de 5s&lt;br&gt;Mecanismo de trauma grave&lt;sup&gt;1&lt;/sup&gt;&lt;br&gt;Comportamento alterado&lt;sup&gt;2&lt;/sup&gt;);
c -- sim --&gt; obstc(&lt;b&gt;Observação vs TC:&lt;/b&gt;&lt;br&gt;Inexperiência do médico&lt;br&gt;Achados múltiplos ou piora&lt;br&gt;Idade &lt; 3 meses);
obstc -- sim --&gt; k(Considerar TC a depender &lt;br&gt;da disponibilidade do serviço);
c -- não --&gt; n(Descartada&lt;br&gt;necessidade de TC);
n --&gt; fim(observar por 6h);
k --&gt; fim;
obstc -- decidido&lt;br&gt;observar --&gt; fim;
&lt;/pre&gt;

&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;_. &lt;strong&gt;Tratado de pediatria 5 edição.&lt;/strong&gt; Organização Sociedade Brasileira de Pediatria - Barueri - SP. Manole, 2022. ISBN 9786555767476.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Acidente vascular cerebral</title>
		<link>https://www.aesclepius.com.br/avc/</link>
		<pubDate>Mon, 04 Nov 2024 19:34:15 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/avc/</guid>
		<description>&lt;h2 id=&#34;escala-de-house-brackmann&#34;&gt;Escala de House-Brackmann&lt;/h2&gt;
&lt;table&gt;
  &lt;tr&gt;
    &lt;th&gt;Grau&lt;/th&gt;
    &lt;th&gt;Descrição&lt;/th&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;I&lt;/td&gt;
    &lt;td&gt;Normal: Função facial normal em repouso e movimento.&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;II&lt;/td&gt;
    &lt;td&gt;Disfunção leve: Pequena assimetria em repouso, movimentos completos. Pequena sinquinesia.&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;III&lt;/td&gt;
    &lt;td&gt;Disfunção moderada: Assimetria visível em repouso, fechamento completo dos olhos e sorriso. Sinquinesia moderada.&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;IV&lt;/td&gt;
    &lt;td&gt;Disfunção moderadamente severa: Assimetria evidente em repouso, fechamento incompleto dos olhos. Sinquinesia acentuada.&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;V&lt;/td&gt;
    &lt;td&gt;Disfunção severa: Movimentos mínimos do lado afetado. Ausência de fechamento completo dos olhos e sorriso.&lt;/td&gt;
  &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td&gt;VI&lt;/td&gt;
    &lt;td&gt;Paralisia total: Ausência completa de movimentos faciais.&lt;/td&gt;
  &lt;/tr&gt;
&lt;/table&gt;
</description>
	</item>
	
	<item>
		<title>Neonatologia e recém-nascidos</title>
		<link>https://www.aesclepius.com.br/neonatologia/</link>
		<pubDate>Sun, 20 Oct 2024 19:17:11 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/neonatologia/</guid>
		<description>&lt;h2 id=&#34;avaliação-pós-parto&#34;&gt;Avaliação pós-parto&lt;/h2&gt;
&lt;h3 id=&#34;procedimentos-de-urgência&#34;&gt;Procedimentos de urgência&lt;/h3&gt;
&lt;h4 id=&#34;cateterismo-de-cordão&#34;&gt;Cateterismo de cordão&lt;/h4&gt;
&lt;h4 id=&#34;reanimação-perinatal&#34;&gt;Reanimação perinatal&lt;/h4&gt;
&lt;h4 id=&#34;intubação-orotraqueal&#34;&gt;Intubação orotraqueal&lt;/h4&gt;
&lt;h2 id=&#34;icterícia&#34;&gt;Icterícia&lt;/h2&gt;
&lt;h3 id=&#34;causas&#34;&gt;Causas&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Hemólise por IgG anti-D na doença hemolítica perinatal;&lt;/li&gt;
&lt;li&gt;Poliglobulia natural da hipóxia uterina;&lt;/li&gt;
&lt;li&gt;Meia vida curta por ser Hb-fetal;&lt;/li&gt;
&lt;li&gt;Ordenha incorreta ou excessiva de cordão no sentido fetal;&lt;/li&gt;
&lt;li&gt;Baixa captação hepática de bilirrubina, principalmente nos prematuros;&lt;/li&gt;
&lt;li&gt;Baixa concentração de enzimas conjugadoras de bilirrubina direta para eliminação;&lt;/li&gt;
&lt;li&gt;Lenta excreção por atividade intestinal; e&lt;/li&gt;
&lt;li&gt;Alta concentração de beta-glucuronidases que promovem a bilirrubina indireta.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;classificações&#34;&gt;Classificações&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Valores séricos normais até 13.&lt;/li&gt;
&lt;li&gt;Antes de 24h é sempre precoce&lt;sup&gt;1&lt;/sup&gt;.&lt;/li&gt;
&lt;li&gt;A fisiológica é tardia, sempre após 36h.&lt;/li&gt;
&lt;li&gt;É prolongada se dura mais de 15 dias.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;valores&#34;&gt;Valores&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Acima de 5 é visível ao olho nu.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;zonas-de-kramer&#34;&gt;Zonas de Kramer&lt;/h4&gt;
&lt;ol&gt;
&lt;li&gt;4 a 8mg/dL : &lt;strong&gt;cabeça e pescoço&lt;/strong&gt;;&lt;/li&gt;
&lt;li&gt;5 a 12mg/dL : &lt;strong&gt;até cicatriz umbilical&lt;/strong&gt;;&lt;/li&gt;
&lt;li&gt;8 a 16.5mg/dL : &lt;strong&gt;até joelhos&lt;/strong&gt;;&lt;/li&gt;
&lt;li&gt;11 a 18mg/dL : &lt;strong&gt;braços e pernas até punho e tornozelos&lt;/strong&gt;; e&lt;/li&gt;
&lt;li&gt;15mg/dL ou mais : &lt;strong&gt;pés e mãos&lt;/strong&gt;.&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;A partir de zona 3, o valor de bilirrubina pode exceder o fisiológico e está formalmente indicada a investigação com bilirrubinômetro ou sérica direta.&lt;/p&gt;
&lt;h3 id=&#34;fatores-de-risco&#34;&gt;Fatores de risco&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Prematuriedade &amp;ndash; antes das 37 e 39 semanas &amp;ndash; e pós-datismo;&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;encefalopatia-bilirrubínica&#34;&gt;Encefalopatia bilirrubínica&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Déficits neurológicos, principalmente auditivo;&lt;/li&gt;
&lt;li&gt;Quase irreversível.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;bilirrubinômetro&#34;&gt;Bilirrubinômetro&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Alto valor preditivo.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;conduta&#34;&gt;Conduta&lt;/h3&gt;
&lt;p&gt;Investigar sempre que zona de Kramer acima de 3, fatores de risco presentes, antes de 36h ou recém-nascido sem ganho de peso.&lt;/p&gt;
&lt;h4 id=&#34;investigação&#34;&gt;Investigação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Hemograma: bilirrubinemia,&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;O fator Rhesus torna mais grave a incompatibilidade sanguínea porque o antígeno é exclusivamente apresentado nas hemoglobinas, já os antígenos AB estão presentes em outros tecidos, diluindo o efeito e avidez das imunoglobulinas.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/maisel-nomogram.png&#34;&gt;
  &lt;figcaption&gt;Nomograma de Maisel&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;p&gt;Exame físico abdominal para investigar visceromegalias.&lt;/p&gt;
&lt;p&gt;Fototerapia.&lt;/p&gt;
&lt;p&gt;Na ocasião da alta, orientar sobre as zonas 3 em diante de Kramer.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;As referências divergem mas é consenso que antes das 24h se trata de icterícia precoce.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Saúde da mulher</title>
		<link>https://www.aesclepius.com.br/saude-mulher/</link>
		<pubDate>Wed, 02 Oct 2024 18:59:35 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/saude-mulher/</guid>
		<description>&lt;h2 id=&#34;sangramento-anormal&#34;&gt;Sangramento anormal&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Quantidade, duração e frequência.&lt;/li&gt;
&lt;li&gt;40% das mulheres.&lt;/li&gt;
&lt;li&gt;Pólipo: pré e peri menopausa&lt;/li&gt;
&lt;li&gt;Adenomiose: dor, fluxo e grande volume, variando conforme a profundidade do implante da massa.&lt;/li&gt;
&lt;li&gt;Miomas: depende&amp;hellip;submucoso pior.&lt;/li&gt;
&lt;li&gt;Coagulopatias: Von Willebrand. Hemofilias e disfunção plaquetária.&lt;/li&gt;
&lt;li&gt;Ovulação: anovulação, insuficiência do corpo lúteo.&lt;/li&gt;
&lt;li&gt;Endométrio: distúrbio da hemostasia local.&lt;/li&gt;
&lt;li&gt;Iatrogenias: &lt;em&gt;spotting&lt;/em&gt; do ACO, AAS, tamoxifeno e corticoides.&lt;/li&gt;
&lt;li&gt;Causas extras: má formação vascular, hipertrofia de endométrio, istmocele e causas mullerianas.&lt;/li&gt;
&lt;/ul&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Tipo&lt;/th&gt;
          &lt;th&gt;Causa&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Estruturais&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;P&lt;/td&gt;
          &lt;td&gt;Pólipo&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;A&lt;/td&gt;
          &lt;td&gt;Adenomiose&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;L&lt;/td&gt;
          &lt;td&gt;Leiomioma&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;M&lt;/td&gt;
          &lt;td&gt;Malignidade&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Funcionais&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;C&lt;/td&gt;
          &lt;td&gt;Coagulopatia&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;O&lt;/td&gt;
          &lt;td&gt;Ovulação disfuncional&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;E&lt;/td&gt;
          &lt;td&gt;Endométrio hiperplásico&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;I&lt;/td&gt;
          &lt;td&gt;Iatrogenia&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;N&lt;/td&gt;
          &lt;td&gt;Não classificadas&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;amenorreia&#34;&gt;Amenorreia&lt;/h2&gt;
&lt;p&gt;Primária: nunca menstruou.
Secundária: parou de menstruar.&lt;/p&gt;
&lt;p&gt;FEBRASGO: 13 anos sem caracteres secundários&lt;/p&gt;

 
&lt;div class=&#34;carousel&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  



&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt; &lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/ciclo_menstrual.jpg&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;




&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt; &lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/eixo-fem.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior&#34;);
  let proximo = document.getElementById(&#34;proximo&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;h3 id=&#34;primárias&#34;&gt;Primárias&lt;/h3&gt;
&lt;p&gt;Rokitansky: 46XX sem útero.
Morris: 46XY tem testículo com antimulleriano e testosterona sem ação periférica. Regride útero. Gonadectomia.&lt;/p&gt;

 
&lt;div class=&#34;carousel2&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior2&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo2&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  



&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt; &lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/causas.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;




&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt; &lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/gentico.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;




&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt; &lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/flux.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel2 .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel2 .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior2&#34;);
  let proximo = document.getElementById(&#34;proximo2&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;h4 id=&#34;disgenesias-gonadas---fsh-alto-e-falta-caracters-secundários&#34;&gt;Disgenesias gonadas - FSH alto e falta caracters secundários:&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Turner 45X0: atresia de folículos, sem caracters secundários. Má formações. FSH alto. Estradiol baixo. Trata com hormônio.&lt;/li&gt;
&lt;li&gt;Agenesia 46XX: sem estigmas. Trata com hormônio.&lt;/li&gt;
&lt;li&gt;Swyer 46XY: Tem testículo, não produz nada. Acaba tendo útero mas sem a parte do eixo gonadal.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;hipotalâmica&#34;&gt;Hipotalâmica:&lt;/h4&gt;
&lt;p&gt;Deficiência na produção de GnRH. Tratamento é TH.&lt;/p&gt;
&lt;h3 id=&#34;secundárias&#34;&gt;Secundárias&lt;/h3&gt;
&lt;p&gt;3 meses sem menstruar ou menos de 9 por ano.&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Principal síndrome de Asherman - curetagem ou manipulação causa sinéquias/fibroses intrauterinas.&lt;/li&gt;
&lt;li&gt;Ovarianas: SOP, falência prematura e hiperandro&lt;/li&gt;
&lt;li&gt;hiperandrogenismo LH &amp;gt; FSH por Critérios de Rotterdam&lt;/li&gt;
&lt;li&gt;Amenorreia funcional: exercícios físicos, estresse. Cortisol alto, endorfinas altas, baixa leptina etc&amp;hellip;todos inibem GnRH.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Na falência precoce tem que repor hormônios.&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Hipofisária: hiperprolactinemia (aumenta dopamina por causa da prolactina, a dopa derruba GnRH). Uso de medicações, como metoclopramida, antipsicótiocs como risperidona. Se prolactina &amp;gt; 100 procurar o tumor.&lt;/li&gt;
&lt;li&gt;Sheehan: isquemia da hipófise. Tratamento: mineralcorticoides.&lt;/li&gt;
&lt;/ul&gt;

 
&lt;div class=&#34;carousel3&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior3&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo3&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  



&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt; &lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/sec.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel3 .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel3 .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior3&#34;);
  let proximo = document.getElementById(&#34;proximo3&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;ul&gt;
&lt;li&gt;Hipotireoidismo com aumento do TRH e TSH causando hiperprolactinemia e amenorreia.&lt;/li&gt;
&lt;/ul&gt;

 
&lt;div class=&#34;carousel4&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior4&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo4&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  



&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt; &lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/rot.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel4 .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel4 .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior4&#34;);
  let proximo = document.getElementById(&#34;proximo4&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;p&gt;Teste da progesterona é dar progesterona por 15 dias.
Teste do estrogênio e progesterona: é pra menstruar! Se não é Asherman.&lt;/p&gt;
&lt;h2 id=&#34;câncer-cervical&#34;&gt;Câncer cervical&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
A[Demanda espontânea, encaminhamentos etc] -- Encaminhamento para coleta do exame colpocitológico com médico ou enfermeiro --&gt; E[Resultado do exame colhido por médico ou enfermeiro];
E --&gt; |Normal| F[Repetir em 1 ano];
F --&gt; H[Normal];
H --&gt; I[Repetir em no mínimo 1 ano e no máximo em 3 anos];
E --&gt; Y[Alterado &lt;br&gt; Encaminhar para o médico] -- LIAG sem descartar microinvasão ou lesão vegetante, carcinoma epidermoide, adenocarcinoma, adenocarcinoma &lt;i&gt;in situ&lt;/i&gt;] --&gt; Z[Colposcopia em 10 dias!];
Y -- LIAG, AGC, ASC-H --&gt; U[Colposcopia em 30 dias.];
Y -- ASC-US, LSIL --&gt; J[Repetir exame em 6 meses];
J --&gt; K[Novamente&lt;br&gt;LSIL ou ASC-US];
K --&gt; L[Colposcopia em 60 dias];
&lt;/pre&gt;

&lt;p&gt;Legenda:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;ASC-US: Atipias de significado indeterminado em células escamosas, possivelmente não neoplásicas.&lt;/li&gt;
&lt;li&gt;ASC-H: Atipias de significado indeterminado em células escamosas não podendo excluir lesão de alto grau.&lt;/li&gt;
&lt;li&gt;AGC: Atipias de significado indeterminado em células glandulares.&lt;/li&gt;
&lt;li&gt;LSIL: Lesão intraepitelial escamosa de baixo grau.&lt;/li&gt;
&lt;li&gt;LIAG: Lesão intraepitelial de alto grau.&lt;/li&gt;
&lt;li&gt;NIC: Neoplasia intraepitelial cervical.&lt;/li&gt;
&lt;/ul&gt;
</description>
	</item>
	
	<item>
		<title>Testículo e prostatopatias</title>
		<link>https://www.aesclepius.com.br/prostatopatias/</link>
		<pubDate>Fri, 20 Sep 2024 16:31:48 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/prostatopatias/</guid>
		<description>&lt;h2 id=&#34;peso-de-próstata-por-idade&#34;&gt;Peso de próstata por idade&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Idade (anos)&lt;/th&gt;
          &lt;th&gt;Peso (g)&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;40&lt;/td&gt;
          &lt;td&gt;Pequena 20;&lt;br&gt;Grande 50 a 100&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;50&lt;/td&gt;
          &lt;td&gt;38&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;60&lt;/td&gt;
          &lt;td&gt;38&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;70&lt;/td&gt;
          &lt;td&gt;50 a 70&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;80&lt;/td&gt;
          &lt;td&gt;50 a 70&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;rastreio-por-antígeno-prostático-específico-psa&#34;&gt;Rastreio por antígeno prostático específico (PSA)&lt;/h2&gt;
&lt;p&gt;Não há guideline com indicação de rastreio para câncer de próstata.&lt;/p&gt;
&lt;p&gt;Guidelines americanos e europeus recomendam &lt;strong&gt;não&lt;/strong&gt; se solicitar PSA para pacientes com mais de 70-75 anos ou expectativa de vida menor que 15 anos.&lt;/p&gt;
&lt;p&gt;O PSA se eleva por diversos motivos, inclusive o câncer.&lt;/p&gt;
&lt;h2 id=&#34;manejo&#34;&gt;Manejo&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Doxasozina&lt;/strong&gt;: um anti-hipertensivo com ação alfa-bloqueadora com efeitos relaxantes sobre a próstata e da bexiga.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Finasterida&lt;/strong&gt;: inibidor da enzima conversora de testosterona em sua forma di-hidrotestosterona, a 5-alfa-redutase.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;emergências-testiculares&#34;&gt;Emergências testiculares.&lt;/h2&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h3 id=&#34;manejo-1&#34;&gt;Manejo&lt;/h3&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/testiculo-suspensorio.jpg&#34;&gt;
  &lt;figcaption&gt;Exemplo de suspensório caseiro para alívio de dor exacerbada pelo efeito gravitacional&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Sistema único de saúde do Brasil</title>
		<link>https://www.aesclepius.com.br/sus/</link>
		<pubDate>Wed, 11 Sep 2024 17:46:56 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/sus/</guid>
		<description>&lt;table&gt;
    &lt;thead&gt;
        &lt;tr&gt;
            &lt;td&gt;Pilar&lt;/td&gt;
            &lt;td&gt;Itens&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/thead&gt;
    &lt;tbody&gt;
        &lt;tr&gt;&lt;td rowspan=4&gt;Princípios&lt;/td&gt;&lt;/tr&gt;
        &lt;tr&gt;&lt;td&gt;Integralidade&lt;/td&gt;&lt;/tr&gt;
        &lt;tr&gt;&lt;td&gt;Equidade&lt;/td&gt;&lt;/tr&gt;
        &lt;tr&gt;&lt;td&gt;Universalidade&lt;/td&gt;&lt;/tr&gt;
        &lt;tr&gt;&lt;td rowspan=4&gt;Objetivos&lt;/td&gt;&lt;/tr&gt;
        &lt;tr&gt;&lt;td&gt;Identificar os condicionantes e determinantes em saúde&lt;/td&gt;&lt;/tr&gt;
        &lt;tr&gt;&lt;td&gt;Formular políticas públicas&lt;/td&gt;&lt;/tr&gt;
        &lt;tr&gt;&lt;td&gt;Executar a assistência em saúde pública&lt;/td&gt;&lt;/tr&gt;
    &lt;/tbody&gt;
&lt;/table&gt;
</description>
	</item>
	
	<item>
		<title>Risco de sangramento: HAS-BLED</title>
		<link>https://www.aesclepius.com.br/risco-sangramento/</link>
		<pubDate>Sat, 07 Sep 2024 22:25:03 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/risco-sangramento/</guid>
		<description>&lt;p&gt;O escore HAS-BLED foi sugerido em 2010&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt; para pacientes com fibrilação atual na tentativa de predizer o risco de sangramento caso seja iniciada a anticoagulação. Foi validado em 2011&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;div class=calculadoras&gt;
&lt;input type=checkbox&gt;Hipertensão&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox&gt;Função hepática anormal&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox&gt;Função renal anormal&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox&gt;Acidente vascular cerebral&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox&gt;Sangramento anterior ou predisposição a sangramento&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox&gt;INR instável sob anticoagulação&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox&gt;Idade acima de 60 anos&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox&gt;Uso de agentes antiplaquetários concomitantes ou NSAIDS&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox&gt;Abuso de álcool&lt;/input&gt;
&lt;br&gt;
&lt;button onclick=calcularHASBLED()&gt;Calcule!&lt;/button&gt;
&lt;p id=resultadoHASBLED&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script src=../../hasbled.js&gt;&lt;/script&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. &lt;strong&gt;A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey&lt;/strong&gt;. Chest. 2010 Nov;138(5):1093-100. doi: 10.1378/chest.10-0134. Epub 2010 Mar 18. PMID: 20299623.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;Lip GY, Frison L, Halperin JL, Lane DA. &lt;strong&gt;Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs/Alcohol Concomitantly) score&lt;/strong&gt;. J Am Coll Cardiol. 2011 Jan 11;57(2):173-80. doi: 10.1016/j.jacc.2010.09.024. Epub 2010 Nov 24. PMID: 21111555.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Complicações cirúrgicas: Clavien Dindo</title>
		<link>https://www.aesclepius.com.br/clavien-dindo/</link>
		<pubDate>Thu, 05 Sep 2024 21:28:31 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/clavien-dindo/</guid>
		<description>&lt;style&gt;
    td:first-child {
        text-align: center;
    }
&lt;/style&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Gradação&lt;/th&gt;
          &lt;th&gt;Definição&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;I&lt;/td&gt;
          &lt;td&gt;Qualquer desvio do curso pós-operatório normal ou necessidade de analgesia, reposição de eltrólitos, diuréticos ou antipiréticos.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;II&lt;/td&gt;
          &lt;td&gt;Necessidade de medicação adicional ou além da gradação I, inclusive transfusões.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;II&lt;/td&gt;
          &lt;td&gt;Necessidade de intervenção cirúrgica, endoscópica ou radiológica.&lt;br&gt;IIa - sem necessidade de anestesia geral&lt;br&gt;IIb - se necessária anestesia geral&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;IV&lt;/td&gt;
          &lt;td&gt;Complicações com ameaça à vida, ao sistema nervoso central (exceto isquemias transitórias) ou necessidade de cuidados intensivos.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;V&lt;/td&gt;
          &lt;td&gt;Morte do paciente.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;br&gt;
&lt;hr&gt;
&lt;h2 id=&#34;bibliografia&#34;&gt;Bibliografia&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;&lt;a href=&#34;https://www.baus.org.uk/patients/surgical_outcomes/grading_of_surgical_complications.aspx&#34;&gt;https://www.baus.org.uk/patients/surgical_outcomes/grading_of_surgical_complications.aspx&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Nefropatias</title>
		<link>https://www.aesclepius.com.br/doenca-renal/</link>
		<pubDate>Sun, 18 Aug 2024 11:10:23 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/doenca-renal/</guid>
		<description>&lt;h2 id=&#34;calculadora-de-tfg&#34;&gt;Calculadora de TFG&lt;/h2&gt;
&lt;script src=&#34;../../tfg.js&#34;&gt;&lt;/script&gt;
&lt;div class=&#34;calculadoras&#34;&gt;
    &lt;label for=&#34;idade&#34;&gt;Idade:&lt;/label&gt;&lt;br&gt;
    &lt;input type=&#34;number&#34; placeholder=&#34;anos&#34; id=&#34;idade&#34;&gt;&lt;br&gt;&lt;br&gt;
    &lt;label for=&#34;peso&#34;&gt;Massa corporal:&lt;/label&gt;&lt;br&gt;
    &lt;input type=&#34;number&#34; placeholder=&#34;Kg&#34; id=&#34;peso&#34;&gt;&lt;br&gt;&lt;br&gt;
    &lt;label for=&#34;creatinina&#34;&gt;Creatinina sérica:&lt;/label&gt;&lt;br&gt;
    &lt;input type=&#34;number&#34; placeholder=&#34;mg/dL&#34; id=&#34;creatinina&#34;&gt;&lt;br&gt;&lt;br&gt;
    &lt;label for=&#34;altura&#34;&gt;Altura:&lt;/label&gt;&lt;br&gt;
    &lt;input type=&#34;number&#34; placeholder=&#34;cm&#34; id=&#34;altura&#34;&gt;&lt;br&gt;&lt;br&gt;
    &lt;label for=&#34;sexo&#34;&gt;Sexo:&lt;/label&gt;&lt;br&gt;
    &lt;select id=&#34;sexo&#34;&gt;
        &lt;option value=&#34;masculino&#34;&gt;Masculino&lt;/option&gt;
        &lt;option value=&#34;feminino&#34;&gt;Feminino&lt;/option&gt;
    &lt;/select&gt;&lt;br&gt;&lt;br&gt;
    &lt;input id=&#34;negro&#34; type=&#34;checkbox&#34;&gt;Negra(o)&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=&#34;calcularTFG()&#34;&gt;Calcular TFG&lt;/button&gt;&lt;br&gt;&lt;br&gt;
    &lt;p id=&#34;resultado&#34;&gt;&lt;/p&gt;
    &lt;button style=&#34;display: none&#34; id=&#34;botao-copiar&#34;&gt;Copiar Resultado&lt;/button&gt;
&lt;/div&gt;
&lt;br&gt;
&lt;h3 id=&#34;os-cálculos-de-cockcroft-gault1&#34;&gt;Os cálculos de Cockcroft-Gault[1]:&lt;/h3&gt;
&lt;p&gt;$$
m_{ideal} = (50_{homem} \wedge 45.5_{mulher}) + 2.3(alt - 60)
$$&lt;/p&gt;
&lt;p&gt;$$
m_{ajustada} = m_{ideal} + 0.4(m - m_{ideal})
$$&lt;/p&gt;
&lt;p&gt;$$
TFG = \frac{(140 - i) m_{ajustada}}{cr * 72} 0.85_{mulher}
$$&lt;/p&gt;
&lt;p&gt;Onde &lt;strong&gt;&lt;em&gt;m(s)&lt;/em&gt;&lt;/strong&gt; são as massas em Kg, &lt;strong&gt;&lt;em&gt;alt&lt;/em&gt;&lt;/strong&gt; a altura em pol, &lt;strong&gt;&lt;em&gt;i&lt;/em&gt;&lt;/strong&gt; a idade em anos, &lt;strong&gt;&lt;em&gt;cr&lt;/em&gt;&lt;/strong&gt; a creatinina sérica em mg/dL e &lt;strong&gt;&lt;em&gt;0.85&lt;/em&gt;&lt;/strong&gt; uma constante de ajuste aplicado às mulheres, apenas.&lt;/p&gt;
&lt;h3 id=&#34;os-cálculos-do-estudo-modification-of-diet-in-renal-disease-mdrd2&#34;&gt;Os cálculos do estudo Modification of Diet in Renal Disease (MDRD)[2]&lt;/h3&gt;
&lt;p&gt;$$
TFG = 175 \frac {(1.212_{negro} \wedge 1_{demais}) (0.742_{mulher} \wedge 1_{homem})} {cr^{-1.154} i^{-0.203}}
$$&lt;/p&gt;
&lt;p&gt;Onde &lt;strong&gt;&lt;em&gt;cr&lt;/em&gt;&lt;/strong&gt; é a creatinina sérica em mg/dL e &lt;strong&gt;&lt;em&gt;i&lt;/em&gt;&lt;/strong&gt; a idade em anos completos. A constante de 175 era originalmente 185 e foi alterada por uma revisão do estudo[2], por isto o valor estimado por MDRD nesta calculadora é uma faixa de valor.&lt;/p&gt;
&lt;h2 id=&#34;injúria-renal-aguda&#34;&gt;Injúria renal aguda&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Estágio&lt;/th&gt;
          &lt;th&gt;Creatinina Sérica em mg/dL&lt;/th&gt;
          &lt;th&gt;Diurese em mL/kg/h&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;1&lt;/td&gt;
          &lt;td&gt;Aumento de 0.3 em 48h ou 50% acima do basal em 7 dias.&lt;/td&gt;
          &lt;td&gt;&amp;lt; 0,5 por 6-12h&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;2&lt;/td&gt;
          &lt;td&gt;Dobrada em 7 dias&lt;/td&gt;
          &lt;td&gt;&amp;lt; 0,5 por 12-24h&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;3&lt;/td&gt;
          &lt;td&gt;Triplicada a qualquer momento&lt;/td&gt;
          &lt;td&gt;&amp;lt; 0,3 em 24h ou anúria&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;3&lt;/td&gt;
          &lt;td&gt;Acima de 4 a qualquer momento&lt;/td&gt;
          &lt;td&gt;&amp;lt; 0,3 em 24h ou anúria&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;3&lt;/td&gt;
          &lt;td&gt;TFG&amp;lt; 35ml/min/1.73m² em &amp;lt; de 18 anos&lt;/td&gt;
          &lt;td&gt;&amp;lt; 0,3 em 24h ou anúria&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Dialítico&lt;/td&gt;
          &lt;td&gt;Necessidade de diálise&lt;/td&gt;
          &lt;td&gt;Anúria&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;doença-renal-crônica&#34;&gt;Doença renal crônica&lt;/h2&gt;
&lt;style&gt;
    table {
    }
    .low-risk {
      background-color: #99ff99; 
      color: black;
    }
    .moderate-risk {
      background-color: #ffff99; 
      color: black;
    }
    .high-risk {
      background-color: #ffcc99; 
      color: black;
    }
    .very-high-risk {
      color: black;
      background-color: #ff6666; 
    }
  &lt;/style&gt;
&lt;table&gt;
  &lt;thead&gt;
    &lt;tr&gt;
      &lt;th rowspan=&#34;2&#34;&gt;Taxa de filtração&lt;br&gt;em mL/min/1,73m²&lt;/th&gt;
      &lt;th colspan=&#34;3&#34;&gt;Albuminúria por creatinina&lt;br&gt;mg/g&lt;/th&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;th&gt;A1&lt;br&gt;&amp;lt; 30&lt;/th&gt;
      &lt;th&gt;A2&lt;br&gt;30-300&lt;/th&gt;
      &lt;th&gt;A3&lt;br&gt;&amp;gt; 300&lt;/th&gt;
    &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
    &lt;tr&gt;
      &lt;td&gt;&amp;gt; 90&lt;br&gt;Estágio 1&lt;/td&gt;
      &lt;td class=&#34;low-risk&#34;&gt;Baixo risco&lt;/td&gt;
      &lt;td class=&#34;moderate-risk&#34;&gt;Risco moderado&lt;/td&gt;
      &lt;td class=&#34;high-risk&#34;&gt;Alto risco&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;60-89&lt;br&gt;Estágio 2&lt;/td&gt;
      &lt;td class=&#34;low-risk&#34;&gt;Baixo risco&lt;/td&gt;
      &lt;td class=&#34;moderate-risk&#34;&gt;Risco moderado&lt;/td&gt;
      &lt;td class=&#34;high-risk&#34;&gt;Alto risco&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;45-59&lt;br&gt;Estágio 3a&lt;/td&gt;
      &lt;td class=&#34;moderate-risk&#34;&gt;Risco moderado&lt;/td&gt;
      &lt;td class=&#34;high-risk&#34;&gt;Alto risco&lt;/td&gt;
      &lt;td class=&#34;very-high-risk&#34;&gt;Risco muito alto&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;30-44&lt;br&gt;Estágio 3b&lt;/td&gt;
      &lt;td class=&#34;moderate-risk&#34;&gt;Risco moderado&lt;/td&gt;
      &lt;td class=&#34;high-risk&#34;&gt;Alto risco&lt;/td&gt;
      &lt;td class=&#34;very-high-risk&#34;&gt;Risco muito alto&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;15-29&lt;br&gt;Estágio 4&lt;/td&gt;
      &lt;td class=&#34;high-risk&#34;&gt;Alto risco&lt;/td&gt;
      &lt;td class=&#34;very-high-risk&#34;&gt;Risco muito alto&lt;/td&gt;
      &lt;td class=&#34;very-high-risk&#34;&gt;Risco muito alto&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
      &lt;td&gt;&amp;lt; 15&lt;br&gt;Estágio 5&lt;/td&gt;
      &lt;td class=&#34;very-high-risk&#34;&gt;Risco muito alto&lt;/td&gt;
      &lt;td class=&#34;very-high-risk&#34;&gt;Risco muito alto&lt;/td&gt;
      &lt;td class=&#34;very-high-risk&#34;&gt;Risco muito alto&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Cockcroft DW, Gault MH. &lt;strong&gt;Prediction of creatinine clearance from serum creatinine&lt;/strong&gt;. Nephron. 1976;16(1):31-41. doi: 10.1159/000180580. PMID: 1244564.&lt;/li&gt;
&lt;li&gt;LEVEY, Andrew S. et al. &lt;strong&gt;A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation&lt;/strong&gt;. Annals of internal medicine, v. 130, n. 6, p. 461-470, 1999.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Calculadoras fetais</title>
		<link>https://www.aesclepius.com.br/calculadoras-fetais/</link>
		<pubDate>Tue, 30 Jul 2024 17:16:14 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/calculadoras-fetais/</guid>
		<description>&lt;h2 id=&#34;calculadora-de-idade-por-haase&#34;&gt;Calculadora de idade por Haase&lt;/h2&gt;


&lt;div class=&#34;calculadoras&#34;&gt;
    &lt;label for=comprimento&gt;Comprimento do feto ou produto de aborto:&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number placeholder=&#34;cm&#34; id=comprimento&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
&lt;button onclick=calculaIdade()&gt;Calcule&lt;/button&gt;
&lt;p id=resultado&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script&gt;
function fim(idade) {
    if (idade == 0 || idade &lt; 0) {
        resultado.innerHTML = &#34;Verifique o comprimento!&#34;;
    } else if (idade &gt; 9) {
        resultado.innerHTML = &#34;Esta calculadora funciona até 50cm!&#34;;
    } else {
        resultado.innerHTML = &#34;A idade gestacional está em torno dos &#34;+idade.toFixed(1)+&#34; meses de vida&#34;;
    };
};

function calculaIdade(){
    let comprimento = document.getElementById(&#34;comprimento&#34;).value;
    let resultado = document.getElementById(&#34;resultado&#34;);
    let idade = 0;

    if (comprimento &lt;= 25 &amp;&amp; comprimento &gt; 0) { 
        idade = Math.sqrt(comprimento);
        fim(idade);
    } else if (comprimento &gt; 25 &amp;&amp; comprimento &lt; 70) {
        idade = comprimento / 5.6;
        fim(idade);
    } else {
        fim(0);
    }
};
&lt;/script&gt;

</description>
	</item>
	
	<item>
		<title>Distúrbios hidroeletrolíticos</title>
		<link>https://www.aesclepius.com.br/disturbios-hidroeletroliticos/</link>
		<pubDate>Tue, 23 Jul 2024 09:48:22 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/disturbios-hidroeletroliticos/</guid>
		<description>&lt;p&gt;HIPONATREMIA&lt;/p&gt;
&lt;p&gt;Nacl 0,9% 445 ml + 55 ml NacL 20%&lt;/p&gt;
&lt;p&gt;Iniciar reposição de ml com equivalente à 1/4 do peso - ex. 14 ml hora&lt;/p&gt;
&lt;p&gt;Avaliar reposição pelo mec subir 8 mecs por dia&lt;/p&gt;
&lt;p&gt;Repor sódio quando abaixo de 120 ou em hiponatremia se o paciente estiver com sensório alterado&lt;/p&gt;
&lt;h2 id=&#34;magnésio&#34;&gt;Magnésio&lt;/h2&gt;
&lt;h3 id=&#34;hipomagnesemia1&#34;&gt;Hipomagnesemia&lt;sup&gt;1&lt;/sup&gt;&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Abaixo de 1.7mg/dL&lt;/li&gt;
&lt;/ul&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
1(Hipomagnesemia) -- promove secreção de K no ducto coletor por inibição da bomba Na-K-ATPase, aumentando a abertura dos canais medulares de excreção de K --&gt; 2(Hipocalemia);
1 -- suprime a liberação de PTH e diminui a sensibilidade orgânica ao hormônio, com consequente redução da reabsorção orgânica de Ca2+ e aumento de calciúria --&gt; 3(Hipocalcemia);
&lt;/pre&gt;

&lt;h3 id=&#34;hipermagnesemia&#34;&gt;Hipermagnesemia&lt;/h3&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Touyz, Rhian M et al. &lt;strong&gt;Magnesium Disorders.&lt;/strong&gt; The New England journal of medicine vol. 390,21 (2024): 1998-2009. doi:10.1056/NEJMra1510603&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Antibioticoterapia</title>
		<link>https://www.aesclepius.com.br/antibioticos/</link>
		<pubDate>Sat, 06 Jul 2024 15:04:34 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/antibioticos/</guid>
		<description>&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
primeira(&lt;b&gt;Primeira geração&lt;/b&gt;) --&gt; 1(Em 1945 Giussepe&lt;br&gt;descobre &lt;i&gt;Cefalosporium&lt;/i&gt;);
1 --&gt; 2(Cefalotina 1962);
2 -- Necessidade de cobrir gram negativos --&gt; 3(Cefazina e cefalexina);
3 --&gt; segunda(&lt;b&gt;Segunda geração&lt;/b&gt;) -- Necessidade de cobertura&lt;br&gt;de novos gram negativos e&lt;br&gt;descoberta das cefalosporinases&lt;br&gt;e &lt;i&gt;catharralys&lt;/i&gt; e &lt;i&gt;H. influenzae&lt;/i&gt; --&gt; 5(Cefuroxima e cefaclor);
5 --&gt; 6(Também as&lt;br&gt;cefamicinas);
6 --&gt; terceira(&lt;b&gt;Terceira geração&lt;/b&gt;);
terceira --&gt; 7(Ceftriaxona, cefotaxima&lt;br&gt;e ceftazidima);
7 --&gt; obs(Obs: perdeu cobertura&lt;br&gt;de &lt;i&gt;Staphilococcus&lt;/i&gt;&lt;br&gt;ganhou cobertura&lt;br&gt;de &lt;i&gt;p. aureaginosa&lt;/i&gt;);
7 --&gt; quarta(&lt;b&gt;Quarta geração&lt;/b&gt;) --&gt; obs2(Recuperação da cobertura&lt;br&gt;de gram positivos e&lt;br&gt;gram negativos mais amplamente);
quarta --&gt; 8(Cefepima) -- Necessidade de cobrir MARSA&lt;sup&gt;*&lt;/sup&gt; --&gt; quinta(&lt;b&gt;Quinta geração&lt;/b&gt;);
quinta --&gt; 9(Ceftarolina);
&lt;/pre&gt;

</description>
	</item>
	
	<item>
		<title>Bases fisiopatológicas do autismo</title>
		<link>https://www.aesclepius.com.br/autismo/</link>
		<pubDate>Tue, 02 Jul 2024 20:49:45 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/autismo/</guid>
		<description>&lt;h2 id=&#34;epidemiologia&#34;&gt;Epidemiologia&lt;/h2&gt;

 
&lt;div class=&#34;carouselprimeiro&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anteriorprimeiro&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximoprimeiro&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  
    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;Organização Pan-Americana da Saúde&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/autism-opas-epidemiology.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;

    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;TACA - The Autism Community in Action&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/taca-epidemiology-autism.jpg&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carouselprimeiro .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carouselprimeiro .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anteriorprimeiro&#34;);
  let proximo = document.getElementById(&#34;proximoprimeiro&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;p&gt;Estima-se que, em todo o mundo, uma em cada 160 crianças tem transtorno do espectro autista. Essa estimativa representa um valor médio e a prevalência relatada varia substancialmente entre os estudos. Algumas pesquisas bem controladas têm, no entanto, relatado números que são significativamente mais elevados. A prevalência de TEA em muitos países de baixa e média renda é até agora desconhecida[3].&lt;/p&gt;
&lt;p&gt;Com base em estudos epidemiológicos realizados nos últimos 50 anos, a prevalência de TEA parece estar aumentando globalmente. Há muitas explicações possíveis para esse aumento aparente, incluindo aumento da conscientização sobre o tema, a expansão dos critérios diagnósticos, melhores ferramentas de diagnóstico e o aprimoramento das informações reportadas[3].&lt;/p&gt;
&lt;p&gt;O aumento significativo do diagnóstico de TEA é uma discussão ainda sem consenso, uma vez que a difusão dos critérios diagnósticos e das ferramentas melhoraram a sensibilidade de detecção e, de forma oposta, a inclusão de antigos diagnósticos no espectro e o diagnóstico equivocado também contribuiram para as estatísticas.&lt;/p&gt;
&lt;h2 id=&#34;alterações-estruturais-do-autismo&#34;&gt;Alterações estruturais do autismo&lt;/h2&gt;
&lt;p&gt;A primeira observação material com relação as estruturas nervosas no autismo foi a circunferência cefálica. Em média, os autistas tem a cabeça até 20% maior em circunferência e esse dado sempre chamou a atenção da neurologia, por indicar algum tipo de desenvolvimento anormal do SNC.&lt;/p&gt;
&lt;p&gt;Com o avanço do auxílio de imagem não invasiva e do mapeamento da atividade metabólica cerebral, foi possível determinar que o autista tem um maior número de sinapses.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/eliminated-synapses.png&#34;&gt;
  &lt;figcaption&gt;Sinapses eliminadas como processo de desenvolvimento do controle motor fino&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;p&gt;Mais tarde, foi possível conhecer que, na verdade, o neurodesenvolvimento do autista cursa ao contrário do desenvolvimento de pessoas normais. Primeiro, &lt;strong&gt;todo o SNC&lt;/strong&gt; é afetado por excesso de matéria cinzenta e branca, além de claro aumento de densidade das sinapses. Segundo, &lt;strong&gt;o período de neurodesenvolvimento&lt;/strong&gt; é bastante aumentado, chegando a extremos como a amígdala que pode se manter em desenvolvimento exagerado até os 18 anos.&lt;/p&gt;
&lt;h3 id=&#34;teoria-da-mente&#34;&gt;Teoria da mente&lt;/h3&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/mentalizing-areas.png&#34;&gt;
  &lt;figcaption&gt;Áreas envolvidas no processo de mentalização&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;p&gt;A &lt;mark&gt;mentalização&lt;/mark&gt; é um conceito neuropsíquico que pode ser definido como a capacidade de atribuir comportamento, presumir ações e entender atitudes de outrem como se fossem suas. Trata-se de uma excelente capacidade humana que provavelmente contribui bastante para a evolução do homem moderno.&lt;/p&gt;
&lt;p&gt;As redes neurais envolvidas na mentalização, bem como a região temporoparietal conhecida por ser ativada durante o contato visual mútuo e monitorização de movimento está hipoativa apesar de hipertrofiada em pessoas que reprovam o teste de Sally-Anne[1].&lt;/p&gt;

 
&lt;div class=&#34;carousel&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  
    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;Teste de mentalização mais elaborado&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/mentalizing-fishing.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;

    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;Experimento Sally-Anne&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/sally-anne.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior&#34;);
  let proximo = document.getElementById(&#34;proximo&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;h3 id=&#34;os-fatores-de-risco&#34;&gt;Os fatores de risco&lt;/h3&gt;
&lt;p&gt;Propostas teóricas mostram que drogas conhecidas por causar autismo atuam de forma similar a outros mecanismos estressores.&lt;/p&gt;
&lt;h4 id=&#34;ácido-valproico&#34;&gt;Ácido valproico&lt;/h4&gt;
&lt;p&gt;A metilaçao do DNA facilitada pela ação intracelular do ácido valproico está comprovada pelo chamado &lt;em&gt;modelo autista em roedores&lt;/em&gt;[4].&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/valproic-acid-autism.png&#34;&gt;
  &lt;figcaption&gt;&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h4 id=&#34;idade-avançada-dos-pais&#34;&gt;Idade avançada dos pais&lt;/h4&gt;
&lt;p&gt;A idade materna &amp;mdash; e paterna em menor grau &amp;mdash; são fatores de risco bem estabelecidos para o TEA da prole. O mecanismo mais aceito até o momento é a excessiva metilação de diferentes regiões do DNA das células reprodutoras.&lt;/p&gt;
&lt;h3 id=&#34;bases-genéticas&#34;&gt;Bases genéticas&lt;/h3&gt;
&lt;p&gt;Até 15% das pessoas com TEA possuem outra alteração genética, em sua grande maioria doenças ligadas ao desenvolvimento[1]. Algumas destas doenças produzem sintomatologia muito próxima ao autismo.&lt;/p&gt;
&lt;h4 id=&#34;síndrome-de-rett&#34;&gt;Síndrome de Rett&lt;/h4&gt;
&lt;p&gt;A síndrome de Rett com prevalência de 1 em 15mil meninas também é um exemplo de doença genética ligada ao cromossomo X que apresenta claras similaridades com o autismo. Sabidamente, as causas são involuções estruturais causadas por remodelamento de cromatina em decorrência de DNA metilado. Outra marcada característica é a redução na expressão de BDNA [1].&lt;/p&gt;
&lt;p&gt;Como o X afetado é incompatível com a vida, somente mulheres tem a doença na forma mosaica.&lt;/p&gt;
&lt;h4 id=&#34;síndrome-do-x-frágil&#34;&gt;Síndrome do X frágil&lt;/h4&gt;
&lt;p&gt;A síndrome do X frágil é notada pela deficiência intelectual do portador, bastante similar ao autismo na sua forma mais típica, contando com elementos bastante específicos como falta de contato visual, comportamento repetitivos, repulsa ao toque etc. Até 25% dos garotos com X frágil são diagnosticados como autistas[1].&lt;/p&gt;
&lt;h4 id=&#34;smith-magenis&#34;&gt;Smith-Magenis&lt;/h4&gt;
&lt;p&gt;A deleção de um braço do cromossomo 17 causa um déficit intelectual e uma queda na habilidade social marcada, com o diferencial de sonolência peculiar.&lt;/p&gt;
&lt;h4 id=&#34;outras&#34;&gt;Outras&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Síndrome de Down&lt;/strong&gt;: até 7% dos portadores de trissomia do 21 são diagnosticados com TEA.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Prader-Willi&lt;/strong&gt;: prejuízo cortical global, similar ao TEA.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Síndrome de Angelman&lt;/strong&gt;: notada ausência da fala com prejuízo amplo do neurodesenvolvimento.&lt;/li&gt;
&lt;/ul&gt;
&lt;!--
## Outro
- Ilhas de habilidade em 10% dos casos[1].
- 6 a 18 meses.
--&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;KANDEL, Eric et al. &lt;strong&gt;Principles of neuroscience 5th&lt;/strong&gt;. AMGH Editora, 2014.&lt;/li&gt;
&lt;li&gt;CHALIHA, Devahuti et al. &lt;strong&gt;A systematic review of the valproic-acid-induced rodent model of autism&lt;/strong&gt;. Developmental neuroscience, v. 42, n. 1, p. 12-48, 2020.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://www.paho.org/pt/topicos/transtorno-do-espectro-autista&#34;&gt;https://www.paho.org/pt/topicos/transtorno-do-espectro-autista&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;CHOMIAK, Taylor; TURNER, Nathanael; HU, Bin. &lt;strong&gt;What we have learned about autism spectrum disorder from valproic acid&lt;/strong&gt;. Pathology research international, v. 2013, n. 1, p. 712758, 2013.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Pirâmide das necessidades de Maslow</title>
		<link>https://www.aesclepius.com.br/piramide-maslow/</link>
		<pubDate>Sat, 22 Jun 2024 14:47:04 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/piramide-maslow/</guid>
		<description>

&lt;div class=&#34;scalidraw&#34;&gt;
&lt;svg version=&#34;1.1&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34; viewBox=&#34;0 0 462.79616540818483 423.32735091678796&#34; width=&#34;462.79616540818483&#34; height=&#34;423.32735091678796&#34;&gt;
  &lt;!-- svg-source:excalidraw --&gt;
  
  &lt;defs&gt;
    &lt;style class=&#34;style-fonts&#34;&gt;
      @font-face {
        font-family: &#34;Virgil&#34;;
        src: url(&#34;https://excalidraw.com/Virgil.woff2&#34;);
      }
      @font-face {
        font-family: &#34;Cascadia&#34;;
        src: url(&#34;https://excalidraw.com/Cascadia.woff2&#34;);
      }
      @font-face {
        font-family: &#34;Assistant&#34;;
        src: url(&#34;https://excalidraw.com/Assistant-Regular.woff2&#34;);
      }
    &lt;/style&gt;
    
  &lt;/defs&gt;
  &lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(210.25411401690917 10.682728766556835) rotate(0 -98 201)&#34;&gt;&lt;path d=&#34;M0.91 0.8 C-31.76 67.86, -163.67 334.57, -196.49 401.41 M-0.07 0.17 C-32.9 67.47, -164.91 335.49, -197.69 402.64&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(214.14311712271547 11.775097618587324) rotate(0 119.5 199)&#34;&gt;&lt;path d=&#34;M0.56 -0.48 C40.38 65.64, 199.07 331.19, 238.65 397.49 M-0.6 -1.78 C39.05 64.43, 197.35 332.08, 237.52 398.77&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(162.55680703810413 108.15140039910116) rotate(0 54.5 0.9999999999999858)&#34;&gt;&lt;path d=&#34;M0.67 -0.59 C18.84 -0.28, 90.62 2.51, 108.54 3.04 M-0.44 1.72 C17.58 2.22, 88.84 1.65, 107.34 1.46&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(10.70483247023077 410.11174303918096) rotate(0 218.49999999999997 0)&#34;&gt;&lt;path d=&#34;M0.49 0.94 C73.16 1.28, 364.4 1, 437.05 1.01 M-0.7 0.39 C71.72 0.51, 363.45 -0.38, 436.12 -0.58&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(78.70483247023077 282.11174303918096) rotate(0 148.49999999999997 1)&#34;&gt;&lt;path d=&#34;M0.25 0.58 C49.84 0.86, 248.57 2.52, 297.98 2.58 M-1.08 -0.16 C48.4 -0.32, 248.07 0.46, 297.54 0.76&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(115.70483247023077 207.111743039181) rotate(0 108.49999999999997 0.5)&#34;&gt;&lt;path d=&#34;M0.55 1.12 C36.5 1.37, 180.25 1.18, 216.42 1.35 M-0.62 0.66 C35.66 0.55, 182.54 -0.55, 218.83 -0.59&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(44.70483247023077 350.11174303918096) rotate(0 186.49999999999997 0.5)&#34;&gt;&lt;path d=&#34;M0.09 0.33 C62.17 0.44, 311.41 1.62, 373.55 1.8 M-1.32 -0.54 C60.56 -0.26, 310.64 0.13, 372.89 0.09&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(171.42744699420405 47.182728766556835) rotate(0 33.43333435058594 25)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.52&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;  Auto&lt;/text&gt;&lt;text x=&#34;0&#34; y=&#34;42.519999999999996&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(175.38744913043456 86.68272876655683) rotate(0 40.69166564941406 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14.016&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;realização&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(167.25411401690917 132.68272876655683) rotate(0 51.5 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14.016&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Necessidades&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(176.25411401690917 178.68272876655683) rotate(0 40.18333435058594 10)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;14.016&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;16px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Estimação&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(117.25411401690917 233.18272876655683) rotate(0 77.49166870117188 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.52&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Pertencimento e&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(278.25411401690917 232.18272876655683) rotate(0 22.733333587646484 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.52&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Amor&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(174.25411401690917 294.6827287665568) rotate(0 49.55833435058594 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.52&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Segurança&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(105.25411401690917 370.6827287665568) rotate(0 132.5749969482422 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.52&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Necessidades e fisiológicas&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(203.25411401690917 155.68272876655683) rotate(0 11.158333778381348 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.52&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;de&lt;/text&gt;&lt;/g&gt;&lt;/svg&gt;
&lt;/div&gt;


</description>
	</item>
	
	<item>
		<title>Sangramento uterino anormal</title>
		<link>https://www.aesclepius.com.br/sangramento-uterino-anormal/</link>
		<pubDate>Thu, 20 Jun 2024 16:10:46 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/sangramento-uterino-anormal/</guid>
		<description>&lt;h2 id=&#34;conceitos&#34;&gt;Conceitos&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Menorragia:&lt;/strong&gt; 80mL de sangramento em meses intercalados ou por mais de sete dias em um episódio.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Metrorragia:&lt;/strong&gt; o sangramento uterino fora do período menstrual habitual da mulher.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Menometrorragia:&lt;/strong&gt; a concorrência das definições anteriores.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;diagnósticos&#34;&gt;Diagnósticos&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/h2&gt;
&lt;h3 id=&#34;sangramentos-uterinos-anormais&#34;&gt;Sangramentos uterinos anormais&lt;/h3&gt;
&lt;p&gt;Todo e qualquer sangramento fora do habitualmente relatado pela paciente ou que tenha impacto na sua saúde física, emocional ou social.&lt;/p&gt;
&lt;p&gt;Antigamente, havia distinção etiológica hormonal entre os conceitos de sangramento anormal disfuncional e não disfuncional&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt;. Esta distinção caiu por terra em 2017&lt;sup id=&#34;fnref:3&#34;&gt;&lt;a href=&#34;#fn:3&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;3&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;p&gt;Atualmente, a Federação Brasileira de Ginecologia e Obstetrícia recomenda que se use a distinção entre etiologias estruturais e não estruturais.&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;&lt;strong&gt;Categoria&lt;/strong&gt;&lt;/th&gt;
          &lt;th&gt;&lt;strong&gt;Descrição&lt;/strong&gt;&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;&lt;strong&gt;Estruturais (PALM)&lt;/strong&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Pólipo&lt;/td&gt;
          &lt;td&gt;Crescimento benigno no endométrio ou canal endocervical.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Adenomiose&lt;/td&gt;
          &lt;td&gt;Presença de tecido endometrial no miométrio.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Leiomioma&lt;/td&gt;
          &lt;td&gt;Tumores benignos do músculo uterino, também conhecidos como miomas.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Malignidade e Hiperplasia&lt;/td&gt;
          &lt;td&gt;Neoplasias malignas ou crescimento excessivo do endométrio.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;&lt;strong&gt;Não Estruturais (COEIN)&lt;/strong&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Coagulopatia&lt;/td&gt;
          &lt;td&gt;Distúrbios hemorrágicos que afetam a coagulação sanguínea.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Disfunção Ovulatória&lt;/td&gt;
          &lt;td&gt;Irregularidades na ovulação, incluindo anovulação.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Endometrial&lt;/td&gt;
          &lt;td&gt;Anormalidades no funcionamento do endométrio sem lesões estruturais.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Iatrogênica&lt;/td&gt;
          &lt;td&gt;Sangramentos causados por intervenções médicas ou uso de medicamentos.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Não Classificado&lt;/td&gt;
          &lt;td&gt;Outras causas não especificadas nas categorias anteriores.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h4 id=&#34;não-disfuncionais&#34;&gt;Não disfuncionais&lt;/h4&gt;
&lt;p&gt;As causas podem ainda ser orgânicas ou não orgânicas:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Orgânicas:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Endometrite ou espectro clínico de doença inflamatória pélvica;&lt;/li&gt;
&lt;li&gt;Mioma;&lt;/li&gt;
&lt;li&gt;Pólipos;&lt;/li&gt;
&lt;li&gt;Hipertrofia endometrial;&lt;/li&gt;
&lt;li&gt;Metaplasia óssea;&lt;/li&gt;
&lt;li&gt;Adenomiose;&lt;/li&gt;
&lt;li&gt;Coagulopatias; e&lt;/li&gt;
&lt;li&gt;Medicamentosas.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Os sangramentos também podem ser classificados como &lt;strong&gt;ovulatórios&lt;/strong&gt;, principalmente durante a &lt;strong&gt;menacme&lt;/strong&gt; ou &lt;strong&gt;anovulatórios&lt;/strong&gt;, notadamente na puberdade e na perimenopausa.&lt;/p&gt;
&lt;h2 id=&#34;conduta&#34;&gt;Conduta&lt;/h2&gt;
&lt;h3 id=&#34;hormonioterapia&#34;&gt;Hormonioterapia&lt;/h3&gt;
&lt;p&gt;O objetivo da prescrição hormonal no sangramento pode ser seu controle imediato ou sua regulação a longo prazo.&lt;/p&gt;
&lt;p&gt;Os progestágenos tendem a estimular uma estabilidade de endométrio, levando a regulação de sangramento em médio ou longo prazo.&lt;/p&gt;
&lt;p&gt;Os estrógenos causam forte vascularização e reforço da trama endometrial, cessando de forma mais intensa os sangramentos. Porém, &lt;u&gt;quando encerrada a terapia&lt;/u&gt; &lt;strong&gt;há forte descamação uterina&lt;/strong&gt;, retornando o sangramento anterior ou até mais intenso.&lt;/p&gt;
&lt;h4 id=&#34;progestagenioterapia&#34;&gt;Progestagenioterapia&lt;/h4&gt;
&lt;p&gt;Não interrompe o sangramento, apenas regula-o, pois a proliferação endometrial continua. Haverá curetagem farmacológica duas semanas após.&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Fármaco&lt;/th&gt;
          &lt;th&gt;Posologia&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Medroxiprogesterona oral&lt;/td&gt;
          &lt;td&gt;&lt;strong&gt;1)&lt;/strong&gt; 60-120mg/dia até parar sangramento, seguidos de 20-40mg/dia por 3 a 6 semanas.&lt;br&gt;&lt;br&gt;&lt;strong&gt;2)&lt;/strong&gt; 10mg/4h até 80mg ou parada do sangramento seguido de 10mg/6h por 4 dias seguido de 10mg/8h por 3 dias seguido de 10mg/12h por 2 dias por até 2 semanas e manutenção com 10mg/dia.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Megestrol oral&lt;/td&gt;
          &lt;td&gt;&lt;strong&gt;1)&lt;/strong&gt; 80-160mg/dia até parar sangramento seguido de 40-80mg/dia por 3 a 6 semanas.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Noretisterona oral&lt;/td&gt;
          &lt;td&gt;&lt;strong&gt;1)&lt;/strong&gt; 5-10mg/4h até parar sangramento seguido de 5-10mg/6h por 4 dias seguido de 5-10mg/8h por 3 dias seguido de 5-10mg/12h por 2 dias e manutenção com 5-10mg/dia.&lt;br&gt;&lt;br&gt;&lt;strong&gt;2)&lt;/strong&gt; 5-15mg por 2 dias seguidos de 5-10mg por 3 a 6.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h4 id=&#34;estrogenioterapia&#34;&gt;Estrogenioterapia&lt;/h4&gt;
&lt;p&gt;Interrompe bem o sangramento, porém provoca sangramento intenso na retirada.&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Fármaco&lt;/th&gt;
          &lt;th&gt;Posologia&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Etinilestradiol oral&lt;/td&gt;
          &lt;td&gt;&lt;strong&gt;1)&lt;/strong&gt; 90mg/8h por 2 dias e 30mcg/dia por mais 3 a 6 semanas.&lt;br&gt;&lt;br&gt;&lt;strong&gt;2)&lt;/strong&gt; 30mcg/6h até parar sangramento.&lt;br&gt;&lt;br&gt;&lt;strong&gt;3)&lt;/strong&gt; 30mcg/8h por 2 a 7 dias.&lt;br&gt;&lt;br&gt;&lt;strong&gt;4)&lt;/strong&gt; 30mcg/12h por 2 a 7 dias, seguido de 30mcg/dia de manutenção.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h4 id=&#34;outras-medicações&#34;&gt;Outras medicações&lt;/h4&gt;
&lt;p&gt;Atuam de forma global, inibindo as vias anticoaguladoras.&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Fármaco&lt;/th&gt;
          &lt;th&gt;Posologia&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Ácido épsilon-aminocaproico&lt;/td&gt;
          &lt;td&gt;&lt;strong&gt;1)&lt;/strong&gt; 1-2g oral de 8/8h ou de 6/6h por até 7 dias.&lt;br&gt;&lt;br&gt;&lt;strong&gt;2)&lt;/strong&gt; 1g endovenoso de 8/8h ou de 6/6h com no máximo 4g por paciente.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Ácido tranexâmico&lt;/td&gt;
          &lt;td&gt;&lt;strong&gt;1)&lt;/strong&gt; 15 a 25mg/kg de 8/8h por no máximo 7 dias.&lt;br&gt;&lt;br&gt;&lt;strong&gt;2)&lt;/strong&gt; 500mg-1g endovenoso de 50mg/ml de 8/8h por no máximo 3 dias.&lt;br&gt;&lt;br&gt;&lt;strong&gt;3)&lt;/strong&gt; acima de 3 dias sempre oral.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h3 id=&#34;fluxogramas-de-conduta&#34;&gt;Fluxogramas de conduta&lt;/h3&gt;

 
&lt;div class=&#34;carousel&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  
  
  
  
  &lt;div class=&#34;legend&#34;&gt;
    &lt;p&gt; &lt;/p&gt;
  &lt;/div&gt;
  &lt;div class=&#34;slide&#34;&gt;
    
    &lt;img src=&#34;../../pix/medicina/sua-agudo.png&#34;&gt;&lt;/img&gt;
    
  &lt;/div&gt;

  
  
  
  &lt;div class=&#34;legend&#34;&gt;
    &lt;p&gt; &lt;/p&gt;
  &lt;/div&gt;
  &lt;div class=&#34;slide&#34;&gt;
    
    &lt;img src=&#34;../../pix/medicina/sua-cronico.png&#34;&gt;&lt;/img&gt;
    
  &lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior&#34;);
  let proximo = document.getElementById(&#34;proximo&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Machado LV. &lt;strong&gt;Sangramento uterino disfuncional&lt;/strong&gt;. Arq Bras Endocrinol Metab [Internet]. 2001Aug;45(4):375–82. Available from: &lt;a href=&#34;https://doi.org/10.1590/S0004-27302001000400010&#34;&gt;https://doi.org/10.1590/S0004-27302001000400010&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;EstratégiaMed. &lt;strong&gt;Guia prático - GO Descomplica&lt;/strong&gt;. 2022. Brasil.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:3&#34;&gt;
&lt;p&gt;FEBRASGO. &lt;strong&gt;Sangramento uterino anormal&lt;/strong&gt;. Pg 11. São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia. 2017. Série Orientações e Recomendações FEBRASGO. n. 7, 2017. ISSN 2525-6416.&amp;#160;&lt;a href=&#34;#fnref:3&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Adicção: os impactos de diversas drogas</title>
		<link>https://www.aesclepius.com.br/adiccao/</link>
		<pubDate>Mon, 17 Jun 2024 23:37:33 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/adiccao/</guid>
		<description>

&lt;div class=&#34;scalidraw&#34;&gt;
&lt;svg width=&#34;900&#34; height=&#34;900&#34; viewBox=&#34;-450 -405 900 900&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34; xmlns:xlink=&#34;http://www.w3.org/1999/xlink&#34; backgroun&gt;
&lt;marker id=&#34;dotR&#34; viewBox=&#34;-1 -1 2 2&#34; markerWidth=&#34;3&#34; markerHeight=&#34;3&#34;&gt;&lt;circle r=&#34;1&#34; fill=&#34;#F00&#34;/&gt;&lt;/marker&gt;
&lt;marker id=&#34;dotG&#34; viewBox=&#34;-1 -1 2 2&#34; markerWidth=&#34;3&#34; markerHeight=&#34;3&#34;&gt;&lt;circle r=&#34;1&#34; fill=&#34;#008000&#34;/&gt;&lt;/marker&gt;
&lt;marker id=&#34;dotB&#34; viewBox=&#34;-1 -1 2 2&#34; markerWidth=&#34;3&#34; markerHeight=&#34;3&#34;&gt;&lt;circle r=&#34;1&#34; fill=&#34;#00F&#34;/&gt;&lt;/marker&gt;
&lt;rect x=&#34;-450&#34; y=&#34;-405&#34; width=&#34;900&#34; height=&#34;900&#34; fill=&#34;none&#34;/&gt;
&lt;g fill=&#34;none&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1.25&#34;&gt;
&lt;circle r=&#34;315&#34; fill=&#34;none&#34;/&gt;
&lt;rect x=&#34;-114.38&#34; y=&#34;397.9&#34; width=&#34;180&#34; height=&#34;86.2&#34; stroke-linejoin=&#34;round&#34;/&gt;
&lt;g stroke-width=&#34;.63&#34;&gt;
&lt;path id=&#34;radial&#34; d=&#34;M-315 0h630M0-315v630&#34;/&gt;
&lt;g id=&#34;radial2&#34;&gt;
&lt;use xlink:href=&#34;#radial&#34; transform=&#34;rotate(18)&#34;/&gt;
&lt;use xlink:href=&#34;#radial&#34; transform=&#34;rotate(36)&#34;/&gt;
&lt;/g&gt;
&lt;use xlink:href=&#34;#radial2&#34; transform=&#34;rotate(36)&#34;/&gt;
&lt;circle r=&#34;52.5&#34;/&gt;
&lt;circle r=&#34;105&#34;/&gt;
&lt;circle r=&#34;157.5&#34;/&gt;
&lt;circle r=&#34;210&#34;/&gt;
&lt;circle r=&#34;262.5&#34;/&gt;
&lt;/g&gt;
&lt;g stroke-width=&#34;1.9&#34;&gt;
&lt;g stroke=&#34;#008000&#34; marker-start=&#34;url(#dotG)&#34;&gt;
&lt;polygon points=&#34;266.7,0 216.7,-70.41 169.89,-123.43 115.41,-158.85 71.71,-220.69 0,-177.45 -53.54,-164.77 -92.58,-127.42 -120.62,-87.64 -148.79,-48.35 -157.5,0 -151.79,49.32 -90.04,65.42 -81.47,112.13 -31.47,96.87 0,118.65 42.18,129.82 67.27,92.59 82.4,59.87 84.88,27.58&#34; marker-mid=&#34;url(#dotG)&#34;/&gt;
&lt;path d=&#34;M-101.78 412.25h25.2&#34; marker-end=&#34;url(#dotG)&#34;/&gt;
&lt;/g&gt;
&lt;g stroke=&#34;#F00&#34; marker-start=&#34;url(#dotR)&#34;&gt;
&lt;polygon points=&#34;315,0 238.67,-77.55 170.74,-124.05 128.37,-176.69 62.62,-192.73 0,-161.7 -59.38,-182.75 -103.07,-141.86 -187.73,-136.4 -163.77,-53.21 -158.55,0 -100.86,32.77 -110.43,80.23 -75.91,104.48 -40.56,124.83 0,92.4 38.61,118.83 69.74,95.99 73.9,53.69 103.86,33.74&#34; marker-mid=&#34;url(#dotR)&#34;/&gt;
&lt;path d=&#34;M-101.78 439.19h25.2&#34; marker-end=&#34;url(#dotR)&#34;/&gt;
&lt;/g&gt;
&lt;g stroke=&#34;#00F&#34; marker-start=&#34;url(#dotB)&#34;&gt;
&lt;polygon points=&#34;291.9,0 232.68,-75.6 189.43,-137.63 114.79,-158 45.43,-139.81 0,-210 -52.89,-162.77 -111.71,-153.75 -105.33,-76.53 -159.78,-51.91 -103.95,0 -127.82,41.53 -122.32,88.87 -69.74,95.99 -42.83,131.82 0,152.25 27.9,85.88 64.8,89.19 79,57.4 49.93,16.22&#34; marker-mid=&#34;url(#dotB)&#34;/&gt;
&lt;path d=&#34;M-101.78 466.13h25.2&#34; marker-end=&#34;url(#dotB)&#34;/&gt;
&lt;/g&gt;
&lt;/g&gt;
&lt;/g&gt;
&lt;g font-family=&#34;fira Sans&#34; font-size=&#34;15&#34; stroke=&#34;var(--fonte)&#34; fill=&#34;var(--fonte)&#34;&gt;
&lt;text x=&#34;56&#34; y=&#34;-4&#34;&gt;0.5&lt;/text&gt;
&lt;text x=&#34;108.2&#34; y=&#34;-10.8&#34;&gt;1.0&lt;/text&gt;
&lt;text x=&#34;160.4&#34; y=&#34;-17.6&#34;&gt;1.5&lt;/text&gt;
&lt;text x=&#34;212.6&#34; y=&#34;-24.4&#34;&gt;2.0&lt;/text&gt;
&lt;text x=&#34;264.8&#34; y=&#34;-31.2&#34;&gt;2.5&lt;/text&gt;
&lt;text x=&#34;317&#34; y=&#34;-38&#34;&gt;3.0 (score médio)&lt;/text&gt;
&lt;text x=&#34;-56&#34; y=&#34;419&#34;&gt;Dano social&lt;/text&gt;
&lt;text x=&#34;-56&#34; y=&#34;445.94&#34;&gt;Dependência&lt;/text&gt;
&lt;text x=&#34;-56&#34; y=&#34;472.88&#34;&gt;Dano físico&lt;/text&gt;
&lt;text x=&#34;107&#34; y=&#34;-323&#34;&gt;Álcool&lt;/text&gt;
&lt;text x=&#34;203&#34; y=&#34;-275&#34;&gt;Metadona de rua&lt;/text&gt;
&lt;text x=&#34;280&#34; y=&#34;-198&#34;&gt;Barbitúricos&lt;/text&gt;
&lt;text x=&#34;330&#34; y=&#34;-100&#34;&gt;Cocaína&lt;/text&gt;
&lt;text x=&#34;346&#34; y=&#34;6&#34;&gt;Heroína&lt;/text&gt;
&lt;text x=&#34;330&#34; y=&#34;112&#34;&gt;Khat&lt;/text&gt;
&lt;text x=&#34;280&#34; y=&#34;207&#34;&gt;Nitritos alquilados&lt;/text&gt;
&lt;text x=&#34;203&#34; y=&#34;284&#34;&gt;Ecstasy&lt;/text&gt;
&lt;text x=&#34;107&#34; y=&#34;335&#34;&gt;GHB&lt;/text&gt;
&lt;g text-anchor=&#34;end&#34;&gt;
&lt;text x=&#34;-110&#34; y=&#34;-325&#34;&gt;Benzodiazepínicos&lt;/text&gt;
&lt;text x=&#34;-206&#34; y=&#34;-276&#34;&gt;Anfetaminas&lt;/text&gt;
&lt;text x=&#34;-282&#34; y=&#34;-198&#34;&gt;Tabaco&lt;/text&gt;
&lt;text x=&#34;-333&#34; y=&#34;-103&#34;&gt;Buprenorfina&lt;/text&gt;
&lt;text x=&#34;-348&#34; y=&#34;6&#34;&gt;Cannabis&lt;/text&gt;
&lt;text x=&#34;-330&#34; y=&#34;112&#34;&gt;Solventes&lt;/text&gt;
&lt;text x=&#34;-282&#34; y=&#34;210&#34;&gt;4-MTA&lt;/text&gt;
&lt;text x=&#34;-205&#34; y=&#34;284&#34;&gt;LSD&lt;/text&gt;
&lt;text x=&#34;-110&#34; y=&#34;335&#34;&gt;Metilfenidato&lt;/text&gt;
&lt;/g&gt;
&lt;g text-anchor=&#34;middle&#34;&gt;
&lt;text y=&#34;-340&#34;&gt;Cetamina&lt;/text&gt;
&lt;text y=&#34;353&#34;&gt;Esteroides anabolizantes&lt;/text&gt;
&lt;/g&gt;
&lt;/g&gt;
&lt;/svg&gt;

&lt;/div&gt;


&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Nutt, David, Leslie A King, William Saulsbury, Colin Blakemore. &lt;strong&gt;Development of a rational scale to assess the harm of drugs of potential misuse&lt;/strong&gt;. The Lancet 2007; 369:1047-1053. PMID:17382831.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Documento em papel timbrado</title>
		<link>https://www.aesclepius.com.br/receituario/</link>
		<pubDate>Wed, 12 Jun 2024 19:15:57 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/receituario/</guid>
		<description>&lt;p&gt;Tendo em vista a necessidade de escrever em papel timbrado em diversas situações do meu quotidiano, criei esta página como facilidade. O usuário se responsabiliza pela criação dos documentos e sua autenticidade depende de assinatura física.&lt;/p&gt;


&lt;style&gt;
/* styles.css */
.rodape {
}
.documento {
}
.container {
  width: 80%;
  max-width: 800px;
  border: 1px solid #ccc;
  padding: 20px;
  box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
}

textarea {
  width: 60vw ; 
  height: 200px; 
  padding: 10px;
  border: 1px solid #ccc;
  border-radius: 4px;
  resize: vertical; 
  margin-bottom: 20px;
}
#titulo {
  width: 60vw;
  height: 10px;
}
@media only screen and (max-width: 800px){
  textarea, #titulo {
    width: 80vw;
  }
}

/*
body {
  font-family: Arial, sans-serif;
  margin: 0;
  padding: 0;
  background-color: #f4f4f9;
  display: flex;
  justify-content: center;
  align-items: center;
  min-height: 100vh;
}
.cabecalho{
  display: flex;
  align-items: center;
  justify-content: space-between;
  padding-bottom: 10px;
  margin-bottom: 20px;
}
#titulo {
  width: 65vw;
}

*/
.logo {
  width: 100px;
  height: auto;
}

.title {
  flex-grow: 1;
  text-align: center;
  font-size: 24px;
  font-weight: bold;
}

.content {
  padding: 10px 0;
  margin-bottom: 20px;
}

.footer {
  display: flex;
  align-items: center;
  justify-content: space-between;
  border-top: 1px solid #ccc;
  padding-top: 10px;
}

.date-field {
  width: 20%;
  text-align: left;
}
.date-field.input,
.date-field.select,
.date-field p {
  margin: 0px;
  padding: 0px;
}

.signature-field {
  width: 60%;
  text-align: right;
}
&lt;/style&gt;
&lt;div class=documento&gt;
    &lt;select id=logoEsq&gt;
        &lt;option value=&#34;&#34;&gt;Logo à esquerda&lt;/option&gt;
        &lt;option value=&#34;sec-saude-novo&#34;&gt;Secretaria de Sáude DF novo&lt;/option&gt;
        &lt;option value=&#34;brasao-gdf&#34;&gt;Brasão do GDF&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;select id=logoDir&gt;
        &lt;option value=&#34;&#34;&gt;Logo à direita&lt;/option&gt;
        &lt;option value=&#34;sec-saude-novo&#34;&gt;Secretaria de Sáude DF novo&lt;/option&gt;
        &lt;option value=&#34;brasao-gdf&#34;&gt;Brasão do GDF&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;div class=&#34;cabecalho&#34;&gt;
        &lt;textarea id=&#34;titulo&#34; rows=&#34;1&#34; cols=&#34;50&#34; placeholder=&#34;Título&#34;&gt;&lt;/textarea&gt;
        &lt;textarea id=&#34;cabecalho&#34; rows=&#34;10&#34; cols=&#34;50&#34; placeholder=&#34;Um cabeçalho centralizado
Pode conter várias linhas
Que centralizam automaticamente&#34;&gt;&lt;/textarea&gt;
    &lt;/div&gt;
    &lt;div class=&#34;content&#34;&gt;
        &lt;textarea id=&#34;corpo&#34; rows=&#34;10&#34; cols=&#34;50&#34; placeholder=&#34;Corpo do texto...&#34;&gt;&lt;/textarea&gt;
    &lt;/div&gt;
    &lt;div class=rodape&gt;
            &lt;select id=&#34;dia&#34; required&gt;
                &lt;option value=&#34;1&#34;&gt;1&lt;/option&gt;
                &lt;option value=&#34;2&#34;&gt;2&lt;/option&gt;
                &lt;option value=&#34;3&#34;&gt;3&lt;/option&gt;
                &lt;option value=&#34;4&#34;&gt;4&lt;/option&gt;
                &lt;option value=&#34;5&#34;&gt;5&lt;/option&gt;
                &lt;option value=&#34;6&#34;&gt;6&lt;/option&gt;
                &lt;option value=&#34;7&#34;&gt;7&lt;/option&gt;
                &lt;option value=&#34;8&#34;&gt;8&lt;/option&gt;
                &lt;option value=&#34;9&#34;&gt;9&lt;/option&gt;
                &lt;option value=&#34;10&#34;&gt;10&lt;/option&gt;
                &lt;option value=&#34;11&#34;&gt;11&lt;/option&gt;
                &lt;option value=&#34;12&#34;&gt;12&lt;/option&gt;
                &lt;option value=&#34;13&#34;&gt;13&lt;/option&gt;
                &lt;option value=&#34;14&#34;&gt;14&lt;/option&gt;
                &lt;option value=&#34;15&#34;&gt;15&lt;/option&gt;
                &lt;option value=&#34;16&#34;&gt;16&lt;/option&gt;
                &lt;option value=&#34;17&#34;&gt;17&lt;/option&gt;
                &lt;option value=&#34;18&#34;&gt;18&lt;/option&gt;
                &lt;option value=&#34;19&#34;&gt;19&lt;/option&gt;
                &lt;option value=&#34;20&#34;&gt;20&lt;/option&gt;
                &lt;option value=&#34;21&#34;&gt;21&lt;/option&gt;
                &lt;option value=&#34;22&#34;&gt;22&lt;/option&gt;
                &lt;option value=&#34;23&#34;&gt;23&lt;/option&gt;
                &lt;option value=&#34;24&#34;&gt;24&lt;/option&gt;
                &lt;option value=&#34;25&#34;&gt;25&lt;/option&gt;
                &lt;option value=&#34;26&#34;&gt;26&lt;/option&gt;
                &lt;option value=&#34;27&#34;&gt;27&lt;/option&gt;
                &lt;option value=&#34;28&#34;&gt;28&lt;/option&gt;
                &lt;option value=&#34;29&#34;&gt;29&lt;/option&gt;
                &lt;option value=&#34;30&#34;&gt;30&lt;/option&gt;
                &lt;option value=&#34;31&#34;&gt;31&lt;/option&gt;
            &lt;/select&gt;
            &lt;select id=&#34;mes&#34; required&gt;
                &lt;option value=&#34;Janeiro&#34;&gt;Janeiro&lt;/option&gt;
                &lt;option value=&#34;Fevereiro&#34;&gt;Fevereiro&lt;/option&gt;
                &lt;option value=&#34;Março&#34;&gt;Março&lt;/option&gt;
                &lt;option value=&#34;Abril&#34;&gt;Abril&lt;/option&gt;
                &lt;option value=&#34;Maio&#34;&gt;Maio&lt;/option&gt;
                &lt;option value=&#34;Junho&#34;&gt;Junho&lt;/option&gt;
                &lt;option value=&#34;Julho&#34;&gt;Julho&lt;/option&gt;
                &lt;option value=&#34;Agosto&#34;&gt;Agosto&lt;/option&gt;
                &lt;option value=&#34;Setembro&#34;&gt;Setembro&lt;/option&gt;
                &lt;option value=&#34;Outubro&#34;&gt;Outubro&lt;/option&gt;
                &lt;option value=&#34;Novembro&#34;&gt;Novembro&lt;/option&gt;
                &lt;option value=&#34;Dezembro&#34;&gt;Dezembro&lt;/option&gt;
            &lt;/select&gt;
            &lt;select id=&#34;ano&#34;&gt;
                &lt;option value=&#34;2024&#34;&gt;2024&lt;/option&gt;
                &lt;option value=&#34;2025&#34;&gt;2025&lt;/option&gt;
                &lt;option value=&#34;2026&#34;&gt;2026&lt;/option&gt;
            &lt;/select&gt;
            &lt;br&gt;
    &lt;br&gt;
    &lt;label for=&#34;assinatura&#34;&gt;Assinante:&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=&#34;text&#34; id=&#34;assinatura&#34; placeholder=&#34;Dr. Fulano&#34; required&gt;
    &lt;/div&gt;
    &lt;br&gt;
    &lt;label for=&#34;nomeArquivo&#34;&gt;Nome do arquivo:&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=&#34;text&#34; id=&#34;nomeArquivo&#34; placeholder=&#34;meu_documento&#34; required&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=&#34;generatePDF()&#34;&gt;Gerar PDF&lt;/button&gt;
&lt;/div&gt;
&lt;script src=&#34;../../receituario.js&#34;&gt;&lt;/script&gt;

</description>
	</item>
	
	<item>
		<title>Febre reumática</title>
		<link>https://www.aesclepius.com.br/febre-reumatica/</link>
		<pubDate>Fri, 07 Jun 2024 07:56:45 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/febre-reumatica/</guid>
		<description>&lt;script src=&#34;../../febre-reumatica.js&#34;&gt;&lt;/script&gt;
&lt;div class=calculadoras&gt;
    &lt;h2&gt;Calculdora de profilaxia de Centor&lt;/h2&gt;
    &lt;label for=idade&gt;Idade&lt;/label&gt;
    &lt;br&gt;
    &lt;input id=idade placeholder=&#34;anos&#34; type=number&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;label for=tonsilas&gt;Tonsilas&lt;/label&gt;
    &lt;br&gt;
    &lt;select id=tonsilas&gt;
        &lt;option value=normal&gt;Normais&lt;/option&gt;
        &lt;option value=anormal&gt;Edema ou exsudato&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;input id=tosse type=checkbox&gt;&lt;/input&gt;
    &lt;label for=tosse&gt;Tosse&lt;/label&gt;
    &lt;br&gt;
    &lt;input id=linfonodomegalia type=checkbox&gt;&lt;/input&gt;
    &lt;label for=linfonodomegalia&gt;Linfonodomegalia&lt;/label&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=&#34;calcular()&#34;&gt;Calcular&lt;/button&gt;
    &lt;p id=resultado&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;br&gt;
&lt;br&gt;
&lt;div class=calculadoras&gt;
    &lt;h2&gt;Calculdora de tratamento Jones&lt;/h2&gt;
    &lt;input id=riscoAlto type=checkbox&gt;População de moderado ou alto risco para exposição ao estreptococo beta-hemolítico do grupo A¹&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=monoartrite type=checkbox&gt;Monoartrite&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=poliartrite type=checkbox&gt;Poliartrite&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=poliartralgia type=checkbox&gt;Poliartralgia&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=cardite type=checkbox&gt;Cardite&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=coreia type=checkbox&gt;Coreia&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=nodulos type=checkbox&gt;Nódulos subcutâneos&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=eritema type=checkbox&gt;Eritema marginado&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=febre type=checkbox&gt;Febre&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=ecg type=checkbox&gt;ECG mostrando aumento de PR&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=cultura type=checkbox&gt;Cultura positiva da orofaringe para estreptococo beta-hemolítico do grupo A&lt;/input&gt;
    &lt;br&gt;
    &lt;input id=titulos type=checkbox&gt;Títulos elevados de ASO ou outro anticorpo estreptocócico, teste rápido para antígenos do estreptococo, escarlatina recente&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=vhs &gt;Velocidade de hemossedimentação&lt;/label&gt;
    &lt;br&gt;
    &lt;input id=vhs placeholder=&#34;mm/h&#34; type=number &gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;label for=pcr&gt;Proteína C reativa&lt;/label&gt;
    &lt;br&gt;
    &lt;input id=pcr placeholder=&#34;mg/dL&#34; type=number&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=&#34;calcularJones()&#34;&gt;Calcular&lt;/button&gt;
    &lt;p id=resultado2&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;O Brasil é considerado país com alto risco para exposição ao estreptococo beta-hemolítico.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE. &lt;strong&gt;Empirical validation of guidelines for the management of pharyngitis in children and adults&lt;/strong&gt;. JAMA. 2004 Apr 7;291(13):1587-95. doi: 10.1001/jama.291.13.1587. Erratum in: JAMA. 2005 Dec 7;294(21):2700. PMID: 15069046.&lt;/li&gt;
&lt;li&gt;Centor RM, Witherspoon JM, Dalton HP, Brody CE, Link K. &lt;strong&gt;The diagnosis of strep throat in adults in the emergency
room&lt;/strong&gt;. Med Decis Making. 1981;1(3):239-46&lt;/li&gt;
&lt;li&gt;Fine AM, Nizet V, Mandl KD. &lt;strong&gt;Large-Scale Validation of the Centor and McIsaac Scores to Predict Group A Streptococcal Pharyngitis&lt;/strong&gt;. Arch Intern Med. 2012 Jun 11; 172(11): 847–852&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Hepatopatias</title>
		<link>https://www.aesclepius.com.br/hepatopatias/</link>
		<pubDate>Wed, 08 May 2024 11:54:37 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/hepatopatias/</guid>
		<description>&lt;script src=&#34;../../hepatopatias.js&#34;&gt;&lt;/script&gt;
&lt;h2 id=&#34;hepatites-virais&#34;&gt;Hepatites Virais&lt;/h2&gt;
&lt;h3 id=&#34;sistema-de-decisão-em-hepatite-b-1&#34;&gt;Sistema de decisão em hepatite B [1]&lt;/h3&gt;
&lt;div class=calculadoras&gt;
    &lt;p&gt;Marque os exames positivados&lt;/p&gt;
    &lt;input type=checkbox id=HbSAg&gt;HbSAg&lt;/input&gt;
    &lt;br&gt;
    &lt;input type=checkbox id=antiHbCIgM&gt;Anti HbC IgM&lt;/input&gt;
    &lt;br&gt;
    &lt;input type=checkbox id=antiHbCIgG&gt;Anti HbC IgG&lt;/input&gt;
    &lt;br&gt;
    &lt;input type=checkbox id=antiHbS&gt;Anti HbS&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=&#34;calcularHepB()&#34;&gt;Calcular&lt;/button&gt;
    &lt;br&gt;
    &lt;p id=resultadoHepB&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h2 id=&#34;cirrose&#34;&gt;Cirrose&lt;/h2&gt;
&lt;h3 id=&#34;child-pugh-score-23&#34;&gt;Child-Pugh Score [2][3]&lt;/h3&gt;
&lt;div class=&#34;calculadoras&#34;&gt;
    &lt;label for=cpsBr&gt;Bilirrubina total&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number id=cpsBr placeholder=&#34;mg/dL&#34; required&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=cpsAb&gt;Albumina&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number id=cpsAb placeholder=g/dL required&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=cpsInr&gt;International Normalized Ratio&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number id=&#34;cpsInr&#34; required&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=ascite&gt;Ascite&lt;/label&gt;
    &lt;br&gt;
    &lt;select id=ascite&gt;
        &lt;option value=0&gt;Ausente&lt;/option&gt;
        &lt;option value=1&gt;Pouca&lt;/option&gt;
        &lt;option value=2&gt;Moderada&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=encefalopatia&gt;Encefalopatia&lt;/label&gt;
    &lt;br&gt;
    &lt;select id=encefalopatia&gt;
        &lt;option value=0&gt;Ausente&lt;/option&gt;
        &lt;option value=1&gt;Grau I ou II&lt;/option&gt;
        &lt;option value=2&gt;Grau III ou IV&lt;/option&gt;
    &lt;/select&gt;
    &lt;p&gt;Na ausência de eletroencefalograma, avalie o grau da encefalopatia:&lt;br&gt;
        I: distúrbio de sono, irritabilidade, agitação, tremor, escrita afetada.&lt;br&gt;
        II: letargia, desorientação temporal, fala inapropriada, asterix, ataxia.&lt;br&gt;
        III: sonolência, estopor, desorientação geográfica, hiperreflexia, rigidez.&lt;br&gt;
        IV: coma, decerebração.
    &lt;/p&gt;
    &lt;br&gt;
    &lt;button onclick=&#34;childPugh()&#34;&gt;Calcular&lt;/button&gt;
    &lt;br&gt;
    &lt;p id=resultadoCPS&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h2 id=&#34;transplante&#34;&gt;Transplante&lt;/h2&gt;
&lt;p&gt;Em breve: critérios de Kings College.
&lt;br&gt;
&lt;br&gt;
&lt;br&gt;&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;DUARTE, Geraldo et al. &lt;strong&gt;Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: hepatites virais&lt;/strong&gt;. Epidemiologia e Serviços de Saúde, v. 30, p. e2020834, 2021.&lt;/li&gt;
&lt;li&gt;Child CG, Turcotte JG. &lt;strong&gt;Surgery and portal hypertension. In: The liver and portal hypertension&lt;/strong&gt;. Edited by CG Child. Philadelphia: Saunders 1964:50-64.&lt;/li&gt;
&lt;li&gt;Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R (1973). &lt;strong&gt;Transection of the oesophagus for bleeding oesophageal varices&lt;/strong&gt;. The British journal of surgery 60 (8).&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Púrpuras e lesões hemáticas</title>
		<link>https://www.aesclepius.com.br/purpuras/</link>
		<pubDate>Wed, 08 May 2024 11:53:29 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/purpuras/</guid>
		<description>&lt;h2 id=&#34;púrpuras&#34;&gt;Púrpuras&lt;/h2&gt;
&lt;h3 id=&#34;diagnóstico-diferencial&#34;&gt;Diagnóstico diferencial&lt;/h3&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Mecanismo&lt;/th&gt;
          &lt;th&gt;Exemplos&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Baixa trombocitopoese&lt;/td&gt;
          &lt;td&gt;Leucemia&lt;br&gt;Linfoma&lt;br&gt;Anemia aplásica&lt;br&gt;Consumo intenso de álcool&lt;br&gt;Anemias por deficiência de vitaminas, incluindo vitamina B12, e anemias por deficiência de folato&lt;br&gt;Alguns distúrbios da medula óssea&lt;br&gt;Alguns medicamentos quimioterápicos&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Sequestro plaquetário esplênico&lt;/td&gt;
          &lt;td&gt;Cirrose hepática, hipertensão arterial hepática ou esplênica&lt;br&gt;Mielofibrose&lt;br&gt;Doença de Gaucher&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Pseudoplaquetopenia&lt;/td&gt;
          &lt;td&gt;Reposição maciça de eritrócitos ou transfusões&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Plaquetólise&lt;/td&gt;
          &lt;td&gt;Trombocitopenia imune&lt;br&gt;Infecção pelo vírus da hepatite C, infecção por HIV e outras infecções virais&lt;br&gt;Medicamentos como heparina, quinina, muitos antibióticos (tais como trimetoprima/sulfametoxazol, rifampicina e vancomicina) e alguns medicamentos orais para diabetes&lt;br&gt;Quadros clínicos que provocam coagulação intravascular disseminada nos vasos sanguíneos, como pode acontecer em algumas complicações do parto, câncer, infecção generalizada do sangue (septicemia) devido a bactérias Gram-negativas e lesões cerebrais traumáticas&lt;br&gt;Cirurgia de revascularização (bypass) cardiopulmonar&lt;br&gt;Púrpura trombocitopênica trombótica&lt;br&gt;Síndrome hemolítico-urêmica&lt;br&gt;Algumas vacinas, como, por exemplo, para sarampo, caxumba e rubéola, gripe, hepatite B, COVID-19&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;equimoses&#34;&gt;Equimoses&lt;/h2&gt;
&lt;p&gt;Ver&lt;/p&gt;
&lt;h2 id=&#34;violência&#34;&gt;Violência&lt;/h2&gt;
&lt;p&gt;Veja melhor em &lt;a href=&#34;http://localhost:1313/medicina-legal/traumato-forense/#les%C3%B5es-e-feridas&#34;&gt;medicina legal&lt;/a&gt;.&lt;/p&gt;
</description>
	</item>
	
	<item>
		<title>Anemias: investigação e tratamento</title>
		<link>https://www.aesclepius.com.br/anemias/</link>
		<pubDate>Sun, 14 Apr 2024 19:58:35 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/anemias/</guid>
		<description>&lt;h2 id=&#34;etiologias&#34;&gt;Etiologias&lt;/h2&gt;
&lt;h3 id=&#34;ferropriva&#34;&gt;Ferropriva&lt;/h3&gt;
&lt;p&gt;Normalmente causada pela deficiência dietética de ferro ou por sangramento crônico, resulta em hemoglobinas deficientes e maturadas ainda com pequeno tamanho, arbitrariamente definido como menor que 9fL.&lt;/p&gt;
&lt;p&gt;Os sintomas comuns incluem a fadiga, fraqueza, palidez, taquicardia e tonturas.&lt;/p&gt;
&lt;p&gt;A busca pelo sangramento crônico, como o algoritmo PALMCOEIN para mulheres, é o tratamento. A correção imediata é feita pela administração de ferro suplementar na forma preferencialmente oral.&lt;/p&gt;
&lt;h3 id=&#34;por-deficiência-de-cobalamina-e-ácido-fólico&#34;&gt;Por deficiência de cobalamina e ácido fólico&lt;/h3&gt;
&lt;p&gt;A cobalamina é o nome genérico a todas formas ativas de vitamina B12. A falta desta e do ácido fólico causa anemias desregulatórias da produção de eritrócitos pelos eritroblastos ainda na medula, resultando em megaloblastia. O volume corpuscular considerado alto é alvo de debate até hoje e recomendo o texto do professor Paulo Cesar Naoum da UNESP: &lt;a href=&#34;../../files/Medicina/Qual-o-verdadeiro-valor-do-VCM-Professor-Paulo-Cesar.pdf&#34;&gt;qual o verdadeiro valor do VCM?&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;O tratamento geralmente envolve administrar a B12 diretamente via intramuscular e o ácido fólico como suplemento alimentar.&lt;/p&gt;
&lt;h4 id=&#34;privação-dietética&#34;&gt;Privação dietética&lt;/h4&gt;
&lt;p&gt;Por privação alimentar do ácido fólico ou da cobalamina, como em dietas veganas, muito restritivas ou doenças absortivas e/ou perda da função intestinal, e.g. íleo.&lt;/p&gt;
&lt;h4 id=&#34;perniciosa&#34;&gt;Perniciosa&lt;/h4&gt;
&lt;p&gt;Trata-se de causa autoimune, quando anticorpos impedem a ligação da B12 ao fator intrínseco, etapa crucial da sua absorção nas células parietais estomacais.&lt;/p&gt;
&lt;h3 id=&#34;esferocitose&#34;&gt;Esferocitose&lt;/h3&gt;
&lt;p&gt;Uma anomalia genética que provoca espectrina e anquirina deficientes que provocam queda na tensão estrutural da hemácea, deixando seu formato esférico. Por esse motivo, são capturadas nos sinusoides esplênicos e hepáticos, destruídas e parcialmente fagocitadas, levando a hemólise.&lt;/p&gt;
&lt;p&gt;Nota-se esplenomegalia, icterícia e bilirrubinemia às custas de indireta.&lt;/p&gt;
&lt;h3 id=&#34;deficiência-de-g6pd-ou-favismo&#34;&gt;Deficiência de G6PD ou favismo&lt;/h3&gt;
&lt;p&gt;A via metabólica do fosfato-pentose é dependente de glicose-6-fosfato-desidrogenase que auxilia na redução de NADP+ a NAPH com consumo de espécies reativas de oxigênio, diminuindo o estresse oxidativo metabólico, principalmente dos eritrócitos. A falta de G6PD torna a hemoglobina pronada a hemólise por estresse químico. Os restos deste processo são típicos e chamados de corpúsculos de Heinz.&lt;/p&gt;
&lt;p&gt;Os sintomas, quando presentes, são a dispneia, fraqueza ao longo prazo e a icterícia. Algumas pessoas são assintomáticas. O diagnóstico é tradicionalmente feito pelo teste de Coombs.&lt;/p&gt;
&lt;h3 id=&#34;falciforme&#34;&gt;Falciforme&lt;/h3&gt;
&lt;p&gt;Por uma mera troca de ácido glutâmico por valina no sexto códon no DNA do cromossomo 11, a hemoglobina do indivíduo tem uma configuração que favorece a polimerização e a hemácea se torna &lt;em&gt;&amp;ldquo;afoiçada&amp;rdquo;&lt;/em&gt;, ou seja, curva, causando vasoclusão em diversos tecidos. Porém, a pior consequência é a incapacidade de carreamento de oxigênio, por isso a oxigenoterapia tende a melhorar os sintomas.&lt;/p&gt;
&lt;p&gt;O paciente tem crises de vasoclusão, geralmente dolorosas em membros, isquêmicas, notadamente grave no SNC e uma peculiar e relativamente comum no pênis, levando ao priapismo. Com o tempo, as vasoclusões esplênicas podem levar a autoesplenectomia.&lt;/p&gt;
&lt;p&gt;Curiosamente, a anemia falciforme se associa a resistência à malária e, talvez por causas evolutivas e pela alta incidência de malária na áfrica, a doença é quase exclusiva de pessoas afrodescendentes.&lt;/p&gt;
&lt;h3 id=&#34;hemorragia-aguda&#34;&gt;Hemorragia aguda&lt;/h3&gt;
&lt;p&gt;Autoexplicável.&lt;/p&gt;
&lt;h3 id=&#34;aplásica&#34;&gt;Aplásica&lt;/h3&gt;
&lt;p&gt;Nome controverso. Ocorre que uma falha de medula causada pelo uso de drogas, substâncias, infecções por CMV, EBV ou ainda idiopática, terminam por interromper a linhagem de produção de eritrócitos, plaquetas e leucócitos. Portanto, trata-se de uma pancitopenia de causa medular.&lt;/p&gt;
&lt;p&gt;Os sintomas comuns giram em torno da facilidade de infecções, sangramentos, indisposição, atraso de desenvolvimento etc. O tratamento definitivo é o transplante de medula.&lt;/p&gt;
&lt;h3 id=&#34;talassemias&#34;&gt;Talassemias&lt;/h3&gt;
&lt;p&gt;Também de natureza hereditária, mais comum na ascendência mediterrânea, pode se apresentar de duas formas:
Na deficiência da subunidade alfa, também chamada alfatalassemia, e alternativamente quando deficiente a subunidade beta, também chamada betatalassemia. Em todo caso, o volume corpuscular é aumentado ou próximo de normal, nunca microcítica.&lt;/p&gt;
&lt;p&gt;Os sintomas são os comuns de anemias, necessitando de transfusões frequentes e o tratamento definitivo é a transfusão de medula.&lt;/p&gt;
&lt;h2 id=&#34;algoritmo-de-investigação&#34;&gt;Algoritmo de investigação&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
1(Volume&lt;br&gt;corpuscular médio acima de 100fl) --&gt; 2(Reticulócitos aumentados?) -- Não --&gt; 3(Sangue periférico);
3 --&gt; 10(Avaliar tabela abaixo de diferencial morfológico);
3 --&gt; 5(Macrócitos ovais e&lt;br&gt;hipersegmentação de neutrófilos) -- Presente --&gt; 6(Deficiência&lt;br&gt;de B12 ou folato);
2 -- Sim --&gt; 4(Hiperproliferativa:&lt;br&gt;Triar para&lt;br&gt;anemias hemolíticas e&lt;br&gt;sangramentos agudos.);
5 -- Ausente --&gt; 7(Hipotireoidismo, síndrome mielodisplásica&lt;br&gt;hepatopatias, medicamentos);
&lt;/pre&gt;

&lt;br&gt;
&lt;br&gt;
&lt;br&gt;
&lt;br&gt;
&lt;table&gt;
       &lt;tr&gt;
           &lt;th&gt;&lt;/th&gt;
           &lt;th class=&#34;header-cell&#34;&gt;RDW: 11-14,5%&lt;/th&gt;
           &lt;th class=&#34;header-cell&#34;&gt;RDW &gt; 14,5%&lt;/th&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
           &lt;td class=&#34;vcm-column&#34;&gt;VCM &lt; 80&lt;/td&gt;
           &lt;td&gt;
               &lt;div class=&#34;diagnostic-cell&#34;&gt;MICROCITOSE HOMOGÊNEA&lt;/div&gt;
               &lt;div class=&#34;conditions&#34;&gt;
                   • Talassemias heterozigotas&lt;br&gt;
                   • Anemia de doença crônica
               &lt;/div&gt;
           &lt;/td&gt;
           &lt;td&gt;
               &lt;div class=&#34;diagnostic-cell&#34;&gt;MICROCITOSE HETEROGÊNEA&lt;/div&gt;
               &lt;div class=&#34;conditions&#34;&gt;
                   • Ferropriva evidente&lt;br&gt;
                   • Fragmentação de hemácias&lt;br&gt;
                   • Sideroblástica
               &lt;/div&gt;
           &lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
           &lt;td class=&#34;vcm-column&#34;&gt;VCM 80-100&lt;/td&gt;
           &lt;td&gt;
               &lt;div class=&#34;diagnostic-cell&#34;&gt;NORMOCITOSE HOMOGÊNEA&lt;/div&gt;
               &lt;div class=&#34;conditions&#34;&gt;
                   • Anemia de doença crônica&lt;br&gt;
                   • Hemoglobinopatias não anêmicas&lt;br&gt;
                   • Transfusão&lt;br&gt;
                   • Doenças oncohematológicas&lt;br&gt;
                   • Hemorragia
               &lt;/div&gt;
           &lt;/td&gt;
           &lt;td&gt;
               &lt;div class=&#34;diagnostic-cell&#34;&gt;NORMOCITOSE HETEROGÊNEA&lt;/div&gt;
               &lt;div class=&#34;conditions&#34;&gt;
                   • Deficiências mistas&lt;br&gt;
                   • Deficiência de Fe ou Folato no início&lt;br&gt;
                   • Hemoglobinopatias anêmicas&lt;br&gt;
                   • Mielofibrose&lt;br&gt;
                   • Sideroblástica
               &lt;/div&gt;
           &lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
           &lt;td class=&#34;vcm-column&#34;&gt;VCM &gt; 100&lt;/td&gt;
           &lt;td&gt;
               &lt;div class=&#34;diagnostic-cell&#34;&gt;MACROCITOSE HOMOGÊNEA&lt;/div&gt;
               &lt;div class=&#34;conditions&#34;&gt;
                   • Anemia Aplástica&lt;br&gt;
                   • Mielodisplasias
               &lt;/div&gt;
           &lt;/td&gt;
           &lt;td&gt;
               &lt;div class=&#34;diagnostic-cell&#34;&gt;MACROCITOSE HETEROGÊNEA&lt;/div&gt;
               &lt;div class=&#34;conditions&#34;&gt;
                   • Deficiência folato, B12&lt;br&gt;
                   • AHAI&lt;br&gt;
                   • Crioaglutininas&lt;br&gt;
                   • LLC com hiperleucocitose&lt;br&gt;
                   • Sideroblástica
               &lt;/div&gt;
           &lt;/td&gt;
       &lt;/tr&gt;
&lt;/table&gt;
&lt;h2 id=&#34;tratamentos&#34;&gt;Tratamentos&lt;/h2&gt;
&lt;h3 id=&#34;calculadora-de-reposição-de-ferro&#34;&gt;Calculadora de reposição de ferro&lt;/h3&gt;
&lt;p&gt;Estima-se que a administração de 400 mg do ferro sacarato seja capaz de aumentar em pelo menos 1g/dL a concentração de hemoglobina, o que corresponde ao incremento esperado quando se administra uma unidade de concentrado de hemácias.&lt;/p&gt;
&lt;p&gt;A fórmula mais aceita é:&lt;/p&gt;
&lt;p&gt;$$
Ferro_{mg} = 2.4massa_{Kg}(Hb_{desejada} - Hb_{atual}) + 500
$$&lt;/p&gt;


&lt;div class=calculadoras&gt;
&lt;h2&gt;Calculadora para sacarato&lt;br&gt;de hidróxido férrico&lt;/h2&gt;
&lt;label for=hbdesejada&gt;Hemoglobina desejada&lt;/label&gt;
&lt;br&gt;
&lt;input type=number placeholder=&#34;g/dL&#34; id=hbdesejada&gt;&lt;/input&gt;
&lt;br&gt;
&lt;label for=hbatual&gt;Hemoglobina atual&lt;/label&gt;
&lt;br&gt;
&lt;input type=number placeholder=&#34;g/dL&#34; id=hbatual&gt;&lt;/input&gt;
&lt;br&gt;
&lt;label for=hbdesejada&gt;Massa corporal&lt;/label&gt;
&lt;br&gt;
&lt;input type=number placeholder=&#34;Kg&#34; id=peso&gt;&lt;/input&gt;
&lt;p id=resultado&gt;&lt;/p&gt;
&lt;br&gt;
&lt;button onclick=calculaFerro()&gt;Calcular&lt;/button&gt;
&lt;/div&gt;
&lt;script&gt;
function calculaFerro(){
    let hbAtual = parseFloat(document.getElementById(&#34;hbatual&#34;).value);
    let hbDesejada = parseFloat(document.getElementById(&#34;hbdesejada&#34;).value);
    let peso = parseFloat(document.getElementById(&#34;peso&#34;).value);

    let resultado = parseFloat(((hbDesejada - hbAtual)*peso*2.4)+500).toFixed(2);

    if (isNaN(hbAtual + hbDesejada + peso)) {
        document.getElementById(&#34;resultado&#34;).innerHTML = &#34;Verifique dados!&#34;;
        return
    }

    document.getElementById(&#34;resultado&#34;).innerHTML = resultado+&#34;mg&#34;;
}
&lt;/script&gt;
&lt;br&gt;

&lt;h4 id=&#34;instruções&#34;&gt;Instruções&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Diluir cada ampola em 100ml de salina.&lt;/li&gt;
&lt;li&gt;Tempo: correr a diluição em 15min para cada ampola.&lt;/li&gt;
&lt;li&gt;Dose máxima por aplicação de 200mg e semanal de 500mg.&lt;/li&gt;
&lt;li&gt;Intervalo mínimo entre doses de 24h.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Embora a administração de ferro por via intramuscular tenha sido muito utilizada, sobretudo em função da experiência negativa com o ferro dextran por via endovenosa na década de 80 e pela facilidade de aplicação, a partir do ano 2000, esta via de administração tem sido gradativamente substituída pela via endovenosa.&lt;/p&gt;
&lt;p&gt;Recomenda-se a dose máxima diária de 200 mg (duas ampolas) de sacarato quando administrado por via intramuscular. Na prática, orienta-se a aplicação de uma ampola, uma a duas vezes por semana, até que se complete a dose total desejada ou calculada.&lt;/p&gt;
&lt;h3 id=&#34;cobalamina-intramuscular&#34;&gt;Cobalamina intramuscular&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;bibliografia&#34;&gt;Bibliografia&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Cançado RD, Lobo C, Friedrich JR. &lt;strong&gt;Tratamento da anemia ferropriva com ferro por via parenteral&lt;/strong&gt;. Rev Bras Hematol Hemoter [Internet]. 2010Jun;32:121–8. Available from: &lt;a href=&#34;https://doi.org/10.1590/S1516-84842010005000066&#34;&gt;https://doi.org/10.1590/S1516-84842010005000066&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Gastrite e úlceras gástricas</title>
		<link>https://www.aesclepius.com.br/gastrite/</link>
		<pubDate>Sun, 14 Apr 2024 18:04:29 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/gastrite/</guid>
		<description>&lt;h2 id=&#34;erradicação-da-h-pylori&#34;&gt;Erradicação da H. Pylori&lt;/h2&gt;
&lt;table border=&#34;1&#34;&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td class=&#34;p-4 tabela-cor-texto&#34;&gt;&lt;strong class=&#34;fs-18 tabela&#34;&gt;Esquema terapêutico&lt;/strong&gt;&lt;/td&gt;
&lt;td class=&#34;p-4 tabela-cor-texto&#34;&gt;&lt;strong class=&#34;fs-18 tabela&#34;&gt;Duração do tratamento&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34; colspan=&#34;2&#34;&gt;&lt;strong&gt;Esquema padrão de primeira linha: IBP* 12/12h associado a:&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Amoxicilina 1g 12/12 horas +&lt;br&gt;
Claritromicina 500mg 12/12 horas&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;14 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34; colspan=&#34;2&#34;&gt;&lt;strong&gt;Esquemas alternativos ou de segunda linha: IBP* 12/12h associado a:&lt;/strong&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Amoxicilina 1g 12/12 horas +&lt;br&gt;
Levofloxacino 500mg 1x/dia&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;10 a 14 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Claritromicina 500mg 12/12 horas +&lt;br&gt;
Levofloxacino 500mg 1x/dia**&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;14 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Amoxicilina 1g 12/12 horas +&lt;br&gt;
Claritromicina 500mg 12/12 horas +&lt;br&gt;
Metronidazol 500mg 12/12 horas ou&lt;br&gt;
Tinidazol 500mg 12/12 horas&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;10 a 14 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Amoxicilina 1g 12/12 horas +&lt;br&gt;
Subcitrato de Bismuto 240mg 12/12 horas +&lt;br&gt;
Levofloxacino 500mg 1x/dia&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;10 a 14 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Metronidazol 500mg 12/12 horas ou 400mg 8/8 horas +&lt;br&gt;
Subcitrato de Bismuto 120mg 6/6 horas&lt;br&gt;
ou 240mg 12/12 horas +&lt;br&gt;
Tetraciclina 500mg 6/6 horas**&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;10 a 14 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Metronidazol 500mg 12/12 horas ou&lt;br&gt;
Tinidazol 500mg 12/12h +&lt;br&gt;
Subcitrato de Bismuto 240mg 12/12 horas +&lt;br&gt;
Doxiciclina 100mg 12/12 horas**&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;10 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Furazolidona 200mg 12/12 horas +&lt;br&gt;
Subcitrato de Bismuto 240mg 12/12 horas +&lt;br&gt;
Amoxicilina 1g 12/12h&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;10 a 14 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34;&gt;Furazolidona 200mg 12/12 horas +&lt;br&gt;
Subcitrato de Bismuto 240mg 12/12 horas +&lt;br&gt;
Tetraciclina 500mg 6/6 horas**&lt;/td&gt;
&lt;td class=&#34;p-3 text-center&#34;&gt;10 dias&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td class=&#34;p-3&#34; colspan=&#34;2&#34;&gt;* IBP: omeprazol 20mg, lansoprazol 30mg, pantoprazol 40mg, esomeprazol 20mg, dexlansoprazol 60mg.&lt;br&gt;
** Podem ser usados em alérgicos a penicilina.&lt;br&gt;
Obs: esquemas com metronidazol podem ser prescritos com 400mg 8/8 horas quando a dose de 500mg não estiver disponível.&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
</description>
	</item>
	
	<item>
		<title>Dengue</title>
		<link>https://www.aesclepius.com.br/dengue/</link>
		<pubDate>Sun, 14 Apr 2024 17:51:58 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/dengue/</guid>
		<description>


&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/dengue-historia.png&#34;&gt;
  &lt;figcaption&gt;&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;!-- em breve. Lembrar da paciente com eritema em Sobradinho. --&gt;
&lt;!-- pedir contagem de plaquetas em frasco coleta com citrato para impedir sequestro e aglutinação plaquetária --&gt;
</description>
	</item>
	
	<item>
		<title>Cetoacidose diabética</title>
		<link>https://www.aesclepius.com.br/cetoacidose/</link>
		<pubDate>Sun, 14 Apr 2024 17:25:02 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/cetoacidose/</guid>
		<description>&lt;h2 id=&#34;diagnóstico&#34;&gt;Diagnóstico&lt;/h2&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h2 id=&#34;tratamento&#34;&gt;Tratamento&lt;/h2&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;p&gt;Se K &amp;gt; 5, faz insulina direto.&lt;/p&gt;
&lt;p&gt;Se K &amp;lt; 5, faz insulina com glicose 25mEq/L de soro NaCl a 0.9%.&lt;/p&gt;
&lt;h2 id=&#34;publicações&#34;&gt;Publicações&lt;/h2&gt;
&lt;p&gt;Estes são compilados recentes de publicações que reorientam a conduta na cetoacidose diabética.
Para preservar a intenção e a informação trazida nos artigos, mantive os textos originais.&lt;/p&gt;
&lt;h3 id=&#34;seven-myths-about-diabetic-ketoacidosis&#34;&gt;Seven myths about diabetic ketoacidosis &lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/h3&gt;
&lt;h4 id=&#34;myth-1-dka-is-a-state-of-extreme-hypovolemia-with-a-need-for-large-volume-resuscitation-eg-100-mlkg&#34;&gt;Myth 1: DKA is a state of extreme hypovolemia with a need for large volume resuscitation (e.g. 100 mL/Kg)&lt;/h4&gt;
&lt;p&gt;Although substantial renal losses can occur due to hyperglycemia, especially over a longer duration, true hypovolemia usually ensues when patients are unable to drink due to nausea and vomiting. The body usually compensates for osmotic diuresis through increased oral intake through activation of physiologically effective circulating volume operators such as increased thirst and other neuro-hormone pathways. Some patients may not be hypovolemic, e.g. patients undergoing chronic dialysis or those with euglycemic DKA, where fluid losses are smaller.&lt;/p&gt;
&lt;h4 id=&#34;myth-2-nacl-09-should-be-the-standard-of-care-for-volume-repletion-in-dka&#34;&gt;Myth 2: NaCl 0.9% should be the standard of care for volume repletion in DKA&lt;/h4&gt;
&lt;p&gt;NaCl 0.9% causes iatrogenic hyperchloremic acidosis and does not prevent cerebral oedema. Buffered crystalloids such as Plasmalyte-148® or Hartmann’s solution will hasten pH correction but with no difference in anion-gap closure. Potassium replacement may however need to be given separately.&lt;/p&gt;
&lt;h4 id=&#34;myth-3-weight-fixed-fluid-infusion-rates-are-necessary-for-the-treatment-of-dka&#34;&gt;Myth 3: Weight-fixed fluid infusion rates are necessary for the treatment of DKA&lt;/h4&gt;
&lt;p&gt;A lower rate of fluid infusion leads to less hyperchloremic acidosis, reduces the risk of fluid overload, and does not affect overall DKA correction rates. Treatment should be personalized to patient needs.&lt;/p&gt;
&lt;h4 id=&#34;myth-4-glucose-corrected-serum-sodium-follows-a-linear-relationship&#34;&gt;Myth 4: Glucose-corrected serum sodium follows a linear relationship&lt;/h4&gt;
&lt;p&gt;A non-linear relationship for glucose-corrected serum sodium is most likely. The clinical significance of glucose-corrected serum sodium is usually low since fluid tonicity does not influence the rate of clinically significant cerebral
oedema.&lt;/p&gt;
&lt;h4 id=&#34;myth-5-hyperchloremic-acidosis-in-dka-is-the-sole-consequence-of-iatrogenesis&#34;&gt;Myth 5: Hyperchloremic acidosis in DKA is the sole consequence of iatrogenesis&lt;/h4&gt;
&lt;p&gt;Hyperchloremic acidosis is not only a function of large volumes of salt-containing solutions, but also of the severity and duration of DKA before treatment is started. In DKA, renal reabsorption of chloride is increased to allow renal excretion of ketoacids, especially β-hydroxybutyrate.&lt;/p&gt;
&lt;h4 id=&#34;myth-6-dka-should-be-treated-only-with-intravenous-insulin&#34;&gt;Myth 6: DKA should be treated only with intravenous insulin&lt;/h4&gt;
&lt;p&gt;In patients who are not very sick, an ultra-rapid subcutaneous insulin regimen (hourly dose of 0.1 U/Kg) may shorten time to DKA treatment and avoid the need for intravenous insulin. With current very long-acting insulins, it is advisable to use only small doses (usually 0.2 U/Kg) in patients with severe DKA at the onset of treatment. This allows a smoother transition from an IV to a SC insulin regimen.&lt;/p&gt;
&lt;h4 id=&#34;myth-7-dka-correction-criteria-include-glucose-levels-and-ketonemia&#34;&gt;Myth 7: DKA correction criteria include glucose levels and ketonemia&lt;/h4&gt;
&lt;p&gt;pH &amp;gt; 7.30 and bicarbonate &amp;gt; 15 mEq/L are the usual minimum criteria for DKA correction. Full correction of hyperglycemia does not ensure DKA reversal, neither is it necessary. Although point-of-care ketonemia may hasten the diagnosis of DKA, its use as a routine treatment target has not been compared to standard approaches. Optimal monitoring and rate of reduction have not been identified.&lt;/p&gt;
&lt;h3 id=&#34;keypoint-of-care-in-ketoacidosis&#34;&gt;Keypoint of care in ketoacidosis&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt;&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Diagnosis of diabetic ketoacidosis (DKA) is based on the biochemical triad of ketonaemia, hyperglycaemia, and acidaemia.&lt;/li&gt;
&lt;li&gt;Cornerstones of management are: fluid and potassium replacement; weight-based fixed rate intravenous insulin infusion (FRIII); and close biochemical monitoring of capillary ketones, serum electrolytes, venous pH and capillary glucose.&lt;/li&gt;
&lt;li&gt;It is not necessary to use arterial blood to assess acid-base status; venous sampling is sufficient as the difference between arterial and venous pH/HCO3 is not significant enough to influence diagnosis or management of DKA.&lt;/li&gt;
&lt;li&gt;The patient’s long acting analogue insulin should be continued alongside the FRIII to prevent rebound hyperglycaemia when intravenous treatment is stopped.&lt;/li&gt;
&lt;li&gt;DKA is preventable; patient education and support must be integral to type 1 diabetes mellitus care.&lt;/li&gt;
&lt;/ul&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;BESEN, Bruno AMP; RANZANI, Otavio T.; SINGER, Mervyn. &lt;strong&gt;Management of diabetic ketoacidosis&lt;/strong&gt;. Intensive Care Medicine, v. 49, n. 1, p. 95-98, 2023.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;EVANS, Kate. &lt;strong&gt;Diabetic ketoacidosis: update on management&lt;/strong&gt;. Clinical Medicine, v. 19, n. 5, p. 396, 2019.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Processo ativo de morte</title>
		<link>https://www.aesclepius.com.br/processo-morte/</link>
		<pubDate>Wed, 10 Apr 2024 06:22:00 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/processo-morte/</guid>
		<description>&lt;h2 id=&#34;a-escala-pps1&#34;&gt;A escala PPS[1]&lt;/h2&gt;
&lt;p&gt;Esta escala foi elaborada pela Victoria Hospice Society no Canada para avaliação de pacientes com curto prognóstico de vida, internados ou em regime de hospice.&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;PPS Level&lt;/th&gt;
          &lt;th&gt;Ambulation&lt;/th&gt;
          &lt;th&gt;Activity &amp;amp; Evidence of Disease&lt;/th&gt;
          &lt;th&gt;Self-Care&lt;/th&gt;
          &lt;th&gt;Intake&lt;/th&gt;
          &lt;th&gt;Conscious Level&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;100%&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
          &lt;td&gt;Normal activity &amp;amp; work&lt;br&gt;No evidence of disease&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
          &lt;td&gt;Normal&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;90%&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
          &lt;td&gt;Normal activity &amp;amp; work&lt;br&gt;Some evidence of disease&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
          &lt;td&gt;Normal&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;80%&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
          &lt;td&gt;Normal activity with Effort&lt;br&gt;Some evidence of disease&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
          &lt;td&gt;Normal or reduced&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;70%&lt;/td&gt;
          &lt;td&gt;Reduced&lt;/td&gt;
          &lt;td&gt;Unable of normal Job/Work&lt;br&gt;Significant disease&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
          &lt;td&gt;Normal or reduced&lt;/td&gt;
          &lt;td&gt;Full&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;60%&lt;/td&gt;
          &lt;td&gt;Reduced&lt;/td&gt;
          &lt;td&gt;Unable to hobby/house work&lt;br&gt;Significant disease&lt;/td&gt;
          &lt;td&gt;Occasional assistance necessary&lt;/td&gt;
          &lt;td&gt;Normal or reduced&lt;/td&gt;
          &lt;td&gt;Full or Confusion&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;50%&lt;/td&gt;
          &lt;td&gt;Mainly Sit/Lie&lt;/td&gt;
          &lt;td&gt;Unable to do any work&lt;br&gt;Extensive disease&lt;/td&gt;
          &lt;td&gt;Considerable assistance required&lt;/td&gt;
          &lt;td&gt;Normal or reduced&lt;/td&gt;
          &lt;td&gt;Full or Confusion&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;40%&lt;/td&gt;
          &lt;td&gt;Mainly in Bed&lt;/td&gt;
          &lt;td&gt;Unable to do most activity&lt;br&gt;Extensive disease&lt;/td&gt;
          &lt;td&gt;Mainly assistance&lt;/td&gt;
          &lt;td&gt;Normal or reduced&lt;/td&gt;
          &lt;td&gt;Full or Drowsy&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;30%&lt;/td&gt;
          &lt;td&gt;Totally Bed Bound&lt;/td&gt;
          &lt;td&gt;Unable to do any activity&lt;br&gt; Extensive disease&lt;/td&gt;
          &lt;td&gt;Total Care&lt;/td&gt;
          &lt;td&gt;Normal or reduced&lt;/td&gt;
          &lt;td&gt;Full or Drowsy&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;20%&lt;/td&gt;
          &lt;td&gt;Totally Bed Bound&lt;/td&gt;
          &lt;td&gt;Unable to do any activity&lt;br&gt; Extensive disease&lt;/td&gt;
          &lt;td&gt;Total Care&lt;/td&gt;
          &lt;td&gt;Minimal to sips&lt;/td&gt;
          &lt;td&gt;Full or Drowsy&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;10%&lt;/td&gt;
          &lt;td&gt;Totally Bed Bound&lt;/td&gt;
          &lt;td&gt;Unable to do any activity&lt;br&gt; Extensive disease&lt;/td&gt;
          &lt;td&gt;Total Care&lt;/td&gt;
          &lt;td&gt;Mouth care only&lt;/td&gt;
          &lt;td&gt;Drowsy or Coma&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;0%&lt;/td&gt;
          &lt;td&gt;Death&lt;/td&gt;
          &lt;td&gt;-&lt;/td&gt;
          &lt;td&gt;-&lt;/td&gt;
          &lt;td&gt;-&lt;/td&gt;
          &lt;td&gt;-&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;indicativos-do-processo-ativo-de-morte&#34;&gt;Indicativos do processo ativo de morte&lt;/h2&gt;
&lt;p&gt;O seguintes indicativos devem ser reportados em prontuário do doente em cuidados paliativos e para familiares sempre que surgirem ou acontecerem mudanças:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;PPS &amp;lt; 20%&lt;/li&gt;
&lt;li&gt;Rebaixamento do nível de consciência&lt;/li&gt;
&lt;li&gt;Delirium hipo ou hiperativo&lt;/li&gt;
&lt;li&gt;Disfunção renal/redução do débito urinário&lt;/li&gt;
&lt;li&gt;Apneia, taquipneia, bradipneia ou Cheyne-Stokes&lt;/li&gt;
&lt;li&gt;Pulso radial fino ou ausente&lt;/li&gt;
&lt;li&gt;Cianose de extremidades&lt;/li&gt;
&lt;li&gt;Sororoca¹&lt;/li&gt;
&lt;li&gt;Disfagia para líquidos&lt;/li&gt;
&lt;li&gt;Anorexia&lt;/li&gt;
&lt;li&gt;Ausência de fechamento palpebral&lt;/li&gt;
&lt;li&gt;Queda de mandíbula&lt;/li&gt;
&lt;li&gt;Respiração mandibular&lt;/li&gt;
&lt;li&gt;Taquicardia sustentada&lt;/li&gt;
&lt;li&gt;Resposta reduzida ao estímulo visual&lt;/li&gt;
&lt;li&gt;Resposta reduzida ao estímulo verbal&lt;/li&gt;
&lt;li&gt;Sangramento novo de trato gastrointestinal&lt;/li&gt;
&lt;li&gt;Pupilas não reagentes&lt;/li&gt;
&lt;li&gt;Hiperextensão do pescoço&lt;/li&gt;
&lt;li&gt;Úlcera terminal de Kennedy²&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Roncos de transmissão bulhares, grossos e geralmente inspiratórios.&lt;/li&gt;
&lt;li&gt;Úlcera de pressão com desenvolvimento rápido. Diz-se, normalmente, da úlcera nova, de surgimento facilitado pelo débil enchimento capilar do paciente em processo ativo de morte.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;&lt;strong&gt;The Palliative Performance Scale version 2 (PPSv2)&lt;/strong&gt;. Victoria Hospice Society to the 1st scale published in J Pall Care 9(4): 26-32], 1996. Disponível em: &lt;a href=&#34;http://www.npcrc.org/files/news/palliative_performance_scale_PPSv2.pdf&#34;&gt;http://www.npcrc.org/files/news/palliative_performance_scale_PPSv2.pdf&lt;/a&gt;. BC - Canada.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Simulador de ventilador mecânico</title>
		<link>https://www.aesclepius.com.br/ventilador-mec/</link>
		<pubDate>Sun, 31 Mar 2024 07:49:10 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/ventilador-mec/</guid>
		<description>&lt;p&gt;Estou construindo este embrião de simulador para um ventilador mecânico.&lt;/p&gt;
&lt;p&gt;Se você tem interesse de participar do desenvolvimento, me chame no Telegram em &lt;a href=&#34;https://t.me/fatiservae&#34;&gt;@fatiservae&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Atualmente, busco implementar em tipos seguros de JavaScript a modelagem discutida em uma referência[1].&lt;/p&gt;
&lt;p&gt;Os valores &lt;strong&gt;servem apenas de prova de conceito, AINDA não é um simulador real!&lt;/strong&gt;&lt;/p&gt;
&lt;br&gt;
&lt;style&gt;
    .modulos{
        display: flex;
        margin-left: 5vw;
        flex-wrap: wrap;
        justify-content: start ; 
    }
    .modulo {
        border: var(--bordas);
        width: fit-content;
        padding: 5px;
        margin: 0px;
    }
    .modulo .modulo {
        margin-left: 0px;
        padding: 0px;
    }
    .modulo h2 {
        padding: 0px;
        margin: 0px;
    }
    label {
    }
&lt;/style&gt;
&lt;div class=modulos&gt;
&lt;div class=&#34;calculadoras&#34; id=&#34;dados-clinicos&#34;&gt;
    &lt;h2&gt;Paciente&lt;/h2&gt;
    &lt;label for=&#34;nome&#34;&gt;Nome&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=&#34;text&#34; id=&#34;nome&#34; name=&#34;nome&#34; value=&#34;José&#34;&gt;
    &lt;br&gt;
    &lt;label for=&#34;idade&#34;&gt;Idade(anos)&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=&#34;number&#34; id=&#34;idade&#34; name=&#34;idade&#34; value=32&gt;
    &lt;br&gt;
    &lt;!-- Adicione mais campos conforme necessário --&gt;
    &lt;label for=&#34;condicao&#34;&gt;Condição&lt;/label&gt;
    &lt;br&gt;
    &lt;select id=&#34;condicao&#34; name=&#34;condicao&#34;&gt;
    &lt;option value=&#34;sepse&#34;&gt;Sepse&lt;/option&gt;
    &lt;option value=&#34;pneumonia&#34;&gt;Pneumonia&lt;/option&gt;
    &lt;option value=&#34;pos-cirurgico&#34;&gt;Pós-cirúrgico&lt;/option&gt;
    &lt;!-- Adicione mais opções conforme necessário --&gt;
    &lt;/select&gt;
&lt;/div&gt;
&lt;div class=&#34;calculadoras&#34; id=&#34;ventilador&#34;&gt;
    &lt;h2&gt;Ventilador&lt;/h2&gt;
    &lt;label for=&#34;volTidal&#34;&gt;Volume Tidal(ml)&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=&#34;number&#34; id=&#34;volTidal&#34; name=&#34;volTidal&#34; value=300 max=1000 min=0&gt;
    &lt;br&gt;
    &lt;label for=&#34;fr&#34;&gt;Frequência Respiratória&lt;br&gt;(irpm)&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=&#34;number&#34; id=&#34;fr&#34; value=&#34;20&#34; min=&#34;0&#34; max=&#34;100&#34; step=&#34;1&#34;&gt;
&lt;/div&gt;
&lt;div class=&#34;calculadoras&#34; id=&#34;gasometria&#34;&gt;
    &lt;h2&gt;Gasometria&lt;/h2&gt;
&lt;!-- PH
&lt;input type=&#34;number&#34; id=&#34;ph&#34; max=7.6 min=7.11 name=&#34;ph&#34; step=&#34;0.01&#34; value=7.31&gt; 
--&gt;
    &lt;label for=&#34;ph&#34;&gt;pH&lt;/label&gt;
    &lt;br&gt;
    &lt;p id=ph&gt;&lt;/p&gt;
    &lt;br&gt;
&lt;!-- PCO2
&lt;input type=&#34;number&#34; value=31 id=&#34;pco2&#34; name=&#34;pco2&#34;&gt; 
--&gt;
    &lt;label for=&#34;pco2&#34;&gt;pCO2(mmHg)&lt;/label&gt;
    &lt;br&gt;
    &lt;p id=pco2&gt;&lt;/p&gt;
&lt;!-- 
--&gt;
    &lt;br&gt;
    &lt;label for=&#34;bic&#34;&gt;Bicarbonato(mEq/L)&lt;/label&gt;
    &lt;br&gt;
        &lt;p id=bic&gt;&lt;/p&gt;
        &lt;!--
    &lt;input type=&#34;number&#34; id=&#34;bicarbonato&#34; name=&#34;Bic&#34; step=&#34;0.1&#34; value=16&gt;
        --&gt;
    &lt;br&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;p&gt;&lt;button id=atualizar onclick=atualizar()&gt;Atualizar&lt;/button&gt;&lt;/p&gt;
&lt;script src=&#34;https://cdn.jsdelivr.net/npm/chart.js&#34;&gt;&lt;/script&gt;
&lt;p&gt;&lt;canvas id=&#34;volume&#34;&gt;&lt;/canvas&gt;
&lt;canvas id=&#34;pressao&#34;&gt;&lt;/canvas&gt;
&lt;canvas id=&#34;fluxo&#34;&gt;&lt;/canvas&gt;&lt;/p&gt;
&lt;script src=&#34;../../medicina/simulador-ventilador/ventilador.js&#34;&gt;   
&lt;/script&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;RICHARD, Paštěka; FORJAN, Mathias; DRAUSCHKE, Andreas. &lt;strong&gt;Comparison of mathematical and controlled mechanical lung simulation in active breathing and ventilated state&lt;/strong&gt;. IFAC-PapersOnLine, v. 51, n. 6, p. 42-47, 2018.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Insuficiência cardíaca</title>
		<link>https://www.aesclepius.com.br/insuficiencia-cardiaca/</link>
		<pubDate>Fri, 29 Mar 2024 09:48:00 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/insuficiencia-cardiaca/</guid>
		<description>&lt;h2 id=&#34;icc-nova-vs-doença-descompensada&#34;&gt;ICC nova vs. doença descompensada&lt;/h2&gt;
&lt;p&gt;O paciente com ICC nova, diagnosticada na emergência se apresenta com sintomatologia mais pulmonar, &lt;strong&gt;como dispneia, asculta grosseira ou com creptação e dessaturação periférica&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Por outro lado, aquele que já tem diagnóstico e descompensa tem sinais sistêmicos como edemas, congestão generalizada e hipervolemia. Também traz história compatível, como:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Ingesta excessiva de sal e água;&lt;/li&gt;
&lt;li&gt;Consumo excessivo de álcool e uso de drogas ilícitas;&lt;/li&gt;
&lt;li&gt;Temperatura ambiente elevada;&lt;/li&gt;
&lt;li&gt;Doenças descompensadoras da IC¹;&lt;/li&gt;
&lt;li&gt;Falta de aderência ao tratamento e/ou falta de acesso ao medicamento;&lt;/li&gt;
&lt;li&gt;Esforço físico excessivo;&lt;/li&gt;
&lt;li&gt;Fibrilação atrial aguda ou outras taquiarritmias/bradiarritmias;&lt;/li&gt;
&lt;li&gt;Sobrecarga de líquidos IV durante a internação ou em internação recente;&lt;/li&gt;
&lt;li&gt;Intoxicação digitálica;&lt;/li&gt;
&lt;li&gt;Drogas que retém água ou inibem prostaglandinas: AINEs, esteroides, estrógenos, andrógenos, clorpropamida, glitazonas, minoxidil;&lt;/li&gt;
&lt;li&gt;Drogas inotrópicas negativas: antiarrítmicos do grupo I, antagonistas de cálcio (exceto amlodipina), antidepressivos tricíclicos;&lt;/li&gt;
&lt;li&gt;Drogas miocárdio-tóxicas: citostáticos como a adriamicina;&lt;/li&gt;
&lt;li&gt;Automedicação, terapias alternativas; e&lt;/li&gt;
&lt;li&gt;Fatores sociais (abandono, isolamento social).&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;critérios-de-framingham&#34;&gt;Critérios de Framingham&lt;/h3&gt;
&lt;p&gt;Em caso de suspeita de ICC descompensada, o diagnóstico é clínico através da concomitância de dois critérios maiores ou um maior e dois menores:&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Tipo&lt;/th&gt;
          &lt;th&gt;critérios&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Maiores&lt;/td&gt;
          &lt;td&gt;cardiomegalia, turgência jugular, refluxo hepatojugular, dispneia paroxística noturna, ortopneia, crepitações pulmonares, edema agudo de pulmão e terceira bulha (galope)&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Menores&lt;/td&gt;
          &lt;td&gt;edema de tornozelos, tosse noturna, dispneia aos esforços, hepatomegalia, derrame pleural e frequência cardíaca acima de 120 bpm&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;perfis&#34;&gt;Perfis&lt;/h2&gt;
&lt;p&gt;A classificação atualmente proposta pela Diretriz 2018 é descritiva. As letrinhas ABCL/ABCD é um &lt;a href=&#34;../../medicina/abaixo-a-medicina/#tara-taxon%C3%B4mica&#34;&gt;cacoete médico risível&lt;/a&gt;. &lt;strong&gt;Nã́o tem essa de paciente tipo C. É paciente frio e úmido!&lt;/strong&gt; Porém, como se trata de uma besteira em voga, é preciso saber:&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Perfil&lt;/th&gt;
          &lt;th&gt;Descrição&lt;/th&gt;
          &lt;th&gt;Conduta&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;A&lt;/td&gt;
          &lt;td&gt;quente e seco&lt;/td&gt;
          &lt;td&gt;alta e ambulatório&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;B&lt;/td&gt;
          &lt;td&gt;quente e úmido&lt;/td&gt;
          &lt;td&gt;terapia diurética&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;C&lt;/td&gt;
          &lt;td&gt;frio e úmido&lt;/td&gt;
          &lt;td&gt;terapias diurética e inotrópica&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;L/D&lt;/td&gt;
          &lt;td&gt;frio e seco&lt;/td&gt;
          &lt;td&gt;fluidoterapia parcimoniosa&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;classificação-por-fração-de-ejeção&#34;&gt;Classificação por fração de ejeção&lt;/h2&gt;
&lt;h3 id=&#34;preservada&#34;&gt;Preservada&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h3 id=&#34;reduzida&#34;&gt;Reduzida&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Prescrição&lt;/strong&gt;: Sacubitril com valsartana.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;manejo-imediato&#34;&gt;Manejo imediato&lt;/h2&gt;
&lt;p&gt;
 
&lt;div class=&#34;carousel&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  
    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;ICC crônica agudizada&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/icc-agudizada.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;

    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;ICC aguda nova&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/icc-aguda-nova.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior&#34;);
  let proximo = document.getElementById(&#34;proximo&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;br&gt;&lt;/p&gt;
&lt;h3 id=&#34;terapia-inotrópica&#34;&gt;Terapia inotrópica&lt;/h3&gt;
&lt;blockquote&gt;
&lt;p&gt;Após retorno da estabilidade hemodinâmica e início do tratamento da causa, desmame dobutamina de forma extremamente lenta e cautelosa.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h3 id=&#34;terapia-diurética&#34;&gt;Terapia diurética&lt;/h3&gt;
&lt;h3 id=&#34;vasodilatação&#34;&gt;Vasodilatação&lt;/h3&gt;
&lt;blockquote&gt;
&lt;p&gt;Vasodilate o paciente o máximo tolerável pela estabilidade hemodinâmica.&lt;/p&gt;
&lt;p&gt;Tolere hipotensão desde que tenha certeza clínica da boa perfusão.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h3 id=&#34;calculadora-de-score-adhere-2&#34;&gt;Calculadora de score ADHERE [2]&lt;/h3&gt;
&lt;p&gt;Ao internar o paciente com insuficiência cardíaca, estime sua mortalidade para ajuste de condutas, expectativas e orientações. O &lt;em&gt;score&lt;/em&gt; validado é o Acute Decompensated Heart Failure National Registry (ADHERE).&lt;/p&gt;
&lt;div class=calculadoras&gt;
    &lt;label for=bun&gt;Nitrogênio ureico&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number placeholder=mg/dL id=bun required&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=pa&gt;Pressão sistólica&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number placeholder=mmHg id=pa required&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=cr&gt;Creatinina&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number placeholder=mg/dL id=cr required&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;p id=resultadoADHERE&gt;&lt;/p&gt;
    &lt;button style=&#34;display:none;&#34; id=buttonCopiarADHERE onclick=copiarADHERE()&gt;Copiar resultado&lt;/button&gt;
    &lt;br&gt;
    &lt;button onclick=adhere()&gt;Calcular&lt;/button&gt;
&lt;/div&gt;
&lt;script src=../../adhere.js&gt;&lt;/script&gt;
&lt;h2 id=&#34;conduta-concomitante-e-alta&#34;&gt;Conduta concomitante e alta&lt;/h2&gt;
&lt;p&gt;Considere:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Dosagem de peptídeo natiurético²;&lt;/li&gt;
&lt;li&gt;Ecocardiografia e eletrocardiografia;&lt;/li&gt;
&lt;li&gt;Monitorar balanços hidroeletrolíticos, função tireoideana, cinética do ferro e hematimetria;&lt;/li&gt;
&lt;li&gt;Radiografar o tórax³;&lt;/li&gt;
&lt;li&gt;Agendar reavaliação clínica preferencialmente em 7 a 14 dias após a alta;&lt;/li&gt;
&lt;/ol&gt;
&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Hipertensão arterial sistêmica, tromboembolismo pulmonar, isquemia miocárdica, disfunção tireoidiana, diabetes descompensado, infecções, insuficiência renal, gravidez, depressão etc.&lt;/li&gt;
&lt;li&gt;Para esclarecimento diagnóstico &lt;strong&gt;se houver dúvida&lt;/strong&gt; e para estratificação prognóstica no acompanhamento ambulatorial com o cardiologista. O pepitídeo natiurético baixo tem alto valor preditivo negativo.&lt;/li&gt;
&lt;li&gt;Avaliar a necessidade de radiografar para fins documentais do índice cardiotorácico e das condições de alta.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Rohde LEP, Montera MW, Bocchi EA, Clausell NO, Albuquerque DC, Rassi S, Colafranceschi AS, et al. &lt;strong&gt;Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda&lt;/strong&gt;. Arq. Bras. Cardiol. 2018;111(3):436-59.&lt;/li&gt;
&lt;li&gt;Rey, H., Rangel, F., Bittencourt, M. et al. &lt;strong&gt;Validation of the ADHERE model for risk stratification in patients with acute heart failure admitted to the critical care unit&lt;/strong&gt;. Crit Care 9 (Suppl 2), P35 (2005). &lt;a href=&#34;https://doi.org/10.1186/cc3579&#34;&gt;https://doi.org/10.1186/cc3579&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Monitorando a sedação: RASS/SAS/FOUR</title>
		<link>https://www.aesclepius.com.br/sedacao/</link>
		<pubDate>Sun, 24 Mar 2024 19:54:15 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/sedacao/</guid>
		<description>&lt;h2 id=&#34;richmond-agitation-sedation-scale---rass&#34;&gt;Richmond agitation sedation scale - RASS&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Score&lt;/th&gt;
          &lt;th&gt;Termos&lt;/th&gt;
          &lt;th&gt;Descrição&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;+4&lt;/td&gt;
          &lt;td&gt;Combativo&lt;/td&gt;
          &lt;td&gt;Violento, perigo à equipe&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;+3&lt;/td&gt;
          &lt;td&gt;Muito agitado&lt;/td&gt;
          &lt;td&gt;Retira dispositivos e agride&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;+2&lt;/td&gt;
          &lt;td&gt;Agitado&lt;/td&gt;
          &lt;td&gt;Se move muito, luta com ventilador&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;+1&lt;/td&gt;
          &lt;td&gt;Impaciente&lt;/td&gt;
          &lt;td&gt;Ansioso, movimentos não-vigorosos&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;0&lt;/td&gt;
          &lt;td&gt;Alerta e calmo&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;-1&lt;/td&gt;
          &lt;td&gt;Sonolento&lt;/td&gt;
          &lt;td&gt;Responde contato verbal com contato visual por mais de 10s&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;-2&lt;/td&gt;
          &lt;td&gt;Sedação leve&lt;/td&gt;
          &lt;td&gt;Responde contato verbal com contato visual por menos de 10s&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;-3&lt;/td&gt;
          &lt;td&gt;Sedação moderada&lt;/td&gt;
          &lt;td&gt;Abre os olhos ao contato verbal sem contato visual sustentado&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;-4&lt;/td&gt;
          &lt;td&gt;Sedação profunda&lt;/td&gt;
          &lt;td&gt;Irresponsivo a comandos verbais, apenas estímulo físico&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;-5&lt;/td&gt;
          &lt;td&gt;Não desperta&lt;/td&gt;
          &lt;td&gt;Nenhuma resposta a nenhum estímulo&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;sedation-agitation-scale---sas&#34;&gt;Sedation agitation scale - SAS&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Pontuação&lt;/th&gt;
          &lt;th&gt;Termo&lt;/th&gt;
          &lt;th&gt;Descrição&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;7&lt;/td&gt;
          &lt;td&gt;Agitação perigosa&lt;/td&gt;
          &lt;td&gt;Arrancando o tubo endotraqueal ou cateteres, tentando remover cateteres, subindo na grade da cama, batendo na equipe, se debatendo de lado a lado.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;6&lt;/td&gt;
          &lt;td&gt;Muito agitado&lt;/td&gt;
          &lt;td&gt;Não se acalma, apesar de frequentes lembretes verbais dos limites; requer restrições físicas, mordendo o tubo endotraqueal.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;5&lt;/td&gt;
          &lt;td&gt;Agitado&lt;/td&gt;
          &lt;td&gt;Ansioso ou levemente agitado, tentando se sentar, se acalma com instruções verbais.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;4&lt;/td&gt;
          &lt;td&gt;Calmo e cooperativo&lt;/td&gt;
          &lt;td&gt;Calmo, acorda facilmente, segue comandos.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;3&lt;/td&gt;
          &lt;td&gt;Sedado&lt;/td&gt;
          &lt;td&gt;Dificil de despertar, acorda com estímulos verbais ou agitação suave, mas volta a dormir, segue comandos simples.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;2&lt;/td&gt;
          &lt;td&gt;Muito sedado&lt;/td&gt;
          &lt;td&gt;Desperta com estímulos físicos, mas não se comunica ou segue comandos, pode se mover espontaneamente.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;1&lt;/td&gt;
          &lt;td&gt;Inconsciente&lt;/td&gt;
          &lt;td&gt;Resposta mínima ou nenhuma a estímulos nocivos, não se comunica ou segue comandos.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;full-outline-of-unresponsiveness-score---four-2&#34;&gt;Full outline of unresponsiveness score - FOUR [2]&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Legenda&lt;/th&gt;
          &lt;th&gt;E - Eye; M - motor; B - brain; R - respiration&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;E4&lt;/td&gt;
          &lt;td&gt;Abre os olhos, pisca e acompanha ao comando&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;E3&lt;/td&gt;
          &lt;td&gt;Abre os olhos, mas não acompanha comando&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;E2&lt;/td&gt;
          &lt;td&gt;Abre os olhos ao chamado vigoroso&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;E1&lt;/td&gt;
          &lt;td&gt;Abre os olhos ao estímulo doloroso&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;E0&lt;/td&gt;
          &lt;td&gt;Não abre os olhos&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;M4&lt;/td&gt;
          &lt;td&gt;Obedece com &amp;ldquo;joinha&amp;rdquo; ou outro sinal&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;M3&lt;/td&gt;
          &lt;td&gt;Localiza dor/estímulo doloroso&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;M2&lt;/td&gt;
          &lt;td&gt;Flexiona como resposta a dor&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;M1&lt;/td&gt;
          &lt;td&gt;Extende como resposta a dor&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;M0&lt;/td&gt;
          &lt;td&gt;Sem movimentos ou mioclonia generalizada&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;B4&lt;/td&gt;
          &lt;td&gt;Reflexos pupilar e córneo presentes&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;B3&lt;/td&gt;
          &lt;td&gt;Uma pupila midriática&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;B2&lt;/td&gt;
          &lt;td&gt;Ausente o reflexo pupilar ou córneo&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;B1&lt;/td&gt;
          &lt;td&gt;Ausente o reflexo pupilar e córneo&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;B0&lt;/td&gt;
          &lt;td&gt;Ausente o reflexo pupilar, córneo e de tosse&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;R4&lt;/td&gt;
          &lt;td&gt;Não intubado, respiração regular&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;R3&lt;/td&gt;
          &lt;td&gt;Não intubado, respiração de Cheyne-Stokes&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;R2&lt;/td&gt;
          &lt;td&gt;Não intubado, respiração irregular&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;R1&lt;/td&gt;
          &lt;td&gt;Respira acima do ritmo de ventilador&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;R0&lt;/td&gt;
          &lt;td&gt;Respira no ritmo do ventilar ou em apneia&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;MOTES, Arunee. &lt;strong&gt;Monitoring sedation during mechanical ventilation&lt;/strong&gt;. The Southwest Respiratory and Critical Care Chronicles, v. 10, n. 45, p. 19-27, 2022.&lt;/li&gt;
&lt;li&gt;Almojuela A, Hasen M, Zeiler FA. &lt;strong&gt;The Full Outline of UnResponsiveness (FOUR) Score and Its Use in Outcome Prediction: A Scoping Systematic Review of the Adult Literature&lt;/strong&gt;. Neurocrit Care. 2019 Aug;31(1):162-175. doi: 10.1007/s12028-018-0630-9. PMID: 30411302.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Eletrocardiograma</title>
		<link>https://www.aesclepius.com.br/eletrocardiograma/</link>
		<pubDate>Fri, 22 Mar 2024 16:15:54 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/eletrocardiograma/</guid>
		<description>&lt;meta name=&#34;description&#34;
  content=&#34;Tudo sobre eletrocardiograma com ilustrações, exemplos e fluxogramas de conduta!&#34;&gt;
&lt;meta name=&#34;keywords&#34;
  content=&#34;eletrocardiograma, ecg, eletro, infarto, conduta iam, síndrome coronariana aguda, sca com supra, supradesnivelamento, fibrilação atrial, bloqueio de ramo esquerdo, bloqueio de ramo direito, artigos de saúde, conteúdo médico, educação médica, doenças, tratamentos, prevenção, pesquisas médicas, blog de saúde&#34;&gt;
&lt;meta name=&#34;keywords&#34;
  content=&#34;fluxogramas, conduta, diagnóstico, cardiologia, calculadoras médicas, artigos médicos, saúde, bem-estar, medicina, especialistas em saúde, consulta online, doenças, tratamentos, diagnóstico médico, telemedicina&#34;&gt;
&lt;meta name=&#34;robots&#34; content=&#34;index, follow&#34;&gt;
&lt;h2 id=&#34;intro&#34;&gt;Intro&lt;/h2&gt;
&lt;p&gt;Este é um compêndio de eletrocardiogramas de condições incomuns, de acordo melhores manuais&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt; e outras referências.&lt;/p&gt;
&lt;!--
## O eletrocardiograma normal adulto
## O eletrocardiograma normal pediátrico 
--&gt;
&lt;h3 id=&#34;geometria-do-eletrocardiograma&#34;&gt;Geometria do eletrocardiograma&lt;/h3&gt;


&lt;div class=&#34;scalidraw&#34;&gt;
&lt;?xml version=&#34;1.0&#34; encoding=&#34;UTF-8&#34; standalone=&#34;no&#34;?&gt;
&lt;!-- Created with Inkscape (http://www.inkscape.org/) --&gt;

&lt;svg
   version=&#34;1.1&#34;
   id=&#34;svg1&#34;
   width=&#34;950&#34;
   height=&#34;850&#34;
   viewBox=&#34;0 0 950 850&#34;
   sodipodi:docname=&#34;card.svg&#34;
   inkscape:export-filename=&#34;card.svg&#34;
   inkscape:export-xdpi=&#34;96&#34;
   inkscape:export-ydpi=&#34;96&#34;
   inkscape:version=&#34;1.4 (e7c3feb100, 2024-10-09)&#34;
   xmlns:inkscape=&#34;http://www.inkscape.org/namespaces/inkscape&#34;
   xmlns:sodipodi=&#34;http://sodipodi.sourceforge.net/DTD/sodipodi-0.dtd&#34;
   xmlns=&#34;http://www.w3.org/2000/svg&#34;
   xmlns:svg=&#34;http://www.w3.org/2000/svg&#34;&gt;
  &lt;sodipodi:namedview
     id=&#34;namedview1&#34;
     pagecolor=&#34;#ffffff&#34;
     bordercolor=&#34;#000000&#34;
     borderopacity=&#34;0.25&#34;
     inkscape:showpageshadow=&#34;2&#34;
     inkscape:pageopacity=&#34;0.0&#34;
     inkscape:pagecheckerboard=&#34;0&#34;
     inkscape:deskcolor=&#34;#d1d1d1&#34;
     inkscape:zoom=&#34;0.93359375&#34;
     inkscape:cx=&#34;499.14644&#34;
     inkscape:cy=&#34;446.12552&#34;
     inkscape:window-width=&#34;2560&#34;
     inkscape:window-height=&#34;1559&#34;
     inkscape:window-x=&#34;0&#34;
     inkscape:window-y=&#34;41&#34;
     inkscape:window-maximized=&#34;1&#34;
     inkscape:current-layer=&#34;svg1&#34; /&gt;
  &lt;defs
     id=&#34;defs1&#34;&gt;
    &lt;clipPath
       clipPathUnits=&#34;userSpaceOnUse&#34;
       id=&#34;clipPath1&#34;&gt;
      &lt;rect
         style=&#34;opacity:0.59;fill:var(--fonte)&#34;
         id=&#34;rect2&#34;
         width=&#34;936.16736&#34;
         height=&#34;889.03766&#34;
         x=&#34;13.924686&#34;
         y=&#34;249.57323&#34; /&gt;
    &lt;/clipPath&gt;
  &lt;/defs&gt;
  &lt;g
     id=&#34;g1&#34;
     transform=&#34;translate(-4.2845196,-260.28452)&#34;
     clip-path=&#34;url(#clipPath1)&#34;
     stroke=&#34;var(--fonte)&#34;
     fill=&#34;var(--fonte)&#34;&gt;
    &lt;path
       id=&#34;path1&#34;
       style=&#34;fill:var(--fonte)&#34;
       d=&#34;m 0,0 v 196 c 0,29.10028 0.07090075,33.85539 0.0859375,55.08984 2.2555463,-1.28605 4.5497749,-2.53899 8.2910156,-4.46484 12.8887699,-6.63463 26.2850819,-12.24806 39.7324219,-17.63086 23.613975,-9.02209 47.575807,-17.31114 72.261715,-22.91016 5.3222,-24.00888 31.76375,-45.11474 79.21875,-42.99023 0.53945,0.0241 1.07969,0.0501 1.61914,0.0742 11.8951,-0.25088 23.76875,-1.25664 35.61719,-2.2793 16.51517,-1.71726 32.9598,-3.99916 49.30664,-6.92773 16.67186,-2.67737 33.38194,-5.28227 50.23828,-6.48242 15.68367,-0.77847 31.3747,-0.89694 47.07618,-0.83594 15.28167,-0.074 30.56301,-0.17216 45.84179,-0.49805 19.19647,-0.43686 38.39474,-1.01719 57.55469,-2.33203 20.73033,-1.55189 41.41706,-3.55597 62.02734,-6.29688 0.69069,-0.0838 1.38158,-0.16624 2.07227,-0.25 8.14592,-12.17108 23.1109,-20.63597 43.35547,-21.36328 13.91509,-0.49991 30.26416,2.6197 48.46484,10.6211 9.3167,4.09582 19.06389,6.81493 28.91602,9.25195 24.83138,4.66998 49.20298,11.37187 73.70312,17.4707 9.77689,2.43377 19.57661,4.77208 29.36524,7.15821 22.02322,5.36851 37.98958,14.39961 48.76953,24.94922 3.52821,1.01224 7.02886,2.17538 10.07617,3.30078 13.23667,4.88843 25.88018,11.01686 38.55859,17.16797 24.8771,12.25835 48.89926,26.11848 72.15039,41.21289 5.38174,3.47531 10.57769,7.20438 15.69727,11.03515 V 191.08008 0 H 480 Z m 410.44336,274.5625 c -0.5374,-0.18335 -0.97961,0.11633 -1.65039,0.78711 -0.82839,0.82839 -2.69435,1.37446 -4.14844,1.21484 -4.07723,-0.44756 -11.84177,3.68943 -16.04687,8.54883 -2.08809,2.41299 -3.53246,3.57506 -3.20899,2.58399 0.3339,-1.02302 0.17545,-1.54631 -0.36719,-1.21094 -0.52566,0.32489 -0.74489,1.81156 -0.48632,3.30273 0.25858,1.49118 0.6256,3.83594 0.81445,5.21094 0.18885,1.375 0.63394,3.175 0.99023,4 0.35629,0.825 1.76975,5.27112 3.14063,9.88086 1.37088,4.60975 3.06097,9.07758 3.75586,9.92773 1.08083,1.32232 1.0083,1.40565 -0.5,0.57227 -1.08723,-0.60072 -4.98866,-0.66625 -10.17969,-0.16797 -11.93715,1.14582 -19.88775,5.09487 -33.67383,16.72656 -5.24286,4.42355 -13.36998,16.96835 -15.37304,23.72852 -0.95051,3.20793 -2.54207,8.53203 -3.53711,11.83203 -6.69038,22.18836 -6.23249,18.72668 -5.66993,42.82812 0.45888,19.6599 0.85689,23.7583 3.51563,36.17188 1.64918,7.7 3.4597,15.4625 4.02148,17.25 1.67749,5.33757 -3.18489,3.7218 -6.69336,-2.22461 -4.93672,-8.36711 -16.84909,-11.99202 -24.52539,-7.46289 -2.42239,1.42924 -5.48132,2.11555 -9.96875,2.24023 -3.56005,0.0989 -6.26175,0.52226 -6.0039,0.93946 0.25785,0.41721 -1.16909,0.75781 -3.17188,0.75781 -3.21769,0 -4.53326,0.90382 -11.30859,7.76562 -4.21717,4.27099 -11.04297,12.8267 -15.16797,19.01368 -4.125,6.18697 -9.58524,14.05482 -12.13281,17.48437 -3.05999,4.11936 -5.40817,8.78163 -6.91992,13.73633 -1.25861,4.125 -2.41238,7.66335 -2.56446,7.86328 -0.24988,0.32849 -15.80527,-8.32936 -32.18945,-17.91601 -6.59429,-3.85842 -6.56319,-4.9579 0.13867,-4.9375 1.74251,0.005 7.51836,-0.52925 12.83594,-1.1875 7.24021,-0.89627 10.88177,-0.91414 14.5,-0.0742 3.85879,0.89562 5.10837,0.85009 6.20117,-0.21875 4.0908,-4.00106 -3.07423,-4.68949 -28.18359,-2.71094 l -19.81446,1.56055 -12.43164,-6.29102 c -11.34308,-5.74048 -14.87131,-8.63411 -9.19531,-7.54101 2.84053,0.54701 7.75586,-1.62647 7.75586,-3.42969 0,-1.07589 -1.08704,-1.26915 -4.75,-0.83985 -2.6125,0.30619 -6.775,0.13521 -9.25,-0.38086 -10.24855,-2.13693 -12,-2.2334 -12,-0.66601 0,1.07568 -0.74021,1.35111 -2.64844,0.98633 -1.82828,-0.3495 -2.42986,-0.15168 -1.9414,0.63867 0.38921,0.62975 1.58089,1.14453 2.64843,1.14453 1.43004,0 1.94141,0.69415 1.94141,2.63477 0,5.04872 2.17965,10.36523 4.25,10.36523 1.71946,0 1.89631,-0.61152 1.5918,-5.50195 -0.18836,-3.02575 -0.24979,-5.50075 -0.13672,-5.5 0.11308,7.5e-4 1.83314,1.10717 3.82226,2.45703 1.98912,1.34985 8.32295,4.74502 14.07422,7.54687 5.75126,2.80185 10.20283,5.50582 9.89258,6.00782 -0.31026,0.502 -2.11864,1.20393 -4.01953,1.56054 -1.92179,0.36053 -3.18263,1.09185 -2.83984,1.64649 0.3754,0.60742 -0.17431,0.74585 -1.4043,0.35547 -1.1304,-0.35878 -2.61647,-0.074 -3.375,0.64453 -0.74545,0.70617 -3.15547,1.39457 -5.35547,1.53125 -8.16989,0.50755 -34.06313,7.82525 -44.81641,12.66601 -14.36308,6.46577 -32.177402,15.82845 -38.396481,20.17969 -6.9767,4.88132 -20.088408,17.50964 -26.287109,25.31641 -4.617776,5.81573 -8.991999,13.29371 -8.367188,14.30468 0.274415,0.44401 -0.880185,2.18683 -2.566406,3.87305 C 41.380184,587.77399 40,589.96806 40,590.96289 c 0,0.99482 -0.672114,3.09651 -1.494141,4.67188 -0.822027,1.57537 -1.764547,4.44023 -2.09375,6.36523 -0.329203,1.925 -2.10396,7.65447 -3.943359,12.73242 l -3.34375,9.23242 3.396484,5.64063 c 1.867917,3.10199 4.594531,9.2975 6.060547,13.76758 1.466016,4.47007 3.605548,9.70195 4.753907,11.62695 5.184598,8.69098 27.730782,29.04051 36.005859,32.49805 4.073212,1.7019 4.273801,2.5329 2.548828,10.57617 -0.897235,4.18366 -0.849436,5.3366 0.25,6.0332 1.015435,0.64338 1.040226,0.8655 0.09766,0.87696 -3.402332,0.0413 3.12909,20.52791 8.175781,25.64453 1.697463,1.72098 3.751656,4.09101 4.566407,5.26562 2.53363,3.65269 18.019527,8.1844 18.019527,5.27344 0,-0.78657 -11.52137,-6.48324 -13.367184,-6.60938 -1.639195,-0.11202 -8.640418,-9.05967 -8.134765,-10.39648 0.278321,-0.73581 -0.385363,-2.08581 -1.474609,-3 C 87.721154,719.22986 85,709.51607 85,703.23242 85,697.13728 86.952319,690 88.619141,690 c 1.707528,0 1.836538,-2.68209 0.15625,-3.24219 -0.846734,-0.28224 -0.20903,-2.46765 2.070312,-7.09765 1.811684,-3.68005 3.72505,-6.426 4.25,-6.10157 0.524951,0.32444 0.830815,0.16136 0.679688,-0.36328 -0.461763,-1.60302 4.246949,-7.29933 5.429689,-6.56836 0.61441,0.37973 0.82378,0.23024 0.47265,-0.33789 -0.34701,-0.56148 0.2122,-1.78467 1.24219,-2.71679 1.45885,-1.32024 1.9877,-1.4042 2.39649,-0.38282 0.35385,0.88409 0.5522,0.76349 0.60547,-0.37109 0.0653,-1.3921 1.65501,-2.4433 5.07812,-3.35352 0.275,-0.0731 1.625,-0.59078 3,-1.15039 3.98215,-1.62071 9.18041,-2.41555 8.49023,-1.29883 -0.3348,0.54175 -0.13128,0.98438 0.45118,0.98438 0.58246,0 1.05859,-0.47297 1.05859,-1.05078 0,-1.82179 12.03238,0.0322 17.19922,2.65039 2.64094,1.33826 4.80078,2.85459 4.80078,3.36914 0,0.51454 2.1375,3.09569 4.75,5.73437 6.8457,6.91432 10.44028,16.58382 11.04102,29.70118 0.53519,11.68598 -0.94755,19.31164 -4.89258,25.16211 C 153.45797,728.66859 141.46195,739 138.97852,739 c -1.02355,0 -2.10581,0.39864 -2.40625,0.88477 -0.80107,1.29615 -9.25848,5.11637 -11.31055,5.10937 -0.9685,-0.003 -3.0662,-0.68633 -4.66016,-1.51758 -3.37472,-1.75993 -8.1656,-1.17864 -13.85156,1.67969 -4.44758,2.23579 -5.14113,4.47884 -1,3.23437 3.29785,-0.99103 10.23173,-0.95998 15.82031,0.0723 3.5816,0.66143 5.23104,0.20556 13.76367,-3.80859 8.33445,-3.92091 10.85265,-5.73327 17.93164,-12.91211 4.52924,-4.59311 8.92832,-9.39924 9.77735,-10.67969 1.92053,-2.89643 4.76848,-2.23162 7.19336,1.67969 1.37149,2.21221 1.71503,2.38729 1.73633,0.88086 0.0233,-1.64679 0.55019,-1.79468 4.27734,-1.19922 3.97617,0.63524 7.70501,2.57617 4.94922,2.57617 -0.66,0 -1.19922,0.45522 -1.19922,1.01172 0,0.61283 1.50936,0.77118 3.82812,0.40039 2.53383,-0.40518 6.4301,0.11627 11.52149,1.54492 4.23105,1.18723 12.52109,3.16648 18.42187,4.39649 l 10.72852,2.23632 0.75195,11.45508 c 0.65273,9.94064 1.16807,12.30398 3.89453,17.8711 3.18854,6.51061 12.17586,17.28745 16.81055,20.1582 4.2223,2.61531 11.71287,4.03864 17.33399,3.29297 5.8412,-0.77486 14.61322,-4.34123 16.61718,-6.75586 1.17292,-1.41328 0.98083,-1.55982 -1.64648,-1.25391 -3.50444,0.40803 -5.48815,1.46687 -4.8086,2.56641 0.26712,0.43221 -0.73872,0.7977 -2.23437,0.8125 -1.49565,0.0148 -5.64375,0.25275 -9.21875,0.52734 -6.78559,0.52119 -15.56518,-1.78102 -17.13086,-4.49219 -0.40356,-0.69881 -2.79772,-3.44038 -5.32031,-6.09179 -7.43891,-7.81879 -9.51183,-12.98643 -10.63477,-26.51172 -1.30677,-15.73953 0.58511,-26.23115 7.07227,-39.20117 2.96465,-5.92736 12.7577,-16.9668 15.05078,-16.9668 0.49525,0 0.6408,-0.675 0.32422,-1.5 -0.44513,-1.15998 0.18522,-1.47749 2.78125,-1.40039 3.19686,0.0949 3.23817,0.14231 0.85742,0.98633 -1.65284,0.58596 -0.80568,0.6442 2.5,0.17383 2.75,-0.39131 8.44768,-0.71937 12.66211,-0.73047 7.08179,-0.0186 7.95348,0.2127 11.5,3.0664 2.11057,1.69826 5.11871,4.97838 6.68359,7.28907 2.28216,3.3698 3.12116,3.974 4.23828,3.04687 1.17296,-0.97347 1.054,-1.65254 -0.7539,-4.29492 -3.2726,-4.78315 -8.03917,-9.65398 -10.92383,-11.16602 -1.42649,-0.74772 -5.02649,-1.61188 -8,-1.91992 -2.97351,-0.30803 -4.73125,-0.2563 -3.90625,0.11524 2.3437,1.05549 -8.48333,3.14561 -13.41406,2.58984 -2.36134,-0.26615 -5.19917,10e-4 -6.30664,0.59375 -1.9612,1.0496 -1.95065,0.85266 0.41211,-7.63477 1.81827,-6.53152 3.07654,-9.20265 5.02343,-10.66211 3.62138,-2.71474 9.33438,-15.52987 9.99414,-22.41992 0.29667,-3.09817 2.10203,-9.32499 4.01368,-13.83789 3.16082,-7.46183 3.80716,-8.31055 7.12695,-9.36328 C 279.296,621.83858 291,611.59699 291,609.67383 c 0,-0.48921 2.29573,-4.32823 5.10156,-8.53125 3.83477,-5.74433 5.85297,-7.84413 8.13086,-8.45508 2.97203,-0.79712 3.01964,-0.90876 2.44141,-5.79102 -0.5393,-4.55353 -0.39167,-5.05421 1.73633,-5.86328 2.10176,-0.79908 4.27355,-3.04729 7.08984,-7.34179 0.74726,-1.13949 1.59246,-1.29217 3.34375,-0.60547 l 2.34375,0.91797 -2.42969,4.24804 c -2.9402,5.14238 -6.38394,13.97781 -7.30859,18.74805 -0.93445,4.82079 -5.26898,15.0757 -7.39649,17.5 -2.0844,2.37519 -3.44705,5.50783 -3.16211,7.26562 0.11287,0.69624 -0.38013,1.14621 -1.09374,1 -0.71362,-0.1462 -1.17262,0.33022 -1.02149,1.0586 0.15112,0.72838 -0.12707,1.07635 -0.61719,0.77344 -0.49012,-0.30291 -1.61123,0.24531 -2.49218,1.21875 -2.47024,2.72958 -9.6711,18.68709 -9.625,21.33007 0.0717,4.11607 3.41942,17.02315 4.45898,17.19141 0.56687,0.0917 1.31007,-3.95265 1.7168,-9.33789 0.9075,-12.01567 1.41051,-13.99557 3.55273,-14.01562 0.99774,-0.009 3.80822,-2.97448 6.63477,-7 2.69703,-3.8411 5.02869,-6.98438 5.18164,-6.98438 0.35097,0 -0.1519,3.55171 -1.08399,7.66211 -0.44386,1.95735 -1.48471,3.36121 -2.73242,3.6875 -1.69342,0.44284 -1.90878,1.05517 -1.35351,3.83789 0.36345,1.82137 1.1608,8.4875 1.77148,14.8125 0.98119,10.16246 0.86954,13.12831 -0.94922,25.5 -1.26699,8.61843 -1.84606,16.28412 -1.50781,19.94336 l 0.54883,5.94531 -3.24219,-3.69531 C 297.25317,702.66157 295.37552,701 294.86523,701 c -2.31267,0 -1.65255,2.94576 1.38086,6.16211 3.84019,4.07179 5.27418,8.11593 6.94922,19.58789 0.66252,4.5375 1.58185,8.25 2.04102,8.25 0.45917,0 0.35237,0.9 -0.23633,2 -0.76727,1.4336 -0.76064,2 0.0234,2 0.60177,0 0.86665,0.36927 0.58789,0.82031 -0.50981,0.82489 -1.58579,5.38964 -1.92774,8.17969 -0.10111,0.825 -0.43267,1.725 -0.73632,2 -0.30366,0.275 -1.38515,2.3 -2.4043,4.5 -1.81474,3.91741 -5.01269,7.5 -6.69531,7.5 -0.46584,0 -0.84766,1.09371 -0.84766,2.43164 0,1.42219 -0.72689,2.68147 -1.75,3.03125 -0.9625,0.32906 -4.12685,2.78155 -7.03125,5.44922 -4.28056,3.93167 -4.96057,4.97355 -3.59375,5.49805 2.00309,0.76866 8.47435,-3.4445 11.78125,-7.66993 l 2.25977,-2.88671 3.00586,1.82421 c 11.90609,7.22102 25.44628,18.77942 27.33203,23.33204 0.76246,1.84072 1.57656,2.66907 1.98047,2.01562 0.41422,-0.67026 1.82312,0.53392 3.56054,3.04102 1.58168,2.28237 5.33835,6.34324 8.34766,9.02539 3.0093,2.68215 5.27677,5.05121 5.03906,5.26367 -0.2377,0.21246 -8.08164,0.63615 -17.43164,0.94141 -12.03303,0.39277 -19.04522,0.16792 -24,-0.76954 -3.85,-0.72842 -9.7,-1.81123 -13,-2.40625 -18.92296,-3.412 -26.63374,-5.81372 -34.73047,-10.8164 C 251.19146,797.09377 246.69419,795.86362 250,798 c 1.21789,0.78706 1.23655,0.97197 0.0977,0.98438 -2.25963,0.0247 2.83586,3.97766 8.40234,6.51757 7.80641,3.56195 18.45073,6.30051 37.5,9.64844 9.88485,1.73728 13.95784,1.93036 29,1.37891 9.625,-0.35285 18.48128,-0.88123 19.68164,-1.17578 1.39906,-0.3433 4.52902,0.75239 8.71875,3.05468 C 360.54502,822.33437 362,822.70705 362,820.61328 362,819.28298 356.37768,816 354.09961,816 353.49523,816 353,815.49696 353,814.88281 c 0,-0.63306 0.88778,-0.8837 2.04883,-0.58008 1.12642,0.29456 6.18892,-0.12008 11.25,-0.91992 16.38189,-2.58896 15.7012,-2.548 15.06445,-0.88867 -0.826,2.15253 0.42037,1.86346 6.55078,-1.51562 2.97782,-1.64138 5.46344,-2.86931 5.52344,-2.73047 2.88342,6.67838 3.43962,10.10745 2.14453,13.20703 -0.7584,1.8151 -1.87435,3.60782 -2.48047,3.98242 -1.45728,0.90066 -1.42461,3.83687 0.0371,3.34961 0.62607,-0.20869 1.90306,-2.33558 2.83789,-4.72656 1.9289,-4.93344 2.74261,-4.07253 3.72461,3.93945 0.30335,2.475 0.8328,4.725 1.17578,5 0.90556,0.72606 1.24552,10.00645 0.36524,9.96875 -0.40836,-0.0175 -1.61598,-0.6925 -2.6836,-1.5 -4.53181,-3.42769 -4.85497,-0.40125 -0.44336,4.15039 2.89436,2.98621 3.131,3.76818 3.33008,11.04688 0.11784,4.30854 0.56252,8.62148 0.99024,9.58398 0.63281,1.42399 0.28089,1.75 -1.89258,1.75 -1.46908,0 -5.11892,1.11948 -8.11133,2.48828 -2.99242,1.36876 -10.4678,3.39376 -16.61133,4.5 -15.47465,2.78645 -22.37674,2.60067 -18.15234,-0.48828 0.92333,-0.67512 1.3148,-1.71962 0.89648,-2.39648 -0.51455,-0.83256 -1.12177,-0.88683 -1.97851,-0.17579 -1.14446,0.94981 -44.05773,2.82327 -54.58594,2.38282 -21.81085,-0.91246 -31.6842,-2.59641 -40.03125,-6.82617 -4.11238,-2.08376 -4.84993,-2.84779 -4.11719,-4.26172 1.92762,-3.71963 2.2713,-11.1034 0.74219,-15.9336 -0.83399,-2.63444 -2.20794,-13.3174 -3.05469,-23.74023 -0.84675,-10.42283 -1.99327,-19.40343 -2.54687,-19.95703 -0.67539,-0.67539 -1.53941,-0.47232 -2.62696,0.61523 -1.34482,1.34482 -1.42808,2.17297 -0.49023,4.86328 0.62167,1.7833 1.59812,9.58425 2.16992,17.33594 0.57181,7.75169 1.55988,17.01875 2.19531,20.59375 1.29654,7.29453 1.50549,13.58826 0.48633,14.60742 -0.3731,0.3731 -1.36483,0.10783 -2.20312,-0.58789 -1.2171,-1.01014 -1.82564,-1.01379 -3.02344,-0.0195 -2.24231,1.86095 -1.93967,2.37878 3.42578,5.85547 14.31701,9.27711 24.79285,11.20125 61.70508,11.33789 21.77688,0.0806 28.36914,0.39256 28.36914,1.33984 0,1.91413 3.99776,2.26742 20.36133,1.79883 17.83618,-0.51076 21.76357,-1.32508 31.27734,-6.48047 3.92578,-2.12733 8.16958,-3.75132 9.43164,-3.60937 1.85702,0.20888 2.42547,-0.35421 2.97852,-2.95313 0.37582,-1.76627 0.38311,-3.34127 0.0156,-3.5 -0.36736,-0.15873 -0.42086,-2.84716 -0.11718,-5.97265 l 0.55273,-5.68164 10.73438,7.18164 c 14.33467,9.59172 23.72893,15.23857 24.84765,14.93359 0.50437,-0.1375 0.80547,0.17318 0.66797,0.68945 -0.1375,0.51627 5.6,4.55068 12.75,8.9668 7.15,4.41612 15.475,9.83862 18.5,12.04883 3.025,2.2102 8.77319,5.39168 12.77344,7.07031 7.20603,3.02387 7.42005,3.04973 23.19922,2.7832 15.42961,-0.26061 15.94389,-0.33662 16.47461,-2.45117 0.49108,-1.95659 1.22136,-2.18772 7.05078,-2.23242 3.57653,-0.0275 6.50195,0.34024 6.50195,0.81836 0,0.47811 0.97025,0.61483 2.15625,0.30469 1.6175,-0.42299 1.95133,-0.23207 1.33594,0.76367 -0.59646,0.96508 -0.36604,1.15369 0.84375,0.68945 0.91522,-0.3512 1.66406,-0.25578 1.66406,0.21289 0,0.46866 3.0375,1.17518 6.75,1.56836 3.7125,0.39318 7.2,1.05564 7.75,1.47266 1.64005,1.24353 13.42932,3.20768 14.66602,2.44336 0.68415,-0.42282 0.87099,-0.26654 0.46484,0.39062 -0.44883,0.72623 0.93786,1.20217 4.09375,1.4043 9.47415,0.60679 24.21135,-0.57558 33.77539,-2.71094 8.00321,-1.78687 18.41488,-6.59458 21.48438,-9.91992 1.36675,-1.48067 3.92057,-3.37311 5.67382,-4.20508 3.38909,-1.60823 6.3418,-6.54795 6.3418,-10.60937 0,-1.3473 0.45893,-3.76491 1.01953,-5.37305 1.65241,-4.74011 3.25628,-22.80565 3.39258,-38.20703 0.11685,-13.20249 0.28295,-14.4107 2.10742,-15.35547 1.08925,-0.56405 2.98687,-2.21469 4.2168,-3.66797 1.95878,-2.31449 2.48964,-2.48509 4.27344,-1.37109 1.74267,1.08832 2.11574,1.01691 2.58593,-0.5 0.57482,-1.85448 1.13463,-2.83625 4.44336,-7.77344 1.18742,-1.77183 1.77196,-3.81878 1.42774,-5 -0.32056,-1.1 -0.79254,-5.6 -1.04883,-10 -0.25628,-4.4 -0.89304,-12.61377 -1.41602,-18.25195 -0.52301,-5.63819 -0.72865,-11.71319 -0.45703,-13.5 0.40393,-2.65713 0.30982,-2.88383 -0.51172,-1.24805 -0.81652,1.62579 -0.95889,1.25158 -0.76758,-2 0.2288,-3.88824 0.15056,-3.99085 -2.76562,-3.69922 -1.65,0.165 -4.87414,1.6275 -7.16406,3.25 -2.28991,1.62249 -4.85396,2.94922 -5.69922,2.94922 -0.84526,0 -1.89806,0.56693 -2.33789,1.25977 -1.14618,1.80553 -7.24081,5.60401 -19.45313,12.125 -9.78172,5.22312 -14.4923,7.17144 -34.17773,14.13476 -10.01258,3.54175 -28.3482,7.43778 -39.98828,8.49609 -5.59848,0.50906 -14.90469,1.36727 -20.67969,1.90821 -18.85515,1.76613 -41,1.26526 -41,-0.92774 0,-1.27226 -4.84769,0.16242 -5.39844,1.59766 -0.34904,0.90958 0.40214,1.57473 2.1836,1.93555 1.49308,0.30242 3.94315,1.18062 5.44336,1.95117 1.50021,0.77056 2.95978,1.02456 3.24414,0.56445 0.28436,-0.4601 1.98105,-0.50726 3.77148,-0.10351 3.63859,0.82052 28.55523,-0.56517 33.32813,-1.85352 1.6897,-0.4561 5.39918,-0.6054 8.24414,-0.33203 2.97188,0.28556 5.72316,0.0413 6.46484,-0.57422 0.71,-0.58925 2.62357,-1.00633 4.25391,-0.92773 1.63034,0.0786 6.11484,-0.25023 9.96484,-0.73047 3.85,-0.48024 7.38974,-0.7773 7.86523,-0.66016 0.47548,0.11714 3.5649,-0.72113 6.86524,-1.86328 7.38664,-2.5563 17.42255,-4.96457 20.76953,-4.98438 1.90504,-0.0113 2.52014,0.51984 2.58594,2.23438 0.0475,1.2375 0.46145,3.11134 0.91992,4.16406 0.5928,1.36121 0.49608,1.70563 -0.33594,1.19141 -1.6459,-1.01722 -1.50106,3.04011 0.45508,12.79492 1.81566,9.05425 3.7509,13.59961 5.79297,13.59961 1.43335,0 2.58203,-2.09292 2.58203,-4.70508 0,-1.1782 -0.31772,-1.27665 -1.34766,-0.42187 -1.09081,0.90529 -1.661,-0.31252 -3,-6.40625 -2.1445,-9.75988 -2.17865,-12.14849 -0.15234,-10.4668 0.825,0.68469 1.5,2.3154 1.5,3.62305 0,1.30766 0.7875,3.17103 1.75,4.14257 0.9625,0.97159 2.54209,2.9885 3.50977,4.48047 2.20128,3.39397 7.20782,6.05698 9.82421,5.22657 1.09112,-0.34631 2.86782,-1.5795 3.94922,-2.74024 C 634.45095,816.91716 627.35536,802 619.17188,802 c -1.11046,0 -3.36846,1.13615 -5.01954,2.52539 l -3.00195,2.52734 -1.57617,-2.25 C 607.45733,801.78038 607.40838,799.26411 609.5,801 c 1.9554,1.62284 1.9231,0.0495 -0.0566,-2.77734 -0.85619,-1.22238 -2.31869,-2.24268 -3.25,-2.26758 -1.91326,-0.051 6.55236,-4.84016 8.67969,-4.91016 1.1069,-0.0365 1.13097,0.24531 0.12695,1.45508 -1.63247,1.96702 -0.0429,1.9179 2.81836,-0.0859 1.45348,-1.01806 2.06222,-2.21427 1.70312,-3.3457 -0.46242,-1.45695 0.52416,-2.03607 5.70899,-3.34961 3.44778,-0.87346 7.00784,-1.54203 7.91015,-1.48633 2.2167,0.13689 7.73589,-4.34057 7.80469,-6.33203 0.0801,-2.31728 9.54072,-8.01397 10.95703,-6.59766 0.79715,0.79715 1.09766,0.63085 1.09766,-0.60351 0,-0.935 0.6535,-1.69922 1.45117,-1.69922 0.79767,0 1.84308,-0.70274 2.32422,-1.5625 0.79332,-1.41758 0.99539,-1.41758 2.17188,0 0.71353,0.85976 2.14313,1.5625 3.17578,1.5625 1.03266,0 1.87695,0.16335 1.87695,0.36328 0,0.19993 0.41476,2.56243 0.92188,5.25 0.50711,2.68757 1.23683,10.73672 1.62109,17.88672 0.38426,7.15 0.91224,13.36485 1.17383,13.81055 1.18364,2.01664 -2.06147,6.64883 -5.43946,7.76367 -1.93397,0.63827 -3.03683,1.45714 -2.44922,1.82031 0.60245,0.37232 -0.89947,1.90501 -3.44531,3.51563 -5.1721,3.27211 -7.11516,2.55298 -4.85742,-1.79883 0.81055,-1.56233 1.46086,-3.80193 1.44336,-4.97656 -0.0296,-1.98826 -0.12459,-2.01397 -1.36133,-0.38477 -1.56028,2.05542 -2.58282,2.13742 -7.66992,0.61328 l -3.79492,-1.13672 2.09375,-2.83203 c 2.85436,-3.86073 3.61087,-12.95254 1.36328,-16.38281 -2.19916,-3.35634 -4.20921,-3.16616 -6.14649,0.58008 -1.50396,2.90834 -1.67974,2.98236 -2.95898,1.25 -2.00358,-2.71328 -4.15341,-0.44124 -2.50195,2.64453 0.64813,1.21106 1.40058,6.54693 1.66992,11.85742 0.47566,9.37843 1.69344,14.15625 3.61133,14.15625 0.51479,0 0.76369,-1.80938 0.55273,-4.02148 -0.2663,-2.79241 -0.0244,-3.88516 0.79102,-3.57227 0.64594,0.24787 3.02204,1.00535 5.27929,1.68164 3.52417,1.05587 4.10352,1.62086 4.10352,4.00391 0,2.49573 -0.85448,3.18479 -8.48047,6.84179 -4.66398,2.23658 -8.71769,4.06641 -9.00781,4.06641 -0.29012,0 -5.58613,2.40715 -11.76953,5.34961 -15.62496,7.43537 -44.6587,16.36952 -60.61719,18.65234 -4.05653,0.58028 -16.7128,1.28908 -28.125,1.57422 -18.76284,0.4688 -20.81236,0.3577 -21.39258,-1.15429 -0.51371,-1.33872 -1.4382,-1.54365 -4.64258,-1.03126 -3.69796,0.59134 -4.08245,0.42993 -5.04492,-2.10156 -0.57295,-1.50696 -1.19378,-11.91429 -1.38086,-23.1289 -0.28153,-16.87623 -0.61111,-20.6619 -1.91015,-21.96094 -1.36892,-1.36892 -1.90371,-1.39099 -4.18164,-0.17188 -2.18036,1.16689 -2.52169,1.90018 -2.06641,4.43555 0.29995,1.67036 1.50617,11.12481 2.68164,21.00977 1.17547,9.88496 2.89499,20.00996 3.82031,22.5 1.95309,5.25582 0.81913,4.98332 22.11719,5.3164 12.59147,0.19692 26.81903,-0.51168 35,-1.74218 1.925,-0.28954 5.975,-0.77205 9,-1.07227 3.025,-0.30022 8.2,-1.16476 11.5,-1.92188 3.3,-0.75711 7.6875,-1.66141 9.75,-2.00976 2.0625,-0.34834 3.75,-1.08281 3.75,-1.63281 0,-0.60965 1.42999,-0.73321 3.66211,-0.31446 3.05014,0.57221 3.56212,0.43009 3.07031,-0.85156 -0.61204,-1.59496 -0.35967,-1.68885 9.30469,-3.50781 2.49511,-0.46961 5.08261,-1.19105 5.75,-1.60352 0.66738,-0.41247 1.21289,-0.33158 1.21289,0.18164 0,1.48156 12.46719,-3.42609 12.79102,-5.03515 0.16035,-0.79674 3.98535,-2.94952 8.5,-4.78321 4.51465,-1.8337 10.34648,-4.39029 12.95898,-5.68164 l 4.75,-2.34765 0.11914,5.26562 c 0.23663,10.43788 -0.32444,17.3222 -1.6543,20.26758 C 645.37123,859.13618 644,868.49049 644,878.14258 c 0,8.28033 -0.15528,8.92224 -2.75,11.36133 -3.69161,3.47019 -11.99513,8.12627 -16,8.9707 -2.84442,0.59974 -3.25,0.42542 -3.25,-1.39453 C 622,895.93637 621.55,895 621,895 c -1.67208,0 -1.13424,5.82566 0.62891,6.8125 2.39795,1.34196 -5.69027,3.93949 -19.0625,6.12305 -13.24847,2.16334 -19.30732,1.8413 -35.56641,-1.89649 -21.96428,-5.04934 -24.22955,-5.38217 -39.33594,-5.78711 -13.03851,-0.34951 -14.98518,-0.19544 -16.0664,1.28321 -0.97863,1.33836 -3.05776,1.71211 -10.16407,1.82422 -7.9447,0.12527 -9.52497,-0.16442 -14.27343,-2.61329 -2.93673,-1.51453 -5.81856,-2.45771 -6.4043,-2.0957 -0.58575,0.36202 -0.7831,0.20449 -0.43945,-0.35156 C 480.96848,897.24376 473.9044,891 472.05859,891 471.47634,891 471,890.65988 471,890.24414 c 0,-0.41574 -1.45764,-1.40236 -3.24023,-2.19141 -1.78258,-0.78904 -5.04508,-2.64478 -7.25,-4.125 -2.20491,-1.48022 -8.84459,-5.7164 -14.75391,-9.41406 -5.90932,-3.69766 -10.52763,-7.07562 -10.26172,-7.50586 0.2659,-0.43024 -0.29928,-0.71993 -1.25586,-0.64453 -0.99334,0.0783 -1.6134,-0.45234 -1.44726,-1.23633 0.19233,-0.90758 -0.26967,-1.15719 -1.36133,-0.73828 -1.06513,0.40873 -2.7027,-0.39581 -4.61719,-2.26758 -1.63224,-1.59582 -4.17103,-3.15673 -5.64062,-3.46679 -3.54819,-0.74858 -8.72739,-5.24463 -6.96485,-6.04688 0.7107,-0.32348 0.28047,-0.33854 -0.95703,-0.0312 -2.19061,0.54342 -2.72701,-0.22434 -2.32422,-3.32617 0.0893,-0.6875 -0.3087,-1.25 -0.88281,-1.25 -0.57411,0 -1.04297,0.50571 -1.04297,1.12305 0,0.77551 -0.46364,0.73705 -1.5,-0.12305 -0.88998,-0.73862 -1.5,-2.92408 -1.5,-5.37305 -10e-6,-2.27016 -1.3417,-10.65195 -2.98242,-18.62695 -1.64071,-7.975 -2.991,-15.66052 -3,-17.08008 -0.0114,-1.74112 -0.858,-3.03081 -2.59961,-3.96289 -2.2521,-1.20528 -3.17779,-1.15365 -7.25,0.41016 -6.70655,2.57545 -25.38577,6.5394 -34.29102,7.27734 l -7.62304,0.63281 -7.92383,-8.18164 c -4.35742,-4.50016 -8.78481,-9.85018 -9.83789,-11.88867 -1.05308,-2.0385 -4.0008,-5.97066 -6.55078,-8.73633 -4.77887,-5.18308 -5.3841,-6.80473 -7.82422,-20.9707 -0.56843,-3.3 -1.28974,-9.0406 -1.60352,-12.75586 l -0.57031,-6.75391 10.27734,0.5586 c 5.6531,0.30743 14.3293,0.9621 19.2793,1.45508 24.50022,2.44003 34.62014,3.02822 47.72266,2.77343 11.27132,-0.21918 14.27734,-0.56518 14.27734,-1.64453 0,-1.10098 -4.04485,-1.43531 -20.77539,-1.71875 -11.42603,-0.19358 -25.60103,-1.03701 -31.5,-1.87304 -5.89897,-0.83603 -17.22186,-1.98569 -25.16406,-2.55469 -7.9422,-0.56901 -14.53759,-1.1353 -14.65625,-1.25977 -0.8441,-0.88541 -2.10021,-20.37622 -1.94727,-30.22656 0.16874,-10.86806 2.65509,-30.25621 4.20117,-32.75781 1.37818,-2.22994 2.20875,-17.25949 1.21094,-21.91211 -1.0628,-4.95567 -4.14968,-9.87478 -5.41016,-8.61914 -0.39264,0.39113 0.0188,2.95029 0.91407,5.6875 2.17541,6.65093 2.02782,16.94132 -0.37305,26.10156 -1.08115,4.125 -1.97342,9.07723 -1.98242,11.00586 -0.009,1.92863 -0.4795,5.07863 -1.04492,7 -1.00865,3.42756 -1.43109,19.58424 -0.66602,25.49414 0.2136,1.65 0.65697,7.275 0.98438,12.5 0.43503,6.94259 0.36888,8.01939 -0.24414,4 -0.46139,-3.025 -1.51326,-9.325 -2.3379,-14 -1.27195,-7.21081 -2.1298,-18.86164 -1.95117,-26.5 0.0257,-1.1 0.76574,-7.07875 1.64453,-13.28516 1.66042,-11.72659 1.91122,-22.14947 0.73828,-30.71484 -0.37653,-2.75 -0.35929,-6.125 0.0391,-7.5 2.00386,-6.91967 5.01058,-25.0615 4.41211,-26.62109 -0.58812,-1.53262 -1.16333,-1.24061 -4.13672,2.10156 -1.89983,2.13547 -3.45508,4.27304 -3.45508,4.75 0,1.94404 -8.44302,12.72685 -9.29688,11.87305 -1.3593,-1.35931 0.0174,-4.57917 3.99024,-9.33008 1.96505,-2.34988 4.30013,-5.84844 5.18945,-7.77344 0.88932,-1.925 2.62307,-4.31563 3.85352,-5.3125 1.42364,-1.15339 3.19075,-4.97167 4.85742,-10.5 C 316.36226,591.68647 318.15,587 319.15039,587 c 1.36387,0 4.8417,-6.24345 4.8457,-8.69922 0.004,-2.3283 3.97785,-7.30078 5.83399,-7.30078 0.60508,0 1.59737,-0.92893 2.20508,-2.06445 0.88369,-1.65119 1.39134,-1.82624 2.53515,-0.87696 1.1715,0.97226 1.7009,0.53662 2.92969,-2.40429 0.82506,-1.97463 1.5,-3.92435 1.5,-4.33399 0,-0.40963 1.8166,-4.41205 4.03711,-8.89453 3.07952,-6.21653 4.84556,-8.58627 7.44531,-9.98633 1.87456,-1.00952 4.98754,-3.90615 6.91797,-6.4375 2.92516,-3.83572 4.08586,-4.61957 6.96484,-4.70117 2.7289,-0.0774 3.57145,0.34961 4.01172,2.0332 0.4417,1.68908 0.81401,1.87545 1.79102,0.89844 2.50692,-2.50692 2.85491,-1.12763 0.50976,2.01758 -1.33281,1.7875 -2.22914,3.77936 -1.99218,4.42578 1.08345,2.95564 -4.36183,10.63168 -17.375,24.4961 -7.43513,7.92146 -10.29883,12.74175 -10.29883,17.32812 0,3.53575 2.67583,9.22688 5.99805,12.75391 2.13327,2.26478 3.60867,4.55298 3.27929,5.08593 -0.32938,0.53295 -0.13959,0.6849 0.42188,0.33789 1.52291,-0.94121 3.6843,2.11976 6.11718,8.66211 2.46795,6.63652 2.47248,6.66016 1.32227,6.66016 -0.46682,0 -3.50432,-3.93487 -6.75,-8.74414 -8.77653,-13.00458 -16.31874,-19.5711 -18.50977,-16.11328 -1.20888,1.90789 -1.09582,3.10225 0.2168,2.29101 0.72437,-0.44769 0.90002,-0.0307 0.50781,1.20508 -0.32971,1.03882 -0.80574,4.68045 -1.05664,8.09375 -0.2509,3.4133 -0.9295,7.09128 -1.50781,8.17188 -0.57832,1.08059 -1.05078,3.27409 -1.05078,4.875 0,1.60092 -0.85209,3.68355 -1.89453,4.62695 -3.52831,3.19308 -4.34385,15.93806 -1.44336,22.57227 3.33691,7.63243 6.84449,14.10315 9.00977,16.62304 2.85752,3.32551 3.98501,6.67948 2.41992,7.20117 -0.87347,0.29117 -0.88687,0.73853 -0.0508,1.7461 0.61837,0.74509 0.95277,2.16342 0.74218,3.15234 -0.30143,1.41557 -0.75101,1.10751 -2.10937,-1.45117 -0.94896,-1.7875 -1.26334,-3.25 -0.69922,-3.25 0.56412,0 1.02539,-0.45 1.02539,-1 0,-0.55 -0.65714,-1 -1.46094,-1 -0.86861,0 -1.91707,-1.68933 -2.58398,-4.16602 -0.79477,-2.95156 -2.99423,-6.06731 -7.53906,-10.67968 -3.529,-3.5815 -6.41602,-6.86473 -6.41602,-7.29492 0,-0.43021 -0.949,-1.66508 -2.10938,-2.7461 -2.01868,-1.88079 -4.89062,-1.88327 -4.89062,-0.006 0,0.49091 3.61384,4.58992 8.03125,9.10938 6.86151,7.02003 8.39758,9.24142 10.53906,15.25 1.37867,3.86829 3.40957,8.2804 4.51367,9.80468 1.1041,1.52429 1.76382,3.16395 1.4668,3.64454 -0.29702,0.48058 0.0262,1.09047 0.7168,1.35546 1.65365,0.63457 9.51687,16.62411 11.17773,22.72852 0.37411,1.375 1.06179,3.4 1.52735,4.5 0.46556,1.1 1.11038,2.82107 1.43359,3.82422 0.34619,1.07447 1.30712,1.6766 2.33984,1.46484 3.0225,-0.61975 0.94062,-8.07746 -5.89648,-21.11133 -2.17792,-4.15186 -5.82971,-18.91096 -5.25,-21.2207 0.88657,-3.53238 -0.21847,-6.9488 -3.46094,-10.68945 -4.6512,-5.36581 -10.42424,-18.17464 -10.92773,-24.2461 -0.37896,-4.56978 -0.0201,-6.14235 2.32812,-10.21093 1.5268,-2.64535 3.10495,-7.06055 3.50782,-9.81055 0.9902,-6.76041 3.13343,-17.91437 3.52929,-18.36523 0.59028,-0.67229 5.43465,5.28682 11.10742,13.66211 3.0905,4.56277 6.45218,8.7411 7.46875,9.28515 1.01658,0.54405 1.84766,1.72143 1.84766,2.61719 0,0.89575 2.39374,5.94241 5.32031,11.21484 2.92662,5.27239 6.3424,11.72344 7.58985,14.33594 2.12163,4.44331 4.24394,5.92645 5.52148,3.85938 0.30254,-0.48953 -0.51516,-2.85204 -1.81836,-5.25 -2.73201,-5.02711 -4.24268,-11.36595 -2.44336,-10.25391 0.70626,0.43649 0.86453,0.2589 0.41602,-0.4668 -0.39798,-0.64395 -1.21875,-0.86442 -1.82422,-0.49023 -0.73412,0.45372 -0.86092,0.053 -0.37891,-1.20313 0.39759,-1.03596 0.40281,-1.56479 0.0117,-1.17383 -1.09986,1.09986 -3.34427,-1.23912 -2.72851,-2.84375 0.30115,-0.78479 0.10863,-1.42773 -0.42774,-1.42773 -0.53636,0 -1.73117,-2.8125 -2.65625,-6.25 -2.84567,-10.57423 -7.75273,-22.12722 -10.48242,-24.67969 -9.54425,-8.92463 -11.39209,-15.39199 -6.47852,-22.68164 1.44195,-2.13925 2.97292,-4.02269 3.40039,-4.1875 1.62509,-0.62655 16.82383,-18.96396 20.43946,-24.66015 l 3.78125,-5.95899 1.83398,2.45899 c 5.81196,7.79361 16.40063,18.26444 22.92383,22.66992 11.07033,7.47641 20.85141,12.87655 26.5,14.63086 7.04928,2.18933 23.78187,3.56721 31.5,2.59375 13.8865,-1.75145 21.85018,-4.31588 29.81836,-9.60352 2.92492,-1.94097 5.46948,-3.37143 5.6543,-3.17969 0.18482,0.19174 0.79584,3.94766 1.35742,8.34766 0.97933,7.67308 3.91314,24.83044 6.2539,36.56445 0.96371,4.83099 0.83862,6.44807 -0.95703,12.26172 -2.38131,7.7098 -2.52074,7.99867 -9.92773,20.67383 -5.26604,9.01145 -11.62316,16.94572 -13.60742,16.98242 -1.91796,0.0355 -11.46135,8.06904 -13.4961,11.36133 -1.29299,2.09211 -3.6681,4.06736 -6.02343,5.00977 -3.00522,1.20245 -4.15875,2.37628 -5.08008,5.16796 -0.65566,1.98665 -0.9232,3.87955 -0.59571,4.20704 0.85871,0.85871 5.60352,-1.48292 5.60352,-2.76563 0,-0.59425 -0.51932,-0.75963 -1.1543,-0.36719 -0.7153,0.44208 -0.88348,0.2739 -0.4414,-0.4414 0.39244,-0.63498 1.40912,-1.1543 2.25976,-1.1543 0.85065,0 2.88348,-1.125 4.51758,-2.5 1.63409,-1.375 4.20022,-2.5 5.70117,-2.5 1.50094,0 4.24656,-1.11972 6.10157,-2.48828 1.85496,-1.36855 3.54572,-2.31561 3.75781,-2.10352 0.21208,0.21209 -0.38787,5.13673 -1.33399,10.94336 -1.68177,10.32155 -1.78659,10.57322 -4.63672,11.19922 -1.60341,0.35212 -3.18242,0.37238 -3.50976,0.0449 -0.32734,-0.32734 0.2681,-0.61025 1.32226,-0.62695 1.64606,-0.0261 1.69414,-0.15898 0.33985,-0.95117 -1.72652,-1.00993 -12.54,-2.49532 -17.62305,-2.41992 -1.75977,0.0261 -2.97113,-0.32278 -2.6914,-0.77539 0.2798,-0.4518 -0.22952,-0.82227 -1.13282,-0.82227 -0.90329,0 -1.46243,0.54058 -1.24218,1.20117 0.57411,1.72234 -6.2498,5.03048 -7.77149,3.76758 -1.54468,-1.28197 -10.77871,5.78975 -16.44922,12.59766 -9.23733,11.09018 -15.35625,29.05267 -14.58398,42.81054 0.95308,16.97876 19.42142,45.35131 31.66601,48.64844 4.03332,1.08606 17.02859,1.65742 19.8086,0.87109 1.0974,-0.3104 1.36318,0.80281 1.2207,5.10352 -0.13011,3.92764 0.62162,7.64412 2.62891,13 2.62324,6.99936 2.76526,8.13414 2.12304,17 -0.37848,5.225 -0.66361,11.75 -0.63281,14.5 0.0308,2.75 0.55339,-0.625 1.16211,-7.5 l 1.10742,-12.5 1.875,4.73828 c 1.29795,3.28038 1.71891,6.20337 1.3711,9.5 -0.27627,2.61896 -0.29665,4.19922 -0.0469,3.51172 1.11823,-3.07653 1.99547,-1.64591 11.71875,19.10938 4.12633,8.80803 7.0111,13.43911 11.21289,18 6.50135,7.05696 7.35547,7.60275 7.35547,4.69335 0,-1.1631 0.72905,-2.39597 1.62109,-2.73828 1.38747,-0.53242 1.27907,-0.90104 -0.75,-2.55468 -1.30454,-1.06316 -1.80859,-1.6423 -1.12109,-1.28711 1.42784,0.73767 1.52094,0.39874 0.57422,-2.06836 -0.62525,-1.62939 -0.72352,-1.61532 -1.34961,0.16992 -0.70766,2.01783 -5.9962,2.92531 -5.65625,0.9707 0.10001,-0.57503 -0.3655,-0.93754 -1.0332,-0.80664 -0.70161,0.13754 -0.97256,-0.39009 -0.64258,-1.25 0.31405,-0.8184 0.14958,-1.48828 -0.36524,-1.48828 -0.89475,0 -3.47078,-5.10596 -6.72265,-13.32227 -0.83197,-2.10208 -1.96626,-3.54041 -2.52149,-3.19726 -0.61105,0.37765 -0.75014,-0.0531 -0.35156,-1.0918 0.41694,-1.08648 0.26818,-1.47541 -0.40625,-1.05859 -0.58583,0.36207 -1.33187,-0.0363 -1.6582,-0.88672 -0.34222,-0.89185 -0.17221,-1.28673 0.40234,-0.93164 1.15566,0.71423 -0.83276,-4.28505 -2.58984,-6.51172 -0.65102,-0.825 -1.77971,-3.1875 -2.50781,-5.25 -0.72814,-2.0625 -1.79604,-3.75766 -2.37305,-3.76562 -0.57701,-0.008 -0.4396,-0.40142 0.30469,-0.87305 0.98992,-0.62729 1.08087,-1.36316 0.34179,-2.74414 -0.55567,-1.0383 -0.77434,-3.12032 -0.48633,-4.62696 0.28804,-1.50665 0.0944,-2.74023 -0.43164,-2.74023 -0.85321,0 -1.95392,-2.81503 -3.80664,-9.74023 -0.32976,-1.23258 -0.24166,-2.80758 0.19532,-3.5 0.43699,-0.69242 0.84721,-3.28477 0.9121,-5.75977 0.0649,-2.475 0.44102,-6.35323 0.83594,-8.61914 0.65195,-3.74073 1.21734,-4.37228 6.14844,-6.86719 10.59579,-5.36098 22.89409,-20.77234 25.52148,-31.98047 0.64888,-2.76804 1.56026,-5.77221 2.0254,-6.67578 0.46512,-0.90357 0.92347,-3.82857 1.01757,-6.5 l 0.17188,-4.85742 11.59961,-0.006 c 13.02799,-0.008 27.11821,-1.68764 34.60156,-4.125 2.75,-0.89568 7.25,-1.96498 10,-2.375 2.75,-0.41003 7.475,-1.67837 10.5,-2.82031 l 5.5,-2.07617 3.14258,6.70117 c 3.59356,7.66558 8.85967,13.14613 15.35742,15.98242 15.09665,6.58974 27.95389,6.8684 37.42383,0.81055 l 5.35937,-3.42774 0.61914,3.09961 c 0.34062,1.70473 0.34076,4.59274 -0.002,6.41797 -0.49576,2.64265 -0.29482,3.31836 0.98828,3.31836 1.74912,0 1.9859,-1.40894 1.64258,-9.74219 -0.20052,-4.86701 0.0842,-5.58265 3.97852,-10 5.53837,-6.2822 7.84001,-10.98366 9.59961,-19.61914 1.39778,-6.85996 3.7677,-10.60291 6.75195,-10.66211 0.62657,-0.0124 3.5842,-1.54407 6.57226,-3.40429 l 5.43164,-3.38282 4.35938,4.84766 C 684.8576,723.74675 694.60013,729 700.05469,729 c 9.31687,0 23.37407,-7.07404 31.03125,-15.61523 8.95565,-9.98959 14.08851,-28.79661 11.25976,-41.25586 -1.56648,-6.89957 -8.59971,-21.83168 -11.22461,-23.83008 -3.90337,-2.97173 -3.51897,-0.61658 1.50586,9.22656 2.95507,5.78869 5.37305,11.44199 5.37305,12.56445 0,1.12247 0.4631,2.90686 1.0293,3.96485 1.40789,2.63066 -0.42717,16.86941 -3.07032,23.81836 -1.12419,2.95555 -1.85641,5.5635 -1.625,5.79492 0.4847,0.4847 -9.30129,10.53724 -14.12695,14.51172 -1.78974,1.47405 -4.8122,3.19564 -6.7168,3.82422 -1.9046,0.62857 -3.72003,1.55848 -4.03515,2.06836 -0.31512,0.50987 -3.17383,0.92773 -6.35352,0.92773 -8.94228,0 -16.65021,-4.28138 -23.06054,-12.81055 -2.76496,-3.67888 -5.92629,-8.48945 -7.0254,-10.68945 -1.09909,-2.2 -3.0688,-5.90921 -4.37695,-8.24219 -5.20429,-9.28146 -4.09012,-26.38236 2.32813,-35.71093 3.77334,-5.48438 12.09584,-12.96687 18.51758,-16.6504 5.55362,-3.1856 13.38374,-3.88328 19.53124,-1.74023 2.97456,1.03694 3.49903,0.92655 5.11915,-1.07422 1.74403,-2.15378 1.73998,-2.30016 -0.10938,-4.28515 -2.36009,-2.53325 -5.50163,-1.72663 -4.73242,1.21484 0.62975,2.40819 0.0851,2.50895 -2.04492,0.3789 -1.29577,-1.29578 -2.78886,-1.47467 -7.67774,-0.92382 -7.45134,0.83956 -10.1559,2.08678 -19.04101,8.78125 -13.90461,10.47641 -19.18176,21.4788 -18.3086,38.17187 0.44449,8.49789 0.8082,9.80824 4.76953,17.14063 2.35911,4.36669 4.716,8.48307 5.23633,9.14648 0.52033,0.6634 0.65937,1.67071 0.3086,2.23828 -0.91082,1.47373 -8.57075,5.71206 -11.57032,6.40235 -2.48548,0.57198 -2.5573,0.42259 -3.76562,-7.63282 -0.67774,-4.51826 -2.23865,-10.86576 -3.4668,-14.10546 -2.2414,-5.91256 -10.17338,-16.07214 -11.77539,-15.08204 -0.47089,0.29102 -1.39484,-0.4971 -2.05273,-1.75 -0.65789,-1.25291 -1.80608,-2.63634 -2.55078,-3.07617 C 636.60881,674.26134 636,673.35475 636,672.6875 c 0,-0.66725 -1.01258,-1.65825 -2.25,-2.20117 -2.40939,-1.05713 -5.22802,-7.86157 -8.8457,-21.35156 -2.47278,-9.22073 -6.20573,-18.24987 -10.04492,-24.30079 -1.99564,-3.14525 -3.07073,-6.27505 -3.29688,-9.5996 -0.18454,-2.71291 -3.11051,-13.66352 -6.50195,-24.33399 -11.41803,-35.92454 -11.13605,-34.8292 -13.5293,-52.72461 -0.53527,-4.00248 -0.4276,-4.27803 1.44531,-3.68359 1.1689,0.37099 2.02344,0.19266 2.02344,-0.42383 0,-0.58707 1.6875,-1.05737 3.75,-1.04297 l 3.75,0.0273 -4,1.96094 -4,1.96094 6.5,-0.63477 c 7.94773,-0.77564 7.06149,-0.80858 15.26758,0.56836 13.15922,2.20805 31.9341,9.27804 38.11914,14.35352 l 2.88672,2.36719 -2.53125,3.93554 c -3.85348,5.99158 -5.08719,13.11368 -4.47266,25.82617 0.48897,10.11528 0.89961,11.95985 4.57031,20.60743 4.95469,11.67243 9.0142,17.23097 16.15235,22.11133 6.05898,4.14251 15.57311,6.58385 21.00586,5.39062 3.57649,-0.78553 16.16994,-7.79322 18.02734,-10.03125 0.67082,-0.80829 1.77769,-1.46875 2.45899,-1.46875 0.68128,0 3.43672,-2.04734 6.125,-4.55078 l 4.88867,-4.55274 1.85547,2.29297 c 1.02084,1.26068 3.00654,4.54553 4.4121,7.30078 2.22623,4.36392 2.59236,6.49186 2.84766,16.50977 0.1844,7.2363 0.68144,11.46329 1.33984,11.40039 3.23987,-0.30963 3.17103,-0.0216 3.07813,-12.90039 -0.0606,-8.39265 -0.33435,-9.55364 -4.05078,-17.19531 -2.19196,-4.50708 -4.84711,-8.79741 -5.90039,-9.53516 -1.88345,-1.31922 -1.8796,-1.43911 0.12304,-7.30469 1.11996,-3.28018 2.26691,-9.87581 2.55079,-14.65625 0.47036,-7.92054 0.22545,-9.56193 -2.76563,-18.5 -3.93243,-11.75105 -6.17239,-15.50237 -12.61133,-21.12109 -6.43217,-5.61283 -12.14077,-7.18043 -24.37695,-6.69531 -11.31859,0.44874 -15.68918,1.25655 -16.36719,3.02343 -0.38788,1.01081 0.18853,1.10911 2.53711,0.43555 2.58357,-0.74096 3.11499,-0.57858 3.55078,1.08789 0.28191,1.07802 0.7363,1.96094 1.00977,1.96094 1.39021,0 8.27196,-4.51305 8.28515,-5.43359 0.009,-0.6136 0.34804,-0.54099 0.80079,0.17187 0.6552,1.03161 5.61553,2.43491 13.18359,3.72852 3.30034,0.56414 5.65927,2.01375 9,5.5332 1.925,2.02798 4.24353,3.95225 5.15234,4.27539 1.72238,0.61242 5.04644,8.43451 7.44727,17.52344 2.73484,10.35339 0.98094,28.93001 -2.9668,31.41406 -0.62277,0.39186 -1.18635,1.68277 -1.25195,2.86914 -0.0682,1.23482 -2.10276,3.85163 -4.75781,6.12109 -2.6902,2.29954 -4.35787,4.45449 -3.97071,5.13086 0.36712,0.64134 0.31247,0.84435 -0.12304,0.45118 -0.43551,-0.39317 -4.66999,1.36873 -9.41016,3.91601 -10.64181,5.71872 -16.42939,6.21618 -25.11914,2.1543 -8.65918,-4.04759 -13.21319,-9.48591 -18.64844,-22.26953 -4.58383,-10.78112 -4.71375,-11.37445 -4.78125,-21.58594 -0.1,-15.129 1.37704,-19.90188 8.30469,-26.83398 3.0941,-3.0961 5.50093,-6.00875 5.34961,-6.47266 -0.15132,-0.46392 0.53921,-0.58564 1.53516,-0.26953 1.33562,0.4239 1.8125,0.0509 1.8125,-1.42383 0,-1.09966 -0.57996,-2 -1.28711,-2 -0.70714,0 -1.28516,0.45 -1.28516,1 0,0.55 -0.675,1 -1.5,1 -0.825,0 -1.5,0.35375 -1.5,0.78516 0,0.43142 -1.28708,1.54388 -2.85938,2.47265 -2.81375,1.66213 -2.90044,1.64118 -5.50781,-1.28515 -1.45696,-1.63519 -3.20737,-2.97552 -3.89062,-2.97852 -0.68326,-0.003 -2.59219,-0.72477 -4.24219,-1.60352 -10.94343,-5.82807 -37.1267,-12.93281 -50.49805,-13.70117 l -7.49804,-0.42968 -1.04102,-7.88086 c -0.57231,-4.33379 -1.87866,-10.03775 -2.9043,-12.67579 -2.11841,-5.44871 -2.25263,-5.19704 5.61719,-10.63281 3.32928,-2.29956 6.51616,-5.65794 8.50586,-8.96484 3.74304,-6.22094 10.65413,-22.84761 10.53125,-25.33594 -0.047,-0.95167 0.33656,-1.9903 0.85156,-2.30859 1.40372,-0.86754 1.12622,-9.80217 -0.45507,-14.67578 -2.26914,-6.99352 -2.80686,-10.02528 -1.6504,-9.31055 0.57204,0.35354 1.04102,0.14758 1.04102,-0.45899 0,-0.60656 -0.7875,-0.9702 -1.75,-0.80859 -1.19169,0.2001 -1.65713,-0.26534 -1.45703,-1.45703 0.16161,-0.9625 -0.16004,-1.75 -0.7168,-1.75 -0.55676,0 -2.7883,-2.40346 -4.95898,-5.3418 -5.5997,-7.58003 -16.33559,-15.24224 -25.31446,-18.0664 -9.74612,-3.06548 -31.0855,-7.5646 -37.26953,-7.85742 -4.61581,-0.21857 -5.01932,-0.44679 -5.69531,-3.23438 -4.05125,-16.70629 -7.40814,-28.05478 -9.85156,-33.30664 -4.71708,-10.13881 -13.47378,-22.7647 -21.50586,-31.00781 -5.67403,-5.8231 -7.33124,-8.14393 -6.9082,-9.67383 1.22264,-4.42166 7.56341,-16.21262 10.46875,-19.46875 2.09735,-2.35059 2.90831,-4.11094 2.53515,-5.5 -0.30186,-1.12361 -0.5545,-2.98961 -0.5625,-4.14649 -0.0215,-3.31685 -8.88865,-10.87727 -15.86914,-13.53125 -2.92435,-1.11184 -8.80056,0.90197 -13.87695,4.75586 -2.13395,1.62005 -3.03408,1.93312 -2.64453,0.91797 0.3507,-0.9139 0.0407,-1.5504 -0.76563,-1.5664 -0.74635,-0.0148 -2.42745,-1.76078 -3.73437,-3.88086 -1.77258,-2.87549 -3.42377,-4.15492 -6.5,-5.03516 -2.26808,-0.64899 -5.43903,-1.59331 -7.04688,-2.09766 -2.9026,-0.91047 -5.57617,0.14336 -5.57617,2.19727 0,0.50148 -2.81381,3.54563 -6.25391,6.76367 -8.16697,7.6398 -13.43802,15.42181 -16.86132,24.90039 -1.54112,4.26712 -2.79703,6.62946 -2.82813,5.31641 -0.084,-3.54496 -7.01696,-27.12494 -9.1543,-31.13672 -1.02557,-1.925 -2.92923,-4.77247 -4.23242,-6.32812 -1.05523,-1.25969 -1.68916,-1.92603 -2.22656,-2.10938 z m -2.04492,6.19922 c 0.39667,0.11225 0.60156,0.37127 0.60156,0.77734 0,0.80324 0.60914,1.16329 1.43164,0.84766 0.90312,-0.34656 2.0088,0.56512 2.99219,2.4668 1.82055,3.52056 2.44316,3.16085 -9.63086,5.59375 -9.29859,1.87367 -8.28411,1.87076 -9.82227,0.0176 -1.51448,-1.82484 0.36149,-3.96125 6.0293,-6.86718 4.29193,-2.20051 7.20841,-3.1727 8.39844,-2.83594 z m 52.11718,0.55469 c 3.54109,-0.68453 7.03702,1.58236 9.37305,6.39062 l 2.0586,4.23828 -3.4375,3.75196 c -1.89055,2.06365 -4.64684,6.01359 -6.125,8.77734 -1.47816,2.76375 -3.8786,6.82539 -5.33399,9.02539 -3.93105,5.94229 -4.17848,7.13132 -2.02148,9.70117 1.65,1.96581 2.07614,2.08151 2.93554,0.79883 0.55275,-0.825 1.01151,-2.55138 1.01954,-3.83594 0.0169,-2.57122 5.08846,-13.33292 8.10937,-17.20703 1.05412,-1.35183 0.45262,0.4912 -1.33789,4.0957 C 459.84257,318.95681 458.87088,322 460.98047,322 462.01916,322 466,314.84344 466,312.97656 c 0,-1.55131 6.13431,-14.09773 7.97461,-16.31054 3.7644,-4.52637 4.80799,-5.42315 9.38086,-8.06641 5.68558,-3.28645 8.4795,-3.07443 14.5625,1.11133 5.1019,3.51066 7.34321,9.23897 4.74023,12.11523 -0.91161,1.00732 -1.65789,2.24527 -1.6582,2.75195 -3.1e-4,0.50669 -1.80735,3.84688 -4.01562,7.42188 -2.20829,3.575 -4.47979,8.20021 -5.04688,10.2793 -0.56709,2.0791 -1.46004,3.51545 -1.98438,3.1914 -1.63756,-1.01208 -1.04381,1.14486 1.04688,3.80274 1.1,1.39842 2,2.78852 2,3.08984 0,1.72805 6.08515,8.96285 12.92969,15.37305 5.683,5.32237 8.48245,8.81662 10.07031,12.56836 1.20957,2.8579 3.46203,7.22031 5.00586,9.69531 2.63263,4.22048 8.99414,25.40371 8.99414,29.94922 0,1.12762 0.41183,2.05078 0.91406,2.05078 1.95278,0 -1.64485,6.45675 -6.15234,11.04297 -5.57753,5.67494 -14.91251,10.52594 -23.14649,12.03125 -5.92219,1.08267 -14.61239,0.48588 -17.87304,-1.22852 -0.96672,-0.50828 -3.44172,-4.2611 -5.5,-8.33984 -3.04801,-6.04 -5.39623,-8.90369 -12.65821,-15.4375 -9.97137,-8.97153 -14.98997,-11.14791 -26.10156,-11.31641 -6.00566,-0.0911 -6.28139,0.0192 -9.86719,3.98828 -7.37286,8.16087 -9.46735,11.79854 -11.66796,20.25977 -1.73265,6.66194 -0.381,19.06254 3.60156,33.03125 3.25353,11.41165 4.21209,17.87384 2.85351,19.23242 -0.32833,0.32834 -0.68775,4.55189 -0.79882,9.38672 -0.19008,8.27326 -0.0537,8.91812 2.31445,10.95508 1.38391,1.19038 3.02352,1.96997 3.64258,1.73242 2.27557,-0.87322 0.42686,-24.39227 -3.01367,-38.33789 -2.4867,-10.07941 -3.72043,-42.10817 -1.64844,-42.79883 0.61295,-0.20431 0.87335,-0.75985 0.58008,-1.23437 -0.29326,-0.47452 1.92902,-3.44553 4.9375,-6.60157 l 5.4707,-5.73828 7.30664,1.2168 c 4.01885,0.66934 8.2841,1.36318 9.47852,1.54102 4.09699,0.61001 17.03645,12.44166 14.57812,13.33007 -0.6875,0.24845 -1.25,1.62627 -1.25,3.06055 0,2.43944 0.0876,2.48785 1.35547,0.75391 1.8601,-2.54383 4.53871,-1.30448 5.28906,2.44726 0.3326,1.66298 0.95537,3.02344 1.38281,3.02344 0.42745,0 1.26502,1.4625 1.86133,3.25 l 1.08399,3.25 -2.07032,-2.75 C 472.82227,418.98633 470,418.04187 470,420.10938 c 0,1.86155 14.45817,16.8897 16.25,16.89062 1.40576,7.1e-4 0.75522,-2.61777 -1.16211,-4.67578 l -1.91406,-2.05274 11.16406,-0.50195 c 9.72542,-0.43697 12.03712,-0.89997 17.95313,-3.5918 7.0966,-3.229 19.1361,-13.60859 20.79492,-17.92773 0.75397,-1.96314 1.57951,-2.25 6.47265,-2.25 3.08447,0 9.05875,0.86001 13.27539,1.91211 4.21663,1.05209 9.69102,2.23281 12.16602,2.62305 7.67793,1.21058 18.25325,5.63087 24,10.03125 8.54787,6.54525 10.44163,8.95725 10.17188,12.96289 -0.2066,3.06763 0.0466,3.4707 2.18359,3.4707 2.7149,0 4.69429,3.31219 6.66211,11.14453 0.85008,3.38367 0.87,5.1969 0.0742,6.68359 -0.6006,1.12224 -1.0918,3.5625 -1.0918,5.42383 0,6.2573 -3.05563,14.44679 -8.86133,23.74805 -0.85825,1.375 -1.65825,3.11037 -1.77734,3.85742 -0.30121,1.88954 -4.44182,6.14258 -5.98047,6.14258 -0.69846,0 -2.52857,1.0837 -4.06836,2.4082 l -2.80078,2.40821 -6.7832,-7.10157 c -3.73135,-3.9055 -7.76472,-7.25074 -8.9629,-7.43359 -1.19816,-0.18285 -2.42378,-0.66076 -2.72265,-1.0625 C 563.94386,481.74119 557.09991,477 556.06641,477 555.47971,477 555,476.59262 555,476.0957 c 0,-1.14626 -8.05803,-2.20269 -19,-2.49218 -4.675,-0.12369 -9.625,-0.59165 -11,-1.03907 -1.375,-0.44745 -2.14485,-0.43894 -1.71094,0.0176 0.43392,0.45641 -2.04108,1.62029 -5.5,2.58789 C 510.5229,477.20257 510,477.2725 510,476.21486 c 0,-1.63806 6.15522,-4.39318 8.5,-3.80468 1.3074,0.32814 2.65689,0.14577 2.99805,-0.40625 1.06902,-1.7297 -6.82773,-1.10802 -9.54883,0.75195 -6.31836,4.31884 -10.48029,10.55083 -13.18555,19.74414 -7.60526,25.84508 -10.2491,44.01141 -7.39844,50.83398 1.81363,4.34064 1.20552,16.87578 -0.99023,20.39258 -2.09229,3.35111 -13.09089,10.10245 -19.875,12.19922 -15.27021,4.71956 -36.56875,2.99124 -51.5,-4.17773 -3.08886,-1.48306 -15.3161,-8.9384 -16,-9.75586 -0.275,-0.32871 -2.075,-1.56024 -4,-2.73633 -3.86272,-2.35996 -11.18019,-9.69533 -15.46875,-15.50586 -2.75139,-3.7278 -2.75523,-3.75 -0.52734,-3.75 1.87873,0 2.03968,-0.24255 0.99609,-1.5 -0.68469,-0.825 -2.3154,-1.5 -3.62305,-1.5 -3.1343,0 -3.00639,-1.83424 0.45899,-6.59961 C 383.90148,526.18474 391.47682,519 392.85547,519 c 0.46683,0 3.7913,-2.59774 7.38867,-5.77344 C 413.49139,501.53213 426.44943,482 420.96094,482 c -0.96441,0 -4.33581,4.67197 -5.30664,7.35352 -2.27836,6.29308 -20.53802,25.37195 -23.76758,24.83398 -1.41144,-0.23512 -1.70872,0.11179 -1.20899,1.41406 0.46194,1.2038 0.29483,1.49964 -0.55468,0.97461 -0.72558,-0.44843 -2.26428,0.29358 -3.80664,1.83594 -1.4237,1.42371 -3.00426,2.58789 -3.51172,2.58789 -0.50746,0 -0.64852,0.44458 -0.3125,0.98828 0.34218,0.55366 -0.0312,0.7418 -0.84961,0.42774 -0.8037,-0.3084 -4.04995,0.6649 -7.21485,2.1621 -3.31899,1.57016 -7.78606,2.80938 -10.55273,2.92774 l -4.79492,0.20508 -0.5918,-4.60547 c -1.98568,-15.48715 -4.54522,-24.53116 -9.61914,-33.98828 -2.83783,-5.28933 -6.55597,-11.39875 -8.26367,-13.57617 C 337.47158,471.54511 334.60235,465 335.98438,465 c 0.41133,0 0.33532,-1.9125 -0.16797,-4.25 -2.52287,-11.71753 -5.16003,-57.60261 -3.99219,-69.46094 0.537,-5.4527 0.58173,-10.02775 0.10156,-10.32812 -0.47408,-0.29657 0.73532,-5.91687 2.6875,-12.49024 2.73959,-9.22473 4.72035,-13.72896 8.6836,-19.73632 2.95267,-4.47569 5.66018,-7.58065 6.36914,-7.3086 0.71038,0.27259 1.01925,-0.0842 0.72851,-0.8418 -0.69283,-1.80548 8.13011,-7.39729 18.82227,-11.92773 6.73033,-2.85174 10.71558,-3.85898 17.49218,-4.42383 l 8.77735,-0.73242 1.66211,-3.5 c 1.34473,-2.83108 1.40431,-3.5596 0.3125,-3.8125 -0.74237,-0.17196 -1.12381,-0.90147 -0.84766,-1.62109 0.27614,-0.71963 -0.19823,-2.00683 -1.05273,-2.86133 -2.66201,-2.66201 -3.6849,-6.53446 -2.3086,-8.73828 0.97236,-1.55704 0.97018,-2.38066 -0.0117,-3.95313 C 391.58664,296.36605 391.67538,295 393.5,295 c 0.825,0 1.44596,0.3375 1.38086,0.75 -0.0651,0.4125 -0.058,1.65 0.0156,2.75 0.10809,1.61648 0.3102,1.72064 1.05274,0.54688 0.5053,-0.79875 0.69544,-1.81321 0.42187,-2.25586 -0.60487,-0.9787 0.21894,-1.22889 9.12891,-2.76172 3.85,-0.66234 7.67938,-1.38525 8.50977,-1.60742 0.92237,-0.24679 1.95164,0.66327 2.64453,2.33789 1.62666,3.93133 5.05854,17.60045 6.40234,25.49609 0.63231,3.71523 1.53486,6.99136 2.00391,7.28125 0.46904,0.28988 0.61938,1.1305 0.33593,1.86914 -0.34625,0.90233 0.30196,1.34375 1.97461,1.34375 1.82473,0 2.82312,-0.80313 3.73633,-3.00781 0.68524,-1.65432 2.22011,-4.18557 3.41211,-5.625 C 436.74648,319.42812 440,310.99404 440,307.91016 c 0,-0.95329 1.56164,-5.38157 3.4707,-9.8418 3.24786,-7.58815 7.38134,-13.03854 9.92578,-13.08984 0.60719,-0.0122 2.22852,-0.90298 3.60352,-1.97852 1.14906,-0.89881 2.33527,-1.45542 3.51562,-1.68359 z M 398.55859,298 c -0.24254,0 -0.71867,0.45 -1.05859,1 -0.33992,0.55 -0.14105,1 0.44141,1 0.58246,0 1.05859,-0.45 1.05859,-1 0,-0.55 -0.19887,-1 -0.44141,-1 z m 39.86329,2.25 c 2.24029,0 2.27361,0.12315 1.00585,3.625 -0.72179,1.99375 -1.56286,5.2 -1.87109,7.125 -0.30824,1.925 -2.35967,6.2 -4.55664,9.5 -3.66144,5.49973 -3.99309,5.76209 -3.99609,3.14453 -0.004,-3.89506 2.70187,-14.03963 5.11523,-19.17383 1.49359,-3.17748 2.55695,-4.2207 4.30274,-4.2207 z m 70.85742,4.12891 c -0.10514,0.10514 -0.17713,0.45463 -0.20118,1.03711 -0.0434,1.05416 0.19311,1.64479 0.5254,1.3125 0.33225,-0.33229 0.36876,-1.19415 0.0801,-1.91602 -0.15961,-0.39887 -0.29916,-0.53873 -0.40429,-0.43359 z m -182.92969,0.49804 c -6.37104,-0.13394 -14.21624,-0.11944 -15.92773,0.0293 -1.73039,0.15039 -10.72596,6.29866 -13.05079,8.91992 -6.3584,7.16918 -8.22036,16.92793 -6.32617,33.17383 2.23076,19.13263 0.94185,51.09722 -2.60156,64.5 -3.95801,14.97098 -11.31679,34.17433 -17.00391,44.375 -2.43184,4.36186 -3.02991,7.20055 -1.78125,8.44922 0.83163,0.83163 3.34149,-1.19429 3.3418,-2.69727 1.2e-4,-0.62016 1.33289,-3.60195 2.96094,-6.62695 1.62805,-3.025 2.9782,-6.05354 3,-6.73047 0.0218,-0.67693 1.90049,-5.17693 4.17578,-10 2.2753,-4.82307 4.50022,-10.11953 4.94336,-11.76953 0.44314,-1.65 1.74784,-6.375 2.90039,-10.5 1.15255,-4.125 2.71329,-12.225 3.4668,-18 1.37646,-10.54921 3.11799,-32.74299 2.69726,-34.37109 C 296.5086,361.1681 294,340.17618 294,337.31445 294,334.20063 294.20916,334 297.46484,334 c 5.04999,0 22.0858,-3.46636 29,-5.90039 7.16368,-2.52186 6.53516,-2.49428 6.53516,-0.27734 0,6.41322 6.98102,17.44385 8.98633,14.19921 0.48474,-0.78433 0.64739,-1.80472 0.36133,-2.26757 -0.28606,-0.46285 -0.016,-1.44764 0.59961,-2.18946 1.05069,-1.26601 0.41245,-4.37618 -3.6875,-17.9707 -0.38794,-1.28638 -0.19903,-1.67413 0.58203,-1.19141 0.68763,0.42498 1.1582,0.0824 1.1582,-0.84375 C 341,316.70113 340.55,316 340,316 c -0.55,0 -1,-0.94461 -1,-2.09961 0,-1.155 -1.53039,-3.63 -3.40039,-5.5 -3.04647,-3.04647 -4.00828,-3.41327 -9.25,-3.52344 z m -9.33399,3.54102 c 5.21761,0.0792 13.1272,1.59651 15.51954,3.33594 2.66712,1.93922 3.28797,5.24609 0.98437,5.24609 -0.81452,0 -1.75101,1.07364 -2.08008,2.38477 -0.86469,3.44521 -11.77775,7.58631 -23.93945,9.08593 -2.75,0.33909 -6.38294,0.82863 -8.07227,1.08594 -3.47345,0.52907 -4.42773,-0.068 -4.42773,-2.76367 0,-6.07952 9.97633,-16.51786 14.66211,-15.3418 1.21888,0.30591 2.49478,0.10476 2.83594,-0.44726 0.34117,-0.55202 0.0305,-1.03151 -0.68946,-1.06641 -0.71996,-0.0349 -0.18359,-0.51896 1.19141,-1.07422 0.83698,-0.338 2.27643,-0.47171 4.01562,-0.44531 z m 89.25,1.25586 c -0.42146,-0.25528 -1.34549,0.16437 -2.05468,0.93164 -1.05908,1.14583 -1.02455,1.39453 0.1914,1.39453 1.69863,0 3.0067,-1.63363 1.86328,-2.32617 z M 368.5,324.03125 c 0.55,0 0.325,0.43559 -0.5,0.96875 -0.825,0.53316 -1.95,0.96875 -2.5,0.96875 -0.55,0 -0.325,-0.43559 0.5,-0.96875 0.825,-0.53316 1.95,-0.96875 2.5,-0.96875 z m 129.11523,12.07617 c -0.32793,-0.70816 0.85918,0.074 3.81641,2.89258 2.59676,2.475 5.15265,5.2875 5.67969,6.25 1.33126,2.43122 1.00625,2.19239 -4.2168,-3.0918 -3.1082,-3.14459 -4.95136,-5.34261 -5.2793,-6.05078 z m 256.46289,42.42188 c -0.99904,0.53548 -0.99443,3.04621 -0.20117,8.73242 0.55535,3.98077 1.30746,10.38573 1.67188,14.23242 0.36442,3.8467 1.34741,8.70796 2.18555,10.80274 3.26818,8.16798 7.47213,2.68099 10.94726,-14.28907 0.84563,-4.12946 1.93995,-8.00647 2.43164,-8.61523 1.46733,-1.81671 -0.12523,-7.53757 -1.99805,-7.17774 -1.18395,0.22746 -1.79747,1.95137 -2.29492,6.45118 -0.84389,7.63358 -4.62054,20.57616 -5.79297,19.85156 -0.47901,-0.29605 -1.14545,-3.57064 -1.48046,-7.27735 -1.24109,-13.73118 -2.76834,-22.11146 -4.12696,-22.63281 -0.5638,-0.21635 -1.00877,-0.25674 -1.3418,-0.0781 z m 25.72852,1.67382 c -2.23919,-0.43265 -2.73791,2.79866 -3.05469,19.77149 l -0.25195,13.47656 3,0.69336 c 3.82485,0.88533 16.61773,-0.059 18.20703,-1.34375 0.9317,-0.75314 0.93817,-1.26518 0.0234,-2.24414 -0.86338,-0.92425 -2.10674,-1.01475 -4.57227,-0.33398 -1.86202,0.51412 -5.63829,0.6249 -8.39258,0.24609 l -5.00781,-0.68945 0.81836,-10.14063 c 1.30154,-16.11232 1.18533,-19.05782 -0.76953,-19.43555 z m -449.29687,3.71876 c 0.32213,0.44157 0.27653,2.96598 -0.11524,8.07812 -0.40043,5.225 -0.71823,10.625 -0.70703,12 0.10468,12.81848 0.70306,24.44582 1.49414,29 0.52545,3.025 0.81213,8.2 0.63672,11.5 l -0.31836,6 -1.74805,-9.54688 c -3.44116,-18.7932 -3.26286,-51.20348 0.3125,-56.79687 0.18985,-0.297 0.33794,-0.3816 0.44532,-0.23437 z m 413.83203,14.0371 c -3.16097,0.14786 -8.50667,4.91152 -11.91016,11.41211 -2.73112,5.21636 -2.76606,5.47036 -1.10352,8.00782 2.24475,3.42592 4.22706,3.3083 7.74805,-0.46094 l 2.87891,-3.08203 2.41797,2.8125 c 2.11045,2.45353 2.77195,2.68696 5.1914,1.83203 3.70545,-1.30936 4.13004,-3.07179 0.72852,-3.02149 -3.95594,0.0586 -5.46981,-3.50891 -4.13672,-9.75195 0.563,-2.63645 0.77223,-5.44895 0.46484,-6.25 -0.41578,-1.0835 -1.22564,-1.54733 -2.27929,-1.49805 z m -1.82618,4.22266 c 0.94421,0.94419 -1.9763,9.02461 -4.08398,11.29883 -4.99958,5.39463 -6.05763,1.47441 -1.5293,-5.66602 2.79848,-4.41274 4.81252,-6.43358 5.61328,-5.63281 z m -19.04882,11.37891 c -0.65555,0.001 -1.6926,0.31428 -3.45899,0.9375 -2.24271,0.79124 -5.35783,1.18195 -6.92187,0.86914 -3.56957,-0.71391 -4.86166,1.1187 -2.57227,3.64843 1.2609,1.39326 2.53391,1.74125 4.84766,1.32227 l 3.13867,-0.56836 -3,2.80664 c -1.65,1.54433 -6.31607,5.92158 -10.36914,9.72656 -4.05307,3.80499 -12.60307,10.31408 -19,14.46485 -55.45386,35.98227 -65.47786,43.70044 -62.07813,47.79687 1.81289,2.18441 2.68814,1.7837 5.54493,-2.5332 1.44427,-2.18244 3.48783,-4.23995 4.54101,-4.57422 1.05318,-0.33427 2.64272,-1.72106 3.53321,-3.08008 1.93137,-2.94768 13.80273,-11.69619 28.88085,-21.28515 25.21572,-16.03599 34.32337,-22.36763 40.94727,-28.46485 3.85,-3.54388 7.14802,-6.2985 7.33008,-6.12109 0.18206,0.1774 -0.15544,1.2328 -0.75,2.34375 -1.52547,2.85037 -1.3419,6.15039 0.3418,6.15039 0.78233,0 1.9361,-1.55322 2.5625,-3.45117 0.62635,-1.89795 2.18113,-4.98604 3.45507,-6.86328 2.84052,-4.18574 4.9341,-10.27203 4.19532,-12.19727 -0.23762,-0.61933 -0.51243,-0.92901 -1.16797,-0.92773 z M 421.8457,414 c 0.66824,0 0.93559,2.30683 0.72461,6.25 -0.18393,3.4375 0.0521,8.69636 0.52539,11.6875 0.84557,5.34411 0.45644,8.56551 -0.47461,3.92969 -1.77577,-8.84189 -2.58519,-17.30348 -1.73632,-18.15235 0.52709,-0.52708 0.72054,-1.57795 0.42968,-2.33593 C 421.02358,414.62094 421.26317,414 421.8457,414 Z m 489.4375,22 c -1.36225,0 -2.2832,0.60478 -2.2832,1.5 0,1.02361 -1.03219,1.50277 -3.25,1.50977 -1.7875,0.005 -16.075,0.94969 -31.75,2.09765 -15.675,1.14795 -31.65,2.29257 -35.5,2.54492 -3.85,0.25234 -7.9,0.84409 -9,1.31446 -2.89848,1.23941 -53.86267,6.52658 -73.5,7.625 -17.05008,0.9537 -41.76415,3.22952 -52.5,4.83398 -10.32145,1.54253 -26.68522,3.54949 -29.73047,3.64649 -0.95167,0.0303 -2.02295,0.52832 -2.38086,1.10742 -0.3579,0.5791 -0.5645,11.81215 -0.45898,24.96093 0.2122,26.44017 0.64938,28.75588 6.29492,33.32813 2.98406,2.41675 3.8085,2.59887 9.27539,2.05078 60.77774,-6.09335 67.76764,-6.66566 87.5,-7.14844 19.28831,-0.47191 33.87308,-2.30944 39.03711,-4.91992 3.49411,-1.76631 9.41787,-2.54775 56.96289,-7.51562 4.675,-0.48848 11.2,-1.33662 14.5,-1.88477 12.69316,-2.10841 31.54805,-3.91728 34.99805,-3.35742 l 3.60742,0.58594 -0.59961,-5.39063 c -2.23729,-20.09019 -3.97901,-30.45897 -6.91992,-41.19726 -0.87489,-3.1945 -1.68838,-8.032 -1.80664,-10.75 C 913.58714,436.52516 913.32299,436 911.2832,436 Z m -5.6582,6.72656 c 3.09226,0.4581 3.15731,0.59232 6.23242,12.61914 1.70931,6.68515 3.56311,15.9793 4.11914,20.6543 0.55604,4.675 1.29379,10.3761 1.63867,12.66992 l 0.62696,4.17188 -4.8711,0.58789 c -2.67906,0.32407 -7.57109,1.02231 -10.87109,1.55078 -14.99595,2.40151 -56.37714,7.47521 -69.5,8.52148 -10.71255,0.8541 -20.10036,2.52545 -23,4.09571 -4.24526,2.29894 -14.1516,4.39072 -16.03125,3.38476 -0.93782,-0.50188 -1.91688,-0.70225 -2.17383,-0.44531 -0.25694,0.25695 -7.40299,0.64618 -15.88086,0.86523 -8.47787,0.21904 -19.23906,0.87904 -23.91406,1.4668 -4.675,0.58775 -12.1,1.28844 -16.5,1.55664 -4.4,0.2682 -14.975,1.18026 -23.5,2.02734 -8.525,0.84709 -18.875,1.52878 -23,1.51368 -13.56677,-0.0497 -14,-0.96207 -14,-29.48438 0,-21.16197 0.0421,-21.60383 2,-20.98242 1.16664,0.37028 2,0.18003 2,-0.45703 0,-1.79259 4.79481,-3.16697 18,-5.1582 22.62507,-3.41167 26.26212,-3.79103 51.5,-5.37891 13.75,-0.86511 35.35,-2.68155 48,-4.03516 12.65,-1.35361 28.27085,-2.91789 34.71289,-3.47656 6.44205,-0.55867 12.74205,-1.39602 14,-1.86133 1.25796,-0.4653 11.51211,-1.39917 22.78711,-2.07422 11.275,-0.67506 23.65,-1.57867 27.5,-2.00976 3.85,-0.4311 8.40616,-0.57691 10.125,-0.32227 z m -573.54102,9.47461 c 0.0458,-0.93543 0.72938,0.97124 1.51954,4.23828 0.79017,3.26703 1.27123,6.41703 1.06836,7 -0.42686,1.22654 -2.71232,-8.69828 -2.5879,-11.23828 z m 553.23243,1.4043 c -1.23007,-0.046 -3.23729,0.27106 -6.34571,0.9375 -3.66087,0.78439 -8.5336,1.12902 -11.2207,0.79297 -4.33688,-0.54237 -4.75,-0.41208 -4.75,1.49023 0,1.59077 0.83038,2.23917 3.51172,2.74219 1.93154,0.36236 4.34993,0.43993 5.375,0.17187 1.56993,-0.41055 1.94891,0.24182 2.4043,4.13672 C 875.4146,473.48664 873.14737,476 863.35156,476 c -4.24507,0 -4.35084,-0.079 -4.33594,-3.25 0.008,-1.7875 0.40364,-3.86312 0.87891,-4.61328 0.50826,-0.80226 0.34395,-3.34046 -0.40039,-6.16211 -1.6193,-6.13849 -2.20491,-7.02239 -4.14648,-6.27734 -1.28598,0.49347 -1.47043,1.60264 -0.97266,5.83789 0.70777,6.02205 0.19497,6.71639 -6.22656,8.43359 -4.87697,1.30417 -5.03151,1.24592 -5.66602,-2.08398 C 840.25676,456.20453 839.83182,455 837.92969,455 836.86869,455 836,455.56593 836,456.25781 c 0,0.69187 -1.125,3.37215 -2.5,5.95508 -1.375,2.58293 -2.5,5.51671 -2.5,6.51953 0,1.00281 -0.62762,2.71758 -1.39453,3.8125 -0.76692,1.09493 -1.55442,4.22067 -1.75,6.94531 -0.29024,4.04325 -0.0417,5.0174 1.34961,5.29688 1.21533,0.24413 1.94842,-0.60955 2.55664,-2.97266 0.67199,-2.61087 1.43916,-3.38288 3.60742,-3.63672 3.33893,-0.39089 5.49432,1.25531 7.29883,5.57227 0.74719,1.7875 1.97951,3.25 2.73828,3.25 2.40392,0 2.71025,-3.16255 0.68359,-7.05078 -1.82988,-3.5107 -1.84668,-3.85045 -0.27343,-5.16016 2.62447,-2.18484 7.40544,-3.9706 8.26953,-3.08789 0.42958,0.43883 0.9234,2.59883 1.09765,4.79883 l 0.31641,4 5.36523,-0.33203 c 2.95122,-0.18298 7.26666,-0.90493 9.58789,-1.60352 4.18354,-1.25906 4.22946,-1.24588 5.29688,1.58203 1.18629,3.14285 4.20109,3.82055 6.21289,1.39649 1.48179,-1.78544 0.51259,-3.66263 -1.49414,-2.89258 -1.52808,0.58638 -1.98031,-1.78148 -1.56055,-8.18359 0.10942,-1.66871 -0.22705,-4.93121 -0.74804,-7.25 C 877.29304,459.35755 877.38008,459 879.20117,459 881.37913,459 887,456.00468 887,454.84375 c 0,-0.78275 -0.45353,-1.19225 -1.68359,-1.23828 z M 898.5293,455 c -3.98925,0 -11.24552,3.80765 -11.89844,6.24414 -1.83425,6.84489 0.4777,15.53219 4.67187,17.55859 3.39038,1.63804 4.31776,1.42249 7.48243,-1.74218 C 904.6152,471.2305 904.42721,455 898.5293,455 Z m -785.93164,3.14648 c -1.02343,0.8061 -1.61823,5.0644 -2.10352,14.125 -0.39123,7.30462 -1.23741,14.57034 -1.88086,16.14454 -1.13659,2.78064 -1.251,2.60827 -3.97656,-6.02735 C 103.0937,477.4998 101.24492,471.925 100.52734,470 c -1.522906,-4.08546 -4.16395,-4.78796 -3.759762,-1 0.462432,4.33381 6.099772,21.35888 8.195312,24.75 2.19169,3.54671 5.56523,4.33168 6.44727,1.5 1.97502,-6.34056 3.83822,-35.3356 2.36523,-36.80859 -0.4484,-0.44841 -0.83659,-0.56362 -1.17773,-0.29493 z M 898.61719,459 c 1.12751,0 -0.32159,12.93925 -1.625,14.50977 -3.16569,3.81442 -6.99219,0.22308 -6.99219,-6.5625 0,-2.31946 0.82145,-3.44134 3.98047,-5.43555 C 896.16954,460.12983 898.25596,459 898.61719,459 Z m -591.09375,0.625 c 1.18369,-0.12073 2.37979,0.0628 4.10156,0.50195 4.56582,1.16459 8.99817,4.8589 11.53711,9.61524 1.19563,2.23985 3.04578,3.6051 6.59375,4.86523 3.99018,1.41719 5.10454,2.33769 5.83789,4.82227 0.61508,2.08388 1.45505,2.97977 2.61328,2.78711 1.85678,-0.30887 3.73791,2.72549 5.75586,9.2832 0.67699,2.2 2.31322,6.77611 3.63477,10.16992 1.32156,3.3938 2.40234,7.08017 2.40234,8.19141 0,1.11123 0.40137,2.26868 0.89258,2.57226 0.52228,0.32276 0.53196,-1.00272 0.0234,-3.1914 -0.47809,-2.05862 -0.84983,-4.64219 -0.82813,-5.74219 0.0796,-4.02888 2.04457,2.81254 2.44141,8.5 0.21107,3.025 0.83139,8.2 1.3789,11.5 0.54751,3.3 0.72635,7.07641 0.39844,8.39258 -0.61722,2.47738 -6.01161,8.02652 -7.85352,8.07812 -1.82323,0.051 -7.92114,7.22467 -13.89453,16.34571 -4.05648,6.19402 -6.21402,8.64664 -7.25781,8.24609 C 321.38665,563.06042 319,562.84304 319,563.99023 c 0,0.66396 -1.25531,2.40121 -2.78906,3.85938 -1.53376,1.45817 -3.81852,4.12022 -5.07813,5.91601 -1.25961,1.79581 -3.60429,3.94457 -5.21093,4.7754 -2.57153,1.32979 -2.92188,2.04919 -2.92188,6.00976 0,3.85544 -0.34986,4.63272 -2.45117,5.43164 -1.34866,0.51276 -3.20332,2.38134 -4.11914,4.15235 -0.91582,1.771 -3.18408,5.38153 -5.04102,8.02343 -1.85695,2.6419 -3.49173,5.35248 -3.63281,6.02539 -0.35003,1.6696 -10.62412,10.54442 -13.93359,12.03516 -1.47283,0.66343 -2.46117,1.55543 -2.19727,1.98242 0.2639,0.427 -0.15792,0.53082 -0.93555,0.23242 -0.99023,-0.37999 -2.1029,1.19678 -3.71484,5.26172 -1.26586,3.19221 -2.6826,6.30662 -3.14844,6.91992 -0.46584,0.6133 -1.24867,4.30574 -1.73828,8.20508 -0.88248,7.0281 -5.95725,19.99627 -8.72461,22.29297 -0.7373,0.61195 -1.04667,1.58877 -0.6875,2.16992 0.40181,0.65014 0.0367,0.81975 -0.94922,0.44141 -1.74112,-0.66812 -2.21519,0.42291 -7.16211,16.52344 -3.5518,11.55992 -6.59153,13.178 -10.61914,5.65234 -1.76249,-3.29325 -7.71435,-32.59431 -9.93359,-48.90039 -0.48655,-3.575 -1.59003,-11.60158 -2.45313,-17.83594 -1.23577,-8.92628 -1.343,-12.75156 -0.5,-18 0.58878,-3.66564 1.28101,-9.13906 1.53711,-12.16406 0.25611,-3.025 1.32594,-8.425 2.37696,-12 2.58518,-8.79342 5.74219,-24.24668 6.55468,-32.07812 0.54145,-5.21894 3.33712,-14.71201 8.22071,-27.92188 0.305,-0.825 0.68309,-2.14876 0.84179,-2.94141 0.8851,-4.42092 1.5923,-5.97554 3.70899,-8.15234 1.2871,-1.32364 6.76429,-8.93125 12.16992,-16.90625 5.40564,-7.975 10.79998,-15.45099 11.98828,-16.61328 3.80612,-3.72282 18.83446,-11.14434 25.04297,-12.36719 3.3,-0.64997 7.8,-2.02789 10,-3.0625 1.66927,-0.78502 2.83975,-1.2113 4.02344,-1.33203 z M 929.81836,461 c -0.6631,0 -0.58758,0.57305 0.20117,1.52344 0.69572,0.83829 1.47096,1.3181 1.72266,1.0664 C 932.43568,462.89634 931.02691,461 929.81836,461 Z m -137.48828,0.30273 c -0.52013,-0.12185 -1.08481,0.0786 -1.70313,0.5918 -1.25288,1.0398 -1.27726,1.70273 -0.16211,4.41406 0.72174,1.75479 1.6227,5.08654 2.00391,7.40235 0.64628,3.92601 0.52303,4.25362 -1.84375,4.84765 -1.39608,0.35042 -3.03437,0.47163 -3.64062,0.26953 -1.13716,-0.37903 -5.97247,-11.35603 -5.98047,-13.57812 -0.003,-0.6875 -0.85134,-1.25 -1.88672,-1.25 -1.6134,0 -1.98219,1.07203 -2.58399,7.49414 -0.3862,4.12133 -1.10053,7.73712 -1.58593,8.03711 -0.4854,0.3 -0.6148,1.87914 -0.28907,3.50781 0.32574,1.62868 0.24947,2.96094 -0.16797,2.96094 -0.86545,0 -8.80569,-2.22659 -9.34765,-2.62109 -0.19609,-0.14275 1.28872,-1.95174 3.29883,-4.02149 2.8522,-2.93682 3.59015,-4.43266 3.35742,-6.81054 -0.24596,-2.51318 -1.17479,-3.5137 -5.29883,-5.71485 -7.1528,-3.81772 -11.26247,-3.65642 -10.61914,0.41797 0.10464,0.66271 -17.26727,1.35476 -22.30859,0.88867 -1.06079,-0.0981 -2.21805,0.28744 -2.57032,0.85742 -0.35227,0.56999 -2.58845,1.22999 -4.96875,1.4668 -5.00848,0.49826 -7.03821,1.93249 -5.25781,3.71289 0.86788,0.86788 2.08318,0.89548 4.64453,0.10938 1.90781,-0.58553 3.61918,-0.91208 3.80469,-0.72657 0.18547,0.1855 0.1648,2.15269 -0.0469,4.3711 -0.3503,3.67327 -0.71018,4.12442 -4.03125,5.04687 -6.71704,1.86572 -7.37551,1.50668 -11.03906,-6.01172 C 711.37473,471.3565 710.26708,470 708.41992,470 c -2.02474,0 -2.23506,0.3811 -1.78906,3.25 0.27789,1.7875 -0.20004,5.21835 -1.0625,7.625 -2.11298,5.89613 -2.10005,12.125 0.0254,12.125 0.87649,0 1.82953,-0.9 2.11719,-2 0.3319,-1.26919 1.36365,-2 2.82422,-2 1.26587,0 3.09117,-0.30334 4.05664,-0.67383 1.38225,-0.53042 1.61053,-0.29603 1.07422,1.10156 -0.4457,1.16149 0.0989,2.59671 1.57617,4.1543 3.6443,3.84239 5.18326,1.86695 3.26562,-4.19336 -0.5579,-1.76314 -0.037,-2.36336 3.16211,-3.64453 l 3.83008,-1.5332 0.67578,4.45117 c 1.09578,7.22457 4.90756,9.88141 6.84961,4.77344 1.33452,-3.51005 1.272,-3.66409 -1.14648,-2.89649 -2.07421,0.65833 -2.11055,0.47501 -1.69532,-8.42968 0.34916,-7.48769 0.76195,-9.34894 2.32813,-10.49415 1.04713,-0.7657 2.53343,-1.15067 3.30273,-0.85546 1.81769,0.69751 0.85804,7.27623 -1.29101,8.84765 -1.63747,1.19735 -2.09941,4.39258 -0.63477,4.39258 0.48879,0 1.18089,1.56151 1.53906,3.4707 0.91047,4.85321 3.78691,6.70137 8.08594,5.19336 4.45975,-1.5644 9.48633,-6.19944 9.48633,-8.74804 0,-1.8904 -0.2573,-1.81303 -2.96875,0.89843 -3.87848,3.87848 -8.4809,5.55409 -10.05273,3.66016 -2.15063,-2.59135 -0.66816,-4.79581 4.02929,-5.99414 5.33026,-1.35976 9.94382,-3.66263 8.38086,-4.18359 -0.60809,-0.2027 -3.64314,0.029 -6.74609,0.51562 -5.34683,0.83846 -5.64139,0.77409 -5.62696,-1.21484 0.008,-1.15423 0.34592,-2.6077 0.75,-3.23047 0.85875,-1.32351 9.41029,-4.36719 12.26954,-4.36719 2.26505,0 2.47452,1.55402 2.03906,15.12891 -0.19536,6.09008 0.0921,8.85569 0.97656,9.40234 1.84418,1.13977 4.14797,-2.52997 3.67578,-5.85547 -0.31636,-2.22798 -0.067,-2.71413 1.18555,-2.30469 13.44395,4.39477 20.86624,5.00882 17.28711,1.42969 -0.66,-0.66 -1.19922,-1.56 -1.19922,-2 0,-1.32417 2.84239,-0.90161 3.70117,0.55078 0.43983,0.74388 2.04731,2.81735 3.57227,4.60547 2.2204,2.60358 3.05249,3.01686 4.18359,2.07813 1.20808,-1.00261 1.14501,-1.79648 -0.4375,-5.48828 -1.3608,-3.17461 -1.55452,-4.6115 -0.73437,-5.43165 2.15162,-2.15162 3.69722,-1.07373 4.8125,3.35547 1.44851,5.75256 3.11192,7.2097 6.47851,5.67578 1.38459,-0.63086 3.95908,-1.17809 5.72071,-1.21679 1.76161,-0.0387 4.07322,-0.41167 5.13671,-0.82813 3.04201,-1.19126 0.27242,-2.27169 -6.76171,-2.63867 -7.05782,-0.36821 -6.44971,0.6798 -8.69141,-14.96289 -0.93876,-6.55066 -2.08999,-9.8317 -3.65039,-10.19727 z m 45.13672,0.20313 0.70898,3.99609 c 0.3899,2.19861 0.73393,4.78555 0.76563,5.74805 0.0392,1.18987 -0.69971,1.75 -2.3086,1.75 h -2.36523 l 1.59961,-5.74805 z m -714.16211,1.08789 c -1.70291,-0.53762 -2.58821,-0.092 -3.95508,1.99414 -1.47646,2.25337 -1.78046,5.21427 -1.88086,18.30078 -0.0659,8.58637 0.0746,16.17383 0.3125,16.86133 0.61014,1.76354 2.88757,1.55406 3.61133,-0.33203 C 121.72643,498.54799 122,495.82799 122,493.37305 v -4.46289 l 3.75,0.65039 c 2.0625,0.358 5.51912,1.78876 7.68164,3.17968 l 3.93164,2.5293 1.81836,-2.24609 c 2.41038,-2.97669 2.29323,-4.02857 -0.43164,-3.8711 -1.2375,0.0715 -3.6,-0.60658 -5.25,-1.50586 -1.65,-0.89929 -3.675,-1.64445 -4.5,-1.65625 -3.53524,-0.0506 -4.04936,-1.47085 -1.99219,-5.50585 3.86302,-7.57709 2.10747,-16.05619 -3.70312,-17.89063 z m -1.61328,2.47852 c 0.62782,-0.81615 3.15798,3.44569 3.72656,6.27734 0.34943,1.74023 -0.14727,4.46417 -1.27539,7 l -1.8457,4.15039 -0.4668,-8.5 c -0.25638,-4.675 -0.31933,-8.69288 -0.13867,-8.92773 z M 682,466 c -0.55,0 -1,0.45 -1,1 0,0.55 0.45,1 1,1 0.55,0 1,-0.45 1,-1 0,-0.55 -0.45,-1 -1,-1 z m 5.3125,2.28906 c -1.83431,-0.70389 -2.08852,-0.3686 -2.84375,3.74219 -0.7893,4.29615 -0.80183,26.62069 -0.0156,27.89258 0.35015,0.56656 1.83825,0.52818 3.81055,-0.0977 1.78009,-0.56463 5.07748,-1.49095 7.32813,-2.05859 2.25066,-0.56764 4.64536,-1.91729 5.32031,-2.99805 1.4722,-2.35737 0.695,-3.5178 -1.26563,-1.89062 -0.77123,0.64006 -3.82082,1.26676 -6.77539,1.39257 L 687.5,494.5 l 0.32227,-6.875 c 0.17724,-3.78122 0.71726,-7.91206 1.19921,-9.17969 1.15134,-3.02824 0.0666,-9.47492 -1.70898,-10.15625 z m 73.67578,0.70117 3.25586,1.32227 c 1.85873,0.75555 3.38,2.15946 3.54492,3.27148 0.17137,1.1554 -1.04919,3.24605 -3,5.13672 l -3.28906,3.1875 -0.25586,-6.45898 z m -676.14453,4.32618 c -0.915682,0.12964 -1.832808,0.40637 -2.583984,0.80664 -2.870476,1.52957 -6.866072,9.56016 -7.865235,15.80859 -0.535373,3.34804 -0.249047,4.30564 1.94336,6.49805 1.41405,1.41405 3.16691,2.57031 3.894531,2.57031 2.264144,0 5.437257,-2.78726 6.732422,-5.91406 l 1.240234,-2.99414 2.646484,1.86914 c 4.192106,2.96064 6.571433,3.27488 8.980469,1.18554 2.873279,-2.492 2.738829,-3.32696 -0.408203,-2.5371 -5.649251,1.41788 -9.404309,-3.70117 -9.417969,-12.83985 -0.0047,-3.17331 -0.390153,-3.82879 -2.582031,-4.37891 -0.748702,-0.1879 -1.664396,-0.20392 -2.580078,-0.0742 z m 695.375,2.92187 c 0.14664,-0.11169 0.38932,0.15524 0.78125,0.76172 0.53316,0.825 0.97636,1.8375 0.98438,2.25 0.008,0.4125 -0.43438,0.75 -0.98438,0.75 -0.55,0 -0.99238,-1.0125 -0.98438,-2.25 0.006,-0.90972 0.0565,-1.40003 0.20313,-1.51172 z m -230.55859,0.55469 7.38476,3.85351 c 8.56677,4.46961 17.74783,13.07119 18.62305,17.44727 0.32748,1.6374 1.3824,3.39761 2.34375,3.91211 2.19964,1.17721 6.49989,9.37196 7.34375,13.99414 0.35144,1.925 1.52518,10.56175 2.60742,19.19336 1.97304,15.7364 3.89823,25.70607 6.04492,31.30664 0.63245,1.65 2.23409,6.825 3.56055,11.5 1.32647,4.675 4.21653,13.8989 6.42187,20.49805 2.20535,6.59914 4.00977,13.09624 4.00977,14.4375 v 2.43945 l -3.00781,-2.88086 c -2.32924,-2.23154 -3.27468,-2.61204 -4.19922,-1.6875 -0.92414,0.92455 -0.92298,1.46293 0.008,2.39258 1.91953,1.91953 1.4389,2.53406 -2.55078,3.26367 -2.0625,0.37718 -5.55,1.69381 -7.75,2.92578 -6.24411,3.49662 -9.99839,3.21093 -17.5,-1.33398 -8.89844,-5.39118 -9.65116,-6.11034 -7.59375,-7.26172 2.63209,-1.47374 0.81526,-2.79297 -3.8498,-2.79297 -3.7586,0 -4.76369,-0.50089 -7.68945,-3.82422 -1.8515,-2.10309 -4.57872,-5.90371 -6.06055,-8.44726 -2.66025,-4.5663 -2.76685,-4.62998 -8.43945,-4.92774 -5.64717,-0.29643 -5.79122,-0.37746 -8.3711,-4.80078 -3.59771,-6.16844 -8.04696,-9 -14.14453,-9 -4.34385,0 -5.25816,-0.41669 -8.71289,-3.97656 -2.89267,-2.98069 -4.01294,-5.09053 -4.46875,-8.41602 -0.54867,-4.00297 -3.22473,-10.06687 -5.89062,-13.34765 -0.5548,-0.68246 -0.80581,-2.62033 -0.5586,-4.30469 0.33082,-2.25402 -0.0364,-3.32031 -1.38672,-4.04297 -4.69648,-2.51348 0.51836,-37.5059 7.83399,-52.56641 3.36401,-6.92543 3.62043,-7.18213 7.95508,-8 2.46309,-0.46475 4.41499,-1.2553 4.33789,-1.75586 -0.33103,-2.14931 4.45905,-3.02412 18.61914,-3.39843 z M 85.134766,477.5625 c 0.396757,-0.20937 0.642635,0.17571 0.976562,1.02734 1.698779,4.33252 0.951523,10.18145 -1.701172,13.33399 -2.492453,2.96212 -4.801923,3.89835 -5.738281,2.32617 -1.170594,-1.96546 0.785994,-8.01897 4.574219,-14.14844 0.942693,-1.52531 1.491914,-2.32969 1.888672,-2.53906 z m 625.080074,0.70312 c 0.43061,-0.20607 1.4223,1.27338 2.57422,3.98438 1.10209,2.59373 1.01999,2.75 -1.42773,2.75 -2.2033,0 -2.50411,-0.33976 -1.99219,-2.25 0.33164,-1.2375 0.60919,-2.90172 0.61719,-3.69922 0.004,-0.46025 0.085,-0.71646 0.22851,-0.78516 z m -432.41015,3.25586 c -0.58131,0.14655 -1.27093,0.50188 -2.02149,1.09961 -7.80828,6.21834 -11.7832,9.95923 -11.7832,11.08985 0,0.70853 0.70525,1.28906 1.56641,1.28906 2.30486,0 5.57322,-1.96494 4.94921,-2.97461 -0.54045,-0.87447 4.53843,-5.02539 6.14844,-5.02539 0.4703,0 1.45028,-0.95234 2.17774,-2.11719 1.47736,-2.36564 0.7068,-3.80097 -1.03711,-3.36133 z M 519.73438,487 c -1.31575,0 -6.97342,8.81808 -8.17969,12.75 -1.30897,4.26669 0.9965,2.23058 5.21484,-4.60547 C 521.37715,487.67763 521.625,487 519.73438,487 Z m 32.45898,9.09766 c -0.48557,0.0651 -0.97916,0.28971 -1.4043,0.71484 -1.45315,1.45315 0.60545,6.3277 4.37891,10.36719 1.58958,1.70165 3.20164,2.78273 3.58203,2.40234 0.38039,-0.3804 0.23441,-1.00413 -0.32422,-1.38672 -2.38199,-1.63138 -5.16935,-7.90296 -4.24609,-9.55273 0.84412,-1.50836 -0.52961,-2.74022 -1.98633,-2.54492 z m -204.125,1.09179 c 0.0979,-0.22315 0.46331,0.12116 1.05273,1.13477 0.58413,1.00375 0.85122,2.0355 0.59375,2.29297 -0.25747,0.25747 -0.74885,-0.26255 -1.09179,-1.15625 -0.48249,-1.25735 -0.65259,-2.04834 -0.55469,-2.27149 z M 285.98828,502 c -0.482,3.20204 -0.79827,21.93239 -0.39258,23.25 0.29636,0.9625 1.12674,1.75 1.84571,1.75 0.93746,0 1.43211,-2.37329 1.74804,-8.39258 0.43838,-8.35231 2.68866,-14.41804 4.85352,-13.08008 2.18361,1.34954 -0.36644,11.42855 -2.71289,10.72266 -0.45706,-0.1375 -0.83008,0.3125 -0.83008,1 0,0.6875 2.19763,2.71914 4.88281,4.51367 3.80795,2.54488 5.18521,3.01061 6.26172,2.11719 1.04393,-0.86639 1.10441,-1.47947 0.24609,-2.51367 -0.62412,-0.75203 -1.64352,-1.38094 -2.26367,-1.39844 -0.62016,-0.0175 -1.91896,-0.63269 -2.88672,-1.36719 -1.60478,-1.21795 -1.62701,-1.5896 -0.25585,-4.21875 3.74531,-7.18157 0.30481,-14.43961 -5.1504,-10.86523 -2.33997,1.53321 -2.58823,1.52119 -3.88476,-0.18946 -0.76181,-1.00513 -1.41954,-1.60312 -1.46094,-1.32812 z m 219.46094,0 c -1.44378,0 -1.82306,1.02897 -1.52149,4.13672 0.0874,0.90022 -0.74533,6.06734 -1.85156,11.48242 -1.91813,9.38942 -1.68169,12.49153 0.83594,10.93555 C 503.51003,528.18515 504,527.00895 504,525.94141 504,524.54194 504.69259,524 506.48047,524 c 1.89811,0 2.97156,0.96618 4.58008,4.11914 1.45893,2.85973 2.42024,3.80046 3.14453,3.07617 0.7243,-0.72428 0.69322,-2.04581 -0.0996,-4.32031 -0.89192,-2.55855 -0.86319,-3.43477 0.12695,-4.00586 0.69729,-0.40219 2.16758,-1.45164 3.26758,-2.33203 1.91038,-1.52898 1.82378,-1.5899 -1.92578,-1.32031 -3.74217,0.26906 -3.96365,0.11976 -4.7461,-3.2168 -2.13438,-9.10165 -4.01606,-14 -5.3789,-14 z m -180.50586,0.48242 C 322.65707,501.75678 317,503.67735 317,505.17969 c 0,0.51573 -0.39925,0.6919 -0.88672,0.39062 -1.23168,-0.76121 -2.08341,2.96387 -2.09961,9.17969 -0.0102,3.92921 0.48949,5.75316 1.98633,7.25 1.1,1.1 3.0125,1.98613 4.25,1.96875 3.24092,-0.0455 7.59942,-4.29019 9.27148,-9.0293 1.32475,-3.75475 1.28121,-4.404 -0.52343,-7.9414 -1.08093,-2.11879 -2.90492,-4.15071 -4.05469,-4.51563 z m 210.55273,0.0937 c -0.94408,0.0561 -1.60509,0.25084 -1.72851,0.6211 -0.66546,1.99637 1.41926,22.32322 2.41211,23.51953 1.53623,1.85104 3.0804,0.42134 2.54883,-2.35938 -0.39537,-2.0683 -0.16156,-2.31445 1.65625,-1.7539 1.16385,0.3589 3.99862,1.74568 6.30078,3.08203 5.08578,2.95216 11.31445,2.48117 11.31445,-0.85547 0,-1.07125 -0.45,-1.67 -1,-1.33008 -0.61506,0.38013 -1,-1.28171 -1,-4.31641 C 556,512.38128 554.99901,508 553.44336,508 c -2.00301,0 -2.61171,3.30449 -1.49805,8.13477 0.55354,2.40076 1.0159,5.40459 1.0293,6.67382 l 0.0254,2.30664 -5.25,-2.80664 c -2.8875,-1.54423 -5.38841,-2.87267 -5.55859,-2.95117 -0.17018,-0.0785 0.61732,-1.87299 1.75,-3.98633 2.34015,-4.36621 2.63743,-8.25825 0.80859,-10.56836 -1.04301,-1.31748 -6.42166,-2.39472 -9.25391,-2.22656 z m -276.01953,0.50781 c -0.37823,-0.19562 -0.74199,-0.16021 -1.0957,0.10352 -0.47162,0.35165 -0.92323,1.11015 -1.36328,2.26758 -1.51077,3.97365 -4.31918,22.31823 -3.67383,24 1.23907,3.22897 3.90887,0.32688 4.09766,-4.45508 0.0326,-0.825 0.99835,-1.63479 2.14648,-1.79883 2.10132,-0.30023 3.9535,1.29059 5.87305,5.04297 2.16146,4.22521 3.934,0.25852 2.1914,-4.9043 -0.62101,-1.83985 -0.20417,-2.33255 2.81836,-3.33007 3.82402,-1.26204 3.82403,-3.55157 0,-2.5918 -3.84727,0.9656 -5.35134,-0.35423 -7.14258,-6.26758 -1.45819,-4.8139 -2.71686,-7.47954 -3.85156,-8.06641 z m 19.54102,0.53125 c -0.58871,-0.0665 -1.12781,-0.003 -1.51758,0.23829 -0.55,0.34047 -2.9949,1.30036 -5.43359,2.13281 -5.53752,1.89024 -6.9985,4.60832 -1.94336,3.61523 7.84565,-1.5413 7.32192,-2.10743 7.71289,8.33203 0.19431,5.18855 0.75001,10.47605 1.23437,11.75 1.12504,2.95907 2.14124,2.92211 3.55664,-0.13086 0.89188,-1.92376 0.83962,-2.5428 -0.25,-2.96093 C 280.71162,525.95305 280.34765,508 282,508 c 0.55,0 1,-0.68853 1,-1.53125 0,-1.27959 -2.2163,-2.65395 -3.98242,-2.85352 z M 568.41406,504 C 565.71417,504 561,509.28073 561,512.30469 c 0,1.85941 0.41617,1.64615 3.07227,-1.57617 1.69005,-2.05031 3.65279,-3.72852 4.36132,-3.72852 0.70853,0 2.35873,2.01621 3.66602,4.48047 l 2.37695,4.48047 -1.91797,3.55859 c -2.21986,4.12204 -4.29995,4.19773 -6.52343,0.23633 -1.25649,-2.2386 -1.3057,-3.09436 -0.27539,-4.74414 1.05367,-1.6872 1.00927,-2.01172 -0.27344,-2.01172 -0.84146,0 -2.02535,1.08708 -2.63086,2.41602 -1.51152,3.31743 1.61624,9.78737 5.14453,10.64257 3.40403,0.82508 4.83059,0.16903 6.45117,-2.96484 2.20305,-4.26022 2.86722,-9.62144 1.51563,-12.23828 C 573.90085,506.85551 570.75457,504 568.41406,504 Z m -262.22461,0.13672 c -0.42824,-0.0482 -0.90868,0.18212 -1.43164,0.70508 -0.98886,0.98886 -0.93796,1.43597 0.25,2.19922 1.0184,0.65431 1.14611,1.19693 0.40235,1.70898 -1.09905,0.75666 -0.33343,13.76665 1.07031,18.18945 0.84915,2.67544 4.12893,2.66378 4.83008,-0.0176 0.39698,-1.51811 0.15919,-1.93307 -0.88282,-1.53321 -1.48458,0.56968 -1.56805,-7.2e-4 -1.98632,-13.70703 -0.14502,-4.7519 -0.96723,-7.40021 -2.25196,-7.54492 z m 218.33789,0.9082 c -0.77916,0.1089 -1.64406,0.7475 -1.98828,1.83203 -0.3922,1.23571 -1.90785,2.08573 -4.4375,2.49024 -4.42679,0.70787 -7.30914,3.23172 -4.79297,4.19726 0.84396,0.32386 2.44006,0.10408 3.54688,-0.48828 4.38057,-2.34441 5.83898,-1.43592 6.57226,4.0918 0.37704,2.84231 1.31238,6.66731 2.07813,8.5 0.76575,1.83269 1.83915,3.33203 2.38476,3.33203 1.48843,0 2.51078,-2.13036 1.37305,-2.86133 -1.28969,-0.8286 -2.08503,-3.51649 -2.77734,-9.38867 -0.45382,-3.84929 -0.269,-4.75 0.97656,-4.75 1.97687,0 2.00637,-2.88302 0.0371,-3.63867 -0.825,-0.31659 -1.5,-1.20259 -1.5,-1.96875 0,-1.03642 -0.69349,-1.45656 -1.47266,-1.34766 z m -201.26562,0.625 c 1.06887,0.35892 1.95769,1.44357 2.71484,3.27149 1.40974,3.40343 -0.63515,9.27072 -3.82617,10.97851 -1.1104,0.59427 -2.25703,1.08008 -2.54883,1.08008 -1.27535,0 -2.59921,-4.2135 -2.57031,-8.18359 0.0246,-3.38283 0.55046,-4.6928 2.43164,-6.06055 1.48061,-1.0765 2.72996,-1.44486 3.79883,-1.08594 z m 216.16211,0.002 c 0.46568,-0.0963 1.00335,0.023 1.61719,0.35156 2.49968,1.33778 2.4898,4.59494 -0.0293,8.72656 -2.90633,4.76673 -4.03685,4.07323 -3.84766,-2.36328 0.12379,-4.21146 0.86273,-6.42585 2.25977,-6.71484 z M 188.5,507.13867 l 6,2.93555 c 3.3,1.61356 7.35,3.76387 9,4.7793 1.65,1.01544 7.35609,4.21764 12.67969,7.11523 5.3236,2.89758 11.08913,6.45091 12.8125,7.89844 3.08825,2.59396 3.11225,2.68441 1.64843,6.16601 -0.81684,1.94288 -2.00655,7.34288 -2.64257,12 -1.35332,9.90954 -3.88442,22.23582 -6.87305,33.4668 -3.50747,13.18076 -4.89173,29.20851 -3.44531,39.91016 0.67578,4.99989 1.98131,14.93984 2.90039,22.08984 0.91908,7.15 2.51405,15.79397 3.54492,19.20898 1.03088,3.415 1.875,7.21069 1.875,8.43555 0,1.22486 0.69814,5.18088 1.55078,8.79102 0.85264,3.61014 1.75802,7.56414 2.01172,8.78515 0.2537,1.221 2.25556,4.1061 4.44922,6.41211 3.8845,4.08346 4.91296,5.55597 3.09375,4.43164 -1.14531,-0.70784 -2.3244,2.2731 -1.45508,3.67969 0.38515,0.62317 0.18459,0.77282 -0.48437,0.35938 -0.7196,-0.44474 -1.94127,1.07129 -3.30079,4.0957 -1.18711,2.64087 -2.60141,5.78301 -3.14453,6.98437 -0.54313,1.20136 -0.74457,3.11506 -0.44726,4.25196 0.2973,1.1369 0.17658,1.84286 -0.26758,1.56836 -0.44415,-0.2745 -1.34645,1.74929 -2.00586,4.49804 -1.13391,4.72669 -1.37019,4.99104 -4.34961,4.88282 -4.56806,-0.16593 -19.03738,-3.49297 -27.15039,-6.24415 -3.85,-1.30552 -11.25899,-3.39031 -16.46484,-4.63281 -5.20584,-1.2425 -10.15736,-2.69202 -11.00391,-3.2207 -1.27464,-0.79602 -1.47865,-2.90357 -1.18164,-12.25977 0.40733,-12.83155 -0.81248,-18.50583 -6.44141,-29.96679 -1.87468,-3.81699 -3.41582,-7.86699 -3.42382,-9 -0.0229,-3.07966 -0.9239,-3.89388 -7.48438,-6.76172 -8.77697,-3.83675 -13.0914,-4.78697 -21.76953,-4.79297 -9.33068,-0.007 -19.7451,3.2527 -25.85742,8.09375 -4.843333,3.83597 -13.485192,15.85547 -14.402347,20.03125 -0.849623,3.86831 -2.708365,4.52188 -6.185547,2.17578 -1.532022,-1.03367 -3.958856,-2.468 -5.394531,-3.1875 -5.630043,-2.82155 -18.578826,-14.92784 -21.125,-19.75195 -1.819779,-3.44785 -3.15702,-4.84708 -4.587891,-4.79688 -1.201587,0.0422 -2.459077,-0.89383 -3.105468,-2.3125 -0.676207,-1.48412 -0.70716,-2.14928 -0.08008,-1.76172 C 46.546372,651.83859 47,651.64105 47,651.05859 47,650.47613 46.407176,650 45.681641,650 c -0.78795,0 -2.398693,-3.52848 -4,-8.76367 C 38.833142,631.92368 38.231382,628.26326 40,631 c 0.828426,1.2819 0.971285,1.24555 0.984375,-0.25 C 40.992797,629.7875 40.325,629 39.5,629 c -1.006431,0 -1.5,-1.00613 -1.5,-3.05859 0,-1.7847 0.416577,-2.80199 1,-2.44141 0.603931,0.37325 1,-0.99005 1,-3.44141 C 40,617.82613 39.55,616 39,616 c -1.451468,0 -1.215424,-3.06357 0.488281,-6.33008 0.812105,-1.55705 1.325816,-4.21657 1.140625,-5.9082 C 40.227602,600.09603 41.961874,595 43.611328,595 c 0.645575,0 1.441987,-0.69916 1.769531,-1.55273 0.341496,-0.88988 0.174282,-1.2898 -0.392578,-0.93946 C 44.444581,592.84383 44,592.58277 44,591.92773 44,590.43173 47.928198,584 48.841797,584 c 0.372841,0 1.269236,-0.94792 1.992187,-2.10547 1.08858,-1.74317 1.086901,-1.97224 -0.0098,-1.33789 -0.728104,0.42124 -0.375635,-0.31834 0.783203,-1.64453 1.158839,-1.32619 3.940359,-5.15553 6.18164,-8.50781 9.034386,-13.5127 22.494645,-24.65455 38.205079,-31.625 3.578535,-1.58773 9.655864,-4.39439 13.505864,-6.23828 7.01402,-3.35924 12.23041,-5.18963 22.49999,-7.89258 3.025,-0.79618 9.1,-2.8898 13.5,-4.65235 14.52539,-5.81854 20.95068,-8.13686 25,-9.02148 2.2,-0.48061 7.15,-1.53911 11,-2.35352 z m 71.28906,6.4043 c 0.46764,0.18096 1.08158,1.27259 1.66602,3.20703 0.50318,1.66546 0.27347,2.25 -0.88672,2.25 C 259.47171,519 259,518.0397 259,515.80078 c 0,-1.70827 0.32142,-2.43877 0.78906,-2.25781 z m 246.76367,0.88867 c 0.53772,-0.51186 0.97251,0.71542 1.76563,4.31836 0.37856,1.71971 0.045,2.25 -1.41211,2.25 -2.02969,0 -2.37558,-2.01688 -0.94336,-5.5 0.21931,-0.53335 0.4106,-0.89774 0.58984,-1.06836 z m -355.95703,1.83008 c 0.47941,0.47941 -19.17894,7.34247 -24.71679,8.6289 -2.54168,0.59044 -5.46668,1.33508 -6.5,1.6543 -1.03331,0.31922 -0.0789,-0.3676 2.12109,-1.52539 3.89336,-2.04895 28.42156,-9.43196 29.0957,-8.75781 z m -34.06836,10.93164 c 0.30789,0.30789 -0.24815,0.86666 -1.23437,1.24219 -1.4252,0.54268 -1.54081,0.42707 -0.56055,-0.56055 0.67834,-0.68342 1.48703,-0.98953 1.79492,-0.68164 z m 257.96485,1.33984 c 0.12938,0.13024 -0.0727,0.46185 -0.55664,1.04492 -1.32028,1.59084 -2.93555,1.88789 -2.93555,0.53907 0,-0.48585 0.92521,-1.12601 2.05664,-1.42188 0.84399,-0.22071 1.30617,-0.29234 1.43555,-0.16211 z M 930.74414,531 c -0.56272,0 -1.52413,0.64283 -2.13476,1.42969 -1.84785,2.38112 -30.18265,4.75594 -78.10938,6.54492 -31.48536,1.17527 -59.604,3.0562 -82.87891,5.54297 C 759.98774,545.33315 751.49958,546 748.75781,546 c -5.36716,0 -11.4824,2.72678 -13.55469,6.04492 -0.91917,1.47184 -0.83676,5.19211 0.36524,16.67578 0.85088,8.12913 1.93427,16.5793 2.4082,18.7793 0.47394,2.2 1.15844,7.6 1.52149,12 0.36304,4.4 0.87995,8.7875 1.14843,9.75 0.92947,3.33221 4.07256,1.81011 3.41993,-1.65625 -0.0939,-0.49889 -0.83281,-6.12389 -1.64258,-12.5 -0.80977,-6.37611 -1.96879,-15.49317 -2.57422,-20.25977 C 738.44151,563.74773 739.43431,553 741.86523,553 c 0.93779,0 4.16399,-0.85179 7.16993,-1.89258 3.00594,-1.04079 11.08984,-2.41596 17.96484,-3.05664 6.875,-0.64068 16.1,-1.5843 20.5,-2.09766 9.51638,-1.11017 35.2758,-2.46578 75,-3.94531 39.93853,-1.48751 47.44064,-2.04902 60.59961,-4.53906 l 3.59961,-0.68164 0.59961,5.81445 c 0.35706,3.45957 0.18043,6.32029 -0.43555,7.0625 -1.242,1.49652 -0.30762,3.33594 1.69531,3.33594 1.0701,0 1.44413,1.35123 1.45313,5.25 0.007,2.8875 0.67349,12 1.48047,20.25 0.80697,8.25 1.47698,15.3375 1.48828,15.75 0.0113,0.4125 -3.46797,0.75863 -7.73047,0.76953 -4.2625,0.0109 -10.675,0.43578 -14.25,0.94336 -16.30675,2.3152 -27.43775,2.93711 -109.5,6.11914 -15.4,0.59714 -33.85,1.61051 -41,2.25195 -11.94458,1.07159 -13,1.32839 -13,3.16602 0,2.3586 -0.66678,2.35455 20,0.12305 8.25,-0.8908 30.075,-2.07082 48.5,-2.62305 47.57992,-1.42606 73.53955,-2.78864 88.47266,-4.64062 8.4022,-1.04202 16.59308,-1.41525 23.25,-1.06055 7.51028,0.40016 10.27553,0.23231 10.26953,-0.625 -0.005,-0.64526 -0.44535,-4.99883 -0.97852,-9.67383 -0.53318,-4.675 -1.65875,-17.03255 -2.50195,-27.46094 -0.8432,-10.42839 -1.97738,-19.40511 -2.52149,-19.94922 -1.2392,-1.23917 -1.29561,-5.28235 -0.084,-6.03125 C 933.07121,534.83868 932.09259,531 930.74414,531 Z m -657.66016,8 c -2.09146,0 -1.82597,1.81906 1.0254,7.0332 1.63614,2.99193 2.55804,5.57831 2.04882,5.74805 -0.94361,0.31454 -0.70159,14.07432 0.35157,19.96875 0.31937,1.7875 1.12392,3.25 1.78711,3.25 0.87117,0 1.20587,-3.19059 1.20507,-11.49609 -6.1e-4,-6.32247 -0.28973,-11.497 -0.64257,-11.5 -0.546,-0.004 -1.36866,-2.21714 -2.41602,-6.50391 -0.75173,-3.0768 -2.52105,-6.5 -3.35938,-6.5 z m 287.54883,2.21289 c -0.94709,-0.1162 -2.00369,0.0208 -3.4414,0.37695 -4.77434,1.18282 -6.70773,4.94257 -6.64063,12.91016 0.0603,7.16441 2.26343,11.89133 6.17774,13.25586 1.53364,0.53463 3.44045,2.26992 4.23828,3.85742 0.79782,1.5875 1.86264,3.44922 2.36523,4.13672 0.5026,0.6875 1.82741,1.25 2.94531,1.25 1.90012,0 1.92611,-0.11777 0.39063,-1.81445 -0.90337,-0.99822 -2.11995,-3.18451 -2.70313,-4.85743 -0.93243,-2.67475 -0.67684,-3.65692 2.11524,-8.14843 5.07708,-8.16732 4.1069,-15.39094 -2.66211,-19.82617 -1.00011,-0.6553 -1.83807,-1.02443 -2.78516,-1.14063 z M 539.33398,544 c -1.07028,0.0721 -2.22508,0.40615 -3.40039,1.03516 -3.13234,1.67638 -2.2665,4.07485 3.40235,9.43554 7.11918,6.73218 8.1705,8.76118 5.70312,10.99414 -3.38681,3.06501 -8.03448,-0.071 -4.83984,-3.26562 1.4741,-1.4741 0.33556,-1.55617 -2.26563,-0.16406 -2.16212,1.15713 -2.57149,4.9285 -0.73437,6.76562 1.9014,1.9014 7.56135,1.43865 9.80078,-0.80078 3.47912,-3.47912 2.58867,-7.32907 -3.16602,-13.68359 -3.08024,-3.4013 -4.67332,-5.86989 -3.94336,-6.11329 0.67346,-0.22446 2.0998,0.38292 3.16797,1.34961 1.82278,1.64961 1.94141,1.65215 1.94141,0.0371 0,-3.6582 -2.45517,-5.80601 -5.66602,-5.58984 z m 21.68164,0.0801 c 1.78022,0.66002 3.8555,2.99785 5.03516,6.57226 0.91707,2.77872 0.7928,3.99654 -0.7207,7.04883 -2.52076,5.08362 -4.00297,5.19331 -4.82031,0.35547 -0.74144,-4.38853 -1.46688,-5.31963 -3.27344,-4.20312 -0.88162,0.54488 -0.83105,1.99841 0.20703,5.93359 1.47614,5.59576 0.61238,6.75345 -2.03125,2.71875 -1.91967,-2.92978 -2.66047,-11.17219 -1.24219,-13.82227 0.94351,-1.76293 1.04942,-1.76596 2.28516,-0.0762 1.1741,1.60568 1.29492,1.50886 1.29492,-1.03125 0,-3.13705 1.48543,-4.15611 3.26562,-3.49609 z m -43.27734,0.5957 c -0.7627,0.12412 -1.70976,0.47139 -2.83789,1.03906 l -3.40039,1.71094 2.71289,0.9668 c 2.4635,0.87841 2.69312,1.38668 2.5,5.53711 -0.18328,3.93886 -0.48914,4.53192 -2.21289,4.29297 -1.97316,-0.27353 -1.97358,-0.25674 -0.0586,1.25 1.06762,0.83999 2.24887,1.52734 2.625,1.52734 0.37613,0 0.94121,1.28812 1.25586,2.86133 0.31464,1.57321 1.75989,4.27321 3.21289,6 1.453,1.72679 3.02059,3.13867 3.48242,3.13867 1.6897,0 3.98242,-3.20844 3.98242,-5.57227 0,-3.19401 -1.6089,-3.11835 -2.41992,0.11329 -0.81425,3.24422 -2.28803,2.33183 -4.61133,-2.85743 l -1.82031,-4.07031 3.92578,-1.75781 c 4.80654,-2.15196 5.20596,-4.04348 0.67578,-3.19922 -1.7875,0.33313 -3.66386,0.65901 -4.16992,0.72461 -0.50607,0.0656 -0.95505,-1.44742 -0.99805,-3.36133 l -0.0781,-3.47851 5.37109,-0.19532 c 7.62362,-0.27554 8.51704,-1.90725 1.49609,-2.73242 -3.15694,-0.37104 -6.26493,-1.11033 -6.90625,-1.64258 -0.38691,-0.3211 -0.96385,-0.41904 -1.72656,-0.29492 z m -227.58984,1.82227 c -1.44533,0.36275 -2.96346,1.18814 -3.37305,1.83203 -0.89179,1.40195 -1.03419,21.83057 -0.16797,24.08789 0.33384,0.86999 1.2847,1.58203 2.11328,1.58203 1.10657,0 1.38929,-0.80047 1.06446,-3.01367 -0.43424,-2.95865 -0.37725,-3.00193 3.13672,-2.40625 1.96829,0.33366 4.85951,1.51041 6.42578,2.61523 3.71753,2.62225 5.7131,1.07179 3.32031,-2.58008 -1.20358,-1.83689 -2.87643,-2.66701 -6.39844,-3.17773 -2.62293,-0.38034 -5.09797,-0.88042 -5.5,-1.11133 -0.40204,-0.23092 0.83837,-1.79909 2.75781,-3.48437 4.8576,-4.26503 5.33299,-7.02346 1.97071,-11.43164 -2.28902,-3.00107 -3.14062,-3.46654 -5.34961,-2.91211 z m -42.70313,0.58984 C 245.94359,546.90544 245,547.19362 245,548 c 0,0.91573 1.40921,1.35242 2.41992,0.75 0.23069,-0.1375 1.46819,0.67849 2.75,1.81445 1.28181,1.13596 3.50215,2.79163 4.9336,3.67774 2.47003,1.52903 2.62872,2.14437 3.13671,12.09765 0.29439,5.76818 0.83792,10.97698 1.20704,11.57422 0.83429,1.34991 3.55273,1.43504 3.55273,0.11133 0,-0.53588 1.26177,-1.62596 2.80469,-2.42383 5.42544,-2.80561 6.98219,-11.38046 2.87109,-15.8164 -1.27822,-1.37922 -3.52822,-3.29737 -5,-4.26172 C 261.8194,554.30709 261,552.9038 261,550.94336 c 0,-3.46481 -1.92804,-4.93415 -2.68359,-2.04492 -0.66042,2.52546 -0.0849,2.515 -5.08008,0.10156 -2.22924,-1.07705 -4.28929,-1.72978 -5.79102,-1.91211 z M 897.38672,549 c -1.46079,0 -1.5817,0.89695 -0.99414,7.38086 0.56804,6.26855 0.42627,7.47443 -0.94336,8 -3.34547,1.28378 -4.32205,0.4205 -7.79688,-6.89648 -3.51139,-7.39401 -6.11516,-9.97134 -7.61718,-7.54102 -0.67067,1.08516 -2.0608,10.94554 -2.33399,16.55664 -0.0536,1.1 -0.79477,2.5625 -1.64844,3.25 -1.38591,1.11613 -1.34284,1.41168 0.40235,2.75977 1.82165,1.40716 1.84129,1.62355 0.29297,3.17187 -1.54833,1.54833 -2.14559,1.49668 -8.77735,-0.75976 l -7.11523,-2.42188 3.59765,-3.02148 c 4.11654,-3.45704 5.60047,-8.75686 3.31055,-11.82422 -1.54364,-2.0677 -11.72901,-5.08935 -12.9707,-3.84766 -1.26351,1.26351 -1.14442,21.18144 0.16406,27.48438 0.7179,3.45809 1.7038,5.70898 2.50195,5.70898 1.57965,0 2.91994,-6.22917 1.97852,-9.19531 -0.48945,-1.54213 -0.30181,-1.96641 0.69727,-1.58399 10.61003,4.06118 17.86523,4.55954 17.86523,1.22852 0,-0.83178 0.7875,-1.80308 1.75,-2.1582 0.9625,-0.35512 2.06285,-1.11549 2.44531,-1.68946 0.88914,-1.33436 7.83682,1.06567 9.44727,3.26367 0.93547,1.27678 1.41837,1.32905 2.67383,0.28711 1.36283,-1.13105 1.36842,-1.66207 0.0527,-4.81054 -1.35873,-3.25188 -1.3319,-3.65292 0.32617,-4.91016 2.76908,-2.09968 3.08153,-1.81831 4.25977,3.81836 1.53864,7.36081 2.18308,8.12879 6.18359,7.37695 1.84844,-0.34738 6.96133,-1.08651 11.36133,-1.64257 10.13562,-1.28094 10.46251,-1.41371 9.78516,-4.00391 -0.42764,-1.63531 -1.06105,-1.99112 -2.67383,-1.50195 -3.19954,0.97045 -18.75219,2.71267 -19.30274,2.1621 -0.9634,-0.96339 -2.26185,-8.25148 -2.28515,-12.83203 -0.0131,-2.58004 -0.41557,-4.9325 -0.89453,-5.22851 -0.47896,-0.29602 -1.14232,-1.89716 -1.47461,-3.5586 C 899.27292,550.11365 898.43697,549 897.38672,549 Z m -605.26563,1.10352 c 0.35235,0.0625 0.7575,0.49781 1.39844,1.33789 1.87414,2.45642 1.86053,3.57116 -0.0762,6.33593 -0.85619,1.22238 -1.98119,2.22266 -2.5,2.22266 -1.25495,0 -1.18239,-7.09575 0.0918,-9 0.43437,-0.64917 0.73359,-0.95904 1.08593,-0.89648 z M 682.5,552 c -1.26966,0 -1.51521,2.57208 -1.59961,16.75 -0.0548,9.2125 -0.4199,17.875 -0.81055,19.25 -0.70114,2.46789 -0.74234,2.44863 -3.17578,-1.5 -1.3558,-2.2 -3.92914,-6.9816 -5.7207,-10.625 -3.26672,-6.64335 -6.64688,-10.75545 -7.84961,-9.55273 -0.73974,0.73975 9.54205,21.08662 13.85937,27.42773 5.6486,8.29631 6.66248,5.2141 6.83204,-20.75 0.14049,-21.51105 0.17829,-21 -1.53516,-21 z m 133.44531,0.31445 c -0.44925,0.0726 -0.7788,0.42223 -1.14258,1.07227 -0.56159,1.00351 -2.21913,1.61328 -4.38671,1.61328 -1.91702,0 -4.60348,0.73239 -5.96875,1.62695 -2.02851,1.32913 -2.26003,1.89519 -1.26368,3.09571 1.35448,1.63204 8.74641,1.00988 9.88477,-0.83204 0.34537,-0.5588 0.92468,3.17472 1.28711,8.29688 0.36244,5.12217 1.13353,11.02698 1.71484,13.12305 0.76583,2.76144 1.52238,3.71602 2.74414,3.46289 1.01167,-0.2096 1.58124,-1.13551 1.42578,-2.3125 -2.39551,-18.13677 -2.92859,-23.08212 -2.56054,-23.71094 0.24143,-0.4125 1.76136,-0.75 3.3789,-0.75 1.94754,0 2.94141,-0.50669 2.94141,-1.5 0,-1.36419 -1.2071,-1.95324 -3.29102,-1.60547 -0.43478,0.0726 -1.73811,-0.3742 -2.89648,-0.99414 -0.84841,-0.45405 -1.41794,-0.65857 -1.86719,-0.58594 z m 14.54883,0.79688 c -1.37381,-0.15974 -1.71206,1.08402 -1.89844,4.73437 -0.11168,2.18737 -0.81203,4.71023 -1.55664,5.60742 -1.02545,1.2356 -1.07408,1.91225 -0.19726,2.78907 0.63669,0.63669 1.1582,3.12233 1.1582,5.52343 0,4.37127 1.33605,8.09035 3.40039,9.46876 3.05626,2.0407 12.29494,-0.75258 15.58008,-4.71094 1.14229,-1.37636 1.09053,-1.88212 -0.3457,-3.31836 -1.59186,-1.59185 -1.7275,-1.56516 -2.2461,0.41797 -0.62015,2.37147 -7.25147,4.87297 -10.32812,3.89648 -1.88498,-0.59827 -3.71181,-6.65647 -2.56641,-8.50976 0.3249,-0.52569 2.32842,-1.42397 4.45313,-1.9961 4.00817,-1.07929 8.96603,-4.42566 7.99804,-5.39844 -0.30473,-0.30624 -2.88279,0.18895 -5.73047,1.09961 -5.80443,1.85617 -6.739,1.50792 -5.8164,-2.16796 0.51946,-2.06971 1.24517,-2.54774 3.87109,-2.55274 5.55892,-0.01 14.02073,-3.03787 12.5625,-4.49609 -0.33599,-0.33599 -3.69956,-0.19744 -7.47265,0.30859 -4.51932,0.60612 -7.62825,0.57043 -9.11329,-0.10547 -0.72072,-0.32803 -1.29401,-0.5366 -1.75195,-0.58984 z M 756.51953,555 c -3.25079,0 -4.33609,3.8222 -2.06836,7.2832 0.89086,1.35962 2.30318,7.06231 3.13867,12.67188 0.83549,5.60956 1.95701,11.35016 2.49219,12.75781 0.92864,2.44251 1.23372,2.53356 6.69531,1.96289 8.3121,-0.8685 12.42493,-1.54407 13.01758,-2.13672 0.28687,-0.28686 1.09692,-0.0431 1.80078,0.54102 0.96501,0.80089 1.66373,0.31915 2.8418,-1.95899 0.85925,-1.6616 1.5625,-3.67137 1.5625,-4.46484 0,-0.79347 0.70743,-1.71304 1.57227,-2.04492 1.80242,-0.69165 5.42773,0.96083 5.42773,2.47461 0,0.55871 1.54425,1.66061 3.43164,2.44922 1.88739,0.7886 3.71352,1.89089 4.05859,2.44922 0.34506,0.55831 1.05082,1.01562 1.56836,1.01562 1.50701,0 1.0869,-4.84856 -0.65039,-7.5 -1.58099,-2.41289 -1.55225,-2.45075 4,-5.17383 3.07584,-1.50853 5.5918,-3.14635 5.5918,-3.64062 0,-0.49427 -0.7875,-0.57497 -1.75,-0.17774 -2.06146,0.85079 -8.31608,2.43485 -9.75,2.46875 -1.31746,0.0311 -7.5,-12.90252 -7.5,-15.68945 0,-1.19329 -0.47982,-2.4656 -1.06641,-2.82813 -1.47323,-0.9105 -3.8681,2.51046 -3.8789,5.54102 -0.005,1.375 -1.48117,7.0805 -3.28125,12.67773 l -3.27344,10.17579 -6.08203,1.07421 c -10.8875,1.92121 -10.98921,1.88131 -12.24805,-4.67773 -1.12553,-5.86444 -2.70947,-18.1775 -3.08789,-24 -0.0447,-0.6875 -1.19798,-1.25 -2.5625,-1.25 z m -259.47461,0.72852 c 0.99854,1.1187 3.95508,10.32968 3.95508,12.32226 0,0.93192 2.25,4.50901 5,7.94922 2.75,3.44021 5,7.00942 5,7.93164 0,2.80009 5.46679,10.50224 10.11523,14.25 7.37694,5.94758 12.93553,8.597 23.88477,11.39063 10.98126,2.8018 12.13448,3.27801 26.13086,10.79296 10.00604,5.37245 13.38658,5.73566 21.09766,2.25782 C 599.41475,619.38193 604,617.9955 604,619.06445 c 0,1.2369 -3.78708,3.48731 -8.25,4.90235 -2.0625,0.65395 -3.75,1.60399 -3.75,2.11132 0,0.50735 -0.675,0.92188 -1.5,0.92188 -0.93333,0 -1.5,0.94444 -1.5,2.5 0,1.375 0.3588,2.5 0.79688,2.5 0.43804,0 0.749,1.2375 0.6914,2.75 -0.0576,1.5125 0.58437,3.65 1.42578,4.75 0.84141,1.1 -0.48402,0.1333 -2.94336,-2.14844 -4.39242,-4.07521 -13.06541,-9.9901 -19.9707,-13.61914 -1.925,-1.01168 -5.92868,-2.05234 -8.89648,-2.3125 -2.96781,-0.26016 -8.14281,-1.56005 -11.5,-2.88867 -3.3572,-1.32862 -7.34102,-2.71568 -8.85352,-3.08203 -1.5125,-0.36636 -2.75,-1.05228 -2.75,-1.52539 0,-0.47312 -0.64786,-0.61237 -1.43945,-0.3086 -0.7916,0.30376 -2.2541,0.0422 -3.25,-0.58007 -1.56931,-0.98057 -1.47722,-1.05126 0.68945,-0.53516 2.16667,0.5161 2.25876,0.44541 0.68945,-0.53516 -0.9959,-0.62234 -2.4584,-0.88383 -3.25,-0.58007 -0.79159,0.30377 -1.43945,0.16442 -1.43945,-0.31055 0,-0.77647 -5.7133,-1.96706 -10.25,-2.13477 -0.9625,-0.0356 -1.75,-0.48613 -1.75,-1.00195 0,-0.51582 -0.66417,-0.9375 -1.47656,-0.9375 -1.0499,0 -1.46273,1.08452 -1.42383,3.75 0.0881,6.03981 -1.82038,16.25091 -4.34766,23.25 -2.69704,7.46924 -7.23923,16.56543 -8.73242,17.48828 -0.56046,0.34638 -1.01953,1.07891 -1.01953,1.62891 0,0.55 0.49474,0.69414 1.09961,0.32031 0.70878,-0.43805 0.66131,0.16355 -0.13477,1.69141 -1.73032,3.3209 -2.33455,3.76622 -1.52148,1.12109 1.56012,-5.07547 -0.83974,-1.67977 -4.94727,7 -4.57588,9.66945 -5.30696,12.18123 -8.08203,27.75 -0.93134,5.225 -2.00407,9.85103 -2.38281,10.2793 -0.37875,0.42827 -1.94353,-0.21056 -3.47852,-1.41797 -2.63169,-2.07009 -2.74856,-2.48392 -2.02148,-7.27735 0.42408,-2.79586 0.81689,-6.7283 0.87109,-8.73828 0.0542,-2.00998 0.43516,-3.44634 0.84766,-3.1914 0.4125,0.25494 0.75,-0.61993 0.75,-1.94532 0,-3.78807 2.05246,-8.70898 3.63281,-8.70898 1.09377,0 1.19845,-0.44728 0.4375,-1.86914 -0.55,-1.02768 -0.6783,-2.21795 -0.28515,-2.64648 0.39315,-0.42854 -0.41016,-0.50907 -1.78516,-0.17774 -2.264,0.54555 -2.17023,0.33194 0.99023,-2.27148 1.91944,-1.58115 3.71944,-2.85714 4,-2.83594 1.85922,0.14016 2.29221,-0.3678 1.00977,-1.1836 -1.23132,-0.78326 -1.279,-1.31352 -0.26172,-2.95507 4.97225,-8.02353 11.65408,-20.44196 13.47656,-25.04883 2.51191,-6.34962 2.89726,-15.28388 1.0586,-24.51172 -4.88145,-24.49902 -8.4031,-53.20777 -6.22852,-50.77148 z M 336,557 c 0.55,0 1,0.42387 1,0.94141 0,0.51754 -0.45,1.21867 -1,1.55859 -0.55,0.33992 -1,-0.0839 -1,-0.94141 C 335,557.70113 335.45,557 336,557 Z m -74.5,0.5 3.25,3.17383 c 3.17083,3.09578 4.26099,7.40794 2.48438,9.82617 -0.40409,0.55 -1.6064,1.675 -2.67188,2.5 -1.77701,1.37594 -1.87875,1.34487 -1.23242,-0.37695 0.45357,-1.20832 0.14228,-2.28883 -0.87305,-3.03125 -1.17957,-0.8625 -1.49932,-2.5326 -1.26758,-6.62305 z m 598.70508,0.5332 c 0.80311,-0.0305 2.00771,0.40074 3.25195,1.31055 2.33009,1.70381 1.57532,5.11858 -1.9668,8.90625 -3.47677,3.71779 -4.87688,3.54539 -4.0625,-0.5 0.35985,-1.7875 0.73273,-4.0375 0.82813,-5 0.0954,-0.9625 0.51285,-1.75 0.92773,-1.75 0.41488,0 0.49432,-0.675 0.17774,-1.5 -0.362,-0.94334 0.0406,-1.43628 0.84375,-1.4668 z m 23.45703,2.34766 c 0.3634,-0.1685 0.87269,0.75265 1.83789,2.61914 0.90611,1.75222 1.50227,3.31319 1.32422,3.46875 -0.17806,0.15557 -1.31215,0.5862 -2.51953,0.95703 -2.05508,0.63119 -2.15674,0.43237 -1.60742,-3.125 0.38488,-2.4925 0.60144,-3.75142 0.96484,-3.91992 z m -93.41992,6.48633 1.8789,3.09179 c 1.03356,1.69955 1.87891,3.52775 1.87891,4.06446 0,0.53671 -1.35,0.97656 -3,0.97656 -3.34645,0 -3.47519,-0.33692 -1.87891,-4.91602 z m 14.03711,2.51172 c -0.10514,0.10514 -0.17717,0.45463 -0.20118,1.03711 -0.0434,1.05416 0.19311,1.64479 0.5254,1.3125 0.33225,-0.33229 0.36876,-1.19415 0.0801,-1.91602 -0.15961,-0.39887 -0.29916,-0.53873 -0.40429,-0.43359 z M 794.94141,578 c 0.58246,0 1.05859,0.45 1.05859,1 0,0.55 -0.19887,1 -0.44141,1 -0.24254,0 -0.71867,-0.45 -1.05859,-1 -0.33992,-0.55 -0.14105,-1 0.44141,-1 z m -96.45118,0.0469 c -0.80606,-0.0866 -1.71502,0.37381 -2.12695,1.44726 -0.31537,0.82184 -0.95886,1.25509 -1.43164,0.96289 C 693.56309,579.6111 689,589.58299 689,593.41992 c 0,1.91741 0.55727,4.70843 1.23828,6.20313 0.99447,2.18258 0.9864,2.80204 -0.041,3.14453 -0.89007,0.29669 -0.62695,0.99267 0.86328,2.28515 1.54277,1.33804 3.02293,1.69065 5.29101,1.26172 4.31573,-0.81615 5.48816,-1.94161 6.24805,-5.99218 1.42025,-7.57057 -4.22669,-11.279 -8.48438,-5.57227 l -2.05273,2.75 -0.0312,-2.84961 c -0.0427,-3.84007 2.73967,-9.45314 5.61914,-11.33984 1.29279,-0.84707 2.34961,-2.38904 2.34961,-3.42578 0,-1.11772 -0.7037,-1.75128 -1.50977,-1.83789 z M 518.36328,581 c 3.3814,0 4.95707,0.59379 7,2.63672 1.45,1.45 2.63958,3.1375 2.64258,3.75 0.003,0.6125 1.06565,2.44073 2.36328,4.0625 2.03821,2.54736 3.08782,2.97049 7.71094,3.11719 3.85599,0.12235 5.63954,0.64977 6.38476,1.88476 0.56884,0.94269 2.47263,3.92621 4.22852,6.63086 1.75588,2.70465 3.10588,4.88405 3,4.84375 -0.10589,-0.0403 -4.04959,-1.13176 -8.76172,-2.42578 -12.80652,-3.51689 -23.29197,-10.36652 -27.00195,-17.63867 C 512.94486,582.01057 513.3027,581 518.36328,581 Z m 180.19531,15 c 0.24254,0 0.44141,0.45 0.44141,1 0,0.55 -0.47613,1 -1.05859,1 -0.58246,0 -0.78133,-0.45 -0.44141,-1 0.33992,-0.55 0.81605,-1 1.05859,-1 z m -1,3 c 0.79254,0 1.44141,0.675 1.44141,1.5 0,1.50623 -2.11148,2.05649 -3.30664,0.86133 C 694.76012,600.42809 695.88794,599 697.55859,599 Z m -133.24609,3.23633 c -0.25592,-0.0148 -0.3125,0.32115 -0.3125,0.99805 0,3.09347 3.50272,5.87017 9.00195,7.13671 8.09639,1.86471 16.63591,1.84817 18.51953,-0.0351 1.47993,-1.47992 2.82772,-1.44769 6.72852,0.1582 1.22372,0.50378 1.75,0.25349 1.75,-0.83008 0,-1.03395 -0.6961,-1.41527 -2.0918,-1.14648 -1.48253,0.2855 -1.93401,-0.007 -1.55078,-1.00586 0.83783,-2.18335 -2.62143,-2.71651 -6.66406,-1.02734 -6.46744,2.70226 -19.27478,1.01507 -23.87109,-3.14454 -0.79893,-0.72301 -1.25385,-1.08874 -1.50977,-1.10351 z m -212.01172,1.93555 c -0.0537,0.16111 0.2392,0.85116 0.83984,2.1914 0.70583,1.57489 1.4654,2.3188 1.6875,1.65234 0.22215,-0.66638 -0.35526,-1.9548 -1.2832,-2.86328 -0.78969,-0.77313 -1.19043,-1.14163 -1.24414,-0.98046 z m 168.36133,8.37304 c 1.4665,-0.52782 3.90366,0.62081 8.83789,2.89649 2.75,1.26831 8.375,3.35147 12.5,4.63086 4.125,1.27938 8.175,2.65364 9,3.05273 0.825,0.39909 4.84821,1.48589 8.94141,2.41406 4.09319,0.92816 10.0451,3.01026 13.22656,4.62696 8.42604,4.28181 20.58,15.49339 29.08789,26.83398 2.2694,3.025 5.47252,6.95506 7.11719,8.73438 1.64466,1.77926 2.79599,3.36031 2.55859,3.51367 -2.41689,1.56126 -12.18824,5.64922 -14.93164,6.24609 -2.28003,0.49605 -4.71997,2.17807 -7,4.82617 -4.85905,5.64346 -11.97528,15.94003 -11.98828,17.34571 -0.006,0.64166 -0.57422,1.39485 -1.26172,1.67382 -0.9727,0.39468 -0.94952,0.71857 0.10352,1.45704 1.01605,0.71249 1.08953,1.44324 0.29296,2.93164 -0.5835,1.09029 -1.54668,5.01301 -2.13867,8.71875 -0.87141,5.45479 -0.78294,7.87881 0.45899,12.72656 0.84372,3.29334 1.5332,6.57797 1.5332,7.29883 0,1.59037 -6.40318,4.27049 -12.23438,5.12109 -2.346,0.34222 -7.86562,1.64994 -12.26562,2.90625 -4.4,1.2563 -12.725,2.80168 -18.5,3.43359 -16.00244,1.75102 -16.26259,1.76881 -19.94141,1.32618 -5.65174,-0.68001 -8.22127,-3.5085 -10.17187,-11.18946 -2.18477,-8.60303 -5.45014,-15.07802 -11.74805,-23.29492 -5.51439,-7.19463 -5.43272,-6.15578 -1.71484,-21.77539 0.85094,-3.575 1.55255,-7.88913 1.56055,-9.58789 0.0168,-3.50261 8.84783,-22.23736 12.56445,-26.6543 1.34769,-1.60164 2.45117,-3.36924 2.45117,-3.92969 0,-0.56038 0.8228,-2.21392 1.82812,-3.67382 2.25933,-3.28071 6.34886,-15.08327 8.81641,-25.44532 1.05527,-4.43142 1.55107,-6.63623 3.01758,-7.16406 z m -486.69336,4.30274 c 0.350809,0.4258 0.567374,2.19158 0.605469,5.24804 0.04047,3.24685 -0.01767,5.9043 -0.128907,5.9043 -0.995004,0 -2.415698,-6.27119 -1.892578,-8.35547 0.579103,-2.30733 1.065207,-3.22268 1.416016,-2.79687 z m 573.70313,5.45703 c 0.99239,-0.46236 1.74462,0.60705 4.41601,4.65234 2.01339,3.04888 5.01582,9.36797 6.67188,14.04297 4.9949,14.1004 8.57707,25.99715 8,26.57422 -0.75215,0.75219 -5.69938,1.12234 -8.98633,0.67187 -3.38983,-0.46457 -8.87539,-6.69165 -12.52149,-14.21484 -1.47417,-3.04173 -3.92529,-6.79527 -5.44726,-8.33984 -1.56419,-1.58743 -3.58638,-5.5001 -4.65039,-9 -1.73178,-5.69639 -1.75225,-6.31912 -0.26758,-7.78125 0.88756,-0.87409 3.43904,-2.10389 5.66992,-2.73243 2.23087,-0.62854 4.91354,-1.95687 5.96289,-2.95312 0.4641,-0.44061 0.82153,-0.7658 1.15235,-0.91992 z M 41.257812,635.1543 c -0.16085,-0.0356 -0.214077,0.27953 -0.226562,0.92968 -0.01673,0.87084 0.268099,1.88334 0.634766,2.25 1.220012,1.22002 1.533804,-0.15807 0.457031,-2.00976 -0.435777,-0.74939 -0.704383,-1.13431 -0.865235,-1.16992 z m 865.580078,1.03906 c -9.6441,-0.19735 -27.17659,0.98192 -29.36523,2.41602 -2.96091,1.94005 -2.3322,3.67895 1.88281,5.20312 4.74641,1.71632 6.12353,1.5239 4.03711,-0.5625 -1.6191,-1.6191 -1.62341,-1.77508 -0.0703,-2.07422 4.15466,-0.80026 5.17637,0.20024 5.20507,5.08789 0.0153,2.60499 -0.32222,4.73633 -0.75,4.73633 -0.42779,0 -0.77734,0.45 -0.77734,1 0,0.55 0.5625,0.8875 1.25,0.75 0.7483,-0.14966 1.37491,1.05441 1.5625,3 0.28081,2.9124 0.0447,3.25 -2.28125,3.25 -1.77242,0 -2.867,0.71356 -3.44922,2.25 -1.20341,3.17575 0.4683,4.75 5.04102,4.75 2.13266,0 3.87695,0.45 3.87695,1 0,1.67662 2.80506,1.1148 4.19336,-0.83984 0.8639,-1.21631 3.1308,-2.05276 6.69141,-2.46875 5.9001,-0.68933 6.64032,-1.03274 5.65625,-2.625 C 909.17815,660.47938 905.81035,660 902.04883,660 c -7.97775,0 -7.9348,0.0517 -8.76563,-10.64258 -0.51386,-6.61441 -0.39302,-7.22726 1.63477,-8.3125 1.24262,-0.66503 5.42793,-1.07726 9.67969,-0.95312 7.84718,0.22913 11.40795,-1.12895 8.39453,-3.20118 -0.60147,-0.41358 -2.9396,-0.63148 -6.1543,-0.69726 z m -189.81836,1.99219 c -0.62862,0.0545 -1.01953,0.29392 -1.01953,0.76172 0,0.49934 1.125,1.79342 2.5,2.875 1.375,1.08158 2.5,2.44047 2.5,3.02148 0,0.58101 0.7875,1.51557 1.75,2.07617 2.46709,1.43695 3.0461,1.33003 4.17188,-0.77344 0.79087,-1.47775 0.40551,-2.41572 -1.89844,-4.62304 -2.08642,-1.99895 -6.11805,-3.50132 -8.00391,-3.33789 z m 134.39063,3.20898 c -0.62069,-0.19594 -1.09293,-0.11015 -1.44922,0.24609 -1.58584,1.58584 0.58548,6.35938 2.89258,6.35938 1.04627,0 2.42863,0.63463 3.07226,1.41016 1.38951,1.67426 0.12555,2.0142 -13.42578,3.61914 -4.95,0.58624 -13.38526,1.72088 -18.74414,2.51953 C 818.39698,656.34747 812.01257,657 809.56641,657 c -2.44616,0 -4.6947,0.39904 -4.9961,0.88672 -1.15043,1.86144 2.24287,2.96807 10.43555,3.4043 4.67193,0.24876 9.84414,0.73986 11.49414,1.09179 2.53368,0.5404 2.37824,0.35021 -1,-1.22461 l -4,-1.86328 3,-0.625 c 6.83652,-1.42048 33.95385,-4.75586 36.37891,-4.47461 2.3768,0.27565 2.06186,0.65155 -3.37891,4.02149 -3.3,2.04397 -6.64187,4.09549 -7.42578,4.56054 -0.78389,0.46505 -1.09528,1.38169 -0.69141,2.03516 0.87726,1.41943 2.28035,1.54065 3.06836,0.26562 0.31343,-0.50715 3.49153,-1.89434 7.06055,-3.08203 3.56903,-1.1877 6.48828,-2.5986 6.48828,-3.13476 0,-0.53616 1.43202,-2.28088 3.18164,-3.87891 2.91528,-2.6627 3.01974,-2.96155 1.25,-3.56054 -4.32273,-1.46322 -14.10525,-6.49721 -16.68359,-8.58594 -0.94813,-0.76809 -1.71721,-1.24547 -2.33789,-1.44141 z m -473.07618,4.93945 c -0.37803,0.37804 0.1362,1.28952 1.14258,2.0254 1.00637,0.73586 1.50867,1.85484 1.11719,2.48828 -0.39149,0.63343 -0.2348,1.15234 0.34766,1.15234 0.58246,0 1.04484,-0.5625 1.02734,-1.25 -0.0466,-1.83288 -2.83289,-5.21789 -3.63477,-4.41602 z m 319.5,9.26758 c -0.67205,0.41535 -0.8035,5.1746 -0.38281,13.76758 0.35359,7.22238 0.25236,13.70079 -0.22461,14.39844 -1.0121,1.48037 -4.49668,-5.59267 -6.28906,-12.76758 -1.20655,-4.82982 -3.42164,-8 -5.5918,-8 -1.97196,0 -1.65135,2.45686 1.01758,7.7832 1.29992,2.59422 2.94505,6.51283 3.65625,8.70703 0.7112,2.19419 2.63492,6.16715 4.27344,8.83008 2.28916,3.72036 3.42865,4.72447 4.92187,4.33399 1.38868,-0.36328 1.78795,-0.10215 1.39649,0.91797 -0.30118,0.78487 -3.1e-4,1.42678 0.66992,1.42578 0.68183,-0.001 1.3304,-1.57086 1.47266,-3.5625 0.156,-2.18417 -0.1338,-3.31834 -0.75,-2.9375 -0.63876,0.39477 -1.04042,-2.40443 -1.10352,-7.68946 -0.27619,-23.14536 -0.70484,-26.66656 -3.06641,-25.20703 z M 496.57031,663 c 0.275,0 0.0184,0.9 -0.57031,2 -0.5887,1.1 -1.29531,2 -1.57031,2 -0.275,0 -0.0184,-0.9 0.57031,-2 0.5887,-1.1 1.29531,-2 1.57031,-2 z m -16.04687,4.21875 c 0.20221,0.24966 -0.0793,0.90596 -0.66406,2.18945 -0.66166,1.45216 -2.23209,2.89711 -3.49024,3.21289 -1.25815,0.31577 -2.86806,1.31804 -3.57812,2.22657 -1.17401,1.50217 -1.10975,1.52136 0.70898,0.20117 1.53606,-1.11498 1.71371,-1.13107 0.76562,-0.0664 -1.37493,1.54399 -4.60064,2.04793 -6.31835,0.98633 -1.47025,-0.90866 6.63232,-7.57387 10.33789,-8.50391 1.34994,-0.33881 2.03606,-0.49575 2.23828,-0.24609 z M 251.05859,669 c 0.58246,0 0.78133,0.45 0.44141,1 -0.33992,0.55 -0.81605,1 -1.05859,1 C 250.19887,671 250,670.55 250,670 c 0,-0.55 0.47613,-1 1.05859,-1 z m 369.16016,2.32031 c 2.22521,-0.21533 6.84034,0.49387 8.16602,1.53125 0.61334,0.47997 2.46253,1.19677 4.10937,1.5918 2.89178,0.69366 8.38164,5.95435 8.46484,8.11133 0.0223,0.57961 1.61602,2.57953 3.54102,4.44531 1.925,1.86578 3.5,4.02131 3.5,4.79102 0,0.7697 0.88352,2.6404 1.96289,4.15625 4.79381,6.73228 5.81889,27.02804 1.97266,39.05273 -2.42147,7.57037 -8.22542,15.10856 -10.15039,13.18359 -2.00233,-2.00233 -3.06344,-1.32108 -2.48047,1.59375 0.46212,2.31062 0.0203,3.13936 -2.625,4.91993 -5.97526,4.02194 -11.25164,6.28313 -16.2168,6.94726 -2.72967,0.36511 -5.23826,1.08222 -5.57422,1.59375 -0.33596,0.51154 -0.88447,0.21681 -1.21875,-0.6543 C 613.33564,761.71286 612.34738,761 611.47266,761 c -0.87476,0 -1.30532,0.46176 -0.95704,1.02539 1.03342,1.67208 -1.90733,0.61788 -3.24218,-1.16211 -1.36342,-1.81809 -5.70275,-3.28931 -8.77344,-2.97656 -1.61853,0.16485 -1.71968,0.0139 -0.5332,-0.78516 1.18462,-0.79777 0.89662,-1.20796 -1.5,-2.14258 -1.63137,-0.63619 -3.53351,-1.25318 -4.22657,-1.36914 -0.69307,-0.11595 -1.81807,-0.83616 -2.5,-1.60156 -1.05406,-1.18307 -0.94049,-1.19188 0.75977,-0.0645 1.1,0.7296 0.65,0.0687 -1,-1.4668 -1.65,-1.53552 -3,-3.05439 -3,-3.375 0,-0.32064 -0.37084,-0.45777 -0.82422,-0.30664 -0.45338,0.15112 -0.60331,-0.0845 -0.33203,-0.52344 0.63756,-1.03159 -5.76295,-19.49875 -6.50195,-18.75976 -0.30744,0.30744 -0.64114,-2.65535 -0.74024,-6.58399 -0.0991,-3.92865 -0.23303,-7.42749 -0.29883,-7.77539 -0.0658,-0.34791 0.14234,-1.30781 0.46289,-2.13281 0.32057,-0.825 1.13293,-3.3 1.80469,-5.5 0.67176,-2.2 2.05062,-5.06726 3.06446,-6.37109 1.17457,-1.51047 1.62887,-3.22088 1.2539,-4.71485 -0.45139,-1.7985 0.19234,-3.07347 2.76172,-5.47461 9.28999,-8.6817 18.96438,-13.99829 28.09961,-15.43945 2.0625,-0.32538 3.75,-1.0608 3.75,-1.63477 0,-0.29938 0.47701,-0.47314 1.21875,-0.54492 z m 98.08984,4.46485 c -0.74075,-0.35515 -2.59303,-0.0415 -4.91992,1.24804 -2.13896,1.18538 -4.27954,2.52654 -4.75781,2.98047 -1.13201,1.07443 -2.60136,9.08726 -1.54688,8.43555 0.44275,-0.27363 0.94119,1.61425 1.10938,4.19726 0.17117,2.62887 0.85723,4.87913 1.55664,5.10938 1.12792,0.37131 1.55998,-0.32274 2.83203,-4.54883 0.56178,-1.86641 4.30338,0.30906 5.34375,3.10742 1.22317,3.29008 0.31527,4.46949 -4.0039,5.19922 -2.39797,0.40513 -3.92188,1.21077 -3.92188,2.07422 0,3.27878 10.42861,0.78624 11.55469,-2.76172 C 723.16598,695.74942 718.49252,689 713.36523,689 712.0644,689 711,688.60589 711,688.12305 c 0,-2.48628 3.22637,-8.04219 5.55859,-9.57032 2.11968,-1.38887 2.49075,-2.41243 1.75,-2.76757 z m -593.04101,3.39843 c -2.44551,0.28324 -2.81254,0.84075 -3.50196,5.31641 -3.60657,23.41347 -7.17383,36.37059 -8.79101,31.92773 -1.13893,-3.12899 -3.26236,-25.23498 -2.5918,-26.98242 C 111.39765,686.80067 109.96377,683 107.95117,683 c -1.00792,0 -2.01439,0.3375 -2.23633,0.75 -0.22194,0.4125 0.21529,6.825 0.97266,14.25 1.42542,13.97438 3.55534,24.38399 5.45898,26.67773 1.37752,1.65982 1.4128,1.65691 4.38868,-0.29296 1.35565,-0.88826 2.46484,-2.49351 2.46484,-3.56641 0,-1.0729 0.51897,-2.92029 1.1543,-4.10742 0.63533,-1.18713 1.08846,-3.88277 1.00586,-5.99024 -0.0846,-2.16005 0.25765,-3.57992 0.78515,-3.2539 0.55218,0.34126 0.70055,-0.87448 0.36133,-2.96485 -0.48588,-2.99412 -0.32254,-3.44599 1.05859,-2.91601 1.27887,0.49075 1.63115,0.007 1.61915,-2.22852 C 124.97248,697.14529 124.75057,696.83857 124,698 c -0.86165,1.33333 -0.96661,1.33333 -0.94141,0 0.0452,-2.39512 2.72336,-13.65766 2.85352,-12 0.21178,2.697 2.05495,-1.14226 2.07227,-4.31641 0.0135,-2.4814 -0.30972,-2.77879 -2.7168,-2.5 z m 0.0117,12.19532 c -0.10514,0.10514 -0.17717,0.45463 -0.20118,1.03711 -0.0434,1.05416 0.1931,1.64479 0.5254,1.3125 0.33225,-0.33229 0.36876,-1.19415 0.0801,-1.91602 -0.15961,-0.39887 -0.29916,-0.53873 -0.40429,-0.43359 z M 244,693 c 0.0516,0.0516 -0.25111,0.45697 -0.87305,1.25 -1.30637,1.66575 -2.12695,2.19609 -2.12695,1.37305 0,-0.20765 0.7875,-0.99515 1.75,-1.75 0.79303,-0.62194 1.19838,-0.92467 1.25,-0.87305 z m 207.93555,4.45703 c 1.80241,-0.0813 4.11011,0.0952 7.63867,0.49609 10.54884,1.19867 15.09177,2.76069 15.91406,5.47266 0.55805,1.84048 0.70647,1.88128 1.32031,0.36133 0.49973,-1.23738 1.1083,-1.45031 2.19141,-0.76563 2.71842,1.71843 3.54655,0.95129 1.13867,-1.05468 -1.29844,-1.0817 -1.92998,-1.9668 -1.40429,-1.9668 1.44056,0 4.37044,3.56119 3.58007,4.35156 -0.3794,0.37939 1.1107,2.59395 3.31055,4.91992 6.30932,6.67103 9.17041,11.06871 12.31445,18.92188 4.18079,10.44273 5.39786,20.33547 3.41993,27.80664 -0.65526,2.475 -1.50031,6.45508 -1.87891,8.8457 -0.3786,2.39061 -1.93546,6.717 -3.45899,9.61328 -3.14695,5.98245 -16.30328,20.10244 -17.84375,19.1504 -0.55862,-0.34525 -1.76479,0.12026 -2.67968,1.03515 -1.85036,1.85036 -7.49805,2.69208 -7.49805,1.11719 0,-0.56965 -0.65041,-0.46715 -1.49805,0.23633 -1.82697,1.51625 -21.80151,2.35518 -25.71093,1.08007 -4.08399,-1.33204 -8.6456,-4.89567 -11.7461,-9.17578 -1.52792,-2.10923 -3.13591,-3.51314 -3.57226,-3.11914 -0.43635,0.39401 -0.50094,0.20613 -0.14454,-0.41797 0.35648,-0.6241 -1.08721,-3.3241 -3.20703,-6 -2.11982,-2.6759 -4.16917,-5.87773 -4.55468,-7.11523 -0.38552,-1.2375 -1.1059,-2.25 -1.60157,-2.25 -0.49568,0 -0.66026,-0.62961 -0.36523,-1.39844 0.29502,-0.76883 -0.44289,-2.30979 -1.63867,-3.42383 -1.24218,-1.15727 -1.85909,-2.53392 -1.43946,-3.21289 0.40396,-0.65362 0.26241,-1.47941 -0.31445,-1.83593 -0.57686,-0.35652 -1.34589,-1.99419 -1.70898,-3.63868 -0.50032,-2.26602 -0.40131,-2.62704 0.40625,-1.49023 0.91993,1.29498 1.06688,1.26081 1.08008,-0.25 0.008,-0.9625 -0.32188,-1.75095 -0.73438,-1.75195 -0.4125,-0.001 -0.86283,-1.57611 -1,-3.5 -0.13717,-1.9239 0.12163,-3.49805 0.57422,-3.49805 0.4526,0 1.31614,-2.65568 1.91992,-5.90234 1.44918,-7.79254 6.55827,-19.26 11.49219,-25.79493 4.72082,-6.25269 15.42194,-14.54478 17.79687,-13.79101 0.90411,0.28696 3.28995,-0.16568 5.30078,-1.00586 1.50271,-0.62787 2.79915,-0.96753 4.60157,-1.04883 z m -314.70117,0.0801 c -1.06372,-0.40818 -2.28128,0.18364 -3.41993,1.66406 -2.22103,2.88768 -7.2577,17.68714 -6.33398,18.61133 1.40107,1.40179 5.58015,0.81313 5.43359,-0.76562 -0.079,-0.85078 -0.0855,-2.67188 -0.0137,-4.04688 0.20121,-3.85554 1.83411,-0.56826 2.64453,5.32422 0.79698,5.79471 3.9e-4,6.63746 -6.29492,6.66016 -4.92485,0.0177 -5.70049,1.98519 -2,5.07226 2.90198,2.42092 3.90384,2.3968 7.17188,-0.17383 1.48061,-1.16467 4.80373,-3.1659 7.38476,-4.44726 4.60003,-2.28371 4.63109,-2.33122 1.58398,-2.38282 -3.07964,-0.0522 -3.11894,-0.12203 -4.38867,-7.54492 -0.70464,-4.12089 -1.01987,-9.70867 -0.69922,-12.41601 0.47439,-4.00552 0.27569,-5.03893 -1.06835,-5.55469 z M 87,698 c -0.55,0 -1,0.45 -1,1 0,0.55 0.45,1 1,1 0.55,0 1,-0.45 1,-1 0,-0.55 -0.45,-1 -1,-1 z m 522.41211,4.10547 c -0.28356,0.18082 -0.48629,0.55443 -0.55273,1.14453 -0.0775,0.6875 -0.0321,8.1125 0.10156,16.5 0.13368,8.3875 0.0238,15.25 -0.24414,15.25 -0.26794,0 -1.03491,-3.7125 -1.70508,-8.25 -0.67016,-4.5375 -1.39506,-9.15 -1.61133,-10.25 -2.03858,-10.36862 -2.99333,-13.5 -4.11523,-13.5 -1.7612,0 -1.6186,2.98837 0.71875,15.11133 3.16664,16.42419 3.78277,19.21158 4.89843,22.13867 0.57649,1.5125 1.52043,2.75 2.09766,2.75 2.16702,0 3,-5.57062 3,-20.06445 C 612,714.59276 612.40397,708 612.91406,708 c 0.50222,0 0.4021,-1.35 -0.2207,-3 -0.84878,-2.24869 -2.43058,-3.43699 -3.28125,-2.89453 z M 234.05859,706 c 0.58246,0 0.78133,0.45 0.44141,1 -0.33992,0.55 -0.81605,1 -1.05859,1 C 233.19887,708 233,707.55 233,707 c 0,-0.55 0.47613,-1 1.05859,-1 z m 485.5,0 c -0.24254,0 -0.71867,0.45 -1.05859,1 -0.33992,0.55 -0.14105,1 0.44141,1 0.58246,0 1.05859,-0.45 1.05859,-1 0,-0.55 -0.19887,-1 -0.44141,-1 z m -232.16992,1.14648 c 0.0616,-0.033 0.24519,0.0785 0.56055,0.35352 5.77046,5.03202 14.06061,20.67479 15.51367,29.27539 1.01582,6.01257 -0.0798,5.24169 -1.41797,-0.99805 -1.49677,-6.97918 -7.05631,-18.33258 -12.20312,-24.91992 -1.72683,-2.21014 -2.63781,-3.61188 -2.45313,-3.71094 z m -216.49219,1.97461 c -1.06126,0.0455 -1.98505,1.63304 -1.6289,3.4961 0.25058,1.3108 -0.16972,6.28634 -0.9336,11.05664 -0.76388,4.7703 -1.54041,9.83308 -1.72656,11.25 -0.18614,1.41692 -0.90499,3.92617 -1.5957,5.57617 -0.69071,1.65 -1.27608,4.25237 -1.30078,5.7832 -0.0296,1.83219 -0.38119,2.44694 -1.03125,1.79688 -0.54315,-0.54315 -1.95545,-8.77248 -3.13672,-18.28516 -1.18127,-9.51269 -2.6482,-18.18543 -3.26172,-19.27344 -1.06851,-1.8949 -1.16839,-1.86518 -2.3457,0.71875 -1.00509,2.20593 -0.93902,3.66019 0.36328,7.97852 0.87588,2.90437 2.07626,9.55625 2.66601,14.78125 1.00346,8.8904 2.74481,19.90425 3.59766,22.75 0.44154,1.47332 2.07344,1.64663 2.90039,0.30859 0.57291,-0.92699 4.33468,-15.80403 6.46289,-25.55859 1.68556,-7.72566 2.91218,-20.90216 2.03516,-21.86328 -0.34165,-0.37441 -0.7107,-0.53079 -1.06446,-0.51563 z M 629.29883,717 c -1.36845,0 -1.71937,2.11288 -1.35938,8.17188 0.16613,2.79619 -0.26262,3.92992 -1.79492,4.75 -1.10698,0.59244 -2.16969,1.07812 -2.36133,1.07812 -0.19163,0 -0.18402,-3.2625 0.0176,-7.25 0.34506,-6.82897 0.27421,-7.1227 -1.22266,-5.07227 -0.96834,1.32652 -1.68497,4.64683 -1.83398,8.5 L 620.5,733.5 l 3.75,-0.11328 c 3.66168,-0.11138 3.75086,-0.0289 3.75586,3.5 0.003,1.98773 0.47409,5.30078 1.04687,7.36328 1.48647,5.3525 4.98365,4.5851 4.93165,-1.08203 -0.0119,-1.29224 -0.20594,-1.36865 -0.85938,-0.33789 -1.91133,3.01502 -2.83624,-9.86225 -1.13477,-15.79492 C 633.11759,723.1043 631.48004,717 629.29883,717 Z m -171.30078,3.5 c -1.20354,0 -1.63691,2.26474 -2.20703,11.5 -0.61652,9.98689 -4.45278,29.11095 -4.70118,23.4375 -0.104,-2.37522 -3.4585,-15.49356 -5.55273,-21.71289 -0.78256,-2.32402 -1.59584,-5.54787 -1.80664,-7.16602 -0.21081,-1.61816 -0.91111,-3.1188 -1.55664,-3.33398 -1.88505,-0.62835 -1.40395,6.15586 0.92578,13.05664 1.15467,3.42015 2.90984,10.39345 3.90039,15.49609 0.99056,5.10263 2.36712,9.9598 3.05859,10.79297 0.69147,0.83317 1.60227,1.15847 2.02539,0.72266 1.46122,-1.50505 6.01524,-19.55232 6.60157,-26.16211 0.3235,-3.64689 1.01308,-7.17093 1.5332,-7.83203 0.53352,-0.67814 0.59295,-2.20354 0.13477,-3.5 -0.44668,-1.2639 -0.82199,-2.97383 -0.83399,-3.79883 -0.012,-0.825 -0.6972,-1.5 -1.52148,-1.5 z M 631,722 c 0.55,0 1,0.45 1,1 0,0.55 -0.45,1 -1,1 -0.55,0 -1,-0.45 -1,-1 0,-0.55 0.45,-1 1,-1 z m -353.04688,7.74023 c -0.5131,-0.35162 -1.05425,-0.2205 -1.875,0.21875 C 270.69399,732.84048 269.03946,738 273.5,738 c 2.53484,0 3.34096,-1.36233 1.48438,-2.50977 C 273.671,734.67853 274.70574,733 276.51953,733 c 1.68229,0 1.71233,2.60329 0.19727,16.75 -0.62523,5.83801 -1.55475,10.25662 -2.15821,10.26562 -0.58273,0.008 -0.38359,0.45122 0.44141,0.98438 1.2718,0.8219 1.22522,0.97136 -0.30859,0.98438 -1.04574,0.009 -1.52512,0.47506 -1.13672,1.10351 0.37436,0.60573 1.6178,0.79041 2.80859,0.41797 1.17543,-0.36764 4.54404,-1.27613 7.48633,-2.01953 6.20122,-1.56681 7.15076,-2.22852 5.12109,-3.5625 -1.40012,-0.92021 -6.26622,-0.51477 -9.71484,0.80859 -1.25665,0.48222 -1.44025,0.19977 -0.84961,-1.30859 1.10227,-2.81497 2.58089,-12.34471 2.58789,-16.67383 0.005,-3.52997 0.19655,-3.75951 3.25586,-3.91016 l 3.25,-0.16015 -3.08984,-0.39063 c -2.36224,-0.29924 -3.47976,-1.21128 -4.75,-3.875 -0.70955,-1.48792 -1.19392,-2.3222 -1.70704,-2.67383 z M 412.05859,734 c 0.58246,0 0.78133,0.45 0.44141,1 -0.33992,0.55 -0.81605,1 -1.05859,1 C 411.19887,736 411,735.55 411,735 c 0,-0.55 0.47613,-1 1.05859,-1 z m 59.61914,6.18945 c -0.68567,-0.22592 -1.47193,-0.23229 -2.32617,0.002 -1.13898,0.31206 -2.39956,1.05184 -3.70508,2.26171 -2.64566,2.45192 -3.44797,4.54688 -1.74023,4.54688 0.49851,0 0.67047,0.9 0.38281,2 -0.31258,1.19529 -0.0301,2 0.70117,2 0.67299,0 0.97499,-0.64565 0.67188,-1.43555 -0.57909,-1.50907 2.81725,-6.56445 4.41016,-6.56445 1.40289,0 1.09941,5.14774 -0.48243,8.17969 -1.73079,3.31744 -1.28411,3.80716 2.85938,3.13476 2.55172,-0.41409 3.74091,-0.0261 5.41016,1.76563 2.54176,2.72828 2.6878,4.96277 0.58593,9.02734 -1.36235,2.63454 -2.01336,2.96822 -5.25,2.69922 -2.70241,-0.22459 -3.96042,-0.91214 -4.68359,-2.56055 -1.17092,-2.669 -2.88794,-2.42731 -3.31641,0.4668 -0.19037,1.2859 0.70302,2.84901 2.38477,4.17188 6.10038,4.79856 14.17694,0.4533 15.14648,-8.14844 0.65181,-5.78286 -1.31747,-9.26744 -5.79101,-10.25 -2.84438,-0.62473 -3.08891,-0.97869 -2.66211,-3.83789 0.61516,-4.12121 -0.53868,-6.78123 -2.59571,-7.45899 z M 504.39258,743 c 0.21616,0 0.65216,0.675 0.96875,1.5 0.31658,0.825 0.14015,1.5 -0.39258,1.5 C 504.43601,746 504,745.325 504,744.5 c 0,-0.825 0.17643,-1.5 0.39258,-1.5 z M 131,744.84766 c 0,0.50521 -0.9,1.15374 -2,1.4414 -1.1,0.28766 -2,0.35651 -2,0.15235 0,-0.20415 0.9,-0.85271 2,-1.44141 1.10492,-0.59134 2,-0.6598 2,-0.15234 z m 176.42188,2.89843 c 0.33861,0.38849 0.80702,1.86176 1.69921,4.75391 1.018,3.3 1.87234,7.8 1.89844,10 0.0261,2.2 0.91779,5.8 1.98047,8 1.06268,2.2 1.9481,4.5625 1.9668,5.25 0.0527,1.94098 -1.00436,1.44946 -7.6875,-3.58008 -9.85913,-7.41969 -10.05783,-7.69073 -7.63477,-10.39844 2.865,-3.20157 5.96501,-8.74405 6.86328,-12.27148 0.36825,-1.44607 0.57541,-2.14239 0.91407,-1.75391 z M 504.66211,750.75 c 0.27741,0.6875 0.27741,1.8125 0,2.5 -0.27741,0.6875 -0.50391,0.125 -0.50391,-1.25 0,-1.375 0.2265,-1.9375 0.50391,-1.25 z m -2.38281,10.62891 c 0.10514,-0.10514 0.24468,0.0347 0.40429,0.43359 0.28891,0.72187 0.2524,1.58373 -0.0801,1.91602 -0.33229,0.33229 -0.56878,-0.25834 -0.5254,-1.3125 0.024,-0.58248 0.096,-0.93197 0.20118,-1.03711 z M 663.05859,764 c 0.51754,0 0.94141,0.675 0.94141,1.5 0,1.54641 -1.18045,1.98751 -2.30664,0.86133 C 660.89443,765.5624 661.79761,764 663.05859,764 Z m -441.90429,1 c -1.54298,0 -3.97844,3.4427 -5.66016,8 -7.48523,20.28419 -8.57182,31.23274 -4.02344,40.5293 3.86913,7.9082 6.65139,9.76381 13.85742,9.24804 l 5.82618,-0.41601 -0.62305,3.31836 c -0.47208,2.51639 -0.27237,3.32031 0.82422,3.32031 1.67678,0 5.5088,-6.07526 6.28711,-9.9668 0.48126,-2.40628 0.13773,-2.78122 -3.53906,-3.88281 -2.23946,-0.67096 -4.54472,-2.10494 -5.12305,-3.18555 -1.0969,-2.04958 -3.98047,-2.7262 -3.98047,-0.93359 0,0.56766 0.65229,2.59266 1.44922,4.5 L 227.89844,819 h -4.29492 c -4.59679,0 -6.18263,-1.16917 -8.91211,-6.56445 -3.0396,-6.00829 -3.14676,-14.11512 -0.32813,-24.70508 1.41619,-5.32081 3.71324,-11.92054 5.10547,-14.66797 2.58057,-5.09252 3.2009,-8.0625 1.68555,-8.0625 z m 419.04492,28.8457 c 0.31503,-0.30146 0.60451,-0.18293 0.91601,0.3086 1.36737,2.15758 1.01598,8.69101 -0.64062,11.89453 -0.83912,1.62269 -1.73912,2.95117 -2,2.95117 -0.94352,0 -0.44805,-9.77948 0.65625,-12.94727 0.41305,-1.18488 0.75333,-1.90556 1.06836,-2.20703 z M 612,794.03125 c -0.825,0 -2.175,0.43559 -3,0.96875 -1.33333,0.86167 -1.33333,0.96875 0,0.96875 0.825,0 2.175,-0.43559 3,-0.96875 1.33333,-0.86167 1.33333,-0.96875 0,-0.96875 z M 468,798.5 c 0.55,-0.33992 0.95521,0.19645 0.90039,1.19141 -0.0548,0.99496 -0.46004,2.93359 -0.90039,4.30859 -0.71916,2.24559 -0.81089,2.12396 -0.90039,-1.19141 C 467.04479,800.77855 467.45,798.83992 468,798.5 Z m 152.16016,7.21875 c 3.28513,0.15296 5.97334,4.51889 6.18945,11.17578 0.12808,3.9456 -0.14449,4.6481 -1.9082,4.90039 C 620.99862,822.28739 617,818.35989 617,814.48633 c 0,-1.85262 0.45,-3.64641 1,-3.98633 1.90523,-1.1775 1.00735,-2.73463 -1.25,-2.16797 l -2.25,0.56445 2.24609,-1.85546 c 1.15823,-0.95672 2.31902,-1.37326 3.41407,-1.32227 z M 466.99023,807 c 0.56714,0 1.00977,2.62912 1.00977,6 0,3.3 -0.225,6 -0.5,6 -0.6589,0 -0.60324,0.32087 -1.0918,-6.25 -0.25911,-3.48499 -0.0298,-5.75 0.58203,-5.75 z m 114.85157,0 0.75195,3.25 c 0.73491,3.1764 0.63657,16.57077 -0.13086,17.8125 -0.54294,0.87848 1.53477,8.17925 2.75391,9.67578 0.55514,0.68098 1.4088,0.99282 1.89648,0.69141 1.33613,-0.82577 1.06425,-5.1832 -0.36328,-5.82227 -0.6875,-0.30777 1.675,-0.32878 5.25,-0.0469 3.575,0.28209 7.85,0.12905 9.5,-0.33985 2.51353,-0.7143 3.0366,-1.40988 3.22656,-4.28711 0.20865,-3.16054 0.13722,-3.25437 -0.90234,-1.18359 -1.00474,2.00143 -1.87973,2.25 -7.91797,2.25 -3.73349,0 -7.05808,-0.43504 -7.38672,-0.9668 -0.32865,-0.53175 1.44522,-3.47442 3.94141,-6.53906 C 599.96718,812.27868 597.78628,807 586.4707,807 Z M 445,808.5 c -1.20436,0 -1.60671,2.07847 -2.04102,10.54883 -0.68672,13.39328 -2.33067,16.70328 -9.5039,19.12109 -2.72476,0.9184 -5.7166,1.7059 -6.64649,1.75 -1.51946,0.072 -1.54763,-0.19366 -0.2832,-2.63086 1.08971,-2.10042 1.13342,-2.88642 0.19141,-3.48242 -1.1561,-0.73144 -1.96172,-0.0127 -5.00977,4.4668 -0.66355,0.97515 -2.29819,1.97709 -3.63281,2.22656 -3.52293,0.65851 -4.44048,1.94552 -3.13086,4.39258 0.88116,1.64646 2.07609,2.10742 5.46875,2.10742 2.63993,0 4.83106,0.58808 5.58789,1.5 0.68469,0.825 2.0904,1.5 3.12305,1.5 2.64144,0 2.40032,-3.40435 -0.37305,-5.27148 -2.23293,-1.5033 -2.22068,-1.51907 1.49219,-2.23047 2.05769,-0.39426 3.53284,-1.05265 3.27929,-1.46289 -0.25354,-0.41024 0.64637,-0.53415 2,-0.27539 1.82038,0.34799 3.2069,-0.32897 5.32618,-2.59766 3.7925,-4.05989 5.57934,-10.78929 5.61914,-21.16211 0.0265,-6.90338 -0.24856,-8.5 -1.4668,-8.5 z m 127.41992,1.47656 c -1.68279,0.19527 -4.18867,0.78659 -8.19531,1.85352 -5.34815,1.42415 -9.86602,2.92064 -10.03906,3.32422 -0.17303,0.40358 -0.91272,0.50347 -1.64453,0.22265 C 550.7327,814.68303 543,816.84067 543,818.03906 543,818.56786 542.325,819 541.5,819 c -0.93333,0 -1.5,-0.94444 -1.5,-2.5 0,-1.60203 -0.56322,-2.5 -1.56641,-2.5 -1.36712,0 -1.48659,1.48887 -0.94336,11.75 0.72499,13.69437 0.40858,13.666 -6.76953,-0.60156 -2.32163,-4.61458 -4.81264,-8.62073 -5.53711,-8.90235 -2.62621,-1.02089 -3.63488,1.71784 -3.41406,9.27735 0.15827,5.41834 -0.12371,7.47202 -1.02539,7.46094 -2.2723,-0.028 -3.32245,-1.43059 -5.59961,-7.48438 -2.7216,-7.23534 -4.74353,-10.5 -6.50391,-10.5 -1.42694,0 -4.63628,10.17763 -4.64648,14.73438 -0.003,1.5208 -0.70028,4.09729 -1.54883,5.7246 -1.46533,2.81011 -1.42765,3.04641 0.75586,4.72657 3.10632,2.39024 3.61336,2.27193 3.98242,-0.93555 0.27712,-2.40849 0.74465,-2.75 3.77149,-2.75 3.21979,0 3.54294,0.29818 4.71875,4.35938 0.69414,2.3975 1.83988,5.06072 2.54492,5.91796 1.10588,1.3446 1.32599,1.11162 1.60156,-1.6914 0.17569,-1.78704 -0.13964,-4.56276 -0.69922,-6.16797 C 518.18714,836.23884 518.29531,836 520.42773,836 c 1.78109,0 2.46184,0.69982 2.92188,3 0.34644,1.73218 1.23414,3 2.09961,3 1.25912,0 1.42072,-1.47982 1.00976,-9.25 -0.35516,-6.71524 -0.21336,-8.61562 0.51758,-6.93555 0.6024,1.38461 1.47412,2.02573 2.16992,1.59571 0.71273,-0.44049 0.89296,-0.28329 0.4668,0.40625 -1.13961,1.84393 5.54474,13.20546 9.32813,15.85547 1.71981,1.20459 1.96216,1.04124 2.56836,-1.71876 0.36816,-1.67637 0.3509,-7.30088 -0.0391,-12.5 L 540.76172,820 h 4.11914 c 3.59678,0 4.12278,0.28523 4.14648,2.25 0.0956,7.94341 2.0349,21.23997 3.2793,22.48438 1.24548,1.24548 1.52325,1.06139 2.11133,-1.4004 0.37242,-1.55905 0.91046,-3.61908 1.19531,-4.57812 0.35952,-1.21045 0.0835,-1.57676 -0.90039,-1.19922 -1.11886,0.42934 -1.53929,-1.0674 -1.99609,-7.10742 -0.31825,-4.20799 -0.18786,-8.6187 0.28906,-9.80078 0.47691,-1.18206 0.89674,-1.74189 0.93164,-1.24414 0.0349,0.49774 0.85,0.22523 1.8125,-0.60742 0.9625,-0.83269 2.7625,-1.76145 4,-2.0625 1.86772,-0.45444 2.25,-0.13296 2.25,1.89062 0,1.34078 -0.6723,2.69635 -1.49414,3.01172 -0.82187,0.31537 -1.20451,1.04293 -0.84961,1.61719 0.35491,0.57425 0.75337,3.37877 0.88477,6.23242 0.13139,2.85364 0.84902,6.16571 1.5957,7.36133 1.7862,2.86016 6.80942,4.57252 6.125,2.08789 -0.13091,-0.47521 0.50543,-0.57915 1.41406,-0.23047 1.1009,0.42245 1.41266,0.24856 0.93555,-0.52344 -0.45496,-0.73613 -0.19349,-0.95868 0.71679,-0.60937 1.56642,0.60108 5.67188,-5.14519 5.67188,-7.93946 0,-2.31217 -1.34894,-2.02322 -2.51367,0.53907 -0.54292,1.19434 -2.23918,3.09482 -3.77149,4.22265 -3.94084,2.90056 -6.12217,1.313 -6.51953,-4.74609 L 563.89062,825 h 3.94336 c 2.42281,0 4.85446,-0.74719 6.30469,-1.9375 l 2.36133,-1.9375 -5.75,0.57812 -5.75,0.57618 v -3.41797 c 0,-3.32547 0.16918,-3.46773 6.19922,-5.25781 5.41592,-1.60777 5.97939,-1.99981 4.47266,-3.10157 -0.71053,-0.51955 -1.56917,-0.72066 -3.25196,-0.52539 z m 14.54688,0.29688 c 0.46551,-0.14966 1.22792,-0.0837 2.41797,0.15429 4.37636,0.87528 4.94607,1.87712 3.23437,5.69141 -0.83464,1.85988 -2.66225,4.73086 -4.0625,6.38086 l -2.54687,3 0.0195,-2.5 c 0.0104,-1.375 0.40971,-4.1875 0.88867,-6.25 0.47895,-2.0625 0.54299,-3.75 0.14258,-3.75 -0.40042,0 -0.72657,-0.71638 -0.72657,-1.5918 0,-0.62061 0.16731,-0.9851 0.63282,-1.13476 z m 26.69531,1.47656 c 0.27741,0.6875 0.27741,1.8125 0,2.5 -0.27741,0.6875 -0.50391,0.125 -0.50391,-1.25 0,-1.375 0.2265,-1.9375 0.50391,-1.25 z m 131.57812,2.23047 c -0.31539,0.0706 -0.50256,0.25911 -0.61523,0.55273 -0.73236,1.9085 1.70393,3.43869 14.44336,9.07032 C 797.80453,840.72736 804.5,844.02811 804.5,846 c 0,0.93546 -1.12908,1.6099 -3,1.79102 -3.6001,0.34851 -8.5,2.17239 -8.5,3.16406 0,0.39161 0.32756,1.04045 0.72852,1.4414 0.97404,0.97405 9.95321,-0.28225 14.03515,-1.96289 4.40828,-1.815 5.16671,-4.17763 2.14258,-6.67968 l -2.40625,-1.99219 2.71484,1.61914 c 3.08292,1.83815 3.78516,1.98067 3.78516,0.76367 0,-1.37061 -11.03671,-9.2399 -12.06641,-8.60351 -0.51383,0.31756 -0.93359,1.22503 -0.93359,2.01757 0,1.64579 -1.15672,1.87724 -2.55078,0.50977 -0.5225,-0.51253 -9.21175,-4.58276 -19.31055,-9.04492 -10.09881,-4.46215 -21.86885,-9.87755 -26.15625,-12.03321 -4.69578,-2.36098 -6.796,-3.22167 -7.74219,-3.00976 z M 511.4043,824.5 l 0.69726,2.5 c 0.38422,1.375 0.74403,3.0625 0.79883,3.75 0.0988,1.2394 -3.05091,1.76549 -4.12695,0.68945 -0.30803,-0.30803 0.15784,-1.99553 1.03515,-3.75 z m -145.83789,1.6543 c -1.64569,-0.31707 -1.73358,0.29755 -1.08789,7.59179 l 0.70117,7.9375 -2.83985,1.11329 c -6.32604,2.48068 -6.58466,2.30826 -8.40429,-5.60352 -1.40667,-6.11625 -1.46051,-7.52583 -0.33594,-8.65039 1.12456,-1.12456 0.79018,-1.34375 -2.04883,-1.34375 -3.98141,0 -4.59345,1.18753 -6.60351,12.80078 -1.84653,10.66837 -1.82749,16.5 0.0527,16.5 0.96719,0 1.61343,-1.17636 1.81836,-3.31055 0.28214,-2.9382 0.61901,-3.27508 3,-3 2.06786,0.23891 2.94036,1.11218 3.8125,3.81055 1.69344,5.23946 3.86914,4.53764 3.86914,-1.24805 0,-4.28949 0.3154,-4.94122 3.27344,-6.75 C 362.5742,844.9008 364.21244,844 364.41208,844 c 0.19964,0 0.53627,3.09441 0.75,6.87695 0.21426,3.7918 1.00378,7.61683 1.75781,8.52539 1.19418,1.4389 1.5698,1.46624 2.97266,0.21094 0.88364,-0.79069 4.28077,-1.92832 7.54883,-2.52734 5.37507,-0.98523 7.49946,-2.20623 7.54297,-4.33594 0.0211,-1.03358 -1.46538,-0.92427 -8.98438,0.66406 -3.575,0.7552 -6.68135,1.20261 -6.90234,0.99414 -0.22096,-0.20847 -0.32904,-5.2219 -0.24024,-11.14258 0.18191,-12.13022 -0.67815,-16.6079 -3.29101,-17.11132 z m -83.65235,0.22461 c -2.94877,-0.47449 -3.98343,-0.0242 -7.58984,3.3125 -7.94262,7.34861 -6.849,12.8275 3.58203,17.96093 7.814,3.84552 9.31821,5.93696 6.12891,8.51954 -2.98141,2.41417 -6.28577,2.31447 -8.61719,-0.26172 -1.80126,-1.99038 -1.80668,-2.15315 -0.125,-3.38282 1.58198,-1.15678 1.59889,-1.35565 0.16406,-1.90625 C 273.3612,849.81685 270,851.65315 270,853.60156 c 0,0.8418 0.4983,2.46146 1.10742,3.59961 0.88829,1.65978 1.2808,1.79456 1.98438,0.6836 0.69365,-1.09527 0.88048,-1.01282 0.89258,0.39648 0.008,0.98023 1.02812,2.19008 2.26562,2.6875 3.41806,1.37389 4.95541,1.20315 8.47266,-0.94141 6.81926,-4.15787 5.00372,-10.11732 -4.55274,-14.9414 -7.51149,-3.79179 -8.5013,-4.98651 -6.91601,-8.34571 1.5176,-3.21578 5.33738,-5.5229 9.10937,-5.5039 2.9321,0.0148 5.18214,-2.08934 3.75781,-3.51367 -0.43706,-0.43706 -2.3295,-1.04164 -4.20703,-1.34375 z m 28.6875,3.24804 c -1.01592,-0.0874 -1.52968,0.17565 -1.99414,0.75 -0.89079,1.10156 -2.85348,1.19207 -10.04297,0.46094 -4.91504,-0.49982 -9.52754,-0.68153 -10.25,-0.4043 -1.97382,0.75743 -1.58016,3.34814 0.61524,4.04493 1.60397,0.50908 1.8284,1.23224 1.33203,4.29101 -0.32846,2.02408 -1.50881,4.42038 -2.625,5.32422 l -2.03125,1.64258 2.19726,1.37305 c 1.75664,1.09702 2.19727,2.31501 2.19727,6.07617 0,9.07259 7.6944,13.43171 12.68945,7.18945 2.24187,-2.80164 3.0152,-5.375 1.61524,-5.375 -0.38241,0 -1.9118,1.16554 -3.39844,2.58984 -3.55903,3.40976 -6.55241,2.05728 -7.41797,-3.35156 -0.32898,-2.05582 -0.75603,-4.52578 -0.94922,-5.48828 -0.19319,-0.9625 0.19936,-1.75 0.87305,-1.75 2.47966,0 11.18267,-2.98541 13.10547,-4.49609 1.87915,-1.47639 1.79975,-1.5319 -1.51758,-1.0293 -12.73027,1.92874 -12,1.94657 -12,-0.27344 0,-1.13895 0.40609,-3.13811 0.90234,-4.44336 0.76003,-1.99904 1.66655,-2.40702 5.75,-2.58398 2.66625,-0.11555 6.00982,-0.44601 7.42969,-0.73438 2.4947,-0.50665 2.62615,-0.28304 3.93359,6.64649 1.23096,6.52378 1.20254,7.28167 -0.33007,8.40234 -2.25284,1.64732 -2.12806,3.16205 0.31445,3.80078 1.67399,0.43776 2,1.36524 2,5.6836 0,2.83765 0.48113,6.05702 1.06836,7.15429 0.58724,1.09726 1.59974,1.80861 2.25,1.58203 1.28405,-0.44743 1.29795,-1.31484 0.16211,-9.95898 l -0.75586,-5.75195 4.63672,-4.31836 c 3.28912,-3.06297 4.63867,-5.09927 4.63867,-7 0,-1.94114 0.50951,-2.67969 1.84961,-2.67969 1.61242,0 1.93191,1.12783 2.47461,8.77344 0.96395,13.58012 3.97628,19.38314 6.47656,12.47656 0.54755,-1.5125 1.34897,-3.65 1.7832,-4.75 0.70622,-1.789 0.60898,-1.85301 -0.92187,-0.60742 -0.94126,0.76585 -1.9983,1.10521 -2.34961,0.7539 -0.8427,-0.8427 -2.02679,-15.49127 -1.3418,-16.5996 0.29261,-0.47345 2.106,-1.2692 4.0293,-1.76758 2.12497,-0.55064 3.63507,-1.61878 3.84766,-2.72266 0.30539,-1.58576 -0.1206,-1.72845 -3.34766,-1.12305 -2.512,0.47125 -3.48581,0.35372 -3.03906,-0.36914 0.38449,-0.62212 -0.21109,-1.06445 -1.4336,-1.06445 -1.14972,0 -2.34943,0.675 -2.66601,1.5 -0.81563,2.12549 -7.5551,1.88868 -14.75391,-0.51953 -2.47186,-0.82691 -3.98994,-1.26614 -5.00586,-1.35352 z m 529.80664,0.39258 c -3.82425,0.11897 -7.40126,0.36417 -10.28711,0.74805 -16.05275,2.13534 -18.06351,3.57951 -12.03711,8.65039 3.14171,2.6436 5.27521,2.68155 4.2754,0.0762 -0.97399,-2.53814 1.99225,-4.15092 8.94531,-4.86328 l 6.77343,-0.69531 -0.64257,5.2832 c -0.67939,5.59188 -4.11482,16.60036 -5.70508,18.28125 -0.59609,0.63006 -0.68878,-1.95955 -0.25,-7 1.07873,-12.39217 1.08123,-12.96734 0.0664,-13.5 -2.08061,-1.09211 -4.64977,9.25985 -4.34376,17.5 l 0.29688,8 -2.75,0.31641 c -1.54208,0.17744 -2.75,0.93246 -2.75,1.71875 0,0.83559 -0.60617,1.16916 -1.5,0.82617 -1.54669,-0.59352 -2.05859,0.74613 -0.77539,2.02929 0.39852,0.39851 1.63602,0.44999 2.75,0.11329 1.11399,-0.3367 7.87336,-1.62433 15.02148,-2.86133 9.83313,-1.70165 13.0712,-2.63214 13.30079,-3.82422 0.22518,-1.16943 -0.83793,-1.74757 -4.12305,-2.24024 -4.16629,-0.62477 -4.46213,-0.8814 -5.03906,-4.37109 -0.84911,-5.136 -0.76105,-18.46251 0.13085,-19.85156 0.53194,-0.82835 3.90823,-0.92016 12.23438,-0.33399 6.325,0.44528 12.18852,1.08241 13.0293,1.41602 0.84079,0.33361 2.41579,-0.0438 3.5,-0.83984 1.90779,-1.40072 1.87403,-1.48554 -1.0293,-2.62305 -3.92331,-1.53715 -17.61905,-2.31198 -29.0918,-1.95508 z m -370.13867,3.0918 c 0.0843,-0.0843 0.36166,0.13096 0.85547,0.62109 0.68342,0.67834 0.98953,1.48703 0.68164,1.79492 -0.30789,0.30789 -0.86666,-0.24815 -1.24219,-1.23437 -0.27134,-0.7126 -0.37925,-1.09731 -0.29492,-1.18164 z M 314.625,834.00391 c 1.1863,0.005 7.375,3.82049 7.375,4.54687 0,1.22491 -2.39838,5.00427 -3.91406,6.16797 -2.43591,1.87023 -3.12827,1.52914 -2.99024,-1.46875 0.0696,-1.5125 -0.20472,-4.2125 -0.60937,-6 -0.40466,-1.7875 -0.34258,-3.24809 0.13867,-3.24609 z m 35.38867,4.13086 c 0.47255,0.12078 0.96038,1.32038 1.32422,3.5625 0.70004,4.31389 0.64782,4.43411 -1.42969,3.27148 -1.07707,-0.60274 -1.43245,-1.84429 -1.12695,-3.92578 0.30401,-2.07141 0.75987,-3.02899 1.23242,-2.9082 z m 486.35938,10.73632 1.26953,4.81446 c 0.69813,2.64775 1.2882,5.37695 1.3125,6.06445 0.0243,0.6875 -1.08008,1.25 -2.45508,1.25 -2.87684,0 -2.89814,-0.11891 -1.3125,-6.98828 z m -353.10352,18.24024 c 0.0843,-0.0843 0.36166,0.13096 0.85547,0.62109 0.68342,0.67834 0.98953,1.48703 0.68164,1.79492 -0.30789,0.30789 -0.86666,-0.24815 -1.24219,-1.23437 -0.27134,-0.7126 -0.37925,-1.09731 -0.29492,-1.18164 z m -36.71094,9.91992 c 0.51762,0.0175 1.8152,0.6925 2.88282,1.5 1.0676,0.80751 1.51762,1.455 1,1.4375 -0.51762,-0.0175 -1.8152,-0.6925 -2.88282,-1.5 -1.0676,-0.80751 -1.51762,-1.455 -1,-1.4375 z M 503.81836,884 c -0.6631,0 -0.58758,0.57305 0.20117,1.52344 0.69572,0.83829 1.47096,1.3181 1.72266,1.0664 C 506.43568,885.89634 505.02691,884 503.81836,884 Z m -239.32617,5.04492 c -1.39891,0.35387 -3.59436,2.4496 -6.28125,6.04883 -1.80879,2.42295 -5.40879,7.03925 -8,10.25781 -2.59122,3.21855 -5.46503,6.80953 -6.38672,7.97852 -1.60761,2.03897 -1.65544,1.88067 -1.19727,-3.85352 0.51488,-6.44385 -0.48206,-9.13026 -3.02539,-8.15429 -1.193,0.4578 -1.60156,1.98473 -1.60156,5.98828 0,2.95485 -0.6243,7.44518 -1.38672,9.97851 -0.76246,2.53332 -1.14256,4.84766 -0.8457,5.14453 0.47823,0.47823 -2.65341,1.99514 -8.08008,3.91211 -0.99736,0.35232 -1.53372,1.0926 -1.19141,1.64649 1.54127,2.49381 8.2776,0.87477 19.73047,-4.74219 12.28421,-6.02467 15.75085,-8.99481 9.27149,-7.94336 -1.94792,0.31611 -5.55248,1.58039 -8.01172,2.80859 -2.45924,1.2282 -4.6756,2.02948 -4.92383,1.78125 -0.24824,-0.24824 4.51066,-6.064 10.57617,-12.92382 11.07904,-12.5299 13.79239,-16.37557 12.47656,-17.69141 -0.27807,-0.27807 -0.65674,-0.35429 -1.12304,-0.23633 z m 256.32031,15.27149 c 0.72187,-0.28891 1.58373,-0.2524 1.91602,0.0801 0.33229,0.33229 -0.25834,0.56879 -1.3125,0.5254 -1.16495,-0.048 -1.40125,-0.28625 -0.60352,-0.60547 z m -42.38867,19.72851 c -1.10779,-0.48556 -1.54725,1.16096 -1.14844,4.69922 0.29409,2.60914 0.0909,5.57298 -0.45117,6.58594 -0.54212,1.01297 -0.66243,2.14046 -0.26758,2.50586 0.39486,0.36539 0.91852,0.10156 1.16406,-0.58594 1.18455,-3.31674 2.09806,-0.22221 3.20703,10.85156 0.66654,6.65573 1.45688,12.84323 1.75586,13.75 0.55083,1.67057 -3.42654,-2.47747 -6.33007,-6.60156 -1.70716,-2.4248 -4.36549,-3.03824 -4.33399,-1 0.0106,0.6875 2.48564,4.82032 5.5,9.18359 3.01436,4.36326 5.48047,8.49187 5.48047,9.17579 0,0.68389 0.7875,1.44965 1.75,1.70117 0.9625,0.25153 2.07623,0.51042 2.47461,0.57422 2.30187,0.36865 8.73423,-22.32436 6.85937,-24.19922 -1.4826,-1.4826 -2.41571,-0.31547 -5.44921,6.81445 -1.40402,3.3 -2.60523,5.325 -2.66993,4.5 -0.0647,-0.825 -0.28692,-2.4 -0.49414,-3.5 -0.20723,-1.1 -0.87143,-7.175 -1.47461,-13.5 -1.09291,-11.46042 -2.36443,-17.37679 -4.24804,-19.75 -0.51152,-0.64447 -0.95496,-1.04322 -1.32422,-1.20508 z m -279.13281,8.00196 c -0.52624,0.1272 -1.38186,0.63058 -2.27344,1.4375 -1.26783,1.14736 -2.40398,1.2646 -5.00196,0.51953 -2.27813,-0.65336 -3.77494,-0.61953 -4.64843,0.10547 -0.72942,0.60536 -4.45201,0.95279 -8.57813,0.79882 -9.55719,-0.35663 -14.45985,1.32389 -10.67968,3.66016 1.26498,0.7818 13.51834,0.67756 16.09765,-0.13672 1.5602,-0.49257 1.68904,0.67103 1.5,13.54883 L 185.5,966.06641 183,966.60352 c -4.07355,0.87272 -7,2.28325 -7,3.375 0,1.44159 1.73076,1.27255 2.33984,-0.22852 0.35045,-0.8637 0.76317,-0.92077 1.33399,-0.18359 0.58223,0.75191 3.77847,0.66689 10.82617,-0.28907 5.5,-0.74603 11.35,-1.5275 13,-1.73632 8.1694,-1.03389 15.0001,-3.18762 15.31641,-4.83008 C 219.0758,961.36403 218.41304,961 215.69531,961 c -5.17448,0 -6.06807,-1.77655 -5.42578,-10.77344 0.30341,-4.24998 0.86488,-8.51406 1.24805,-9.47656 0.7532,-1.89197 3.50004,-2.33141 5.0332,-0.80469 1.27083,1.26549 5.97102,-2.29117 5.0332,-3.80859 -0.39073,-0.63221 -3.22876,-1.13953 -6.39257,-1.14453 -8.13202,-0.0124 -16.23227,-1.11791 -15.60743,-2.12891 0.42965,-0.69519 0.23327,-0.94369 -0.29296,-0.8164 z M 206.31445,938 c 1.20957,0 1.36688,1.93212 0.95117,11.75 -0.27359,6.4625 -0.6146,11.88175 -0.75781,12.04297 -0.75625,0.85138 -1.21888,-3.4031 -1.41797,-13.04297 -0.18212,-8.81821 0.0371,-10.75 1.22461,-10.75 z m -13.57617,0.19141 c 2.03645,-0.29933 2.09887,0.0475 1.9961,11 -0.0584,6.21999 0.23205,12.32109 0.64648,13.55859 0.65421,1.95348 0.40723,2.25 -1.87305,2.25 -1.83493,0 -2.39968,-0.37667 -1.875,-1.25 0.51696,-0.86048 0.22689,-0.82473 -0.92969,0.11328 -2.53351,2.05475 -3.10123,-0.53246 -2.35156,-10.70703 0.84297,-11.44076 1.76383,-14.57931 4.38672,-14.96484 z m 6.01563,0.96289 c 0.545,-0.26437 0.90103,3.9295 0.83984,11.84375 -0.051,6.59841 -0.22024,11.998 -0.375,12 -1.29069,0.0132 -2.34361,-12.08084 -1.60156,-18.39453 0.41444,-3.52623 0.80972,-5.2906 1.13672,-5.44922 z m 240.35547,23.41015 c -0.78006,-0.33548 -2.72026,0.0741 -5.33594,1.4375 -2.28438,1.19068 -6.74902,4.20217 -9.91992,6.69336 -7.21729,5.67023 -17.61466,9.28189 -38.66797,13.42969 -19.87337,3.91534 -28.16797,4.04821 -53.0293,0.8457 -21.83433,-2.8126 -23.2837,-3.03614 -26.94531,-4.15039 -3.43263,-1.04458 -6.82098,0.38317 -5.59961,2.35938 0.34589,0.5597 -1.0008,0.82248 -3.26172,0.63672 -2.96755,-0.24382 -3.78501,-0.70568 -3.56836,-2.01172 0.24926,-1.5026 -0.50742,-1.62701 -6.68164,-1.10938 -6.00212,0.50319 -7.47116,0.28159 -10.65625,-1.59765 -2.03208,-1.19896 -3.97713,-1.89768 -4.32031,-1.55469 -0.86003,0.85951 -1.04427,4.17731 -0.94727,16.95703 0.0459,6.05 -0.005,15.1912 -0.11328,20.3145 -0.12139,5.7527 0.41484,11.8715 1.40234,16 0.87946,3.6767 1.80985,7.6672 2.06836,8.8671 0.42579,1.9763 2.29448,2.3915 6.23633,1.3868 0.14868,-0.038 -0.60454,-1.787 -1.67578,-3.8868 -1.07123,-2.0998 -2.44943,-7.4813 -3.0625,-11.9589 -1.27667,-9.3243 -1.18888,-29.55242 0.14453,-33.13481 0.57168,-1.5359 0.52154,-2.79096 -0.13867,-3.45117 C 274.46667,988.06628 274,986.88378 274,986.00781 c 0,-1.42815 1.00721,-1.47293 9.75,-0.42187 6.46375,0.77707 12.61494,0.87972 18.25,0.30273 8.50708,-0.87105 17.90796,-0.12929 46.5,3.66602 14.04517,1.8644 25.85646,1.84877 32.0918,-0.043 2.69991,-0.81904 5.16023,-1.494 5.46875,-1.5 0.30852,-0.006 1.15195,2.28995 1.87304,5.10351 1.1005,4.29372 1.0891,5.2528 -0.0625,5.9668 -1.41812,0.87926 -1.57439,11.1249 -0.29297,19.168 0.69466,4.3601 0.25422,4.4993 -7.14648,2.2539 -7.86695,-2.3868 -8.33617,-2.9338 -5.31836,-6.207 6.63823,-7.2 7.59131,-11.3642 3.125,-13.6739 -3.7465,-1.93702 -10.7704,-2.51114 -10.63867,-0.86912 0.23327,2.90772 0.45257,3.33182 1.41601,2.73632 0.55899,-0.3454 0.76888,-1.0287 0.4668,-1.5175 -0.30208,-0.4887 0.70377,-0.2359 2.23438,0.5625 1.53061,0.7984 3.31957,1.4589 3.97461,1.4589 2.2788,0.012 2.43743,2.0629 0.41211,5.3399 -2.28851,3.7029 -6.08293,7.4535 -6.14063,6.0703 -0.12912,-3.0939 -1.25366,-8.996 -1.80664,-9.4863 -0.36121,-0.3203 -3.07083,-1.3328 -6.02148,-2.25 -6.18015,-1.9211 -13.69316,-2.19 -14.72071,-0.5274 -0.38741,0.6268 -0.88422,6.7555 -1.10351,13.6211 -0.45574,14.2681 0.31914,16.2383 6.38476,16.2383 4.24274,0 11.30469,-3.5151 11.30469,-5.627 0,-1.1289 -0.50486,-1.3711 -1.75,-0.8398 -8.09491,3.4543 -10.05453,3.8748 -11.69922,2.5098 -1.1534,-0.9572 -1.55896,-2.6008 -1.34961,-5.4571 L 349.5,1018.5 l 6.30273,-0.6035 c 9.53423,-0.9116 10.39903,-2.8965 1.26172,-2.8965 h -7.33593 l 0.64453,-4.7109 c 0.35504,-2.5903 1.01997,-5.0825 1.47656,-5.5391 0.45659,-0.4561 3.7146,-0.474 7.24023,-0.039 l 6.41016,0.7891 0.23438,4 c 0.60198,10.2981 2.60843,21.5 3.85156,21.5 2.02962,0 2.36134,-1.3012 1.4082,-5.5273 -0.4858,-2.1542 -0.74709,-4.0537 -0.58008,-4.2207 0.6541,-0.6541 17.19169,5.1189 18.89453,6.5957 1.32617,1.1501 2.24278,1.2939 3.43946,0.539 2.18793,-1.3801 2.87231,-3.5625 0.87695,-2.7969 -1.61154,0.6184 -1.99997,-0.4044 -3.00586,-7.8964 -0.6145,-4.5769 0.35799,-13.8253 1.38672,-13.1895 0.40279,0.2489 1.06233,2.3749 1.4668,4.7246 l 0.73632,4.2715 1.19336,-3.3789 c 1.38964,-3.9312 5.85547,-8.1211 8.6543,-8.1211 1.06933,0 2.81073,0.8674 3.87109,1.9277 3.5909,3.5909 3.88735,16.4392 0.41016,17.7735 -2.10162,0.8065 -5.92405,-1.499 -7.22656,-4.3574 -1.34647,-2.9552 -1.47712,-8.6887 -0.17969,-7.8868 1.65175,1.0208 2.09888,-1.1873 0.50781,-2.5078 -1.25627,-1.0426 -1.79101,-1.0175 -2.91015,0.1367 -1.53748,1.5856 -1.81976,2.9119 -1.64844,7.7813 0.0875,2.4878 1.13394,4.382 4.00195,7.25 4.50203,4.5021 6.3058,4.786 9.58594,1.5058 1.56907,-1.569 2.71367,-2.0402 3.36719,-1.3867 1.38302,1.383 3.16406,0.042 3.16406,-2.3808 0,-1.8193 0.536,-1.6464 5.25,1.6972 2.8875,2.0481 6.24006,4.7872 7.45117,6.086 2.50914,2.6906 5.29883,3.1141 5.29883,0.8047 0,-1.8878 -4.85099,-6.4649 -11.16211,-10.5332 -6.74401,-4.3474 -6.79278,-5.4162 -0.50586,-11.0196 6.27163,-5.5898 8.40283,-9.65038 6.7168,-12.80076 -1.60136,-2.99216 -4.94699,-2.58169 -8.71289,1.06836 l -3.25782,3.15821 -2.07421,-2.40821 -2.07227,-2.4082 0.65234,7.75 c 0.45672,5.4319 0.31645,7.75 -0.46679,7.75 -0.61462,0 -1.1191,-0.7875 -1.1211,-1.75 -0.002,-0.9625 -0.89451,-3.2125 -1.98437,-5 -2.63684,-4.32474 -7.0771,-4.43323 -12.76563,-0.3125 l -4.05468,2.9375 -1.03321,-2.6875 c -0.56803,-1.4779 -1.30271,-4.2625 -1.63281,-6.1875 -0.5977,-3.48548 -0.59366,-3.48963 0.90234,-1 l 1.50196,2.5 0.0273,-2.5 c 0.0159,-1.375 -0.86376,-3.85 -1.95508,-5.5 l -1.98437,-3 6.74219,-1.64258 c 3.70745,-0.90393 8.09023,-2.10569 9.74023,-2.66992 3.0294,-1.03591 6.84917,-2.05328 18.25,-4.85938 3.4375,-0.84604 6.25,-1.9414 6.25,-2.43359 0,-0.4922 0.45,-0.89453 1,-0.89453 0.55,0 1.00095,1.9125 1.00195,4.25 10e-4,2.3375 1.1261,11.86751 2.5,21.17773 2.50152,16.95157 3.1095,27.16917 1.73243,29.10547 -0.40409,0.5681 -3.09048,2.7403 -5.97071,4.8262 -2.88023,2.0858 -6.1064,4.8965 -7.16797,6.2461 -1.13125,1.4381 -4.13597,3.1003 -7.26172,4.0175 -2.9332,0.8607 -8.36428,2.8856 -12.06836,4.5 -10.25238,4.4684 -30.50924,6.3592 -68.26562,6.3692 -29.89131,0.01 -30.03442,0 -39.5,-2.7774 -5.225,-1.5321 -12.03122,-3.8946 -15.125,-5.25 -6.44773,-2.8248 -8.72102,-3.1896 -7.00586,-1.123 0.61254,0.7381 0.84891,1.6062 0.52539,1.9297 -1.73366,1.7337 20.29483,9.1202 31.4668,10.5508 11.22095,1.4369 48.2178,1.281 61.13867,-0.2578 6.875,-0.8187 16.90877,-1.9588 22.29688,-2.5313 6.3967,-0.6797 11.25535,-1.7915 14,-3.207 6.73394,-3.4729 24.99986,-8.9298 26.125,-7.8047 0.53838,0.5384 1.41364,0.9785 1.94531,0.9785 0.53166,0 0.72126,-0.2456 0.42187,-0.5449 -0.53338,-0.5334 5.51624,-6.9821 8.40039,-8.9551 1.23187,-0.8427 1.34461,-3.4386 0.72071,-16.5 -1.28553,-26.91233 -1.84366,-40.35448 -1.87696,-45.14258 -0.0292,-4.19059 -0.29317,-4.70616 -2.71679,-5.31445 l -2.68555,-0.67383 2.85156,-2.27344 c 2.02723,-1.61645 2.40701,-2.69577 1.62696,-3.03125 z m -6.87891,6.08203 c 1.05312,-0.31153 1.45624,0.0718 0.81836,1.26368 -0.50452,0.94271 -2.63236,2.24008 -4.72656,2.88281 l -3.80665,1.16797 2.99219,-2.41211 c 1.96567,-1.58468 3.66953,-2.59082 4.72266,-2.90235 z m 76.48828,14.79493 c -1.94111,0.25935 -3.7597,0.91416 -4.49609,1.83593 -1.21348,1.51897 -3.49255,14.47776 -2.75586,15.66996 0.84398,1.3656 -0.53126,4.0527 -2.07422,4.0527 -0.76615,0 -1.39258,0.675 -1.39258,1.5 0,0.825 0.86446,1.5 1.92188,1.5 2.11662,0 3.73754,3.796 4.42382,10.3633 0.22206,2.1249 1.00029,4.2324 1.73047,4.6836 3.44644,2.1301 3.81958,-2.1324 0.92188,-10.5547 -1.10142,-3.2014 -1.87984,-5.9444 -1.72852,-6.0957 0.15131,-0.1513 1.5069,-0.4987 3.01172,-0.7715 4.95385,-0.8983 6.70828,-1.735 7.76367,-3.707 1.43331,-2.67835 -1.05387,-3.53252 -5.98633,-2.05472 -5.5143,1.65212 -5.59029,1.59712 -5.21679,-3.79101 0.39752,-5.73446 2.29558,-7.94552 7.1582,-8.33985 4.0042,-0.32473 4.95446,-2.15064 1.95508,-3.75586 -1.23115,-0.65889 -3.29522,-0.79451 -5.23633,-0.53515 z m -301.39258,0.83007 c -2.86872,-0.948 -1.57544,16.69412 1.6875,23.02542 2.67587,5.1923 6.95281,9.8419 8.29297,9.0136 0.55082,-0.3404 0.69696,-0.1266 0.32422,0.4766 -1.81916,2.9434 12.04667,5.7198 18.4375,3.6914 1.98431,-0.6298 1.98517,-0.6145 -0.0312,2.6934 -1.11586,1.8302 -2.0312,4.1432 -2.0332,5.1406 -0.003,1.437 0.65623,1.7482 3.16992,1.5 1.74514,-0.1724 3.37985,-0.9476 3.63476,-1.7227 0.31831,-0.968 -0.0479,-1.2125 -1.17187,-0.7812 -3.13775,1.204 -1.59987,-1.5374 3.51172,-6.2617 4.8411,-4.4744 5.71244,-7.0469 2.38672,-7.0469 -0.82669,0 -1.15733,-0.7266 -0.85547,-1.8809 0.29646,-1.1337 -0.38027,-2.6953 -1.70313,-3.9277 -4.79478,-4.467 -9.91613,2.1665 -5.77539,7.4805 1.52664,1.9593 -9.09688,2.818 -13.26367,1.0722 -9.18998,-3.8503 -13.8876,-11.4621 -14.83203,-24.02926 -0.35944,-4.783 -1.08289,-8.21322 -1.7793,-8.44336 z m 276.52539,1.92774 c -0.94676,0.33158 -1.77481,2.38155 -1.39648,4.30078 2.93229,14.8752 5.68145,24.5341 7.98437,28.0488 3.19591,4.8776 4.8922,2.297 5.94727,-9.0488 1.5009,-16.14001 1.85243,-18.47003 2.71094,-17.93945 1.24055,0.7667 1.07263,-0.62817 -0.39454,-3.26758 -2.29872,-4.13557 -3.62427,-1.0846 -4.67187,10.75195 -0.55761,6.30008 -1.01844,12.01758 -1.02344,12.70508 -0.005,0.6875 -0.38392,1.25 -0.84375,1.25 -1.02384,0 -3.60079,-9.066 -5.25781,-18.5 -0.67622,-3.85 -1.62523,-7.44679 -2.10937,-7.99219 -0.30192,-0.34011 -0.62973,-0.41912 -0.94532,-0.30859 z m -205.21484,8.00195 c -0.66258,-0.25295 -2.03449,0.4902 -2.4082,1.61133 -0.24358,0.73075 0.21359,0.95576 1.1875,0.58203 0.87096,-0.33422 1.58398,-1.04699 1.58398,-1.58398 0,-0.3286 -0.14242,-0.52506 -0.36328,-0.60938 z m 147.10937,1.2793 c 1.6794,-0.45218 2.65076,0.91425 1.42774,3.16211 -1.52875,2.80972 -8.17383,8.92472 -8.17383,7.52152 0,-2.3164 2.7236,-7.66393 4.88477,-9.58988 0.66157,-0.58957 1.30153,-0.94302 1.86132,-1.09375 z m 45.33203,0.5293 v 0.002 c -2.98953,0.23606 -4.8949,2.52917 -7.63281,8.24223 -4.32052,9.0154 -4.56048,14.2667 -0.85547,18.6699 1.4239,1.6922 3.53239,3.0762 4.68555,3.0762 2.37573,0 6.72461,-3.6694 6.72461,-5.6738 0,-1.6257 0.49988,-1.6549 2.88086,-0.168 2.43447,1.5204 4.86094,0.5039 6.29102,-2.6348 1.32211,-2.9017 0.17776,-4.9007 -1.29688,-2.2656 -1.2519,2.2353 -3.55266,2.2327 -4.70312,-0.01 -1.3841,-2.6963 -2.36816,-16.25 -1.17969,-16.25 2.0611,0 0.91766,-1.98501 -1.49219,-2.58985 -1.30842,-0.3284 -2.42536,-0.47712 -3.42188,-0.39843 z M 334.71875,1000 C 325.4193,1000 323,1002.0788 323,1010.0723 c 0,4.6021 -0.33537,5.9277 -1.5,5.9277 -2.06583,0 -1.89018,2.7197 0.25,3.8711 1.00142,0.5387 2.55066,3.7623 3.62305,7.5351 1.14319,4.0227 2.4106,6.5938 3.25,6.5938 1.76789,0 1.7383,-1.7244 -0.12305,-7 -2.21192,-6.2693 -2.02196,-6.7015 3.25,-7.4121 12.03894,-1.6229 12.95618,-1.8605 10.25,-2.6543 -1.375,-0.4033 -5.5375,-0.779 -9.25,-0.834 L 326,1016 v -4.9414 c 0,-2.8546 0.52781,-5.2826 1.25,-5.75 0.6875,-0.4449 3.91689,-1.2586 7.17578,-1.8086 8.40197,-1.418 8.57626,-3.5 0.29297,-3.5 z m -19.89844,1.0625 c -1.16512,0.049 -1.90353,2.0319 -1.46679,4.8125 0.31309,1.9934 0.87196,7.225 1.24218,11.625 l 0.67383,8 -2.26367,-2 c -4.1943,-3.7046 -7.2982,-9.7698 -7.91211,-15.4648 -0.42821,-3.9724 -1.04656,-5.5985 -2.21484,-5.8223 -2.01435,-0.386 -2.71413,1.974 -3.5293,11.8984 -0.73977,9.0066 0.12772,14.8887 2.19531,14.8887 1.1459,0 1.45926,-1.6451 1.47656,-7.75 l 0.0215,-7.75 1.86523,4.1055 c 2.33503,5.1417 4.75864,8.1095 8.56641,10.4883 1.72364,1.0768 3.34689,1.4851 3.85937,0.9726 1.51323,-1.5132 0.42166,-25.7112 -1.23437,-27.3672 -0.45557,-0.4556 -0.89092,-0.6531 -1.2793,-0.6367 z m -22.40625,0.041 c -0.72638,0.2439 -1.44309,1.2917 -1.78906,3.0215 -0.80189,4.0092 -0.79011,21.2392 0.0176,26.125 0.47258,2.8591 1.08901,3.75 2.5957,3.75 1.48078,0 1.80134,-0.4387 1.2793,-1.75 -1.289,-3.2379 -1.74227,-16.7046 -0.74414,-22.0977 0.54425,-2.9407 0.76397,-6.2032 0.49023,-7.25 -0.38794,-1.4834 -1.12323,-2.0426 -1.84961,-1.7988 z m 177.54102,0.7481 c 0.85456,0 1.18518,1.624 2.03515,7.0879 1.08748,6.9906 1.03487,8.092 -0.50195,10.4375 -2.14247,3.2698 -6.20887,3.5551 -7.33398,0.5136 -1.20351,-3.2534 -0.4263,-10.9316 1.29882,-12.8379 0.85091,-0.9402 1.54688,-2.1287 1.54688,-2.6406 0,-0.5119 0.84867,-1.4611 1.88672,-2.1094 0.43981,-0.2746 0.78351,-0.4527 1.06836,-0.4511 z m 277.8164,0.3476 c -0.12445,-0.075 -0.33219,0.2008 -0.66601,0.8008 -0.45906,0.825 -1.12483,2.85 -1.47852,4.5 l -0.64257,3 1.47265,-2.5 c 0.80999,-1.375 1.47356,-3.4 1.47656,-4.5 0.002,-0.7999 -0.0376,-1.2258 -0.16211,-1.3008 z m -505.83203,8.3379 c 0.51671,-0.3193 0.87091,0.3295 0.78711,1.4414 -0.0838,1.1119 -0.5065,2.0215 -0.93945,2.0215 -1.10577,0 -0.98432,-2.7604 0.15234,-3.4629 z m 196.56055,22.0645 -2.44922,2.7246 c -1.34671,1.4988 -3.77705,3.3884 -5.40234,4.1992 -5.39106,2.6894 -6.39232,1.7002 -1.3125,-1.2969 1.83499,-1.0827 4.64749,-2.7906 6.25,-3.7969 z m 39.70312,1.3867 c -0.29759,-0.1013 -0.77179,0.18 -1.41992,0.8281 -0.91111,0.9111 -0.86867,1.1836 0.1836,1.1836 0.75166,0 1.02968,0.3375 0.61718,0.75 -0.4125,0.4125 -1.24583,0.75 -1.85156,0.75 -0.60572,0 -1.65363,2.025 -2.32812,4.5 -0.6745,2.475 -1.96285,7.2 -2.86328,10.5 -2.27108,8.3233 -6.37202,19.5573 -8.12305,22.25 -1.61016,2.4761 -4.37716,2.8685 -7.73438,1.0977 -2.45792,-1.2965 -4.53903,-3.394 -10.08984,-10.168 -3.46514,-4.2288 -3.63131,-4.6797 -1.71484,-4.6797 1.45379,0 2.12109,-0.6288 2.12109,-2 0,-1.2724 -0.66624,-2 -1.83203,-2 -1.01942,0 -2.90976,-1.6638 -4.25977,-3.75 -1.33469,-2.0625 -3.06531,-3.75 -3.8457,-3.75 -1.71805,0 -3.35335,5.4448 -2.0918,6.9648 0.49497,0.5964 0.65967,4.057 0.36524,7.6895 -0.37274,4.5987 -0.16787,6.8321 0.67578,7.3535 1.55494,0.961 2.95299,-1.2495 2.97266,-4.6992 0.0239,-4.2019 1.52225,-4.1266 4.53906,0.2266 3.53244,5.0973 9.78905,10.7584 13.83203,12.5175 4.50293,1.9593 5.52357,1.7912 8.49414,-1.4062 2.68118,-2.8859 6.23666,-12.2886 12.25391,-32.4024 2.30231,-7.6959 2.99245,-11.4521 2.0996,-11.7558 z m 243.97657,88.7695 c -1.29336,-0.3382 -2.70595,0.1677 -3.77735,1.3516 -2.07946,2.2978 -0.24472,2.5637 3.47071,0.5039 2.30908,-1.2801 2.31719,-1.3297 0.30664,-1.8555 z M 909.5,1128 c -0.825,0 -1.5,0.45 -1.5,1 0,0.55 0.675,1 1.5,1 0.825,0 1.5,-0.45 1.5,-1 0,-0.55 -0.675,-1 -1.5,-1 z m -885.220703,26.3789 c -0.105141,0.1051 -0.177182,0.4546 -0.201172,1.0371 -0.04342,1.0541 0.193099,1.6448 0.525391,1.3125 0.332294,-0.3323 0.368937,-1.1941 0.08008,-1.916 -0.159613,-0.3989 -0.299156,-0.5387 -0.404297,-0.4336 z M 0,1164 v 58 58 l 92.25,-0.1738 c 50.7375,-0.096 90.3375,-0.3481 88,-0.5586 -2.3375,-0.2105 -4.25,-0.8644 -4.25,-1.4531 0,-0.6886 -1.42642,-0.8412 -4,-0.4297 -2.45258,0.3922 -4,0.2473 -4,-0.3731 0,-0.5565 -1.8,-1.0117 -4,-1.0117 -3.33333,0 -4,-0.3333 -4,-2 0,-1.6596 0.66602,-2 3.91602,-2 2.15416,0 4.09422,0.5308 4.31054,1.1797 0.25606,0.7682 1.0709,0.8891 2.33399,0.3457 1.76537,-0.7596 1.7819,-0.873 0.18945,-1.2539 -1.29849,-0.3106 -1.75,-1.4322 -1.75,-4.3457 V 1264 h -8 -8 l -0.17383,-4.25 -0.17578,-4.25 -0.38281,4.25 c -0.43649,4.8463 -1.58337,5.2298 -5.45508,1.8203 -2.38907,-2.1039 -2.65346,-2.9629 -2.37305,-7.7187 0.17353,-2.9431 0.11737,-4.1141 -0.125,-2.6016 -0.4378,2.732 -0.49229,2.75 -8.37695,2.75 -7.62854,0 -7.9375,-0.091 -7.9375,-2.3145 0,-1.2724 -1.06049,-4.5119 -2.35742,-7.1992 -2.13879,-4.4316 -2.4614,-4.7037 -3.4668,-2.9355 -2.77,4.8717 -2.75877,4.8682 -6.5664,1.8301 -1.98566,-1.5843 -3.60936,-3.6494 -3.60938,-4.5899 -2e-5,-1.1284 -1.3602,-2.1173 -4,-2.9082 -2.2,-0.6592 -4,-1.803 -4,-2.541 0,-0.7379 0.45,-1.3418 1,-1.3418 0.55,0 1,-0.45 1,-1 0,-0.55 -1.35,-1 -3,-1 -1.65,0 -3,0.45 -3,1 0,1.176 -3.678472,1.364 -4.166016,0.2129 -0.183333,-0.4329 -2.216258,-2.2827 -4.515625,-4.1113 -3.42718,-2.7254 -4.868643,-3.2598 -8.001953,-2.961 l -3.822265,0.3653 0.345703,-3.627 0.345703,-3.6269 -7.677735,-0.7188 c -6.980816,-0.6541 -7.883441,-0.5286 -9.917968,1.3828 C 60.340838,1220.0288 59,1219.8118 59,1217.334 c 0,-0.7555 1.083333,-1.334 2.5,-1.334 1.375,0 2.5,-0.45 2.5,-1 0,-0.55 1.8,-1 4,-1 3.333333,0 4,-0.3333 4,-2 0,-1.6667 -0.666667,-2 -4,-2 -2.2,0 -4,-0.45 -4,-1 0,-0.55 -0.533495,-1 -1.185547,-1 -0.652052,0 -2.250817,-1.0015 -3.552734,-2.2246 -1.891205,-1.7767 -2.536572,-1.95 -3.207031,-0.8652 -0.657652,1.0641 -1.781879,0.6282 -5.197266,-2.0157 -2.396981,-1.8555 -4.552683,-3.498 -4.791016,-3.6504 -0.238334,-0.1524 0.09917,-0.81 0.75,-1.4609 0.911111,-0.9111 1.183594,-0.7913 1.183594,0.5176 0,1.3167 0.901961,1.6992 4,1.6992 h 4 v -4.5 -4.5 l -3.75,0.016 c -4.222978,0.017 -5.606416,0.7013 -6.541016,3.2344 -0.382143,1.0357 -1.679529,1.75 -3.177734,1.75 H 40 l -0.173828,-10.25 c -0.09609,-5.6375 -0.348059,-8.3375 -0.558594,-6 -0.368399,4.0902 -0.510192,4.25 -3.777344,4.25 h -3.394531 l -0.298828,6.1855 c -0.28785,5.9807 -0.356693,6.1248 -2.113281,4.3614 -1.341361,-1.3467 -1.749962,-3.0755 -1.5625,-6.6074 0.150172,-2.8294 -0.282114,-5.4281 -1.056641,-6.3614 C 25.274937,1179.4195 24,1179.5973 24,1182 c 0,1.1 -0.45,2 -1,2 -0.55,0 -1,-1.7221 -1,-3.8262 0,-2.8543 -0.669169,-4.4412 -2.636719,-6.25 -1.806486,-1.6607 -2.778364,-2.0301 -3.083984,-1.1738 -0.255856,0.7168 -2.149442,1.25 -4.439453,1.25 -3.8750789,0 -3.9871209,-0.096 -3.8144534,-3.25 C 8.3860105,1164.1632 8.2879914,1164 4,1164 Z m 956,4 c -3.33333,0 -4,0.3333 -4,2 0,1.3333 -0.66667,2 -2,2 -1.11111,0 -2,-0.6667 -2,-1.5 0,-2.1176 -2.97844,-1.8774 -3.09961,0.25 -0.0665,1.1667 -0.36663,0.9167 -0.90039,-0.75 -0.68015,-2.1238 -0.81569,-1.8604 -0.90039,1.75 -0.0719,3.0668 -0.51721,4.25 -1.59961,4.25 -1.10753,0 -1.5,1.1578 -1.5,4.4277 0,2.8285 -0.61144,5.0412 -1.69336,6.1231 -1.57715,1.5771 -1.73422,1.5817 -2.2793,0.025 -0.51007,-1.4541 -1.0601,-1.3096 -4.27343,1.1269 -2.02848,1.538 -3.51943,3.2889 -3.3125,3.8907 0.23,0.6684 -0.56068,0.9143 -2.03321,0.6328 -2.22942,-0.4262 -2.4082,-0.154 -2.4082,3.6562 0,3.4499 -0.32389,4.1172 -2,4.1172 -1.33333,0 -2,-0.6667 -2,-2 0,-1.1 -0.44759,-2 -0.99414,-2 -1.6435,0 -7.00586,8.1282 -7.00586,10.6191 0,2.2831 -0.1228,2.3086 -8,1.7012 -5.71331,-0.4406 -8,-0.2887 -8,0.5313 0,0.6729 -1.65577,1.1484 -4,1.1484 -2.2,0 -4,0.45 -4,1 0,0.5833 -3.33333,1 -8,1 -6.07871,0 -8,0.3259 -8,1.3594 0,0.9091 -1.78062,1.5436 -5.36914,1.914 -6.1065,0.6302 -11.18381,4.5012 -10.30664,7.8555 0.42353,1.6196 -0.10476,1.8711 -3.91797,1.8711 -4.36918,0 -4.40625,0.03 -4.40625,3.5 0,3.431 -0.0817,3.5 -4.10156,3.5 h -4.09961 l 0.34961,4.25 0.35156,4.25 -4.25,-0.3516 c -3.38513,-0.2793 -4.25,-0.7372 -4.25,-2.25 0,-1.0446 -0.36078,-1.8984 -0.80078,-1.8984 -1.90626,0 -3.19922,2.708 -3.19922,6.6992 0,2.9667 -0.62016,4.921 -2,6.3008 -1.55556,1.5556 -2,1.6667 -2,0.5 0,-0.825 -0.45,-1.5 -1,-1.5 -0.55,0 -1.03116,-1.0125 -1.06836,-2.25 l -0.0664,-2.25 -1.08593,2.25 c -0.59683,1.2375 -1.88322,2.25 -2.85938,2.25 -1.11561,0 -2.44288,1.5158 -3.57422,4.0801 -1.60111,3.6289 -2.10246,4.0185 -4.52929,3.5332 -2.11759,-0.4235 -2.60076,-0.2181 -2.16407,0.9199 0.35829,0.9337 -0.0545,1.4668 -1.13672,1.4668 -0.93457,0 -2.84376,0.9 -4.24218,2 -1.54651,1.2165 -4.05726,2 -6.40821,2 -2.14582,0 -3.86523,0.4905 -3.86523,1.1016 0,0.687 -1.64532,0.9687 -4.37305,0.75 -3.19349,-0.2561 -4.24307,-0.014 -3.89257,0.8984 0.26395,0.6875 -0.1891,1.25 -1.00586,1.25 -0.81676,0 -2.10284,0.8898 -2.85743,1.9766 -1.22073,1.758 -2.00345,1.8856 -7.10742,1.1679 -5.08926,-0.7156 -5.80088,-0.5988 -6.3164,1.0254 -0.37557,1.1833 -1.54444,1.8301 -3.30274,1.8301 -1.56774,0 -4.1864,1.2535 -6.18164,2.959 -2.75664,2.3562 -4.43092,2.968 -8.21289,3 -2.6125,0.022 -4.75,-0.409 -4.75,-0.959 0,-0.55 -0.675,-1 -1.5,-1 -1.24638,0 -1.20411,0.3234 0.25,1.916 1.70301,1.8652 4.64335,1.919 109.5,2 L 960,1280 v -56 -56 z m -26,26.7109 c 1.1,0.2876 2,0.6955 2,0.9063 0,0.2109 -0.9,0.3828 -2,0.3828 -1.1,0 -2,-0.4078 -2,-0.9062 0,-0.4986 0.9,-0.6706 2,-0.3829 z m 5,1 c 1.1,-0.2877 2,-0.1159 2,0.3829 0,0.4981 -0.9,0.9062 -2,0.9062 -1.1,0 -2,-0.1719 -2,-0.3828 0,-0.2108 0.9,-0.6187 2,-0.9063 z m 4.05859,2.2891 c 0.58246,0 0.78133,0.45 0.44141,1 -0.33992,0.55 -0.81605,1 -1.05859,1 -0.24254,0 -0.44141,-0.45 -0.44141,-1 0,-0.55 0.47613,-1 1.05859,-1 z m -10.24609,0.3164 c 0.72187,-0.2888 1.58373,-0.2516 1.91602,0.08 0.33229,0.3323 -0.25834,0.5684 -1.3125,0.5254 -1.16495,-0.048 -1.40125,-0.2863 -0.60352,-0.6055 z m -45.0625,0.9512 c -2.3375,0.2105 -0.425,0.3828 4.25,0.3828 4.675,0 6.5875,-0.1723 4.25,-0.3828 -2.3375,-0.2105 -6.1625,-0.2105 -8.5,0 z m -819.011719,4.8203 C 64.258656,1204.2249 64,1204.8666 64,1206 c 0,1.3333 0.666667,2 2,2 2.266708,0 2.563776,-1.0378 0.800781,-2.8008 -0.881497,-0.8815 -1.582874,-1.2483 -2.0625,-1.1113 z M 80,1208.832 76,1212 c -2.2,1.7424 -4,3.3552 -4,3.584 0,0.2288 1.8,0.416 4,0.416 3.92262,0 4,-0.069 4,-3.584 z M 905.05859,1212 c 0.58246,0 0.78133,0.45 0.44141,1 -0.33992,0.55 -0.81605,1 -1.05859,1 -0.24254,0 -0.44141,-0.45 -0.44141,-1 0,-0.55 0.47613,-1 1.05859,-1 z M 111,1224 c -0.55,0 -1,0.45 -1,1 0,0.55 0.45,1 1,1 0.55,0 1,-0.45 1,-1 0,-0.55 -0.45,-1 -1,-1 z m -13.845703,3.2578 C 96.538848,1227.1699 96,1227.533 96,1228.416 c 0,0.8708 0.713151,1.584 1.583984,1.584 0.870834,0 1.405209,-0.5344 1.1875,-1.1875 -0.309037,-0.9271 -1.001738,-1.4668 -1.617187,-1.5547 z M 823,1240 c -0.55,0 -1,0.7012 -1,1.5586 0,0.858 0.45,1.2813 1,0.9414 0.55,-0.3399 1,-1.0411 1,-1.5586 0,-0.5176 -0.45,-0.9414 -1,-0.9414 z m -6.31055,1.25 c -0.25153,-0.9625 -0.45703,-0.175 -0.45703,1.75 0,1.925 0.2055,2.7125 0.45703,1.75 0.25152,-0.9625 0.25152,-2.5375 0,-3.5 z M 793.58398,1264 c 0.87084,0 1.40521,0.5344 1.1875,1.1875 -0.61807,1.8542 -2.77148,2.1625 -2.77148,0.3965 0,-0.8708 0.71315,-1.584 1.58398,-1.584 z M 177.75,1272.2949 c -1.2375,0.2383 -0.225,0.4336 2.25,0.4336 2.475,0 3.4875,-0.1953 2.25,-0.4336 -1.2375,-0.2384 -3.2625,-0.2384 -4.5,0 z&#34; /&gt;
  &lt;/g&gt;
&lt;/svg&gt;

&lt;/div&gt;

  &lt;p style=&#34;font-size: 80%&#34;&gt;Em breve: desenho tridimensional.&lt;/p&gt;


&lt;h2 id=&#34;arritmias-atriais&#34;&gt;Arritmias atriais&lt;/h2&gt;
&lt;h3 id=&#34;derivação-de-lewis&#34;&gt;Derivação de Lewis&lt;/h3&gt;
&lt;p&gt;A identificação das ondas $P$ é de extrema importância em diagnósticos eletrocardiográficos atriais. Quando a linha de base do exame não oferecer boa visualização destas ondas, existe a opção de posicionar derivações bipolares, sendo a mais famosa a de Lewis&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;O eletrodo do braço direito é colocado no 2º espaço intercostal direito;&lt;/li&gt;
&lt;li&gt;O eletrodo do braço esquerdo no 4º espaço intercostal direito; e&lt;/li&gt;
&lt;li&gt;Registra-se a atividade da derivação $I$.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;taquiarritmia-supraventricular-paroxística&#34;&gt;Taquiarritmia supraventricular paroxística&lt;/h3&gt;
&lt;p&gt;Vias acessórias de condução, Wolff-Parkinson-White e outras condições preciptantes tornam o ritmo cardíaco acelerado mantendo origem atrial, preservando-se a morfologia de $\overline{QRS}$.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/taqui-supra-paroxistica.jpg&#34;&gt;
  &lt;figcaption&gt;Registro oportuno do fim de taquicardia supraventricular paroxística.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h3 id=&#34;fenômeno-de-ashman&#34;&gt;Fenômeno de Ashman&lt;/h3&gt;
&lt;p&gt;$QRS$s alargados, com morfologia de BRD que aparecem com $\overline{RR}$ curto se comparado ao prévio. Pode se apresentar em quaisquer arritmias, porém é mais comum na fibrilação atrial.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/ashman.jpeg&#34;&gt;
  &lt;figcaption&gt;Exemplo real de paciente com fibrilação atrial. Note a morfologia de BRD&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h3 id=&#34;fibrilação-atrial&#34;&gt;Fibrilação atrial&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;$QRS$ estreito;&lt;/li&gt;
&lt;li&gt;Ritmo irregularmente irregular;&lt;/li&gt;
&lt;li&gt;Ondas $P$ não identificadas ou desorganizadas; e&lt;/li&gt;
&lt;li&gt;Possível presença de ondas $f$ que possuem linha de base elétrica e chamadas grosseiras quando possuírem voltagem superior a 0,5mm ou 1mm.&lt;/li&gt;
&lt;/ul&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
2(Presença de ondas &lt;i&gt;f&lt;/i&gt;.&lt;br&gt;Ritmo irregularmente irregular.) --&gt; fa(Fibrilação atrial);
fa -- hemodinamicamente&lt;br&gt;instável --&gt; cve(&lt;span&gt;1. Internação;&lt;br&gt;2. Cardioversão elétrica imediata:&lt;br&gt;200J iniciais&lt;br&gt;ou&lt;br&gt;Bifásico 200J&lt;br&gt;ou&lt;br&gt;Pás anteroposteriorizadas&lt;/span&gt;);
fa -- hemodinamicamente&lt;br&gt;estável --&gt; t(Tempo de sintomas) -- menor que 48h&lt;br&gt;ou&lt;br&gt;paciente já anticoagulado --&gt; 3(Cardioversão elétrica ou química);
t -- menor que 7 dias --&gt; 4(Ainda compensa&lt;br&gt;tentar cardioversão&lt;br&gt;química);
t -- maior que 7 dias&lt;br&gt;ou&lt;br&gt;anticoagulação desconhecida --&gt; 6(&lt;span&gt;1. Anticoagular;&lt;br&gt;2. Jejum;&lt;br&gt;3. Sedação;&lt;br&gt;4. Cardioversão elétrica.&lt;/span&gt;);
3 --&gt; alta(Na alta:&lt;br&gt;Anticoagular todos pacientes, exceto se CHADSVASC zero!);
4 --&gt; alta;
6 --&gt; alta;
&lt;/pre&gt;

&lt;h4 id=&#34;cardioversão-química&#34;&gt;Cardioversão química&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Amiodarona em bolo de 5 a 7mg/kg em 30 minutos; e&lt;/li&gt;
&lt;li&gt;Propafenona oral de 600 mg ou 2 mg/kg intravenosa.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;flutter-atrial&#34;&gt;Flutter atrial&lt;/h3&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/ecg-flutter.jpg&#34;&gt;
  &lt;figcaption&gt;ECG típico com ondas F de base elétrica perdida.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;ul&gt;
&lt;li&gt;Ritmo pode ser irregular ou regular;&lt;/li&gt;
&lt;li&gt;Possíveis ondas $F$ de base isoelétrica perdida. O mais comum é que a polaridade dessa onda seja negativa em DII, DIII e aVF; e&lt;/li&gt;
&lt;li&gt;A frequência ventricular costuma ser metade ou outra fração inteira da frequência atrial.&lt;/li&gt;
&lt;li&gt;Se ondas $F$ ou serrilhado em todas derivações, pense em interferência elétrica!&lt;/li&gt;
&lt;/ul&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
5(Presença de ondas &lt;i&gt;F&lt;/i&gt; em II, III e aVF&lt;br&gt;possivelmente negativas.&lt;br&gt;Base isoelétrica perdida.) --&gt; ff(Flutter atrial); 
ff --&gt; t2(Tempo de sintomas) -- menor que 48h --&gt; 7(Tentar cardioversão com 50J) -- falha --&gt; 8(Repetir com 200J);
t2 -- maior que 48h --&gt; 9(1 Controle de frequência ventricular.&lt;br&gt;2 Ecocardio para&lt;br&gt;descartar trombos.);
&lt;/pre&gt;

&lt;h4 id=&#34;controle-de-frequência-ventricular&#34;&gt;Controle de frequência ventricular&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Diltiazem intravenoso a 0,25mg/kg em 2 minutos;&lt;/li&gt;
&lt;li&gt;Verapamil intravenoso 5mg em 2min; ou&lt;/li&gt;
&lt;li&gt;Metoprolol intravenoso 5mg em 5min.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;observações&#34;&gt;Observações&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;A adenosina a 6mg/bolo intravenoso pode ser usada em toda arritmia supraventricular, porém a reversão para ritmo sinusal é rara. &lt;strong&gt;Funciona mais como um redutor de frequência cardíaca, permitindo diagnóstico mais apurado, e.g. quando há confusão entre flutter e fibrilação atrial;&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;Pode-se repetir o bolus de adenosina dentro de 2min ou em momento diferente;&lt;/li&gt;
&lt;li&gt;O flutter pode ser curado por meio da ablação por radiofrequência;&lt;/li&gt;
&lt;li&gt;No flutter, está &lt;mark&gt;contraindicada&lt;/mark&gt; a tentativa de reversão química, notadamente com amiodarona, porque o ritmo pode se converter em um mais lento, levando a instabilidade hemodinâmica.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;extrassístoles-supraventriculares&#34;&gt;Extrassístoles supraventriculares&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Complexos $\overline{QRS}$ de origem distintas, facilmente identificados por suas ondas $P$ distintas.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/extrassistoles-supraventriculares.jpg&#34;&gt;
  &lt;figcaption&gt;Observe as diferentes ondas P precedendo diferentes QRSs&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;bloqueio-atrioventricular&#34;&gt;Bloqueio atrioventricular&lt;/h2&gt;
&lt;h3 id=&#34;de-grau-1&#34;&gt;De grau 1&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Todas ondas P&amp;rsquo;s associadas a um $\overline{QRS}$ sequente.&lt;/li&gt;
&lt;li&gt;Intervalo $\overline{PR}$ vai alargando acima de 200ms.&lt;/li&gt;
&lt;/ul&gt;

 
&lt;div class=&#34;carousel&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  



&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt;Grau 1&lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/ecg/bavt1.jpg&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;




&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt;Grau 1&lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/ecg/bavt1-2.jpg&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior&#34;);
  let proximo = document.getElementById(&#34;proximo&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;h3 id=&#34;de-grau-2---mobitz-i&#34;&gt;De grau 2 - Mobitz I&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Há perda de condução de ondas P&amp;rsquo;s com progressivo alargamento do $\overline{PR}$, como em grau 1.&lt;/li&gt;
&lt;li&gt;Intervalo $\overline{PR}$ vai alargando acima de 200ms até ocorrer a onda P perdida, é &lt;strong&gt;o fenômeno de Wenckebach&lt;/strong&gt;.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/bavt2mobitzi.png&#34;&gt;
  &lt;figcaption&gt;Grau 2 Mobitz I&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h3 id=&#34;de-grau-2---mobitz-ii&#34;&gt;De grau 2 - Mobitz II&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Há perda de ondas P&amp;rsquo;s sem progressivo alargamento de $\overline{PR}$, ou seja, sem Wenckebach.&lt;/li&gt;
&lt;li&gt;É benigno quando o QRS é estreito, dito &lt;strong&gt;supra-hissiano&lt;/strong&gt;.&lt;/li&gt;
&lt;li&gt;É maligno quando o QRS é alargado &lt;strong&gt;infra-hissiano&lt;/strong&gt;.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/bavt2mobitzii.jpg&#34;&gt;
  &lt;figcaption&gt;Grau 2 Mobitz II&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;p&gt;Causas:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Anterior MI (due to septal infarction with necrosis of the bundle branches)&lt;/li&gt;
&lt;li&gt;Idiopathic fibrosis of the conducting system (Lenègre-Lev disease)&lt;/li&gt;
&lt;li&gt;Cardiac surgery, especially surgery occurring close to the septum e.g. mitral valve repair&lt;/li&gt;
&lt;li&gt;Inflammatory conditions (rheumatic fever, myocarditis, Lyme disease)&lt;/li&gt;
&lt;li&gt;Autoimmune (SLE, systemic sclerosis)&lt;/li&gt;
&lt;li&gt;Infiltrative myocardial disease (amyloidosis, haemochromatosis, sarcoidosis)&lt;/li&gt;
&lt;li&gt;Hyperkalaemia&lt;/li&gt;
&lt;li&gt;Drugs: beta-blockers, calcium channel blockers, digoxin, amiodarone&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;de-grau-3-ou-bloqueio-total&#34;&gt;De grau 3 ou bloqueio total&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;As ondas P&amp;rsquo;s tem ritmo totalmente alheio ao dos $\overline{QRS}$.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/bavt3.jpg&#34;&gt;
  &lt;figcaption&gt;Grau 3 - total: note que as ondas P&amp;#39;s estão em taquifrequência e os QRS não&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;bloqueio-divisional-anterosuperior&#34;&gt;Bloqueio divisional anterosuperior&lt;/h2&gt;
&lt;p&gt;O bloqueio escondido! Geralmente assintomático, a única suspeita será o eixo desviado. Quando apresenta clínica, são sintomas indeterminados como síncopes.&lt;/p&gt;
&lt;p&gt;Critério obrigatório:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Desvio de eixo para esquerda;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Critérios não obrigatórios:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;rS em $II, III$ e $aVF$ com S3 maior que S2;&lt;/li&gt;
&lt;li&gt;$QRS$ estreito;&lt;/li&gt;
&lt;li&gt;Onda S em $III$ maior que 15mm;&lt;/li&gt;
&lt;li&gt;$qR$ em $I e aVL$ com tempo de deflexão maior que 50ms ou $qRs$ com $S$ mínima em $I$;&lt;/li&gt;
&lt;li&gt;$qR$ em $aVL$ com $R$ empastado;&lt;/li&gt;
&lt;li&gt;Progressão lenta de $R$;&lt;/li&gt;
&lt;li&gt;Presença de $S$ de $V4 a V6$ &amp;mdash; ausência de sobrecarga no ventrículo esquerdo.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/bdas-brd.jpg&#34;&gt;
  &lt;figcaption&gt;Bloqueio anterosuperior com eixo desviado e vários critérios preenchidos. Há, também, um claro bloqueio de ramo direito&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;ritmo-juncional&#34;&gt;Ritmo juncional&lt;/h2&gt;
&lt;p&gt;Na ausência de ritmo predominante do nó sinoatrial, pode ocorrer do nó atrioventricular, &lt;strong&gt;da região de junção entre câmaras superiores e inferiores&lt;/strong&gt;, assumir a regulagem cardíaca, com uma frequência caracteristicamente baixa de mais ou menos 40 a 60bpm, débito cardíaco existente mas reduzido e sintomas gerais de baixo débito. Na verdade, pode ser confundido com bloqueio grau 3. O manejo pode ser feito como bradicardia instável, com uso de atropina em bomba, adrenalina ou marca-passo.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/juncional.jpg&#34;&gt;
  &lt;figcaption&gt;Note em precordiais V2 a V4 esboços de ondas P perdidas. Entretanto, este traçado não consegue fechar um bloqueio de 3 grau, com ritmo assumido pelo nó atrioventricular. A frequência gira em torno dos 35 a 40bpm.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;bloqueios-de-ramos&#34;&gt;Bloqueios de ramos&lt;/h2&gt;
&lt;p&gt;Patients have an LBBB when the QRS duration exceeds
120 ms (Figure 13.7); the QRS complex is largely nega-
tive in leads V1–V3 and positive in leads I, aVl, V5, and
V6. The LBBB is associated with STE with upright
T waves in leads V1 through V3 and ST segment depres-
sion with inverted T waves in the lateral leads I, aVl, V5, and V6&lt;/p&gt;
&lt;h3 id=&#34;esquerdo&#34;&gt;Esquerdo&lt;/h3&gt;
&lt;p&gt;Necessário:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;$QRS$ com duração ≥ 120ms;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Achados:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;$QRS$ predominantemente negativo em $V1-V3$ e positivo em $I$, $aVL$, $V5-6$;&lt;/li&gt;
&lt;li&gt;Supradesnivelamento de $\overline{ST}$ de $V1-3$ e infradesnivelamento de $\overline{ST}$ com $T$ invertida em $I$, $aVL$ e $V5-6$.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/bloquei-ramo-esq-com-fa.jpg&#34;&gt;
  &lt;figcaption&gt;Bloqueio de ramo na vigência duma fibrilação atrial&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h3 id=&#34;direito&#34;&gt;Direito&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h2 id=&#34;ondas-delta&#34;&gt;Ondas delta&lt;/h2&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/onda-delta.jpg&#34;&gt;
  &lt;figcaption&gt;Destaque para onda delta no início do QRS&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;wolff-parkinson-white&#34;&gt;Wolff Parkinson White&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;PR encurtado;&lt;/li&gt;
&lt;li&gt;Onda delta;&lt;/li&gt;
&lt;li&gt;QRS largo;&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Causa&lt;/strong&gt;: circuito de condução anômalo congênito prévio ao nó atrioventricular.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/wolff%e2%80%93parkinson%e2%80%93white.JPG&#34;&gt;
  &lt;figcaption&gt;ECG típico em síndrome Wolff-Parkinson-White&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;sobrecarga-atrial&#34;&gt;Sobrecarga atrial&lt;/h2&gt;
&lt;h3 id=&#34;esquerda&#34;&gt;Esquerda&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Índice de Morris:&lt;/strong&gt; feito pelo produto da duração da fase negativa da onda $P$ pela sua amplitude. É positivo e indica sobrecarga atrial esquerda quando esse produto supera 40msmm ou 4msmV. Estudos indicam que $V1$ costuma apresentar artefatos comuns que provocam muitos falsos positivos&lt;sup id=&#34;fnref:3&#34;&gt;&lt;a href=&#34;#fn:3&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;3&lt;/a&gt;&lt;/sup&gt;.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/morris.jpeg&#34;&gt;
  &lt;figcaption&gt;ECG com Morris de 16msmV ou 160msmm em V2. Note que em V1 o índice pode ser ainda maior por se tratar de provável artefato.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;sobrecarga-ventricular&#34;&gt;Sobrecarga ventricular&lt;/h2&gt;
&lt;h3 id=&#34;esquerda-1&#34;&gt;Esquerda&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Índice de Sokolov-Lyon:&lt;/strong&gt; se a soma de S em V1 com R de V5 ou V6 somam mais de 35mm ou 40mm se paciente atleta ou muito jovem.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Índice de Cornell:&lt;/strong&gt; Se R de aVL ou S de V3 somam 28mm em homens e 20mm em mulheres.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;direita&#34;&gt;Direita&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Onda S em V5 ou V6 com pelo menos 7mm.
– Onda R dominante em V1 e/ou V2.&lt;/li&gt;
&lt;li&gt;Ocasionalmente, bloqueio de ramo direito.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;ondas-j-ou-de-osborn&#34;&gt;Ondas J ou de Osborn&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Entalhe similar a uma onda $R$ no fim do $QRS$, alterando o ponto $J$, daí seu nome;&lt;/li&gt;
&lt;li&gt;Causas comuns envolvem hipotermia, hipercalcemia, lesões cerebrais, hemorragia subaracnóidea, parada cardíaca relacionada à sedação, angina vasoespástica e fibrilação ventricular idiopática.&lt;/li&gt;
&lt;/ul&gt;

 
&lt;div class=&#34;carouselosborn&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anteriorosborn&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximoosborn&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  



&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt;ECG de sobrecarga de câmaras esquerdas com onda de Osborn&lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/ecg/sobrecarga-ondas-osborn.jpg&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;




&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt; &lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/ecg/ondas-osborn.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carouselosborn .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carouselosborn .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anteriorosborn&#34;);
  let proximo = document.getElementById(&#34;proximoosborn&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;h2 id=&#34;achados-isquêmicos&#34;&gt;Achados isquêmicos&lt;/h2&gt;
&lt;h3 id=&#34;alterações-de-repolarização&#34;&gt;Alterações de repolarização&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h3 id=&#34;infradesnivelamento-de-st&#34;&gt;Infradesnivelamento de ST&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h3 id=&#34;supradesnivelamento-de-st&#34;&gt;Supradesnivelamento de ST&lt;/h3&gt;
&lt;p&gt;O ponto $J$ se desnivela acima da linha de base em $V2$ e $V3$:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Em mulheres, pelo menos 1,5mm;&lt;/li&gt;
&lt;li&gt;Em homens com mais de 40 anos, mais que 2mm;&lt;/li&gt;
&lt;li&gt;Em homens com menos de 40 anos, mais que 2,5mm;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Nas derivações de plano horizontal e em $V1$, $V4$ a $V6$:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Elevação acima de 1mm em quaisquer destas derivações, para quaisquer pessoas; e&lt;/li&gt;
&lt;li&gt;Para derivações $V3R, V4R$ e $V7$ a $V9$, quaisquer desnivelamentos de pelo menos 0,5mm em todos indivíduos.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;supradesnivelamento-de-st-na-vigência-de-bloqueio-de-ramo&#34;&gt;Supradesnivelamento de ST na vigência de bloqueio de ramo&lt;/h3&gt;
&lt;p&gt;Quando identificado um bloqueio de ramo, é necessário alguma ferramenta de diferenciação entre supradesnivelamento causado pelo bloqueio &lt;em&gt;versus&lt;/em&gt; o causado pela isquemia. Estas ferramentas são os critérios diferenciadores, sendo o de Sgarbossa o mais utilizado.&lt;/p&gt;
&lt;p&gt;Porém, este critério tem alta especificidade e baixa sensibilidade, tornando seu uso na emergência controverso, já que teria pouco poder preditivo negativo.&lt;/p&gt;
&lt;p&gt;Mais recentemente foi proposto o critério de Barcelona&lt;sup id=&#34;fnref:4&#34;&gt;&lt;a href=&#34;#fn:4&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;4&lt;/a&gt;&lt;/sup&gt;, onde se averigua se quaisquer tipos de desnivelamentos maiores que 1mm alcaçam algum dos critérios:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Se na mesma orientação da polaridade do $QRS$; ou&lt;/li&gt;
&lt;li&gt;Se oposto à polaridade do $QRS$ em derivações com baixa tensão de registro, isto é, $R$ ou $S$ menores que 7mm.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/barcelona-ii.jpeg&#34;&gt;
  &lt;figcaption&gt;Registro de derivação II preenchendo critério de Barcelona com infra de 1mm discordante da polaridade de QRS que não alcança 7mm. Note o bloqueio de ramo esquerdo.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h3 id=&#34;padrão-wellens&#34;&gt;Padrão Wellens&lt;/h3&gt;
&lt;p&gt;Um extenso infarto está iminente. A repolarização mostra alterações por grande estenose ou outra forma de obstrução que estão em iminência de agravamento, por isso ainda não há sinais de dano franco miocárdico como supradesnivelamento, onda Q patológica ou má progressão de R.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/wellens.jpg&#34;&gt;
  &lt;figcaption&gt; &lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;ul&gt;
&lt;li&gt;Ondas T bifásicas ou simétricas e invertidas em $V2$ e $V3$. Pode ou não haver em V1, V4, V5 e V6.&lt;/li&gt;
&lt;li&gt;Ausência de ondas Q patológicas.&lt;/li&gt;
&lt;li&gt;Ondas R no plano horizontal (V1-V6) com progressão normal.&lt;/li&gt;
&lt;li&gt;Supradesnivelamento do segmento ST pequeno ou ausente.&lt;/li&gt;
&lt;li&gt;Sem indicadores de necrose miocárdica.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;padrão-winter&#34;&gt;Padrão Winter&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h3 id=&#34;padrão-aslanger&#34;&gt;Padrão Aslanger &lt;sup id=&#34;fnref:5&#34;&gt;&lt;a href=&#34;#fn:5&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;5&lt;/a&gt;&lt;/sup&gt;&lt;/h3&gt;
&lt;p&gt;Um infarto transmural de parede inferior sem configuração tradicional de infarto com supra.&lt;/p&gt;
&lt;p&gt;Além disso, o comprometimento de circunflexa e outros infartos difusos também podem apresentar correlação com o padrão.&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Supra isolado de $III$;&lt;/li&gt;
&lt;li&gt;Infra concomitante em qualquer derivação de $V4$ a $V6$ com onda $T$ ou final da onda $T$ positiva; e&lt;/li&gt;
&lt;li&gt;$\overline{ST}$ em $V1$ mais alto do que em $V2$.&lt;/li&gt;
&lt;/ul&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/aslanger.jpg&#34;&gt;
  &lt;figcaption&gt;Aslanger típico.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h3 id=&#34;isquemia-circunferencial&#34;&gt;Isquemia circunferencial&lt;/h3&gt;
&lt;p&gt;Supradesnivelamento de $\overline{ST}$ em $aVR$ e infradesnivelamento em derivações precordiais. A literatura pode divergir sobre quantas derivações com infra são necessárias para diagnóstico.&lt;/p&gt;

 
&lt;div class=&#34;carouselcircunf&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anteriorcircunf&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximocircunf&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  
    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt; &lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/ecg/circunferencial.jpg&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;

    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;Isquemia circunferencial provavelmente em início, note o padrão de supra ascendente &amp;#34;feliz&amp;#34; em aVR.&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/ecg/supra-avr.jpg&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;

    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt; &lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/ecg/circunferencial2.jpeg&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carouselcircunf .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carouselcircunf .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anteriorcircunf&#34;);
  let proximo = document.getElementById(&#34;proximocircunf&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;h3 id=&#34;padrão-de-ascenção-côncava-para-baixo-ou-feliz&#34;&gt;Padrão de ascenção côncava para baixo ou &amp;ldquo;feliz&amp;rdquo;&lt;/h3&gt;
&lt;p&gt;Indica início de infarto miocárdico ou alterações não isquêmicas na topografia da derivação ou globais, como alterações eletrolíticas.



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/supra-bom.jpg&#34;&gt;
  &lt;figcaption&gt;Supradesnivelamento com aspecto de concavidade voltada para cima.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;&lt;/p&gt;
&lt;h2 id=&#34;conduta-na-isquemia-miocárdica&#34;&gt;Conduta na isquemia miocárdica&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
A(Paciente com dor torácica suspeita de SCA) --&gt; B{Realizar ECG em ≤10 minutos};
B --&gt;|ECG com supradesnivelamento ST| C(Diagnóstico: STEMI);
B --&gt;|ECG sem supradesnivelamento ST| D(Avaliar biomarcadores);
D --&gt; Z(Reavaliar biomarcadores em 1h e avaliar curva)
Z --&gt;|Biomarcadores elevados| E(Diagnóstico: NSTEMI);
Z --&gt;|Biomarcadores normais| F(Diagnóstico: Angina Instável);
C --&gt; G(Reperfusão imediata);
G --&gt; H{Disponibilidade de ICP primária em ≤90 minutos?};
H --&gt;|Sim| I(Intervenção Coronária Percutânea);
H --&gt;|Não| J(Terapia fibrinolítica);
J --&gt; K(Encaminhar para angiografia em 3-24h);
I --&gt; L(Continuar DAPT + Anticoagulante);
E --&gt; M{Estratificação de risco};
F --&gt; M;
M --&gt;|Alto risco| N(Estratégia invasiva em ≤24h);
M --&gt;|Baixo risco| O(Tratamento clínico + Teste não invasivo);
N --&gt; P(Angiografia coronária);
P --&gt; Q{Lesão significativa?};
Q --&gt;|Sim| R(Revascularização);
Q --&gt;|Não| S(Otimizar terapia clínica);
O --&gt; T(Avaliação com TC coronária ou teste de estresse);
T --&gt;|Positivo| P;
T --&gt;|Negativo| U(Alta com orientações);
L --&gt; V(Prevenção secundária);
R --&gt; V;
S --&gt; V;
V(Estatinas, Betabloqueadores, IECA/ARA II, Reabilitação cardíaca);
&lt;/pre&gt;

&lt;h3 id=&#34;marcadores-miocárdicos&#34;&gt;Marcadores miocárdicos&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h4 id=&#34;progressão-temporal-dos-marcadores&#34;&gt;Progressão temporal dos marcadores&lt;/h4&gt;


&lt;div class=&#34;scalidraw&#34;&gt;
&lt;svg version=&#34;1.1&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34; viewBox=&#34;0 0 609.3950496540637 415.33379075489944&#34; width=&#34;609.3950496540637&#34; height=&#34;415.33379075489944&#34;&gt;&lt;!-- svg-source:excalidraw --&gt;&lt;metadata&gt;&lt;/metadata&gt;&lt;defs&gt;&lt;style class=&#34;style-fonts&#34;&gt;
      @font-face { font-family: Excalifont; src: url(data:font/woff2;base64,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); }&lt;/style&gt;&lt;/defs&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(84.49505575757922 368.4587526079267) rotate(0 1.350006103515625 -179.32498931884766)&#34;&gt;&lt;path d=&#34;M-1.05 -0.08 C-0.38 -59.74, 2.64 -298.83, 3.31 -358.46 M0.6 -1.16 C1.23 -60.56, 2.39 -297.05, 2.68 -356.82&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(84.49505575757922 368.4587526079267) rotate(0 1.350006103515625 -179.32498931884766)&#34;&gt;&lt;path d=&#34;M11.11 -333.29 C9.05 -338.02, 7.46 -344.25, 2.68 -356.82 M11.11 -333.29 C8.84 -342.67, 4.87 -350.26, 2.68 -356.82&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(84.49505575757922 368.4587526079267) rotate(0 1.350006103515625 -179.32498931884766)&#34;&gt;&lt;path d=&#34;M-5.99 -333.37 C-3.93 -337.94, -1.4 -344.15, 2.68 -356.82 M-5.99 -333.37 C-1.98 -342.58, 0.33 -350.15, 2.68 -356.82&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(84.0450740681261 368.908764814958) rotate(0 251.32498168945312 -3.375)&#34;&gt;&lt;path d=&#34;M0.61 0.19 C84.6 -0.79, 419.27 -4.62, 502.92 -5.94 M-0.53 -0.75 C83.42 -2.06, 418.42 -6.61, 502.12 -7.64&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(84.0450740681261 368.908764814958) rotate(0 251.32498168945312 -3.375)&#34;&gt;&lt;path d=&#34;M478.74 1.22 C484.03 -0.33, 490.03 -2.92, 502.12 -7.64 M478.74 1.22 C483.69 -0.18, 489.52 -2.64, 502.12 -7.64&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(84.0450740681261 368.908764814958) rotate(0 251.32498168945312 -3.375)&#34;&gt;&lt;path d=&#34;M478.51 -15.88 C483.85 -13.8, 489.89 -12.75, 502.12 -7.64 M478.51 -15.88 C483.65 -13.55, 489.53 -12.28, 502.12 -7.64&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(520.4783829873968 369.8587770219892) rotate(0 19.75 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;dias&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(89.8950496540636 365.3087892290205) rotate(0 235.35000610351562 -161.77500915527344)&#34;&gt;&lt;path d=&#34;M0.95 -0.8 C9.44 -52.69, 38.56 -258.47, 50.76 -312.29 C62.96 -366.11, 66.56 -334.14, 74.13 -323.73 C81.7 -313.33, 76.14 -298.63, 96.17 -249.85 C116.21 -201.08, 131.8 -69.81, 194.34 -31.1 C256.88 7.61, 425.37 -19.93, 471.42 -17.59 M-0.01 1.39 C8.33 -50.77, 37.47 -260.19, 49.77 -314.17 C62.06 -368.16, 65.94 -333.33, 73.78 -322.51 C81.62 -311.7, 76.91 -297.95, 96.83 -249.28 C116.75 -200.61, 131.2 -68.9, 193.32 -30.5 C255.44 7.9, 423.23 -20.91, 469.55 -18.88&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(90.7950740681261 368.0088014360517) rotate(0 236.02499389648438 -132.07501220703125)&#34;&gt;&lt;path d=&#34;M-0.09 0.46 C18.78 -43.46, 67.01 -247.74, 114.18 -264.33 C161.35 -280.93, 229.66 -135.5, 282.92 -99.1 C336.18 -62.71, 402.1 -54.51, 433.74 -45.95 C465.38 -37.39, 466.4 -47.53, 472.77 -47.74 M-1.6 -0.35 C17.1 -44.01, 66.29 -246.56, 113.65 -262.89 C161.01 -279.22, 229.1 -134.69, 282.57 -98.31 C336.03 -61.94, 402.92 -53.09, 434.43 -44.64 C465.95 -36.18, 465.19 -47.01, 471.68 -47.6&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(86.2950740681261 368.0088014360517) rotate(0 238.04998779296875 -82.80001831054688)&#34;&gt;&lt;path d=&#34;M0.78 -0.18 C4.3 -28.03, 6.76 -159.5, 21.02 -166.6 C35.28 -173.71, 10.38 -66.44, 86.34 -42.8 C162.31 -19.16, 411.87 -27.88, 476.82 -24.79 M-0.26 -1.32 C3.17 -29.09, 6.1 -158.33, 20.48 -165.59 C34.86 -172.86, 9.86 -68.54, 86.02 -44.93 C162.18 -21.32, 412.7 -27.46, 477.44 -23.94&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(56.59506186109485 204.20878312550485) rotate(0 11.11111068725586 11.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;16.900390625&#34; font-family=&#34;Helvetica, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;20&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(28.245055757579223 38.15878007374704) rotate(0 25.27777862548828 11.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;16.900390625&#34; font-family=&#34;Helvetica, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;&amp;gt; 100&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(41.74505575757922 103.85877702198923) rotate(0 16.94444465637207 11.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;16.900390625&#34; font-family=&#34;Helvetica, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;~50&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(70.09506186109485 291.5087709184736) rotate(0 5.55555534362793 11.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;16.900390625&#34; font-family=&#34;Helvetica, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;1&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(593.4450374470323 298.70878312550485) rotate(0 -254.24998474121094 0.4499969482421875)&#34;&gt;&lt;path d=&#34;M-0.08 -0.69 C-84.74 -0.45, -423.19 1.44, -508.05 1.52 M-1.59 1.56 C-86.36 1.44, -424.56 -0.11, -508.76 -0.28&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(445.81171632073034 257.95878312550485) rotate(0 76.79166666666667 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Nível de decisão&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(-113.7049259318739 192.2421134070804) rotate(269.33642044967 137.8000030517578 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Múltiplos do nível de decisão&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(93.0450740681261 365.3087892290205) rotate(0 243.44998168945312 -51.75)&#34;&gt;&lt;path d=&#34;M0.23 0.35 C5.67 -16.52, 20.7 -85.07, 31.88 -102.34 C43.06 -119.6, 41.5 -117.55, 67.3 -103.27 C93.09 -88.98, 116.55 -30.63, 186.65 -16.61 C256.76 -2.58, 438.04 -18.66, 487.91 -19.11 M-1.11 -0.52 C4.76 -17.63, 22.74 -87.2, 34.08 -104.08 C45.41 -120.97, 41.39 -116.06, 66.89 -101.83 C92.4 -87.59, 117.07 -32.54, 187.09 -18.67 C257.1 -4.8, 437.03 -18.32, 486.97 -18.59&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(177.69506796461047 62.45878312550485) rotate(0 7.222222328186035 11.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;16.900390625&#34; font-family=&#34;Helvetica, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;C&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(282.94503744703235 140.90876481495798) rotate(0 7.222222328186035 11.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;16.900390625&#34; font-family=&#34;Helvetica, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;D&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(152.2950740681261 236.30878922902048) rotate(0 6.666666507720947 11.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;16.900390625&#34; font-family=&#34;Helvetica, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;B&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(97.09506186109485 178.50880143605173) rotate(0 6.666666507720947 11.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;16.900390625&#34; font-family=&#34;Helvetica, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;A&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(123.00986949862732 378.6671240882327) rotate(0 4.266666889190674 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;1&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(169.67653616529407 380.33379075489944) rotate(0 7 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;2&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(226.3432028319607 378.6671240882327) rotate(0 6.083333492279053 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;3&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(280.67653616529407 376.6671240882327) rotate(0 5.849999904632568 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;4&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(344.67653616529407 374.33379075489944) rotate(0 6.183333396911621 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;5&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(401.3432028319607 376.33379075489944) rotate(0 6.400000095367432 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;6&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(454.67653616529407 373.33379075489944) rotate(0 5.583333492279053 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Excalifont, Xiaolai, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;7&lt;/text&gt;&lt;/g&gt;&lt;/svg&gt;
&lt;/div&gt;


&lt;h2 id=&#34;achados-diversos&#34;&gt;Achados diversos&lt;/h2&gt;
&lt;h3 id=&#34;inversão-fisiológica-de-ondas-t&#34;&gt;Inversão fisiológica de ondas T&lt;/h3&gt;
&lt;p&gt;É possível o achado de ondas T precordias invertidas, principalmente em mulheres jovens e atletas.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/t-invertida-mulher.jpg&#34;&gt;
  &lt;figcaption&gt;Eletrocardiograma de mulher jovem sem sintomas e comorbidades mostrando V1 e V2 com T invertida.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h3 id=&#34;marca-passo&#34;&gt;Marca-passo&lt;/h3&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/marcapasso.jpg&#34;&gt;
  &lt;figcaption&gt;Espículas pequenas precedendo QRSs efetivos.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h3 id=&#34;sinal-de-crochetage&#34;&gt;Sinal de Crochetage&lt;/h3&gt;
&lt;p&gt;Indica comunicação entre átrios e trata-se de um entalhe no topo das ondas $R$ de derivações inferiores.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/ecg/crochetage.jpg&#34;&gt;
  &lt;figcaption&gt;Topo de onda R entalhada em aVF em paciente com comunicação iteratrial conhecida.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;br&gt;
&lt;br&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Malcolm S Thaler. &lt;strong&gt;ECG essencial 7°ed.&lt;/strong&gt; Artmed, 2013. Porto Alegre - Brasil. ISBN 978-85-65852-76-0 1.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;Cavalcanti, Eduardo et al. &lt;strong&gt;Manual de Eletrocardiografia Cardiopapers&lt;/strong&gt;. Atheneu, 2017. [S. l]. Brasil. ISBN-13: 978-8538807926.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:3&#34;&gt;
&lt;p&gt;Maria Uggen Rasmussen, Andreas Fabricius-Bjerre, Preman Kumarathurai, Bjørn Strøier Larsen, Helena Domínguez, Jørgen K. Kanters, Ahmad Sajadieh. &lt;strong&gt;Common source of miscalculation and misclassification of P-wave negativity and P-wave terminal force in lead V1&lt;/strong&gt;. Journal of Electrocardiology, Volume 53, 2019, Pages 85-88, ISSN 0022-0736, &lt;a href=&#34;https://doi.org/10.1016/j.jelectrocard.2019.01.088&#34;&gt;https://doi.org/10.1016/j.jelectrocard.2019.01.088&lt;/a&gt;.&amp;#160;&lt;a href=&#34;#fnref:3&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:4&#34;&gt;
&lt;p&gt;DI MARCO, Andrea et al. &lt;strong&gt;New electrocardiographic algorithm for the diagnosis of acute myocardial infarction in patients with left bundle branch block&lt;/strong&gt;. Journal of the American Heart Association, v. 9, n. 14, p. e015573, 2020.&amp;#160;&lt;a href=&#34;#fnref:4&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:5&#34;&gt;
&lt;p&gt;Aslanger EK, Smith SW. &lt;strong&gt;Response to: “A new electrocardiographic pattern indicating inferior myocardial infarction”&lt;/strong&gt;. J Electrocardiol. 2020 Nov 18.&amp;#160;&lt;a href=&#34;#fnref:5&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Nomeclatura das neoplasias</title>
		<link>https://www.aesclepius.com.br/neoplasias/</link>
		<pubDate>Thu, 21 Mar 2024 21:47:16 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/neoplasias/</guid>
		<description>&lt;br&gt;
&lt;br&gt;
&lt;table&gt;
    &lt;thead&gt;
        &lt;th&gt;Linhagem histogenética&lt;/th&gt;
        &lt;th&gt;Benigna&lt;/th&gt;
        &lt;th&gt;Maligna&lt;/th&gt;
    &lt;thead&gt;
        &lt;th style=&#34;text-align: left&#34; colspan=3&gt;Medula óssea&lt;/th&gt;
    &lt;/thead&gt;
        &lt;tr&gt;
            &lt;td&gt;Blastos&lt;/td&gt;
            &lt;td&gt;Mielodisplasias&lt;/td&gt;
            &lt;td&gt;Leucemia aguda ou crônica&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;Mieloproliferativas&lt;/td&gt;
            &lt;td&gt;Trombocitose essencial e policitemia vera&lt;/td&gt;
            &lt;td&gt;Mielofibrose&lt;/td&gt;
        &lt;/tr&gt;
    &lt;thead&gt;
        &lt;th style=&#34;text-align: left&#34; colspan=3&gt;Sangue periférico&lt;/th&gt;
    &lt;/thead&gt;
        &lt;tr&gt;
            &lt;td&gt;Linfócitos T&lt;/td&gt;
            &lt;td&gt;&lt;/td&gt;
            &lt;td&gt;Linfomas cutis, anaplásico etc&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;Linfócitos B&lt;/td&gt;
            &lt;td&gt;&lt;/td&gt;
            &lt;td&gt;Mielomas&lt;/td&gt;
        &lt;/tr&gt;
    &lt;thead&gt;
        &lt;th style=&#34;text-align: left&#34; colspan=3&gt;Endotelial&lt;/th&gt;
    &lt;/thead&gt;
    &lt;tr&gt;
        &lt;td&gt;Sanguíneos&lt;/td&gt;
        &lt;td&gt;Hemangioma&lt;/td&gt;
        &lt;td&gt;Angiossarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Linfáticos&lt;/td&gt;
        &lt;td&gt;Linfangioma&lt;/td&gt;
        &lt;td&gt;Linfangiossarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;thead&gt;
        &lt;th style=&#34;text-align: left&#34; colspan=3&gt;Muscular&lt;/th&gt;
    &lt;/thead&gt;
    &lt;tr&gt;
        &lt;td&gt;Liso&lt;/td&gt;
        &lt;td&gt;Leiomioma&lt;/td&gt;
        &lt;td&gt;Meiomiossarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Estriado&lt;/td&gt;
        &lt;td&gt;Rabdomioma&lt;/td&gt;
        &lt;td&gt;Rabdomiossarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Mesênquima&lt;/td&gt;
        &lt;td&gt;&lt;/td&gt;
        &lt;td&gt;Sarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Fibroso&lt;/td&gt;
        &lt;td&gt;Fibroma&lt;/td&gt;
        &lt;td&gt;Fibrossarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Gordura&lt;/td&gt;
        &lt;td&gt;Lipoma&lt;/td&gt;
        &lt;td&gt;Lipossarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Cartilagem&lt;/td&gt;
        &lt;td&gt;Condroma&lt;/td&gt;
        &lt;td&gt;Condrossarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Osso&lt;/td&gt;
        &lt;td&gt;Osteoma&lt;/td&gt;
        &lt;td&gt;Osteossarcoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Epitélio&lt;/td&gt;
        &lt;td&gt;&lt;/td&gt;
        &lt;td&gt;Carcinoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Escamoso estratificado&lt;/td&gt;
        &lt;td&gt;Papiloma&lt;/td&gt;
        &lt;td&gt;Carcinoma de células escamosas - CEC&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Basal da pele e anexos&lt;/td&gt;
        &lt;td&gt;&lt;/td&gt;
        &lt;td&gt;Carcinoma basocelular - CBC&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td rowspan=3&gt;Glandulas - ácinos e ductos&lt;/td&gt;
        &lt;td&gt;Adenoma&lt;/td&gt;
        &lt;td&gt;Adenocarcinoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Adenoma papilar ou papiloma&lt;/td&gt;
        &lt;td&gt;Carcinoma papilífero&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Cistoadenoma&lt;/td&gt;
        &lt;td&gt;Cistoadenocarcinoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Respiratório&lt;/td&gt;
        &lt;td&gt;Adenoma brônquico&lt;/td&gt;
        &lt;td&gt;Carcinoma brônquico&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Renal&lt;/td&gt;
        &lt;td&gt;Adenoma tubular renal&lt;/td&gt;
        &lt;td&gt;Carcinoma de células renais&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Fígado - hepatócitos, epitélio biliar (colangiócitos)
        &lt;/td&gt;
        &lt;td&gt;Adenoma hepatocelular&lt;br&gt;Adenoma biliar/colangioma&lt;/td&gt;
        &lt;td&gt;Carcinoma hepatocelular&lt;br&gt;hepatocarcinoma&lt;br&gt;colangiocarcinoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Vias urinárias&lt;/td&gt;
        &lt;td&gt;Papiloma de células transicionais/uroteliais&lt;/td&gt;
        &lt;td&gt;Carcinoma de céulas transicionais&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Placenta&lt;/td&gt;
        &lt;td&gt;Mola hidatiforme&lt;/td&gt;
        &lt;td&gt;Coriocarcinoma&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Células germinativas de testículo&lt;/td&gt;
        &lt;td&gt;&lt;/td&gt;
        &lt;td&gt;Seminona&lt;br&gt;carcinoma embrionário&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Revestimento do encéfalo&lt;/td&gt;
        &lt;td&gt;Meningioma&lt;/td&gt;
        &lt;td&gt;Meningioma maligno&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Melanócitos&lt;/td&gt;
        &lt;td&gt;Nevus&lt;/td&gt;
        &lt;td&gt;Melanoma maligno&lt;/td&gt;
    &lt;/tr&gt;
    &lt;thead&gt;
       &lt;th style=&#34;text-align: left&#34; colspan=3&gt;Mista&lt;/th&gt;
    &lt;/thead&gt;
    &lt;tr&gt;
        &lt;td&gt;Glândulas salivares&lt;/td&gt;
        &lt;td&gt;Adenoma pleomórfico&lt;/td&gt;
        &lt;td&gt;Tumor misto maligno&lt;/td&gt;
    &lt;/tr&gt;
    &lt;tr&gt;
        &lt;td&gt;Células renais primordiais&lt;/td&gt;
        &lt;td&gt;&lt;/td&gt;
        &lt;td&gt;Tumor de Wilms&lt;/td&gt;
    &lt;/tr&gt;
    &lt;thead&gt;
       &lt;th style=&#34;text-align: left&#34; colspan=3&gt;Células germinativas&lt;/th&gt;
    &lt;/thead&gt;
    &lt;tr&gt;
        &lt;td&gt;Células totipotentes gonadais e restos embrionários&lt;/td&gt;
        &lt;td&gt;Teratoma maduro e cisto dermoide&lt;/td&gt;
        &lt;td&gt;Teratoma imaturo e teratocarcinoma&lt;/td&gt;
    &lt;/tr&gt;
&lt;/table&gt; 
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;HOFF, Paulo Marcelo Gehm et. al. &lt;strong&gt;Tratado de Oncologia&lt;/strong&gt;. Editora Atheneu, 2013. São Paulo - Brasil. ISBN 978-85-388-0312-6&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Surdez aguda</title>
		<link>https://www.aesclepius.com.br/surdez/</link>
		<pubDate>Fri, 15 Mar 2024 15:46:55 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/surdez/</guid>
		<description>&lt;h2 id=&#34;teste-de-rinner&#34;&gt;Teste de Rinner&lt;/h2&gt;
&lt;p&gt;O diapasão é apresentado por contato no processo mastoide, de um dos lados. Após a exposição por um tempo &lt;em&gt;t&lt;/em&gt;, deve ser apresentado ao lado do ouvido para que o paciente relate percepção sonora por, no mínimo &lt;em&gt;2t&lt;/em&gt;.&lt;/p&gt;
&lt;h2 id=&#34;teste-de-weber&#34;&gt;Teste de Weber&lt;/h2&gt;
&lt;p&gt;O diapasão deve ser posicionado em qualquer parte média-anterior do crânio, prefrencialmente no topo do vértice. Anota-se a perceção do paciente em ambos lados e espera se nível e tempo simétrico. O teste é dito &lt;strong&gt;anormal&lt;/strong&gt; se lateralizado.&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Perda&lt;/th&gt;
          &lt;th&gt;Rinne&lt;/th&gt;
          &lt;th&gt;Weber&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Condutiva&lt;/td&gt;
          &lt;td&gt;Condução óssea superior que aérea&lt;/td&gt;
          &lt;td&gt;Lateralização da percepção par lado afetado&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Neurosensorial&lt;/td&gt;
          &lt;td&gt;Condução aérea superior a óssea&lt;/td&gt;
          &lt;td&gt;Lateralização para o lado normal&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
</description>
	</item>
	
	<item>
		<title>Estatística bayesiana para o diagnóstico médico</title>
		<link>https://www.aesclepius.com.br/estatistica-diagnostica/</link>
		<pubDate>Sat, 09 Mar 2024 17:43:11 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/estatistica-diagnostica/</guid>
		<description>&lt;!-- 
Transformar esta página em uma calculadora universal que checka primeiro os campos preenchidos e tenta calcular os restantes. Fazer em typescritp? como em
https://www.msdmanuals.com/pt-br/profissional/multimedia/clinical-calculator/multicalc-para-estat%C3%ADstica-bayesiana-i
--&gt;
&lt;h2 id=&#34;introdução&#34;&gt;Introdução&lt;/h2&gt;
&lt;p&gt;Na medicina, o diagnóstico é alcançado através de testes ajustados em sequência.&lt;/p&gt;
&lt;p&gt;Mais especificamente, qualquer pessoa tem chance de ter qualquer diagnóstico em qualquer momento.&lt;/p&gt;
&lt;p&gt;Para afunilarmos esta probabilidade, as ferramentas estatísticas utilizadas dependem do contexto.&lt;/p&gt;
&lt;h2 id=&#34;primeiro-contexto-paciente-aleatório-de-uma-determinada-população&#34;&gt;Primeiro contexto: paciente aleatório de uma determinada população&lt;/h2&gt;
&lt;p&gt;A probabilidade basal de qualquer diagnóstico é dada pelo levantamento percentual populacional, ou seja, quantas pessoas tem aquele diagnóstico naquela determinada população em determinado momento. Esta estatística deve ser levantada por estudos.&lt;/p&gt;
&lt;p&gt;Seu resultado é chamado de &lt;strong&gt;prevalência&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Exemplo, a prevalência de diabetes no Brasil é de 10.2%. Esta é a probabilidade pré-teste para qualquer brasileiro selecionado aleatoriamente, segundo estudos atualizados até 2023.&lt;/p&gt;
&lt;h2 id=&#34;segundo-contexto-o-paciente-aleatório-faz-um-exame-ou-tem-um-sintoma&#34;&gt;Segundo contexto: o paciente aleatório faz um exame ou tem um sintoma&lt;/h2&gt;
&lt;p&gt;A partir do momento que um paciente realiza um teste&lt;sup&gt;1&lt;/sup&gt;, seu resultado deve ser analisado à luz das estatísticas relacionadas ao teste, mais precisamente suas sensibilidade e especificidade.&lt;/p&gt;
&lt;p&gt;No caso do resultado positivo, um cálculo condicional para nova probabilidade deve ser realizado. Este cálculo é:&lt;/p&gt;
&lt;p&gt;$$
p(A\mid B) = \frac{p(B \mid A)\ p(A)}{p(B)}
$$&lt;/p&gt;
&lt;p&gt;Leia-se:&lt;/p&gt;
&lt;div style=&#34;display:flex; align-content:center&#34;&gt;
  &lt;span class=&#34;etiqueta&#34;&gt;
A probabilidade de A dado B é igual a probabilidade de B dado A vezes a probabilidade de A dividido pela probabilidade de B.
 &lt;/span&gt;
&lt;/div&gt;


&lt;p&gt;Este é o &lt;a href=&#34;https://pt.wikipedia.org/wiki/Teorema_de_Bayes&#34;&gt;Teorema de Bayes&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;No caso do exame, lemos:&lt;/p&gt;
&lt;div style=&#34;display:flex; align-content:center&#34;&gt;
  &lt;span class=&#34;etiqueta&#34;&gt;
A probabilidade do diagnóstico dado o teste positivo é igual a probabilidade do teste ser positivo verdadeiro vezes a probabilidade geral do diagnóstico dividido pela probabilidade do exame ser positivo aleatoriamente.
 &lt;/span&gt;
&lt;/div&gt;


&lt;p&gt;Finalmente:&lt;/p&gt;
&lt;div style=&#34;display:flex; align-content:center&#34;&gt;
  &lt;span class=&#34;etiqueta&#34;&gt;
A probabilidade do diagnóstico pelo exame é igual a especificidade vezes a prevalência dividido pela sensibilidade.
 &lt;/span&gt;
&lt;/div&gt;


&lt;p&gt;Para tanto, $p(B)$ deve ser entendido como a soma de todas probabilidades de dar positivo, ou seja:&lt;/p&gt;
&lt;p&gt;$$
p(B)=p(B\mid A)p(A) + p(B\mid ¬A)p(¬A)
$$&lt;/p&gt;
&lt;p&gt;Onde:&lt;/p&gt;
&lt;p&gt;$p(B\mid A)p(A)$ são todos os positivos verdadeiros expressos em probabilidade; e&lt;/p&gt;
&lt;p&gt;$p(B\mid ¬A)p(¬A)$ são todos os falsos positivos, em probabilidade.&lt;/p&gt;
&lt;h3 id=&#34;exemplo-concreto&#34;&gt;Exemplo concreto&lt;/h3&gt;
&lt;p&gt;Atualmente em Brasília (2024), estamos vivendo um surto de dengue. A probabilidade geral do diagnóstico de dengue é de 2.6%, porque as notícias relatam 72.600 casos da doença sendo a população de 2.817.381 habitantes.&lt;/p&gt;
&lt;p&gt;$$
prevalência = \frac{72600}{2.817.381} \approx 0.026
$$&lt;/p&gt;
&lt;p&gt;Suponhamos que um paciente se apresente apenas com dor retro-orbitária há 4 dias.&lt;/p&gt;
&lt;p&gt;Vamos supor, também, que esse sintoma tem probabilidade geral de 1%, ou seja, somadas todas as outras formas de dor retro-orbitária em Brasília no momento, 1 a cada 100 pessoas terá o sintoma.&lt;/p&gt;
&lt;p&gt;Este sintoma é extremamente comum na dengue, digamos que 85% das pessoas com dengue tenham dor retro-orbitária.&lt;/p&gt;
&lt;p&gt;Assim sendo, qual a probabilidade desta pessoa ter dengue?&lt;/p&gt;
&lt;p&gt;$$
p(Dengue\mid dorRetro) = \frac{p(dorRetro\mid Dengue) p(Dengue)}{p(dorRetro\mid Dengue)p(Dengue) + p(dorRetro\mid ¬Dengue)p(¬Dengue)}
$$&lt;/p&gt;
&lt;p&gt;Resolvendo o denominador para facilitar:&lt;/p&gt;
&lt;p&gt;$$
p(dorRetro\mid Dengue)p(Dengue) + p(dorRetro\mid ¬Dengue)p(¬Dengue) =
$$&lt;/p&gt;
&lt;p&gt;$$
0.85*0.026 + 0.01*0.934 \approx 0.031
$$&lt;/p&gt;
&lt;p&gt;Já que a probabilidade de se ter dorRetro retro-orbitária sem dengue é de 0.01 e a &lt;em&gt;&amp;ldquo;prevalência de não-dengue&amp;rdquo;&lt;/em&gt; é de $1 - 0.026$, ou melhor, 0.934.&lt;/p&gt;
&lt;p&gt;Então:&lt;/p&gt;
&lt;p&gt;$$
p(Dengue\mid dorRetro) = \frac{0.85*0.026}{0.031} \approx 0.71
$$&lt;/p&gt;
&lt;p&gt;Ou seja, &lt;strong&gt;temos &lt;mark&gt;71%&lt;/mark&gt; de chance deste paciente ter dengue!&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Note que, para este valor alto de probabilide diagnóstica, utilizamos apenas um sintoma. Se combinado com outros, é fácil entender porque podemos ter certezas diagnósticas próximas de 100% mesmo em contextos com poucas informações.&lt;/p&gt;
&lt;h2 id=&#34;terceiro-contexto-um-estudo-foi-feito-para-determinar-fatores-de-risco&#34;&gt;Terceiro contexto: um estudo foi feito para determinar fatores de risco&lt;/h2&gt;
&lt;p&gt;Existem situações específicas em que um terceiro dado se correlaciona ao diagnóstico.&lt;/p&gt;
&lt;p&gt;Um exemplo clássico é o hábito de fumar e o câncer de pulmão. Estudos mostram que um fumante tem uma probabilidade adicional de 30% de desenvolver câncer de pulmão.&lt;/p&gt;
&lt;p&gt;Este &lt;em&gt;risco associado&lt;/em&gt; a um fator é chamado de &lt;strong&gt;risco relativo&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Em outras palavras, este paciente deixa de ter a velha prevalência como probabilidade pré-teste. Sua estatística, agora, parte de 30% &lt;strong&gt;independentemente da prevalência global&lt;/strong&gt;.&lt;/p&gt;
&lt;h2 id=&#34;o-nomograma-de-fagan&#34;&gt;O nomograma de Fagan&lt;/h2&gt;
&lt;p&gt;No caso dos testes e exames, a probabilidade pós-teste pode ser calculada utilizando uma régua prática chamada &lt;strong&gt;diagrama de Fagan&lt;/strong&gt;. Traçamos uma reta entre os valores de pré-teste e de verossimilhança (likelihood) para lermos onde a reta toca no eixo pós-teste.&lt;/p&gt;
&lt;p&gt;Serve apenas no cenário da lógica de pós-teste ajustado por verossimilhança, obviamente.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/fagan-nomogram.jpg&#34;&gt;
  &lt;figcaption&gt; &lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;p&gt;&lt;a href=&#34;https://en.wikipedia.org/wiki/Pre-_and_post-test_probability&#34;&gt;Leia mais sobre&lt;/a&gt;.&lt;/p&gt;
&lt;h2 id=&#34;calculadora-para-teste-positivo&#34;&gt;Calculadora para teste positivo&lt;/h2&gt;
&lt;p&gt;Calcule a probabilidade de doença após exame positivo.&lt;/p&gt;
&lt;p&gt;Lembre-se: &lt;strong&gt;a prevalência pode ser a prevalência basal ou um valor de risco relativo&lt;/strong&gt;&lt;sup&gt;2&lt;/sup&gt;.&lt;/p&gt;


&lt;style&gt;
    #probPosT {
        color: var(--negrito);
    }
&lt;/style&gt;
&lt;br&gt;
&lt;br&gt;
&lt;div class=&#34;calculadoras&#34;&gt;
&lt;!--
    &lt;select id=tipo&gt;
        &lt;option value=prevalencia&gt;Prevalência&lt;/option&gt;
        &lt;option value=testeClinico&gt;Testes clínicos&lt;/option&gt;
        &lt;option value=riscoRelativo&gt;Risco relativo&lt;/option&gt;
    &lt;/select&gt;
--&gt;
    &lt;label for=&#34;probPreT&#34;&gt;Probabilidade pré-teste&lt;/label&gt;
    &lt;br&gt;
    &lt;input type=&#34;number&#34; id=&#34;probPreT&#34; placeholder=&#34;%&#34; &gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=sensibilidade&gt;Sensibilidade &lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number id=sensibilidade placeholder=&#34;%&#34; &gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=especificidade&gt;Especificidade &lt;/label&gt;
    &lt;br&gt;
    &lt;input type=number id=especificidade placeholder=&#34;%&#34; &gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;div class=&#34;resultado&#34;&gt;
        &lt;label for=probPosT&gt;Probabilidade pós-teste&lt;/label&gt;
        &lt;p id=probPosT&gt;0&lt;/p&gt;
    &lt;/div&gt;
    &lt;button id=calc onclick=&#34;calcPosT()&#34;&gt;Calcular!&lt;/button&gt;
    &lt;script src=../../diagnostico.js&gt;&lt;/script&gt;
&lt;/div&gt;
    &lt;br&gt;
    &lt;br&gt;

&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Entenda por &lt;em&gt;&amp;ldquo;teste&amp;rdquo;&lt;/em&gt; qualquer exame ou sintoma pelo qual eu possa atribuir um valor estatístico na interpretação de seu resultado.&lt;/li&gt;
&lt;li&gt;Não existe, na literatura formal, indicação de se utilizar outro valor de prevalência para cálculo de pós-teste após exame. Porém, também é consenso que não é justo o seu paciente queixoso em consultório ser comparado ao transeunte saudável sem queixas. Portanto, conhecendo fatores de risco, você deve fazer um ajuste na prevalência, de acordo com o conhecimento médico, a experiência ou, melhor ainda, estudos disponíveis.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;JAMA Networks. &lt;strong&gt;JAMA guide to statistics and methods.&lt;/strong&gt; Disponível em (2024): &lt;a href=&#34;https://jamanetwork.com/collections/44042/jama-guide-to-statistics-and-methods&#34;&gt;https://jamanetwork.com/collections/44042/jama-guide-to-statistics-and-methods&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://agenciabrasil.ebc.com.br/saude/noticia/2023-11/mais-de-10-dos-brasileiros-vivem-com-diabetes&#34;&gt;https://agenciabrasil.ebc.com.br/saude/noticia/2023-11/mais-de-10-dos-brasileiros-vivem-com-diabetes&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;BRASIL. &lt;strong&gt;Tabaco e saúde pulmonar: dia mundial sem tabaco: manual 2019&lt;/strong&gt;. Instituto Nacional de Câncer José Alencar Gomes da Silva. – Rio de Janeiro: INCA, 2019.&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://agenciabrasil.ebc.com.br/saude/noticia/2024-02/df-ja-pode-ter-ultrapassado-recorde-de-casos-de-dengue-diz-saude&#34;&gt;https://agenciabrasil.ebc.com.br/saude/noticia/2024-02/df-ja-pode-ter-ultrapassado-recorde-de-casos-de-dengue-diz-saude&lt;/a&gt;&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Dislipidemias</title>
		<link>https://www.aesclepius.com.br/colesterol/</link>
		<pubDate>Fri, 08 Mar 2024 23:33:58 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/colesterol/</guid>
		<description>&lt;style&gt;
table{
    text-align: center;
}
&lt;/style&gt;
&lt;h2 id=&#34;valores-de-normalidade&#34;&gt;Valores de normalidade&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Lipídeo&lt;/th&gt;
          &lt;th&gt;jejum (mg/dL)&lt;/th&gt;
          &lt;th&gt;sem jejum (mg/dL)&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Colesterol total&lt;/td&gt;
          &lt;td&gt;até 190&lt;/td&gt;
          &lt;td&gt;até 190&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Triglicerídeos&lt;/td&gt;
          &lt;td&gt;até 150&lt;/td&gt;
          &lt;td&gt;até 175&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;HDLc&lt;/td&gt;
          &lt;td&gt;pelo menos 40&lt;/td&gt;
          &lt;td&gt;pelo menos 40&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;classificações-das-dislipidemias&#34;&gt;Classificações das dislipidemias&lt;/h2&gt;
&lt;h3 id=&#34;etiológica&#34;&gt;Etiológica&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;Primárias&lt;/strong&gt;: distúrbio genético.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Secundárias&lt;/strong&gt;: decorre do estilo de vida, uso de medicamentos ou condições de saúde diversas.&lt;/p&gt;
&lt;h3 id=&#34;laboratorial&#34;&gt;Laboratorial&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;Hipercolesterolemia isolada&lt;/strong&gt;: apenas o LDLc acima de 159mg/dL.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Hipertrigliceridemia isolada&lt;/strong&gt;: apenas triglicerídeos acima de 149mg/dL no jejum ou 175mg/dL sem jejum.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Hiperlipidemia mista&lt;/strong&gt;: se ambos os critérios anteriores ou se o não-HDLc superar 190mg/dL quando os triglicerídeos forem de 400mg/dL ou superiores².&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Baixo HDLc&lt;/strong&gt;: Homens com HDLc abaixo que 40mg/dL e mulheres abaixo de 50mg/dL.&lt;/p&gt;
&lt;h2 id=&#34;categorias-de-risco&#34;&gt;Categorias de risco&lt;/h2&gt;
&lt;p&gt;Acesse &lt;a href=&#34;http://departamentos.cardiol.br/sbc-da/2015/CALCULADORAER2017/index.html&#34;&gt;aqui&lt;/a&gt; a caluladora de risco cardiovascular da SBC.&lt;/p&gt;
&lt;p&gt;Para cada nível de risco cardiológico global há um lipidograma desejável, conforme tabela abaixo.&lt;/p&gt;
&lt;table&gt;
    &lt;thead&gt;
        &lt;tr&gt;
            &lt;th&gt;Lipídios&lt;/th&gt;
            &lt;th&gt;máximo¹ (mg/dL)&lt;/th&gt;
            &lt;th&gt;risco&lt;/th&gt;
        &lt;/tr&gt;
    &lt;/thead&gt;
    &lt;tbody&gt;
        &lt;tr&gt;
            &lt;td rowspan=4&gt;LDLc&lt;/td&gt;
            &lt;td&gt;130&lt;/td&gt;
            &lt;td&gt;baixo&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;100&lt;/td&gt;
            &lt;td&gt;intermediário&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;70&lt;/td&gt;
            &lt;td&gt;alto&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;50&lt;/td&gt;
            &lt;td&gt;muito alto&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td rowspan=4&gt;Não-HDLc&lt;/td&gt;
            &lt;td&gt;160&lt;/td&gt;
            &lt;td&gt;baixo&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;130&lt;/td&gt;
            &lt;td&gt;intermediário&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;100&lt;/td&gt;
            &lt;td&gt;alto&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;80&lt;/td&gt;
            &lt;td&gt;muito alto&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;estatinas&#34;&gt;Estatinas&lt;/h2&gt;
&lt;h3 id=&#34;metas-terapêuticas&#34;&gt;Metas terapêuticas&lt;/h3&gt;
&lt;table&gt;
    &lt;thead&gt;
        &lt;tr&gt;
            &lt;th rowspan=2&gt;Risco&lt;/th&gt;
            &lt;th&gt;sem estatina&lt;/th&gt;
            &lt;th colspan=2&gt;máximos com estatina&lt;/th&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;th&gt;Reduzir em&lt;/th&gt;
            &lt;th&gt;LDLc (mg/dL)&lt;/th&gt;
            &lt;th&gt;Não-HDLc (mg/dL)&lt;/th&gt;
        &lt;/tr&gt;
    &lt;/thead&gt;
    &lt;tbody&gt;
        &lt;tr&gt;
            &lt;td&gt;Muito alto&lt;/td&gt;
            &lt;td&gt;mais de 50%&lt;/td&gt;
            &lt;td&gt;50&lt;/td&gt;
            &lt;td&gt;80&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;Alto&lt;/td&gt;
            &lt;td&gt;mais de 50%&lt;/td&gt;
            &lt;td&gt;70&lt;/td&gt;
            &lt;td&gt;100&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;Intermediário&lt;/td&gt;
            &lt;td&gt;pelo menos 30%&lt;/td&gt;
            &lt;td&gt;100&lt;/td&gt;
            &lt;td&gt;130&lt;/td&gt;
        &lt;/tr&gt;
        &lt;tr&gt;
            &lt;td&gt;Intermediário&lt;/td&gt;
            &lt;td&gt;pelo menos 30%&lt;/td&gt;
            &lt;td&gt;130&lt;/td&gt;
            &lt;td&gt;160&lt;/td&gt;
        &lt;/tr&gt;
    &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;Atorvastatina de 40mg ou mais, Rosuvastatina de 20mg ou mais e sinvastatina combinada com ezetimiba tem poder de redução do LDL alto com &lt;strong&gt;queda esperada de 50% ou mais.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Quaisquer estatinas acima de 40mg, a pitavastatina de 2mg ou mais, a sinvastatina de 20mg, a atorvastatina de 10mg ou mais ou a rosuvastatina de 5mg ou mais têm poder de redução do HDL moderado, &lt;strong&gt;esperando-se queda de 30-50% do valor.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;A fluvastatina de 40mg, a sinvastatina de 10mg, a pitavastatina de 1mg ou todas outras estatinas com dosagem diária menor de 40mg tem baixo poder de redução do HDL com &lt;strong&gt;queda esperada não maior que 30%&lt;/strong&gt;.&lt;/p&gt;
&lt;h3 id=&#34;ação-antiinflamatória-das-estatinas&#34;&gt;Ação antiinflamatória das estatinas&lt;/h3&gt;
&lt;p&gt;Está provada a ação antiinflamatória das estatinas ao inibir certas citocinas[1].&lt;/p&gt;
&lt;p&gt;Por exemplo, a CXCL9, uma quimiocina regulada por interferon que está envolvida na patogênese do lúpus eritomatoso sistêmico é inibida pelas estatinas[2].&lt;/p&gt;
&lt;h2 id=&#34;fibratos&#34;&gt;Fibratos&lt;/h2&gt;
&lt;p&gt;Na hipertrigliceridemia com falha do tratamento não farmacológico, introduz-se os fibratos conforme dosagem diária de bula. Para triglicerídeos acima de 500mg/dL, faz-se de imediato a introdução de fibratos, concomitantes às medidas não farmacológicas.&lt;/p&gt;
&lt;!--
## Cálculo de risco



&lt;select id=&#34;calcRisco&#34;&gt;
    &lt;option value=&#34;alto&#34;&gt;Selecione&lt;/option&gt;
    &lt;option value=&#34;alto&#34;&gt;Artéria ocluída&lt;/option&gt;
    &lt;option value=&#34;alto&#34;&gt;História IAMs&lt;/option&gt;
    &lt;option value=&#34;alto&#34;&gt;História AVEs&lt;/option&gt;
&lt;/select&gt;
&lt;script&gt;
    var risco = document.getElementById(&#34;calcRisco&#34;).value;

    if (risco === &#34;Selecione&#34;) {
        console.log();
    } else if {
        console.log();
    } else if (
        console.log();
&lt;/script&gt;

--&gt;
&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Com ou sem jejum.&lt;/li&gt;
&lt;li&gt;Porque a fórmula de Friedewald não deve ser usada se triglicerídeos maiores que 400mg/dL.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;bibliografia&#34;&gt;Bibliografia&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Faludi AA, Izar MCO, Saraiva JFK, Chacra APM, Bianco HT, Afiune Neto A, Bertolami A, et al. &lt;strong&gt;Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017&lt;/strong&gt;. Arq. Bras. Cardiol. 2017;109(2 suppl 1):1-76.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Jain, M., Ridker, P. &lt;strong&gt;Anti-Inflammatory Effects of Statins: Clinical Evidence and Basic Mechanisms&lt;/strong&gt;. Nat Rev Drug Discov 4, 977–987 (2005). &lt;a href=&#34;https://doi.org/10.1038/nrd1901&#34;&gt;https://doi.org/10.1038/nrd1901&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;Ferreira GA, Teixeira AL, Sato EI. &lt;strong&gt;Atorvastatin therapy reduces interferon- regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus&lt;/strong&gt;. Lupus. 2010;19(8):927-34.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Intubação orotraqueal</title>
		<link>https://www.aesclepius.com.br/intubacao/</link>
		<pubDate>Sun, 11 Feb 2024 16:31:22 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/intubacao/</guid>
		<description>&lt;h2 id=&#34;verificação-do-material&#34;&gt;Verificação do material&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Observar as condições do balão ventilatório.&lt;/li&gt;
&lt;li&gt;Certificar-se que a fonte de oxigênio está operante.&lt;/li&gt;
&lt;li&gt;Ligar monitores e ter certeza da ciência da equipe sobre o procedimento.&lt;/li&gt;
&lt;li&gt;Verifique a luz do laringoscópio e a firmeza de sua lâmina.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;preparo-e-escolha-das-medicações&#34;&gt;Preparo e escolha das medicações&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Hipinótico&lt;/th&gt;
          &lt;th&gt;Dose&lt;/th&gt;
          &lt;th&gt;Preparo&lt;/th&gt;
          &lt;th&gt;Observações&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Midazolam&lt;/td&gt;
          &lt;td&gt;0.1-0.3mg/Kg&lt;/td&gt;
          &lt;td&gt;Boa amnésia retrógrada.&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Diazepam&lt;/td&gt;
          &lt;td&gt;0.3-0.5mg/Kg&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;Efeito mais duradouro que midazolam.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Tiopental&lt;/td&gt;
          &lt;td&gt;2-4mg/Kg lento&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;Uso em traumatismo craniano e convulsões. &lt;b&gt;Não usar em crise de asma.&lt;/b&gt;&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;br&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Analgésico&lt;/th&gt;
          &lt;th&gt;Dose&lt;/th&gt;
          &lt;th&gt;Preparo&lt;/th&gt;
          &lt;th&gt;Observações&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Fentanil&lt;/td&gt;
          &lt;td&gt;1 a 4mcg/Kg lento&lt;/td&gt;
          &lt;td&gt;Ampolas de 50mcg/mL. Em bolo.&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Morfina&lt;/td&gt;
          &lt;td&gt;0.05 a 0.2mg/Kg&lt;/td&gt;
          &lt;td&gt;Ampolas de 10mg/mL. Em bolo.&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;br&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Coadjuvante&lt;/th&gt;
          &lt;th&gt;Dose&lt;/th&gt;
          &lt;th&gt;Preparo&lt;/th&gt;
          &lt;th&gt;Observações&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Adrenalina&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;Misturar ampola de 1ml/Kg em 19ml de soro.&lt;br&gt;Cada mililitro terá 0.5mg.&lt;br&gt; Considerar diluir em 9ml para menor volume em pediatria.&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;br&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Bloqueador neuromuscular&lt;/th&gt;
          &lt;th&gt;Dose&lt;/th&gt;
          &lt;th&gt;Preparo&lt;/th&gt;
          &lt;th&gt;Observações&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Rocurônio&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;abordagem-do-paciente&#34;&gt;Abordagem do paciente&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Explicar ao paciente que o procedimento é necessário e suas justificativas.&lt;/li&gt;
&lt;li&gt;Esclareça que haverá analgesia e sedação.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;avalie-a-fisiologia-do-paciente&#34;&gt;Avalie a fisiologia do paciente&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Pacientes obesos ou muito grandes, com limitações de posição ou dispositivos podem exigir adaptações, coxins maiores ou técnicas não ortodoxas.&lt;/li&gt;
&lt;li&gt;Avalie a via aérea do paciente.&lt;/li&gt;
&lt;li&gt;Aspire secreções se necessário.&lt;/li&gt;
&lt;li&gt;Escolha o tubo.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;escala-mallampati&#34;&gt;Escala Mallampati&lt;/h3&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Classe&lt;/th&gt;
          &lt;th&gt;Visualização&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;I&lt;/td&gt;
          &lt;td&gt;Ponta da úvula, língua, palatos e tonsilas completos.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;II&lt;/td&gt;
          &lt;td&gt;Apenas parte superior das tonsilas e parte da úvula. Demais podem ser normais.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;III&lt;/td&gt;
          &lt;td&gt;Palato mole e duro visível, mas apenas base da úvula.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;IV&lt;/td&gt;
          &lt;td&gt;Apenas palato duro.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;calculadora-de-tubo&#34;&gt;Calculadora de tubo&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;&lt;/h2&gt;
&lt;p&gt;Criei a calculadora a seguir para ser extremamente flexível e rápida, evitando consultas desncessárias no momento do procedimento. &lt;strong&gt;Use pontos, não vírgulas&lt;/strong&gt;.&lt;/p&gt;
&lt;div class=calculadoras&gt;
&lt;select id=sexo&gt;
   &lt;option value=1&gt;Masculino&lt;/option&gt;
   &lt;option value=0&gt;Feminino&lt;/option&gt;
&lt;/select&gt;
&lt;br&gt;
&lt;input id=idadeTuboPed placeholder=&#34;idade (anos)&#34;type=number&gt;&lt;/input&gt;
&lt;br&gt;
&lt;input id=altura placeholder=&#34;altura (m)&#34; pattern=&#34;[^,]*&#34; type=number&gt;&lt;/input&gt;
&lt;br&gt;
&lt;input type=checkbox id=comCuff&gt;Com cuff&lt;/input&gt;
&lt;br&gt;
&lt;button onclick=calcularTuboPed()&gt;Calcular&lt;/button&gt;
&lt;p id=resultadoTuboPed&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script src=../../calcTuboPed.js&gt;&lt;/script&gt;
&lt;h2 id=&#34;ventilação-mecânica-inicial&#34;&gt;Ventilação mecânica inicial&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt;&lt;/h2&gt;
&lt;h3 id=&#34;modo-volume&#34;&gt;Modo volume&lt;/h3&gt;
&lt;p&gt;Calcule a massa ideal estimada do paciente e o consequente volume corrente indicado. Use a calculdora abaixo.&lt;/p&gt;
&lt;p&gt;Depois, ajuste uma pressão expiratória final positiva (PEEP) de 5cmH&lt;sub&gt;2&lt;/sub&gt;O e uma fração de oxigênio em 100% e a titule até conseguir uma saturação de O&lt;sub&gt;2&lt;/sub&gt; periférica de 96%.&lt;/p&gt;
&lt;p&gt;Considere ajustes de PEEP a depender da patologia de base.&lt;/p&gt;
&lt;div class=calculadoras&gt;
    &lt;h2&gt;Volume corrente inicial indicado&lt;/h2&gt;
    &lt;input type=number id=alturaVol placeholder=&#34;altura (cm)&#34;&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;select id=sexoVol&gt;
        &lt;option value=&#34;true&#34; selected&gt;Masculino&lt;/option&gt;
        &lt;option value=&#34;false&#34;&gt;Feminino&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=pesoIdeal()&gt;Calcular&lt;/button&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;p id=resultadoPesoIdeal&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script&gt;
    function pesoIdeal() {
        let constante = 45.5;
        let homem = document.getElementById(&#34;sexoVol&#34;).value === &#34;true&#34;;
        if (homem) {
            constante = 50;
            console.log(homem);
        };
        let altura = parseInt(document.getElementById(&#34;alturaVol&#34;).value);
        let resultado1 = 6*(constante + 0.91*(altura - 152.4));
        let resultado2 = resultado1*8/6;
        console.log(resultado1+&#34;  &#34;+resultado2)
        document.getElementById(&#34;resultadoPesoIdeal&#34;).innerText = &#34;Use entre &#34;+resultado1.toFixed(2)+&#34; a &#34;+resultado2.toFixed(2)+&#34;mL de volume corrente inicial.&#34;;
    }
&lt;/script&gt;
&lt;h3 id=&#34;modo-pressão&#34;&gt;Modo pressão&lt;/h3&gt;
&lt;p&gt;O modo pressão facilita a vida com relação a segurança.&lt;/p&gt;
&lt;h4 id=&#34;adulto&#34;&gt;Adulto&lt;/h4&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h4 id=&#34;pediatria&#34;&gt;Pediatria&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;PEEP de 5 a 6cmH&lt;sub&gt;2&lt;/sub&gt;O;&lt;/li&gt;
&lt;li&gt;P&lt;sub&gt;ins&lt;/sub&gt; de 15 a 25cmH&lt;sub&gt;2&lt;/sub&gt;O;&lt;/li&gt;
&lt;li&gt;Frequência respiratória de 25 a 35irpm; e&lt;/li&gt;
&lt;li&gt;FiO&lt;sub&gt;2&lt;/sub&gt; de 100%.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Titule a FiO&lt;sub&gt;2&lt;/sub&gt; para o menor valor possível até saturação periférica de O&lt;sub&gt;2&lt;/sub&gt; de 96%.&lt;/p&gt;
&lt;h2 id=&#34;sedação-contínua&#34;&gt;Sedação contínua&lt;/h2&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;!--
Cânula = 3,5 + idade / 4
Até 1 ano: 3 / até 2 anos: 3,5

Pré - Oxigenação 
- Respiração espontânea: MNR, 7 L/min, Fi 100%
- Apenica: Bolsa-mascara 100% 1:2 - 1:3

Pré - Tratamento 
(Atropina 0.02mg/kg, max 1mg, IV ou IM)
- Criança &lt; 1 ano 
- Choque 
- Criança &lt; 5 anos, com Succinilcolina 
- 2a dose de Succinilcolina (causa bradicardia)

Indução / Sedação 
- Etomidato 0,3 mg/kg IV
   Não usar para choque séptico 
- Ketamina 1 - 2 mg/kg IV ou 3 - 7 mg/kg IM
   Não usar na suspeita de HIC
- Propofol 1 - 1,5 mg/kg IV
   Não usar em Instabilidade Hemodinâmica 
- Midazolam 0,2 - 0,3 mg/kg, Max 10 mg
   Não usar em Instabilidade Hemodinâmica 
   Demora 2 a 3 minutos 

Paralítico (1 a 2 minutos pós Sedativo)
- Rocuronio 1 mg/kg
   Antídoto: sugammadex 
- Succinilcolina 1 - 1,5 mg/kg (2 mg/kg se &lt; 5 anos)
                            4 mg/kg se for IM
   CI: risco de rabdomiólise ou HiperCalemia (queimados, lesão por esmagamento, ...)

Intubação (1 minuto pós Paralítico)

Instabilidade 
D - Deslocamento do tubo
O - Obstrução da Cânula 
P - Pneumotórax 
E - Equipamento falho
--&gt;
&lt;h2 id=&#34;meu-simulador-de-ventilação-mecânica&#34;&gt;Meu simulador de ventilação mecânica&lt;/h2&gt;
&lt;p&gt;&lt;img src=../../pix/medicina/sim_vent.png&gt;&lt;/img&gt;&lt;/p&gt;
&lt;p&gt;Estou montando um &lt;a href=&#34;../../ventilador-mec/&#34;&gt;simulador de ventilador mecânica em JavaScript&lt;/a&gt;, um protótipo embrião. Se tem interesse em participar, contacte-me.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Os cálculos para cânula em pediatria é: $ Tubo_{num} = (idade/4) + (4_{com\ cuff} | 3.5_{sem\ cuff}) $. Já no contexto adulto, a regra geral é que homens e mulheres de até 1.8m recebam tubo 7 ou 6 respectivamente e pessoas maiores o tubo 8.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;Ferreira1 JC, Vianna2 AOA, Pinheiro3 BV, Maia4 IS, 5 , Baldisserotto6 SV, et al. &lt;strong&gt;Joint statement on evidence-based practices in mechanical ventilation: suggestions from two Brazilian medical societies&lt;/strong&gt;. J Bras Pneumol. 2025;51(1):e20240255&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Minhas apresentações</title>
		<link>https://www.aesclepius.com.br/apresentacoes/</link>
		<pubDate>Thu, 08 Feb 2024 11:18:33 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/apresentacoes/</guid>
		<description>


&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/projector.png&#34;&gt;
  &lt;figcaption&gt;&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;p&gt;Os arquivos devem ser acessados preferencialmente no formato original &lt;a href=&#34;../../tecnologia/stultus-visio/&#34;&gt;StultusVisio&lt;/a&gt;, pois contém vídeos e outros conteúdos interativos impossíveis em PDF.&lt;/p&gt;
&lt;h2 id=&#34;aula-sobre-dor-torácica&#34;&gt;Aula sobre dor torácica&lt;/h2&gt;
&lt;p&gt;Apresentei esta aula no Hospital de Sobradinho - DF em outubro de 2023.&lt;/p&gt;
&lt;p&gt;Slides para &lt;em&gt;desktop&lt;/em&gt; em StultusVisio disponível &lt;a href=&#34;../../medicina/aulas/DorToracicaDispneia.html&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Versão em PDF &lt;a href=&#34;../../files/Medicina/JeffersonT-Dor-Toracica.pdf&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
&lt;h2 id=&#34;aula-sobre-o-artigo-appendiceal-neoplasms-secondary-analysis-of-the-coda-trial&#34;&gt;Aula sobre o artigo Appendiceal neoplasms: secondary analysis of the CODA trial&lt;/h2&gt;
&lt;p&gt;Apresentei este artigo em janeiro de 2024 no Hospital Regional da Asa Norte de Brasília-DF.&lt;/p&gt;
&lt;p&gt;Slides para &lt;em&gt;desktop&lt;/em&gt; em StultusVisio disponível &lt;a href=&#34;../../neoplasia-apendice/neoapendice.html&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
&lt;p&gt;Versão em PDF &lt;a href=&#34;../../files/Medicina/JeffersonT-Apresentacao-Neoplasia-Apendice.pdf&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
&lt;h2 id=&#34;caso-clínico-abcesso-hepático&#34;&gt;Caso clínico: abcesso hepático&lt;/h2&gt;
&lt;p&gt;Apresentado em 08/02/24 no Hospital Regional da Asa Norte em Brasília.&lt;/p&gt;
&lt;p&gt;Acesse &lt;a href=&#34;../../medicina/casos-clinicos/abcesso-hep-dss.html&#34;&gt;aqui&lt;/a&gt; a versão em StultusVisio.&lt;/p&gt;
&lt;p&gt;Versão em PDF &lt;a href=&#34;../../files/Medicina/JeffersonT-Caso-Clinico-Abcesso-Hepatico.pdf&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
&lt;h2 id=&#34;caso-clínico-lesão-de-vértebra-lombar-l2&#34;&gt;Caso clínico: lesão de vértebra lombar L2&lt;/h2&gt;
&lt;p&gt;Apresentado em 22/02/24 no Hospital de BASE de Brasília.&lt;/p&gt;
&lt;p&gt;Acesse &lt;a href=&#34;../../medicina/casos-clinicos/caso-base-explosao-l2.html&#34;&gt;aqui&lt;/a&gt; a versão em StultusVisio.&lt;/p&gt;
&lt;p&gt;Versão em PDF &lt;a href=&#34;../../files/Medicina/JeffersonT-Caso-Clinico-explosao-l2.pdf&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
</description>
	</item>
	
	<item>
		<title>Prescrição de hidratação: um resumo breve</title>
		<link>https://www.aesclepius.com.br/hidratacao/</link>
		<pubDate>Sun, 04 Feb 2024 15:26:54 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/hidratacao/</guid>
		<description>

&lt;img class=&#34;fundo-only-big&#34; src=&#34;../../pix/medicina/paudesoro.webp&#34;&gt;&lt;/img&gt;

&lt;h2 id=&#34;as-três-hidratações&#34;&gt;As três hidratações&lt;/h2&gt;
&lt;p&gt;Existem três hidratações, por assim se dizer:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;A ressuscitação volêmica;&lt;/li&gt;
&lt;li&gt;A manutenção hidro-calórica;&lt;/li&gt;
&lt;li&gt;A reposição hídrica.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;A &lt;strong&gt;ressuscitação volêmica&lt;/strong&gt; é uma medida de urgência, conduta padrão para o diagnóstico de &lt;em&gt;choque hipovolêmico&lt;/em&gt; ou a &lt;em&gt;desidratação&lt;/em&gt;. Se baseia no exame físico e deve ser iniciada no paciente que demonstre anúria, pele seca, ausência de humidade nas mucosas de boca e olhos, além de sinais mais graves como rebaixamento de consciência e confusão.&lt;/p&gt;
&lt;p&gt;A &lt;strong&gt;manutenção hidro-calórica&lt;/strong&gt; é a prescrição pós-ressuscitação e tem por objetivo dar suporte calórico e líquido ao paciente em recuperação. Esta abordagem é uma &lt;em&gt;evolução médica&lt;/em&gt;, ou seja, direciona-se ao paciente internado que teve manejo ou estabilização anterior.&lt;/p&gt;
&lt;p&gt;A &lt;strong&gt;reposição hídrica&lt;/strong&gt; é uma ação concomitante que visa devolver a autonomia do paciente, isto é, a volta a normalidade fisiológica. Costuma ser ofertada de preferência por ingesta oral expontânea, o mais cedo possível. O paciente recém manejado pode ter sede e este é um bom sinal, sobretudo no retorno da consciência.&lt;/p&gt;
&lt;h2 id=&#34;ressuscitação-volêmica&#34;&gt;Ressuscitação volêmica&lt;/h2&gt;
&lt;p&gt;Existem dois aspectos da ressuscitação:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Sua forma simples, prescrição de 20 a 50ml por Kg de massa corporal;&lt;/li&gt;
&lt;li&gt;Manejos complexos de UTI, onde se deve considerar aspectos como perdas significativas (grandes queimados), sangramentos (trauma e pós-cirúrgico) e doenças com desequilíbrio hídrico intrínseco (hidrocefalias, insuficiência cardíaca etc).&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Na abordagem simples, temos um paciente desidratado por síndromes globais (febril, infecciosa, dengue, diarreia aguda etc) e que necessita restaurar volumes imediatamente.&lt;/p&gt;
&lt;p&gt;Na complexa, cada caso deve ser considerado por julgamento clínico e aspectos mais graves. A função renal e integridade fisiológica devem ser pesadas porque as perdas de líquido no paciente de UTI são menores, principalmente se mecanicamente ventilado.&lt;/p&gt;
&lt;h2 id=&#34;manutenção-hidro-calórica&#34;&gt;Manutenção hidro-calórica&lt;/h2&gt;
&lt;p&gt;O corpo humano necessita de cerca de 100ml de água para cada 100kcal processadas. Isto significa que, ao hidratar um paciente, devemos também nutri-lo e vice-versa.&lt;/p&gt;
&lt;p&gt;Porém, esta situação traz consigo aspectos osmolares em relação aos eletrólitos. Tendo em vista que a mera hidratação e fornecimento de glicose pura vão diluir os eletrólitos corporais, podemos terminar em situações graves, e.g. hipocalemia.&lt;/p&gt;
&lt;p&gt;Para isto, fórmulas foram desenvolvidas, notadamente a fórmula de Holliday-Segar e suas variações.&lt;/p&gt;
&lt;p&gt;Acesse &lt;a href=&#34;../../medicina/holliday/&#34;&gt;aqui&lt;/a&gt; a calculadora de Holliday-Segar que eu fiz.&lt;/p&gt;
&lt;h2 id=&#34;reposição-hídrica&#34;&gt;Reposição hídrica&lt;/h2&gt;
&lt;p&gt;Normalmente feita através de soros de reidratação oral, de oferta livre, a pelo menos 1L/dia. Espera se a ingesta mínima baseada em guideline de 2L/dia pro adulto. Porém estes valores são contestados atualmente.&lt;/p&gt;
&lt;p&gt;Na prática, pode se optar por soros caseiros, preparados com açúcar e sal, mas estes devem ser evitados sempre que soros industrializados forem disponíveis.&lt;/p&gt;
&lt;h2 id=&#34;a-falácia-do-fluido-fisiológico&#34;&gt;A falácia do &amp;ldquo;fluido fisiológico&amp;rdquo;&lt;/h2&gt;
&lt;p&gt;Nenhum fluido é fisiológico. Na verdade, diversos estudos tentam determinar quando um fluido pode, na verdade, ser danoso ao estado do doente. Este assunto é particularmente importante no caso de pacientes com injúria cerebral[2].&lt;/p&gt;
&lt;p&gt;Até o momento, nenhum fluido alcança o status de fisiológico, devendo o médico sempre considerar a repercussão da conduta a depender da composição da prescrição.&lt;/p&gt;
&lt;h2 id=&#34;dicas-da-ressuscitação-volêmica-do-paciente-crítico-3&#34;&gt;Dicas da ressuscitação volêmica do paciente crítico [3]&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;A responsividade ao fluido é &lt;strong&gt;o essencial&lt;/strong&gt;. Porém, o exame físico, as imagens de tórax, a média de pressão arterial e a ultrassonografia cardíaca são incapazes de determinar, isoladamente, o status de responsividade.&lt;/li&gt;
&lt;li&gt;O padrão ouro é a &lt;strong&gt;avaliação de débito cardíaco frente ao desafio de fluido.&lt;/strong&gt; Ou seja, realiza-se o bolus de fluido e é esperado aumento imediato do débito cardíaco determinado por Doppler.&lt;/li&gt;
&lt;li&gt;A &lt;strong&gt;manobra de elevação passiva dos membros inferiores&lt;/strong&gt; pode substituir o bolus de fluido e pela segurança e baixo custo deve ser uma opção sempre tentada.&lt;/li&gt;
&lt;li&gt;A resposta à administração de fluidos costuma ser rápida e pueril. A melhora clínica depende muito mais da correção do distúrbio base.&lt;/li&gt;
&lt;li&gt;A pressão venosa central é o principal preditor de mau prognóstico¹ e deve estar sempre &lt;strong&gt;acima de 65mmHg&lt;/strong&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Na verdade, a baixa pressão venosa central se correlaciona diretamente a má perfusão de órgãos centrais. Portanto, apesar de não ser muito útil para se determinar a resposta ao fluido, tem alto valor na predição de prognóstico ruim.&lt;/li&gt;
&lt;/ol&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;GHOSH, Supradip. &lt;strong&gt;Handbook of Intravenous Fluids&lt;/strong&gt;. Springer, 2022.&lt;/li&gt;
&lt;li&gt;Roquilly A, Loutrel O, Cinotti R, Rosenczweig E, Flet L, Mahe PJ, et al. &lt;strong&gt;Balanced versus chloride-rich solutions for fluid resusci- tation in brain-injured patients: a randomised double-blind pilot study&lt;/strong&gt;. Crit Care. 2013;17:R77.&lt;/li&gt;
&lt;li&gt;MARIK, Paul E. &lt;strong&gt;Fluid responsiveness and the six guiding principles of fluid resuscitation&lt;/strong&gt;. Critical care medicine, v. 44, n. 10, p. 1920-1922, 2016.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Calculadoras de superfície corporal</title>
		<link>https://www.aesclepius.com.br/antropometria/</link>
		<pubDate>Sun, 04 Feb 2024 07:49:46 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/antropometria/</guid>
		<description>&lt;h2 id=&#34;superfície-corporal&#34;&gt;Superfície corporal&lt;/h2&gt;
&lt;h3 id=&#34;estimativa-de-costeff&#34;&gt;Estimativa de Costeff&lt;/h3&gt;
&lt;p&gt;Este cálculo proposto por Costeff em 1966 é mais acurado que Du Bois e Boyd (1916) e pode ser usado para pacientes de 1.5Kg até 100Kg.&lt;/p&gt;
&lt;p&gt;Trata-se de um ajuste empírico em regressão linear, testada em 220 pacientes para determinar a área de superfície corporal (ASC) de humanos a partir de suas respectivas massas.&lt;/p&gt;
&lt;p&gt;$$
ASC = {{ 4m + 7 } \over { m + 90 }}
$$&lt;/p&gt;
&lt;p&gt;A perda hídrica &lt;strong&gt;insensível&lt;/strong&gt; estimada¹ é de 300-400mL/m²/dia.&lt;/p&gt;
&lt;p&gt;Considere também a perda &lt;strong&gt;sensível&lt;/strong&gt; de diurese, evacuação e sangramentos (&lt;a href=&#34;../../medicina/cockcroft-gault/&#34;&gt;calcule a TFG via Cockcroft-Gault&lt;/a&gt;).&lt;/p&gt;
&lt;div class=&#34;calculadoras&#34;&gt;
&lt;label for=&#34;massa&#34;&gt;Massa do paciente&lt;/label&gt;
&lt;br&gt;
&lt;input placeholder=&#34;Kg&#34; type=&#34;number&#34; id=&#34;massa&#34;/&gt;
&lt;p id=&#34;resultado&#34;&gt;&lt;/p&gt;
&lt;p&gt;&lt;button onClick=&#34;bsa()&#34;&gt;Calcular&lt;/button&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;h3 id=&#34;queimados&#34;&gt;Queimados&lt;/h3&gt;
&lt;p&gt;Veja &lt;a href=&#34;../../medicina/queimados/&#34;&gt;grandes queimados&lt;/a&gt;.&lt;/p&gt;
&lt;script&gt;
    function bsa(){
        const massa = parseFloat(document.getElementById(&#34;massa&#34;).value);
        if (isNaN(massa)) {
            document.getElementById(&#34;resultado&#34;).innerText = &#34;Insira valor da massa!&#34;;
            return
        }
        console.log(massa)

        let numerador = (massa * 4) + 7;
        let denominador = massa + 90;
        
        console.log(&#34;Numerador:&#34;, numerador);
        console.log(&#34;Denominador:&#34;, denominador);
        
        let resultado = numerador / denominador;
        console.log(&#34;Resultado:&#34;, resultado);

        let resultadoMm = resultado * 10000;
        document.getElementById(&#34;resultado&#34;).innerText = resultado.toFixed(2)+&#34;m² de área corporal estimada.\nEm milímetros são &#34;+resultadoMm.toFixed(2)+&#34;mm².&#34;;
    }
&lt;/script&gt;
&lt;br&gt;
&lt;h2 id=&#34;peso-real-estimado&#34;&gt;Peso real estimado&lt;/h2&gt;
&lt;p&gt;Apesar do cacoete médico, &amp;ldquo;peso real&amp;rdquo; se refere a massa ideal estimada do paciente.&lt;/p&gt;
&lt;div class=calculadoras&gt;
    &lt;h2&gt;Massa ideal estimada&lt;/h2&gt;
    &lt;input type=number id=altura placeholder=&#34;altura (cm)&#34;&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;select id=sexo&gt;
        &lt;option value=&#34;true&#34; selected&gt;Masculino&lt;/option&gt;
        &lt;option value=&#34;false&#34;&gt;Feminino&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=pesoIdeal()&gt;Calcular&lt;/button&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;p id=resultadoPesoIdeal&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script&gt;
    function pesoIdeal() {
        let constante = 45.5;
        let homem = document.getElementById(&#34;sexo&#34;).value === &#34;true&#34;;
        if (homem) {
            constante = 50;
            console.log(homem);
        };
        let altura = parseInt(document.getElementById(&#34;altura&#34;).value);
        let resultado = (constante + 0.91*(altura - 152.4));
        document.getElementById(&#34;resultadoPesoIdeal&#34;).innerText = resultado.toFixed(2)+&#34;Kg&#34;;
    }
&lt;/script&gt;
&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Esta estimativa foi feita para pacientes de 10kg ou mais.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Costeff H. &lt;strong&gt;A simple empirical formula for calculating approximate surface area in children&lt;/strong&gt;. Arch Dis Child. 1966 Dec;41(220):681-3. doi: 10.1136/adc.41.220.681. PMID: 5927924; PMCID: PMC2019700.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Fluidoterapia de manutenção: Holliday-Segar</title>
		<link>https://www.aesclepius.com.br/holliday/</link>
		<pubDate>Tue, 30 Jan 2024 15:44:34 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/holliday/</guid>
		<description>&lt;!-- &lt;span style=&#34;background: red; color: black&#34;&gt;ESTA CALCULADORA ESTÁ EM CONSTRUÇÃO, NÃO USE!!&lt;/span&gt; --&gt;


&lt;img class=&#34;fundo-only-big&#34; src=&#34;../../pix/medicina/paudesoro.webp&#34;&gt;&lt;/img&gt;

&lt;style&gt;
    h2 {
    }
&lt;/style&gt;

&lt;h2 id=&#34;calculadora-de-manutenção-hidroeletrolítica-de-holliday-segar&#34;&gt;Calculadora de manutenção hidroeletrolítica de Holliday-Segar&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Esta ferramenta deve ser usada para pacientes já fluido-ressuscitados e sem desidratação ou distúrbios hidro-eletrolíticos.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Nenhuma calculadora substitui seu julgamento clínico!&lt;/p&gt;
&lt;p&gt;Esta calculadora aceita valores decimais nas unidades indicadas.&lt;/p&gt;
&lt;p&gt;Use pontos e não vírgulas.&lt;/p&gt;
&lt;p&gt;Ao usar soro glicosado como fluido principal, deixe em branco os campos de glicose.&lt;/p&gt;
&lt;p&gt;Veja &lt;a href=&#34;../../medicina/hidratacao/&#34;&gt;aqui&lt;/a&gt; sobre hidratação venosa em geral.
&lt;br&gt;&lt;/p&gt;
&lt;div class=&#34;calculadoras&#34;&gt;
&lt;h2&gt;Fluido&lt;/h2&gt;
&lt;label for=&#34;massa&#34;&gt;Massa do paciente&lt;/label&gt;&lt;br&gt;
&lt;input type=&#34;number&#34; placeholder=&#34;Kg&#34; id=&#34;massa&#34;&gt;&lt;/input&gt;&lt;br&gt;&lt;br&gt;
&lt;label for=&#34;fluidoPrincipal&#34;&gt;Fluido principal&lt;/label&gt;&lt;br&gt;
&lt;select id=&#34;tipoFluidoPrincipal&#34;&gt;
    &lt;!-- 
    &lt;option value=&#34;sf5&#34;&gt;Soro fisiológico a 5%&lt;/option&gt;
    &lt;option value=&#34;sf10&#34;&gt;Soro fisiológico a 10%&lt;/option&gt;
    &lt;option value=&#34;sf20&#34;&gt;Soro fisiológico a 20%&lt;/option&gt;
    --&gt;
    &lt;option value=&#34;&#34;&gt;Selecione fluido principal&lt;/option&gt;
    &lt;option value=&#34;ringer&#34;&gt;Ringer Lactato&lt;/option&gt;
    &lt;option value=&#34;sg5&#34;&gt;Soro glicosado a 5%&lt;/option&gt;
    &lt;option value=&#34;sg10&#34;&gt;Soro glicosado a 10%&lt;/option&gt;
    &lt;option value=&#34;sg20&#34;&gt;Soro glicosado a 20%&lt;/option&gt;
    &lt;option value=&#34;sf09&#34;&gt;Soro fisiológico (0.9% de Na)&lt;/option&gt;
    &lt;/select&gt;
&lt;br&gt;&lt;br&gt;
&lt;h2&gt;Sódio&lt;/h2&gt;
&lt;label for=&#34;volumeAmpNa&#34;&gt;Volume de cada ampola de sódio&lt;/label&gt;&lt;br&gt;
&lt;input type=&#34;number&#34; placeholder=&#34;mL&#34; id=&#34;volumeAmpNa&#34;&gt;&lt;/input&gt; &lt;br&gt;&lt;br&gt;
&lt;label for=&#34;concentAmpNa&#34;&gt;Ampola de sódio concentrado&lt;/label&gt;&lt;br&gt;
&lt;select id=&#34;concentAmpNa&#34;&gt;
    &lt;option value=&#34;&#34;&gt;Selecione sódio concentrado&lt;/option&gt;
    &lt;option value=&#34;10&#34;&gt;Cloreto de sódio a 10%&lt;/option&gt;
    &lt;option value=&#34;20&#34;&gt;Cloreto de sódio a 20%&lt;/option&gt;
&lt;/select&gt;
&lt;br&gt;
&lt;br&gt;
&lt;h2&gt;Tonicidade do sódio&lt;/h2&gt;
&lt;form&gt;
    &lt;input name=&#34;tonicidade&#34; type=&#34;radio&#34; id=&#34;sodioIso&#34;&gt;Isotônico - 135mEq/L&lt;/input&gt; &lt;br&gt;
    &lt;input name=&#34;tonicidade&#34; type=&#34;radio&#34; id=&#34;sodioHipo&#34;&gt;Hipotônico - 30mEq/L&lt;/input&gt; 
&lt;/form&gt;
&lt;br&gt;&lt;br&gt;
&lt;h2&gt;Potássio&lt;/h2&gt;
&lt;label for=&#34;volumeAmpK&#34;&gt;Volume de cada ampola de potássio&lt;/label&gt;&lt;br&gt;
&lt;input type=&#34;number&#34; placeholder=&#34;mL&#34; id=&#34;volumeAmpK&#34;&gt;&lt;/input&gt; &lt;br&gt;&lt;br&gt;
&lt;label for=&#34;concentAmpK&#34;&gt;Concentração de potássio da ampola&lt;label&gt;&lt;br&gt;
&lt;select id=&#34;concentAmpK&#34;&gt;
    &lt;option value=&#34;&#34;&gt;Selecione ampola&lt;/option&gt;
    &lt;option value=&#34;19&#34;&gt;Cloreto de Potássio a 19,1%&lt;/option&gt;
    &lt;option value=&#34;10&#34;&gt;Cloreto de Potássio a 10%&lt;/option&gt;
    &lt;option value=&#34;fosft2meqml&#34;&gt;Fosfato de Potássio a 2mEq/mL&lt;/option&gt;
&lt;/select&gt;&lt;br&gt;
&lt;br&gt;&lt;br&gt;
&lt;h2&gt;Glicose&lt;/h2&gt;
&lt;label for=&#34;volumeAmpGlic&#34;&gt;Volume de cada ampola de glicose&lt;/label&gt;&lt;br&gt;
&lt;input type=&#34;number&#34; placeholder=&#34;mL&#34; id=&#34;volumeAmpGlic&#34;&gt;&lt;/input&gt; &lt;br&gt;&lt;br&gt;
&lt;label for=&#34;percentualGlic&#34;&gt;Percentual de glicose da ampola&lt;label&gt;&lt;br&gt;
&lt;select id=&#34;percentualGlic&#34;&gt;
    &lt;option value=&#34;&#34;&gt;Selecione tipo de ampola&lt;/option&gt;
    &lt;option value=5&gt;Glicose a 5%&lt;/option&gt;
    &lt;option value=50&gt;Glicose a 50%&lt;/option&gt; 
&lt;/select&gt;&lt;br&gt;
&lt;br&gt;
&lt;p&gt;&lt;button onclick=&#34;holliday()&#34;&gt;Calcular&lt;/button&gt;&lt;/p&gt;
&lt;p id=&#34;resultado&#34; style=&#34;max-width: 60vw;&#34;&gt;&lt;/p&gt;
&lt;p id=&#34;alertas&#34; style=&#34;display: none;&#34;&gt;
O potássio deve ser realizado idealmente em 0.3-0.5 mEq/kg/h.
&lt;br&gt;
– A velocidade de infusão máxima de potássio é 10-20 mEq/h!
&lt;br&gt;
– A concentração ideal em acesso periférico é de no máx. 40-50mEq/L.
&lt;br&gt;
– A concentração ideal em acesso central é de no máx. 80-100mEq/L.
&lt;br&gt;
– Não prescreva potássio ao paciente anúrico!
&lt;/p&gt;
&lt;/div&gt;
&lt;script src=&#34;../../holliday.js&#34;&gt;&lt;/script&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;HOLLIDAY MA, SEGAR WE. &lt;strong&gt;The maintenance need for water in parenteral fluid therapy.&lt;/strong&gt; Pediatrics. 1957 May;19(5):823-32. PMID: 13431307.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Concepção, gestação, pré-natal e pós-parto</title>
		<link>https://www.aesclepius.com.br/gestacao/</link>
		<pubDate>Sun, 28 Jan 2024 20:44:01 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/gestacao/</guid>
		<description>&lt;h2 id=&#34;timeline&#34;&gt;Timeline&lt;/h2&gt;
&lt;h3 id=&#34;primeiro-trimestre&#34;&gt;Primeiro trimestre&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Estratificar o risco gestacional;&lt;/li&gt;
&lt;li&gt;GS/Rh&lt;/li&gt;
&lt;li&gt;Coombs indireto&lt;/li&gt;
&lt;li&gt;Glicemia jejum&lt;/li&gt;
&lt;li&gt;Rastreio de doença trofoblástica&lt;/li&gt;
&lt;/ul&gt;
&lt;!-- marcador de mola p-57 (se positivo, é parcial; se negativo, é completa)--&gt;
&lt;h3 id=&#34;segundo-trimestre&#34;&gt;Segundo trimestre&lt;/h3&gt;
&lt;h3 id=&#34;terceiro-trimestre&#34;&gt;Terceiro trimestre&lt;/h3&gt;
&lt;h3 id=&#34;puerpério&#34;&gt;Puerpério&lt;/h3&gt;
&lt;h2 id=&#34;idade-gestacional&#34;&gt;Idade gestacional&lt;/h2&gt;
&lt;p&gt;Erro entre idade gestacional determinada por ultrassonografia e data da última menstruação:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;+- 3 dias&lt;/strong&gt;: entre a 7 e a 10 semana.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;+- 7 dias&lt;/strong&gt;: entre a 10 e a 14 semana.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;+- 2 a 4 semanas&lt;/strong&gt;: segundo e terceiros trimestres.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;
 
&lt;div class=&#34;carouselig&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anteriorig&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximoig&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  
    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;Altura uterina por idade gestacional&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/altura-uterina-ig.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;

    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;Tamanho do útero por idade gestacional&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/ig-tamanho-utero.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carouselig .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carouselig .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anteriorig&#34;);
  let proximo = document.getElementById(&#34;proximoig&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;br&gt;
&lt;br&gt;&lt;/p&gt;
&lt;h3 id=&#34;calculadora-de-idade-gestacional&#34;&gt;Calculadora de idade gestacional&lt;/h3&gt;
&lt;div class=&#34;calculadoras&#34;&gt;
    &lt;h4&gt;Data da última menstruação&lt;/h4&gt;
    &lt;input type=date id=dum&gt;&lt;/input&gt;
    &lt;h4&gt;Data da ultrassonografia mais adequada&lt;/h4&gt;
    &lt;input type=date id=us&gt;&lt;/input&gt;
    &lt;h4&gt;Idade gestacional da ultrassonografia&lt;/h4&gt;
        &lt;select id=&#34;semanasUS&#34;&gt;
            &lt;option value=&gt;Semanas&lt;/option&gt;
            &lt;option value=&#34;1&#34;&gt;1&lt;/option&gt;
            &lt;option value=&#34;2&#34;&gt;2&lt;/option&gt;
            &lt;option value=&#34;3&#34;&gt;3&lt;/option&gt;
            &lt;option value=&#34;4&#34;&gt;4&lt;/option&gt;
            &lt;option value=&#34;5&#34;&gt;5&lt;/option&gt;
            &lt;option value=&#34;6&#34;&gt;6&lt;/option&gt;
            &lt;option value=&#34;7&#34;&gt;7&lt;/option&gt;
            &lt;option value=&#34;8&#34;&gt;8&lt;/option&gt;
            &lt;option value=&#34;9&#34;&gt;9&lt;/option&gt;
            &lt;option value=&#34;10&#34;&gt;10&lt;/option&gt;
            &lt;option value=&#34;11&#34;&gt;11&lt;/option&gt;
            &lt;option value=&#34;12&#34;&gt;12&lt;/option&gt;
            &lt;option value=&#34;13&#34;&gt;13&lt;/option&gt;
            &lt;option value=&#34;14&#34;&gt;14&lt;/option&gt;
            &lt;option value=&#34;15&#34;&gt;15&lt;/option&gt;
            &lt;option value=&#34;16&#34;&gt;16&lt;/option&gt;
            &lt;option value=&#34;17&#34;&gt;+16 semanas&lt;/option&gt;
        &lt;/select&gt;
        &lt;select id=&#34;diasUS&#34;&gt;
            &lt;option value=&gt;Dias&lt;/option&gt;
            &lt;option value=&#34;1&#34;&gt;1&lt;/option&gt;
            &lt;option value=&#34;2&#34;&gt;2&lt;/option&gt;
            &lt;option value=&#34;3&#34;&gt;3&lt;/option&gt;
            &lt;option value=&#34;4&#34;&gt;4&lt;/option&gt;
            &lt;option value=&#34;5&#34;&gt;5&lt;/option&gt;
            &lt;option value=&#34;6&#34;&gt;6&lt;/option&gt;
            &lt;option value=&#34;7&#34;&gt;7&lt;/option&gt;
        &lt;/select&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=&#34;naegele()&#34;&gt;Calcular&lt;/button&gt;
    &lt;br&gt;
    &lt;p id=&#34;resultadoNaegele&#34;&gt;&lt;/p&gt;
    &lt;script src=&#34;../../naegele.js&#34;&gt;&lt;/script&gt;
&lt;/div&gt;
&lt;h2 id=&#34;alto-risco-gestacional&#34;&gt;Alto risco gestacional&lt;/h2&gt;
&lt;h3 id=&#34;biológicos&#34;&gt;Biológicos&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Idade materna &amp;lt; 16 ou &amp;gt; 35 anos&lt;/li&gt;
&lt;li&gt;Peso inicial inferior a 50 kg&lt;/li&gt;
&lt;li&gt;Estatura inferior a 150 cm&lt;/li&gt;
&lt;li&gt;História familiar de doenças hereditárias&lt;/li&gt;
&lt;li&gt;Clínicos&lt;/li&gt;
&lt;li&gt;Hipertensão arterial&lt;/li&gt;
&lt;li&gt;Nefropatia&lt;/li&gt;
&lt;li&gt;Diabetes&lt;/li&gt;
&lt;li&gt;ISTs&lt;/li&gt;
&lt;li&gt;Cardiopatia&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;ambientais&#34;&gt;Ambientais&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Saneamento básico inexistente ou inadequado&lt;/li&gt;
&lt;li&gt;Estilo de vida não saudável&lt;/li&gt;
&lt;li&gt;Comportamentais&lt;/li&gt;
&lt;li&gt;Tabagismo&lt;/li&gt;
&lt;li&gt;Etilismo&lt;/li&gt;
&lt;li&gt;Uso de drogas ilícitas&lt;/li&gt;
&lt;li&gt;Atividade em trabalho braçal exaustivo&lt;/li&gt;
&lt;li&gt;Sedentarismo&lt;/li&gt;
&lt;li&gt;Relacionados com assistência à saúde&lt;/li&gt;
&lt;li&gt;Má qualidade da assistência&lt;/li&gt;
&lt;li&gt;Cobertura insuficiente ao pré-natal&lt;/li&gt;
&lt;li&gt;Falta de integração interinstitucional&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;socioculturais&#34;&gt;Socioculturais&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Baixa escolaridade&lt;/li&gt;
&lt;li&gt;Gestantes solteiras&lt;/li&gt;
&lt;li&gt;Adolescência e não aceitação da gravidez&lt;/li&gt;
&lt;li&gt;Econômicos&lt;/li&gt;
&lt;li&gt;Baixa renda&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;obstétricos&#34;&gt;Obstétricos&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;História de infertilidade&lt;/li&gt;
&lt;li&gt;Gravidez anterior com qualquer intercorrência, incluindo distocia e/ou cicatriz uterina prévia&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;condições-atuais&#34;&gt;Condições atuais&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Pré-natal ausente ou tardio&lt;/li&gt;
&lt;li&gt;Hemorragia anteparto&lt;/li&gt;
&lt;li&gt;Gestação múltipla&lt;/li&gt;
&lt;li&gt;Hipertensão arterial sistêmica&lt;/li&gt;
&lt;li&gt;Rotura prematura de membranas&lt;/li&gt;
&lt;li&gt;Aloimunização e incompatibilidade sanguínea materno-fetal&lt;/li&gt;
&lt;li&gt;Gestação prolongada&lt;/li&gt;
&lt;li&gt;Restrição de crescimento fetal&lt;/li&gt;
&lt;li&gt;Polidrâmnio&lt;/li&gt;
&lt;li&gt;Anemia&lt;/li&gt;
&lt;li&gt;Apresentação anômala&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;rastreios&#34;&gt;Rastreios&lt;/h2&gt;
&lt;h3 id=&#34;incompatibilidade-sanguínea&#34;&gt;Incompatibilidade sanguínea&lt;/h3&gt;
&lt;ol&gt;
&lt;li&gt;saber se a gestante tinha coombs indireto positivo na primeira gestacao&lt;/li&gt;
&lt;li&gt;saber se ela ja transfundiu, pode ser anticorpo adquirido apos transfusao&lt;/li&gt;
&lt;li&gt;saber a fenotipagem do esposo, pra comparar se o anticorpo que esta surgindo pode ser do filho atual, pelo risco de doenca hemolitica perinatal&lt;/li&gt;
&lt;li&gt;acompanhar titulacao desse coombs indireto&lt;/li&gt;
&lt;li&gt;acompanhar o feto com doppler de arteria cerebral (saber se esta desenvolvendo anemia)&lt;/li&gt;
&lt;/ol&gt;
&lt;h3 id=&#34;diabetes-mellitus-gestacional&#34;&gt;Diabetes mellitus gestacional&lt;/h3&gt;
&lt;p&gt;A gestante que se encontra entre 20 e 24 semanas sem pré-natal iniciado deve iniciá-lo e realizar teste de tolerância oral à glicose (TOTG) na 24° semana.&lt;/p&gt;
&lt;h4 id=&#34;conduta&#34;&gt;Conduta&lt;/h4&gt;

 
&lt;div class=&#34;carousel&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  



&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt;Gestante com viabilidade finananceira&lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/dmg-financeiro-viavel.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;




&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt;Gestante sem viabilidade finananceira&lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/dmg-financeiro-nao-viavel.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;




&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt;Puérpera com viabilidade financeira&lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/puerpera-dmg-financeiro-viavel.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;




&lt;div class=&#34;legend&#34;&gt;
  &lt;p&gt;Puérpera sem viabilidade financeira&lt;/p&gt;
&lt;/div&gt;
&lt;div class=&#34;slide&#34;&gt;
  
  &lt;img src=&#34;../../pix/medicina/puerpera-dmg-financeiro-nao-viavel.png&#34;&gt;&lt;/img&gt;
  
&lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior&#34;);
  let proximo = document.getElementById(&#34;proximo&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;br&gt;
&lt;h3 id=&#34;eclâmpsia&#34;&gt;Eclâmpsia&lt;/h3&gt;
&lt;p&gt;Pré-eclâmpsia é um diagnóstico somativo de:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;gestação a pelo menos 20 semanas;&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;hipertensão; e&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;proteinúria&lt;/strong&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Considera-se hipertensa a grávida com &lt;strong&gt;PA de pelo menos 140mmHg de sistólica ou 90mmHg de diastólica&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Proteinúria é a &lt;strong&gt;detecção de 300mg ou mais na urina de 24h&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Na ausência de proteinúria de 24h, aceita-se o diagnóstico mais prático da &lt;strong&gt;relação proteína/creatinina¹ de 0.3&lt;/strong&gt; em amostra aleatória. Considera-se, também, qualquer lesão de órgão-alvo como a &lt;a href=&#34;../../medicina/doenca-renal&#34;&gt;insuficiência renal aguda&lt;/a&gt;, o edema pulmonar agudo, a disfução hepática e a trombocitopenia.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Eclâmpsia&lt;/strong&gt; é a ocorrência de &lt;mark&gt;convulsões&lt;/mark&gt; durante o diagnóstico de pré-eclâmpsia.&lt;/p&gt;
&lt;h4 id=&#34;conduta-1&#34;&gt;Conduta&lt;/h4&gt;
&lt;p&gt;A conduta é a &lt;strong&gt;interrupção da convulsão com sulfato de magnésio&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;A cura é o &lt;strong&gt;parto&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;&lt;img src=&#34;../../pix/medicina/esquemas-sulfato.png&#34; alt=&#34;Esquemas de sulfato de magnésio&#34;&gt;&lt;/p&gt;
&lt;h5 id=&#34;cuidados&#34;&gt;Cuidados&lt;/h5&gt;
&lt;p&gt;O reflexo patelar desaparece com 10mEq/L de sulfato e ocorre parada cardíaca com 12mEq/L.&lt;/p&gt;
&lt;p&gt;Mantenha o antídoto preparado &lt;strong&gt;ANTES&lt;/strong&gt; de administrar o sulfato.&lt;/p&gt;
&lt;p&gt;O gluconato de cálcio a &lt;strong&gt;1g por via endovenosa&lt;/strong&gt; (geralmente 10mL a 10%) deve ser administrado &lt;mark&gt;lentamente &lt;/mark&gt;nos casos de sinais de intoxicação por magnésio.&lt;/p&gt;
&lt;h4 id=&#34;prevenção&#34;&gt;Prevenção&lt;/h4&gt;
&lt;p&gt;A medicina baseada em evidências consegue demostrar benefício no uso de &lt;strong&gt;ácido acetilsalicílico a 150mg/dia&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Caso se tenha deficiência de cálcio na dieta presumida clinicamente ou por diagnóstico laboratorial, prescreve-se &lt;strong&gt;cálcio oral dietético suplementar a 1-2g/dia&lt;/strong&gt;.&lt;/p&gt;
&lt;h3 id=&#34;ultrassonografias&#34;&gt;Ultrassonografias&lt;/h3&gt;
&lt;p&gt;Agora ultrassom é obrigatório no pré-natal.&lt;/p&gt;
&lt;p&gt;Pelo menos dois nos quatro primeiros meses, transvaginal[1].&lt;/p&gt;
&lt;h3 id=&#34;suplementação-de-ferro&#34;&gt;Suplementação de ferro&lt;/h3&gt;
&lt;p&gt;sup de SO4Fe 600mg&lt;/p&gt;
&lt;h3 id=&#34;fator-rh&#34;&gt;Fator Rh&lt;/h3&gt;
&lt;p&gt;A imunoglobulina anti Rh(D) (conhecida como vacina Rogan) é utilizada para prevenir a sensibilização materna ao fator sanguíneo de um bebê Rh positivo quando a mãe possui o fator Rh negativo.&lt;/p&gt;
&lt;p&gt;A imunoglobulina é administrada com 28s para que sua vida circulatória de 12s coincida com o momento de encerramento do parto.&lt;/p&gt;
&lt;p&gt;Papo de GO:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Rh- coombs mensal + haloimunização&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;parto&#34;&gt;Parto&lt;/h2&gt;
&lt;p&gt;Ocitocina
Rotura prematura de membrana (clinda e genta)
Corticoide
20-26 semana ???
faz com intervalo de 24h??
Como faz ac. tranaxemico
Noripurum etc&lt;/p&gt;
&lt;h2 id=&#34;pós-parto&#34;&gt;Pós-parto&lt;/h2&gt;
&lt;p&gt;Baby blues:&lt;/p&gt;
&lt;pre&gt;&lt;code&gt;Sintomas: Irritabilidade, tristeza leve, fadiga, mudanças de humor e choro fácil.
Duração: 2 a 3 semanas após o parto.
Gravidade: Sintomas leves e transitórios, não interferem significativamente nas atividades diárias.
Tratamento: Normalmente não requer intervenção; melhora espontânea.
&lt;/code&gt;&lt;/pre&gt;
&lt;p&gt;Depressão pós-parto:&lt;/p&gt;
&lt;pre&gt;&lt;code&gt;Sintomas: Tristeza profunda, perda de interesse, insônia ou hipersonia, fadiga extrema, sentimentos de culpa ou inutilidade, dificuldade em cuidar do bebê.
Duração: Mais de 2 semanas, podendo durar meses se não tratada.
Gravidade: Interfere nas atividades diárias e no vínculo com o bebê.
Tratamento: Necessita de intervenção, como psicoterapia e/ou medicamentos antidepressivos.
&lt;/code&gt;&lt;/pre&gt;
&lt;h2 id=&#34;triagem-do-neonato&#34;&gt;Triagem do neonato&lt;/h2&gt;
&lt;h3 id=&#34;erros-inatos-do-metabolismo&#34;&gt;Erros inatos do metabolismo&lt;/h3&gt;
&lt;h4 id=&#34;fenilcetonúria&#34;&gt;Fenilcetonúria&lt;/h4&gt;
&lt;p&gt;Deficiência de hidroxilase da fenilalanina com consequente acúmulo da substância.&lt;/p&gt;
&lt;h3 id=&#34;distúrbios-endócrinos&#34;&gt;Distúrbios endócrinos&lt;/h3&gt;
&lt;h4 id=&#34;hipotireoidismo-congênito&#34;&gt;Hipotireoidismo congênito&lt;/h4&gt;
&lt;h3 id=&#34;hemoglobinopatias&#34;&gt;Hemoglobinopatias&lt;/h3&gt;
&lt;h3 id=&#34;imunodeficiência&#34;&gt;Imunodeficiência&lt;/h3&gt;
&lt;h3 id=&#34;fibrose-cística&#34;&gt;Fibrose cística&lt;/h3&gt;
&lt;h3 id=&#34;defeitos-cardíacos-congênitos-críticos&#34;&gt;Defeitos cardíacos congênitos críticos&lt;/h3&gt;
&lt;p&gt;O teste do coraçãozinho é o principal, com oximetria aferida segundo algoritmo específico para rastrear diferença de saturação de oxigênio superior a 3% entre os membros superiores (pré-ductal) e inferiores (pós-ductal).&lt;/p&gt;
&lt;p&gt;Em casos alterados, solicitar &lt;mark&gt;imediatamente&lt;/mark&gt; ultrassonografia cardíaca.&lt;/p&gt;
&lt;p&gt;Em casos sintomáticos, oferecer oxigenoterapia com alvo de saturação de oxigênio periférico entre 85 e 90%, evitar antiinflamatórios, principalmente não esteroidais, e, se possível, &lt;strong&gt;administrar análogos ou a prória prostaglandina E1&lt;/strong&gt; para manter a comunicação intercâmaras que provavelmente é necessária a sustentação da vida.&lt;/p&gt;
&lt;h3 id=&#34;doenças-raras&#34;&gt;Doenças raras&lt;/h3&gt;
&lt;h3 id=&#34;síndromes-falciformes&#34;&gt;Síndromes falciformes&lt;/h3&gt;
&lt;h3 id=&#34;fibrose-cística-1&#34;&gt;Fibrose cística&lt;/h3&gt;
&lt;h3 id=&#34;hiperplasia-adrenal-congênita&#34;&gt;Hiperplasia adrenal congênita&lt;/h3&gt;
&lt;h3 id=&#34;deficiência-de-biotinidase&#34;&gt;Deficiência de biotinidase&lt;/h3&gt;
&lt;h3 id=&#34;surdez&#34;&gt;Surdez&lt;/h3&gt;
&lt;h4 id=&#34;brain-evoked-response-auditory&#34;&gt;Brain Evoked Response Auditory&lt;/h4&gt;
&lt;p&gt;Teste encefalográfico que avalia a resposta cerebral a estímulos sonoros, feito em qualquer idade, preferencialmente antes da alta e nos casos de pacientes com fatores de risco obrigatoriamente durante a internação em unidade de cuidados intensivos externos.&lt;/p&gt;
&lt;h4 id=&#34;fatores-de-risco&#34;&gt;Fatores de risco&lt;/h4&gt;
&lt;p&gt;Asfixia (Apgar &amp;lt; 6 no 5º minuto), história familiar, infecção TORCHS, hiperbilirrubinemia, sepse e meningite, hemorragia intraventricular, drogas ototóxicas, peso nascimento &amp;lt; 1500g e ventilação mecânica &amp;gt; 5 dias.&lt;/p&gt;
&lt;h3 id=&#34;teste-da-linguinha&#34;&gt;Teste da linguinha&lt;/h3&gt;
&lt;p&gt;Utilizar o Bristol Tongue Assessment Tool disponível na Nota Técnica 35/2018 do Ministério da Saúde &lt;a href=&#34;../../files/Medicina/Pediatria/NT35-2018-MS-Anquiloglossia.pdf&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
&lt;h3 id=&#34;teste-do-olhinho&#34;&gt;Teste do olhinho&lt;/h3&gt;
&lt;p&gt;De baixo custo, consiste em observar a uniformidade e bilateralidade do reflexo vermelho do fundo de olho. Quaisquer alterações grosseiras do teste devem ser indicativo de exame oftalmológico com dilatação pupilar.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;notas&#34;&gt;Notas&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Proteína total dividida pela creatinina medidas em mesma unidade.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;&lt;a href=&#34;https://www12.senado.leg.br/noticias/materias/2023/06/15/sancionada-lei-que-garante-mais-exames-para-gestantes-no-sus&#34;&gt;https://www12.senado.leg.br/noticias/materias/2023/06/15/sancionada-lei-que-garante-mais-exames-para-gestantes-no-sus&lt;/a&gt;.&lt;/li&gt;
&lt;/ol&gt;
&lt;h2 id=&#34;bibliografia&#34;&gt;Bibliografia&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;FEBRASGO. &lt;strong&gt;Protocolo no. 73 - 2021&lt;/strong&gt;. Federação Brasileira de Ginecologia e Obstetrícia. Brasil.&lt;/li&gt;
&lt;li&gt;FEBRASGO. &lt;strong&gt;Revista Feminina - Volume 47, Número 11&lt;/strong&gt;. Federação Brasileira de Ginecologia e Obstetrícia. Brasil. 2019.&lt;/li&gt;
&lt;/ol&gt;
&lt;!--
&lt;select id=&#34;diaDum&#34;&gt;
            &lt;option value=&#34;1&#34;&gt;1&lt;/option&gt;
            &lt;option value=&#34;2&#34;&gt;2&lt;/option&gt;
            &lt;option value=&#34;3&#34;&gt;3&lt;/option&gt;
            &lt;option value=&#34;4&#34;&gt;4&lt;/option&gt;
            &lt;option value=&#34;5&#34;&gt;5&lt;/option&gt;
            &lt;option value=&#34;6&#34;&gt;6&lt;/option&gt;
            &lt;option value=&#34;7&#34;&gt;7&lt;/option&gt;
            &lt;option value=&#34;8&#34;&gt;8&lt;/option&gt;
            &lt;option value=&#34;9&#34;&gt;9&lt;/option&gt;
            &lt;option value=&#34;10&#34;&gt;10&lt;/option&gt;
            &lt;option value=&#34;11&#34;&gt;11&lt;/option&gt;
            &lt;option value=&#34;12&#34;&gt;12&lt;/option&gt;
            &lt;option value=&#34;13&#34;&gt;13&lt;/option&gt;
            &lt;option value=&#34;14&#34;&gt;14&lt;/option&gt;
            &lt;option value=&#34;15&#34;&gt;15&lt;/option&gt;
            &lt;option value=&#34;16&#34;&gt;16&lt;/option&gt;
            &lt;option value=&#34;17&#34;&gt;17&lt;/option&gt;
            &lt;option value=&#34;18&#34;&gt;18&lt;/option&gt;
            &lt;option value=&#34;19&#34;&gt;19&lt;/option&gt;
            &lt;option value=&#34;20&#34;&gt;20&lt;/option&gt;
            &lt;option value=&#34;21&#34;&gt;21&lt;/option&gt;
            &lt;option value=&#34;22&#34;&gt;22&lt;/option&gt;
            &lt;option value=&#34;23&#34;&gt;23&lt;/option&gt;
            &lt;option value=&#34;24&#34;&gt;24&lt;/option&gt;
            &lt;option value=&#34;25&#34;&gt;25&lt;/option&gt;
            &lt;option value=&#34;26&#34;&gt;26&lt;/option&gt;
            &lt;option value=&#34;27&#34;&gt;27&lt;/option&gt;
            &lt;option value=&#34;28&#34;&gt;28&lt;/option&gt;
            &lt;option value=&#34;29&#34;&gt;29&lt;/option&gt;
            &lt;option value=&#34;30&#34;&gt;30&lt;/option&gt;
            &lt;option value=&#34;31&#34;&gt;31&lt;/option&gt;
        &lt;/select&gt;
        &lt;select id=&#34;mesDum&#34; required&gt;
            &lt;option value=&#34;1&#34;&gt;Janeiro&lt;/option&gt;
            &lt;option value=&#34;2&#34;&gt;Fevereiro&lt;/option&gt;
            &lt;option value=&#34;3&#34;&gt;Março&lt;/option&gt;
            &lt;option value=&#34;4&#34;&gt;Abril&lt;/option&gt;
            &lt;option value=&#34;5&#34;&gt;Maio&lt;/option&gt;
            &lt;option value=&#34;6&#34;&gt;Junho&lt;/option&gt;
            &lt;option value=&#34;7&#34;&gt;Julho&lt;/option&gt;
            &lt;option value=&#34;8&#34;&gt;Agosto&lt;/option&gt;
            &lt;option value=&#34;9&#34;&gt;Setembro&lt;/option&gt;
            &lt;option value=&#34;10&#34;&gt;Outubro&lt;/option&gt;
            &lt;option value=&#34;11&#34;&gt;Novembro&lt;/option&gt;
            &lt;option value=&#34;12&#34;&gt;Dezembro&lt;/option&gt;
            &lt;option value=&#34;20&#34;&gt;Dezembro&lt;/option&gt;
        &lt;/select&gt;
        &lt;select id=&#34;anoDum&#34;&gt;
            &lt;option value=&#34;2024&#34;&gt;2024&lt;/option&gt;
            &lt;option value=&#34;2025&#34;&gt;2025&lt;/option&gt;
            &lt;option value=&#34;2026&#34;&gt;2026&lt;/option&gt;
            &lt;option value=&#34;2028&#34;&gt;2028&lt;/option&gt;
        &lt;/select&gt;
        &lt;select id=&#34;diaUS&#34;&gt;
            &lt;option value=&#34;1&#34;&gt;1&lt;/option&gt;
            &lt;option value=&#34;2&#34;&gt;2&lt;/option&gt;
            &lt;option value=&#34;3&#34;&gt;3&lt;/option&gt;
            &lt;option value=&#34;4&#34;&gt;4&lt;/option&gt;
            &lt;option value=&#34;5&#34;&gt;5&lt;/option&gt;
            &lt;option value=&#34;6&#34;&gt;6&lt;/option&gt;
            &lt;option value=&#34;7&#34;&gt;7&lt;/option&gt;
            &lt;option value=&#34;8&#34;&gt;8&lt;/option&gt;
            &lt;option value=&#34;9&#34;&gt;9&lt;/option&gt;
            &lt;option value=&#34;10&#34;&gt;10&lt;/option&gt;
            &lt;option value=&#34;11&#34;&gt;11&lt;/option&gt;
            &lt;option value=&#34;12&#34;&gt;12&lt;/option&gt;
            &lt;option value=&#34;13&#34;&gt;13&lt;/option&gt;
            &lt;option value=&#34;14&#34;&gt;14&lt;/option&gt;
            &lt;option value=&#34;15&#34;&gt;15&lt;/option&gt;
            &lt;option value=&#34;16&#34;&gt;16&lt;/option&gt;
            &lt;option value=&#34;17&#34;&gt;17&lt;/option&gt;
            &lt;option value=&#34;18&#34;&gt;18&lt;/option&gt;
            &lt;option value=&#34;19&#34;&gt;19&lt;/option&gt;
            &lt;option value=&#34;20&#34;&gt;20&lt;/option&gt;
            &lt;option value=&#34;21&#34;&gt;21&lt;/option&gt;
            &lt;option value=&#34;22&#34;&gt;22&lt;/option&gt;
            &lt;option value=&#34;23&#34;&gt;23&lt;/option&gt;
            &lt;option value=&#34;24&#34;&gt;24&lt;/option&gt;
            &lt;option value=&#34;25&#34;&gt;25&lt;/option&gt;
            &lt;option value=&#34;26&#34;&gt;26&lt;/option&gt;
            &lt;option value=&#34;27&#34;&gt;27&lt;/option&gt;
            &lt;option value=&#34;28&#34;&gt;28&lt;/option&gt;
            &lt;option value=&#34;29&#34;&gt;29&lt;/option&gt;
            &lt;option value=&#34;30&#34;&gt;30&lt;/option&gt;
            &lt;option value=&#34;31&#34;&gt;31&lt;/option&gt;
        &lt;/select&gt;
        &lt;select id=&#34;mesUS&#34; required&gt;
            &lt;option value=&#34;1&#34;&gt;Janeiro&lt;/option&gt;
            &lt;option value=&#34;2&#34;&gt;Fevereiro&lt;/option&gt;
            &lt;option value=&#34;3&#34;&gt;Março&lt;/option&gt;
            &lt;option value=&#34;4&#34;&gt;Abril&lt;/option&gt;
            &lt;option value=&#34;5&#34;&gt;Maio&lt;/option&gt;
            &lt;option value=&#34;6&#34;&gt;Junho&lt;/option&gt;
            &lt;option value=&#34;7&#34;&gt;Julho&lt;/option&gt;
            &lt;option value=&#34;8&#34;&gt;Agosto&lt;/option&gt;
            &lt;option value=&#34;9&#34;&gt;Setembro&lt;/option&gt;
            &lt;option value=&#34;10&#34;&gt;Outubro&lt;/option&gt;
            &lt;option value=&#34;11&#34;&gt;Novembro&lt;/option&gt;
            &lt;option value=&#34;12&#34;&gt;Dezembro&lt;/option&gt;
            &lt;option value=&#34;20&#34;&gt;Dezembro&lt;/option&gt;
        &lt;/select&gt;
        &lt;select id=&#34;anoUS&#34;&gt;
            &lt;option value=&#34;2024&#34;&gt;2024&lt;/option&gt;
            &lt;option value=&#34;2025&#34;&gt;2025&lt;/option&gt;
            &lt;option value=&#34;2026&#34;&gt;2026&lt;/option&gt;
            &lt;option value=&#34;2028&#34;&gt;2028&lt;/option&gt;
        &lt;/select&gt;
--&gt;
</description>
	</item>
	
	<item>
		<title>Hanseníase</title>
		<link>https://www.aesclepius.com.br/hanseniase/</link>
		<pubDate>Sun, 07 Jan 2024 14:43:03 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/hanseniase/</guid>
		<description>&lt;p&gt;&lt;div style=&#34;display:flex; align-content:center&#34;&gt;
  &lt;span class=&#34;etiqueta&#34;&gt;
O agente etiológico da hanseníase é o &lt;em&gt;Mycobacterium leprae&lt;/em&gt;, que foi descrito em 1873 pelo cientista norueguês &lt;b&gt;Gerhard Henry Armauer Hansen&lt;/b&gt;, razão pela qual também é denominado de Bacilo de Hansen. &lt;br&gt;&lt;b&gt;Não é cultivável.&lt;/b&gt;
 &lt;/span&gt;
&lt;/div&gt;


&lt;br&gt;


&lt;div class=&#34;scalidraw&#34;&gt;
&lt;svg version=&#34;1.1&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34; viewBox=&#34;0 0 624.5 373&#34; width=&#34;624.5&#34; height=&#34;373&#34;&gt;
  &lt;!-- svg-source:excalidraw --&gt;
  
  &lt;defs&gt;
    &lt;style class=&#34;style-fonts&#34;&gt;
      @font-face {
        font-family: &#34;Virgil&#34;;
        src: url(&#34;https://excalidraw.com/Virgil.woff2&#34;);
      }
      @font-face {
        font-family: &#34;Cascadia&#34;;
        src: url(&#34;https://excalidraw.com/Cascadia.woff2&#34;);
      }
      @font-face {
        font-family: &#34;Assistant&#34;;
        src: url(&#34;https://excalidraw.com/Assistant-Regular.woff2&#34;);
      }
    &lt;/style&gt;
    
  &lt;/defs&gt;
  &lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(92 324) rotate(0 1.5 -142.5)&#34;&gt;&lt;path d=&#34;M-0.56 -0.66 C-0.11 -48.2, 2.84 -238.64, 3.6 -286.12 M1.35 1.61 C1.61 -45.75, 2.56 -237.48, 2.97 -285.17&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(92 324) rotate(0 1.5 -142.5)&#34;&gt;&lt;path d=&#34;M11.36 -261.62 C7.28 -269.51, 3.36 -277.66, 2.97 -285.17 M11.36 -261.62 C8.46 -266.91, 6.73 -272.75, 2.97 -285.17&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(92 324) rotate(0 1.5 -142.5)&#34;&gt;&lt;path d=&#34;M-5.74 -261.73 C-3.4 -269.5, -0.89 -277.6, 2.97 -285.17 M-5.74 -261.73 C-4.28 -267.03, -1.66 -272.85, 2.97 -285.17&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(527 24) rotate(0 3 151)&#34;&gt;&lt;path d=&#34;M-1.01 1.07 C-0.18 51.44, 4.44 251.71, 5.66 301.8 M0.65 0.59 C1.24 51.18, 3.69 252.88, 4.54 303.23&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(527 24) rotate(0 3 151)&#34;&gt;&lt;path d=&#34;M-4.34 279.86 C0.53 287.69, 1.57 297.08, 4.54 303.23 M-4.34 279.86 C-2.52 286.12, -0.56 291.72, 4.54 303.23&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(527 24) rotate(0 3 151)&#34;&gt;&lt;path d=&#34;M12.75 279.62 C11.54 287.39, 6.5 296.87, 4.54 303.23 M12.75 279.62 C10.01 285.99, 7.39 291.66, 4.54 303.23&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(545 34) rotate(0 34.75 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;Bacilos&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(10 10) rotate(0 45.90833282470703 25)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;Resposta&lt;/text&gt;&lt;text x=&#34;0&#34; y=&#34;25&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;Imune&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(391.155626748483 327.71194156055856) rotate(0 -169.0778133742415 -2.8559707802792786)&#34;&gt;&lt;path d=&#34;M0.41 1.16 C-28.63 0.75, -117.59 -0.81, -174.17 -1.87 C-230.75 -2.94, -311.74 -4.79, -339.07 -5.24 M-0.83 0.73 C-30.04 -0.07, -119.16 -2.21, -175.13 -3.56 C-231.1 -4.9, -309.53 -6.84, -336.65 -7.34&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(391.155626748483 327.71194156055856) rotate(0 -169.0778133742415 -2.8559707802792786)&#34;&gt;&lt;path d=&#34;M-312.98 -15.38 C-318.26 -12.86, -326.06 -11.89, -336.65 -7.34 M-312.98 -15.38 C-320.81 -13.23, -329.25 -10.02, -336.65 -7.34&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(391.155626748483 327.71194156055856) rotate(0 -169.0778133742415 -2.8559707802792786)&#34;&gt;&lt;path d=&#34;M-313.35 1.72 C-318.6 -1.01, -326.29 -5.28, -336.65 -7.34 M-313.35 1.72 C-321.06 -1.94, -329.37 -4.53, -336.65 -7.34&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(348.61531237299516 328.3634882663277) rotate(0 113.19234381350242 -0.1817441331638463)&#34;&gt;&lt;path d=&#34;M-0.97 0.68 C36.99 0.46, 189.22 -1.07, 227.26 -1.17 M0.72 -0.01 C38.64 -0.1, 189.07 0.27, 226.77 -0.05&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(348.61531237299516 328.3634882663277) rotate(0 113.19234381350242 -0.1817441331638463)&#34;&gt;&lt;path d=&#34;M203.29 8.55 C210.54 7.95, 214.18 5.67, 226.77 -0.05 M203.29 8.55 C211.25 5.83, 218.76 2.91, 226.77 -0.05&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(348.61531237299516 328.3634882663277) rotate(0 113.19234381350242 -0.1817441331638463)&#34;&gt;&lt;path d=&#34;M203.25 -8.55 C210.53 -4.69, 214.18 -2.52, 226.77 -0.05 M203.25 -8.55 C211.24 -5.46, 218.77 -2.58, 226.77 -0.05&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(304 322) rotate(0 0.030859788936993482 -59.5)&#34;&gt;&lt;path d=&#34;M-1.01 -0.86 C-1.01 -20.68, -1.4 -99.27, -1.06 -118.95 M0.65 1.3 C1.11 -18.3, 1.04 -97.57, 1.06 -117.38&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(304 322) rotate(0 0.030859788936993482 -59.5)&#34;&gt;&lt;path d=&#34;M9.6 -93.88 C6.38 -100.76, 6.12 -102.19, 1.06 -117.38 M9.6 -93.88 C6.61 -100.45, 3.74 -108.67, 1.06 -117.38&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(304 322) rotate(0 0.030859788936993482 -59.5)&#34;&gt;&lt;path d=&#34;M-7.5 -93.89 C-7.12 -100.62, -3.8 -102.05, 1.06 -117.38 M-7.5 -93.89 C-5.23 -100.31, -2.84 -108.52, 1.06 -117.38&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(291.2750015258789 170.5) rotate(0 108.7249984741211 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;x  Polo Indeterminado&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(285 167.48382959937663) rotate(0 -32.00982476973064 -30.146513351485353)&#34;&gt;&lt;path d=&#34;M0.81 -0.89 C-9.92 -10.96, -52.86 -50.23, -63.78 -60.08 M-0.22 1.26 C-11.14 -9.23, -53.67 -52.14, -64.6 -62.09&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(285 167.48382959937663) rotate(0 -32.00982476973064 -30.146513351485353)&#34;&gt;&lt;path d=&#34;M-41.76 -51.92 C-51.26 -54.93, -57.42 -59.99, -64.6 -62.09 M-41.76 -51.92 C-49.96 -54.23, -56.01 -57.96, -64.6 -62.09&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(285 167.48382959937663) rotate(0 -32.00982476973064 -30.146513351485353)&#34;&gt;&lt;path d=&#34;M-53.64 -39.62 C-59.02 -47.01, -61.02 -56.37, -64.6 -62.09 M-53.64 -39.62 C-58.07 -46.04, -60.23 -53.8, -64.6 -62.09&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(127 53) rotate(0 58.40833282470703 25)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;Forma &lt;/text&gt;&lt;text x=&#34;0&#34; y=&#34;25&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;tuberculoide&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(399 241) rotate(0 53.44166564941406 25)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;Forma&lt;/text&gt;&lt;text x=&#34;0&#34; y=&#34;25&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;Virchowiana&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(313 194) rotate(0 58.711935173225015 23)&#34;&gt;&lt;path d=&#34;M-0.32 -0.75 C19.37 6.62, 98.94 37.16, 118.53 44.89 M1.71 1.46 C21.31 8.89, 99.05 38.3, 118.16 45.84&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(313 194) rotate(0 58.711935173225015 23)&#34;&gt;&lt;path d=&#34;M93.17 45.38 C100.21 47.44, 107.91 45.47, 118.16 45.84 M93.17 45.38 C99.68 44.85, 105.56 46.47, 118.16 45.84&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(313 194) rotate(0 58.711935173225015 23)&#34;&gt;&lt;path d=&#34;M99.31 29.42 C104.4 36.77, 110.06 40.09, 118.16 45.84 M99.31 29.42 C104.17 33.15, 108.41 39.04, 118.16 45.84&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(295 338) rotate(0 6.883333206176758 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;0&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(514 331) rotate(0 11.899999618530273 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;+t&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(82 326) rotate(0 11.899999618530273 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;+t&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(25 69) rotate(0 15.691666603088379 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;Th1&lt;/text&gt;&lt;/g&gt;&lt;g transform=&#34;translate(31 278) rotate(0 20.100000381469727 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;Th2&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(42 179) rotate(0 1 -38.5)&#34;&gt;&lt;path d=&#34;M-0.38 0.22 C-0.38 -12.54, 0.54 -63.69, 1.03 -76.36 M1.62 -0.72 C1.9 -13.83, 3.16 -65.34, 3.24 -78.15&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(42 179) rotate(0 1 -38.5)&#34;&gt;&lt;path d=&#34;M11.4 -54.51 C8.6 -65.22, 6.17 -71.71, 3.24 -78.15 M11.4 -54.51 C8.5 -64.79, 5.81 -73.79, 3.24 -78.15&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(42 179) rotate(0 1 -38.5)&#34;&gt;&lt;path d=&#34;M-5.7 -54.8 C-1.94 -65.34, 2.2 -71.73, 3.24 -78.15 M-5.7 -54.8 C-1.81 -64.97, 2.31 -73.85, 3.24 -78.15&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g transform=&#34;translate(43 177) rotate(0 0 41)&#34;&gt;&lt;path d=&#34;M-0.64 0.98 C-0.69 14.44, -0.97 67.55, -0.72 81.25 M1.22 0.45 C1.6 14.01, 1.73 68.9, 1.61 82.4&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(43 177) rotate(0 0 41)&#34;&gt;&lt;path d=&#34;M-6.89 58.89 C-2.93 63.9, -3.58 72.62, 1.61 82.4 M-6.89 58.89 C-2.31 68.34, -0.3 78.36, 1.61 82.4&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g transform=&#34;translate(43 177) rotate(0 0 41)&#34;&gt;&lt;path d=&#34;M10.21 58.92 C9.68 63.84, 4.54 72.55, 1.61 82.4 M10.21 58.92 C7.98 68.42, 3.16 78.42, 1.61 82.4&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;2&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g transform=&#34;translate(-21 164) rotate(268.8818117937933 45.61666488647461 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;0&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;text-before-edge&#34;&gt;predomíno&lt;/text&gt;&lt;/g&gt;&lt;/svg&gt;

&lt;/div&gt;

&lt;/p&gt;
&lt;p class=&#34;legend&#34;&gt;O ponto de tempo zero &lt;em&gt;t=0&lt;/em&gt; é o momento da descoberta de lesões indeterminadas;&lt;br&gt;A partir de então, o número de bacilos infiltrados nos diversos tecidos do corpo podem cair ou aumentar;&lt;br&gt;A resposta imune pode ser mediada por macrófagos predominantemente Th1 ou Th2.&lt;/p&gt; 
&lt;h2 id=&#34;a-doença&#34;&gt;A doença&lt;/h2&gt;
&lt;p&gt;A infecção ocorre pelas vias aéreas a partir de contato íntimo e prolongado entre pessoas. Alguns animais são infectados, como o tatu, porém não se conhece caso de transmissão ao homem. O bacilo é intracelular obrigatório.&lt;/p&gt;
&lt;p&gt;A hanseníase evolui de forma muito dependente do hospedeiro. Se a reação imune é intensa e capaz de conter a infiltração, lesões granulomatosas vão se formar e os bacilos serão contidos na lesão. Do contrário, a infiltração será generalizada e o número de bacilos aumentará.&lt;/p&gt;
&lt;h2 id=&#34;resposta-imune-forte&#34;&gt;Resposta imune forte&lt;/h2&gt;
&lt;p&gt;Uma resposta imune competente montada a tempo fará com que a doença evolua com uma característica fixa de lesões típicas, &lt;strong&gt;acrômicas, indolores, secas e de localização fixa&lt;/strong&gt;.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/hanseniase-hipocromicas.webp&#34;&gt;
  &lt;figcaption&gt;Forma clássica&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;resposta-imune-fraca&#34;&gt;Resposta imune fraca&lt;/h2&gt;
&lt;p&gt;A resposta de predomínio Th2 ou a ausência de resposta imune permite a exacerbada replicação bacilar, levando a infiltração disseminada e sintomatologia mais rica. Pode afetar quaisquer tecidos, notadamente os de origem ectodérmica: a pele e o sistema nervoso. Curiosamente, o SNC costuma ser poupado.&lt;/p&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/hanseniase-eritematoferruginosa.jpeg&#34;&gt;
  &lt;figcaption&gt;Desconfie de lesões com aspecto purpúrico somadas a sintomas neurológicos. A pele é lisa e caracteristicamente infiltrada.&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;h2 id=&#34;classificação-da-oms&#34;&gt;Classificação da OMS&lt;/h2&gt;
&lt;p&gt;A OMS visa uma classificação mais operacional, sem a preocupação imunohistológica.&lt;/p&gt;
&lt;p&gt;A importância é epidemiológica, já que o convívio com multibacilares deve aumentar a probabilidade diagnóstica &lt;strong&gt;sempre&lt;/strong&gt;.&lt;/p&gt;
&lt;h3 id=&#34;multibacilar-ou-dimorfa&#34;&gt;Multibacilar ou dimorfa&lt;/h3&gt;
&lt;p&gt;Se há mais de cinco lesões ao todo ou se há lesão neurológica, por conclusão clínica ou por imagem.&lt;/p&gt;
&lt;h3 id=&#34;paucibacilares&#34;&gt;Paucibacilares&lt;/h3&gt;
&lt;p&gt;Os demais indivíduos não multibacilares.&lt;/p&gt;
&lt;br&gt;
&lt;h2 id=&#34;diagnóstico&#34;&gt;Diagnóstico&lt;/h2&gt;
&lt;p&gt;A investigação clínica envolve primeiro determinar a plausibilidade epidemiológica. Se a probabilidade pré-teste é alta e as lesões compatíveis com descrição literária, o diagnóstico clínico é feito, principalmente se a prevalência local é alta ou se há convívio-contato com outro indivíduo multibacilar.&lt;/p&gt;
&lt;p&gt;O diagnóstico laboratorial ou por exames específicos não é a prática comum.&lt;/p&gt;
&lt;p&gt;O raspado ou a biópsia de lesão/pele pode confirmar o diagnóstico mas é normalmente utilizada em situações de extrema dúvida ou para fins acadêmicos.&lt;/p&gt;
&lt;h2 id=&#34;tratamento&#34;&gt;Tratamento&lt;/h2&gt;
&lt;p&gt;O tratamento, no Brasil, é a poliquimioterapia padrão da OMS (PQT/OMS).&lt;/p&gt;
&lt;p&gt;No Distrito Federal, em 2023, estão vigentes os seguintes esquemas:&lt;/p&gt;
&lt;table&gt;
	&lt;tbody&gt;
		&lt;tr&gt;
			&lt;td colspan=&#34;2&#34;&gt;&lt;b&gt;Medicamentos padronizados para o tratamento da Hanseníase&lt;/b&gt;&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td&gt;
			&lt;p&gt;Tratamento de 1ª linha adulto&lt;/p&gt;
			&lt;/td&gt;
			&lt;td&gt;Poliquimioterapia Única adulto (PQT-U adulto)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td&gt;
			&lt;p&gt;Tratamento de 1ª linha infantil&lt;/p&gt;
			&lt;/td&gt;
			&lt;td&gt;Poliquimioterapia Única infantil (PQT-U infantil)&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td&gt;
			&lt;p&gt;Tratamento das reações hansênicas&lt;/p&gt;
			&lt;/td&gt;
			&lt;td&gt;Clofazimina 50mg e 100mg &lt;br&gt; Prednisona 5mg e 20mg &lt;br&gt; Pentoxifilina 400mg&lt;br&gt; Talidomida 100mg&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td&gt;
			&lt;p&gt;Tratamento de 2ª linha&lt;/p&gt;
			&lt;/td&gt;
			&lt;td&gt;Clofazimina 50mg e 100mg &lt;br&gt; Minociclina 100mg &lt;br&gt; Rifampicina 300mg &lt;br&gt; Ofloxacino 400mg&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td&gt;
			&lt;p&gt;Esquema Farmacológico ROM1&lt;/p&gt;
			&lt;/td&gt;
			&lt;td&gt;Rifampicina 600mg &lt;br&gt; Ofloxacino 400mg &lt;br&gt; Minociclina 100mg&lt;/td&gt;
		&lt;/tr&gt;
		&lt;tr&gt;
			&lt;td&gt;
			&lt;p&gt;Tratamento para os casos resistentes&lt;/p&gt;
			&lt;/td&gt;
			&lt;td&gt;Ofloxacino 400mg &lt;br&gt; Minociclina 100mg &lt;br&gt; Claritromicina 500mg&lt;br&gt;Clofazimina 50mg&lt;/td&gt;
		&lt;/tr&gt;
	&lt;/tbody&gt;
&lt;/table&gt;
&lt;br&gt;
&lt;h3 id=&#34;reações-hansênicas&#34;&gt;Reações hansênicas&lt;/h3&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;h2 id=&#34;operacional-na-ses-df&#34;&gt;Operacional na SES-DF&lt;/h2&gt;
&lt;p&gt;Para detalhes de dispensação, documentos e responsáveis, visite a referência 2 no fim da página.
&lt;br&gt;
&lt;br&gt;&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;TAVARES, Walter; MARINHO, Luiz Alberto Carneiro. &lt;strong&gt;Rotinas de diagnóstico e tratamento das doenças infecciosas e parasitárias&lt;/strong&gt;. In: Rotinas de diagnóstico e tratamento das doenças infecciosas e parasitárias. 2005. p. 1206-1206.&lt;/li&gt;
&lt;li&gt;GDF, Governo do Distrito Federal. &lt;strong&gt;&lt;a href=&#34;https://www.saude.df.gov.br/medicamentos-hanseniase&#34;&gt;https://www.saude.df.gov.br/medicamentos-hanseniase&lt;/a&gt;&lt;/strong&gt;. Visitado em 07 de janeiro de 2024.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Drogas vasoativas</title>
		<link>https://www.aesclepius.com.br/drogas-vasoativas/</link>
		<pubDate>Tue, 02 Jan 2024 11:11:09 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/drogas-vasoativas/</guid>
		<description>

&lt;div class=&#34;scalidraw&#34;&gt;
&lt;svg version=&#34;1.1&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34; viewBox=&#34;0 0 557.8000030517578 494&#34; width=&#34;557.8000030517578&#34; height=&#34;494&#34;&gt;
  &lt;!-- svg-source:excalidraw --&gt;
  
  &lt;defs&gt;
    &lt;style class=&#34;style-fonts&#34;&gt;
      @font-face {
        font-family: Virgil;
        src: url(data:font/woff2;base64,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);
          }
    &lt;/style&gt;
    
  &lt;/defs&gt;
  &lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(55 247) rotate(0 -0.5 103.5)&#34;&gt;&lt;path d=&#34;M-0.36 -0.07 C-0.59 34.49, -1.57 172.93, -1.59 207.32 M1.65 -1.16 C1.83 33.03, 1.25 170.65, 0.82 205.37&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(55 247) rotate(0 -0.5 103.5)&#34;&gt;&lt;path d=&#34;M-7.56 181.81 C-5.31 187.55, -2.27 196.12, 0.82 205.37 M-7.56 181.81 C-5.49 187.96, -3.85 192.32, 0.82 205.37&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(55 247) rotate(0 -0.5 103.5)&#34;&gt;&lt;path d=&#34;M9.54 181.94 C6.93 187.59, 5.11 196.12, 0.82 205.37 M9.54 181.94 C7.55 188.01, 5.12 192.33, 0.82 205.37&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(55 242) rotate(0 0 -105)&#34;&gt;&lt;path d=&#34;M-0.65 -0.88 C-0.85 -36.07, -0.78 -175.71, -0.62 -210.46 M1.22 1.28 C1.36 -33.81, 2.01 -173.73, 1.77 -209.17&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(55 242) rotate(0 0 -105)&#34;&gt;&lt;path d=&#34;M10.33 -185.68 C5.75 -194.95, 3.45 -201.55, 1.77 -209.17 M10.33 -185.68 C8.08 -194.61, 3.17 -202.43, 1.77 -209.17&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(55 242) rotate(0 0 -105)&#34;&gt;&lt;path d=&#34;M-6.77 -185.67 C-5.39 -194.85, -1.72 -201.46, 1.77 -209.17 M-6.77 -185.67 C-2.99 -194.51, -1.87 -202.34, 1.77 -209.17&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(11 10) rotate(0 77.81666564941406 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Vasoconstricção&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(10 459) rotate(0 69.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Vasodilatação&lt;/text&gt;&lt;/g&gt;&lt;g stroke-linecap=&#34;round&#34;&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(32 244) rotate(0 239.5 1)&#34;&gt;&lt;path d=&#34;M-0.41 1.2 C79.3 1.58, 399.29 2.32, 479.35 2.4 M1.57 0.78 C81.07 0.78, 398.9 0.15, 478.59 0.48&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(32 244) rotate(0 239.5 1)&#34;&gt;&lt;path d=&#34;M455.09 9.02 C466.16 6.39, 473.91 4.14, 478.59 0.48 M455.09 9.02 C460.95 7.58, 468.38 4.76, 478.59 0.48&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(32 244) rotate(0 239.5 1)&#34;&gt;&lt;path d=&#34;M455.11 -8.08 C466.19 -4.1, 473.93 0.26, 478.59 0.48 M455.11 -8.08 C460.99 -4.88, 468.42 -3.07, 478.59 0.48&#34; stroke=&#34;var(--fonte)&#34; stroke-width=&#34;1&#34; fill=&#34;none&#34;&gt;&lt;/path&gt;&lt;/g&gt;&lt;/g&gt;&lt;mask&gt;&lt;/mask&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(405 217) rotate(0 55.54999923706055 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Inotropismo&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(304 150) rotate(0 98.51667022705078 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Dopamina alta dose&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(336 106) rotate(0 103.23332977294922 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Adrenalina alta dose&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(150 188) rotate(0 87.78333282470703 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Adrenalina e dopa&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(87 64) rotate(0 48.83333206176758 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Fenilefrina&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(70 108) rotate(0 61.88333511352539 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Vasopressina&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(397.0166668891907 370.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(128.01666688919067 338.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(148.01666688919067 277.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(50.016666889190674 366.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(50.016666889190674 110.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(51.016666889190674 65.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(128.01666688919067 188.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(319.0166668891907 100.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(281.0166668891907 148.5) rotate(0 5.983333110809326 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;X&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(71 368) rotate(0 69.91666412353516 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Nitroprussiato&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(172 281) rotate(0 56.266666412353516 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Dobutamina&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(144 341) rotate(0 40.5 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Milrinona&lt;/text&gt;&lt;/g&gt;&lt;g stroke-opacity=&#34;0.9&#34; fill-opacity=&#34;0.9&#34; transform=&#34;translate(418 370) rotate(0 64.9000015258789 12.5)&#34;&gt;&lt;text x=&#34;0&#34; y=&#34;17.619999999999997&#34; font-family=&#34;Virgil, Segoe UI Emoji&#34; font-size=&#34;20px&#34; fill=&#34;var(--fonte)&#34; text-anchor=&#34;start&#34; style=&#34;white-space: pre;&#34; direction=&#34;ltr&#34; dominant-baseline=&#34;alphabetic&#34;&gt;Isoproterenol&lt;/text&gt;&lt;/g&gt;&lt;/svg&gt;
&lt;/div&gt;


&lt;h2 id=&#34;lista-de-drogas&#34;&gt;Lista de drogas&lt;/h2&gt;
&lt;h3 id=&#34;noradrenalina&#34;&gt;Noradrenalina&lt;/h3&gt;
&lt;h4 id=&#34;indicação&#34;&gt;Indicação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Choque distributivo.&lt;/li&gt;
&lt;li&gt;Choque refratário.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;apresentações&#34;&gt;Apresentações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Hemitartarato de norepinefrina 8 mg/4ml.&lt;/li&gt;
&lt;li&gt;Bitartarato de norepinefrina 4mg/4ml.&lt;/li&gt;
&lt;li&gt;A apresentação de bitartarato é sal duplo e equivale a forma hemitartarato, ou seja, para cada 1mg de bitartarato são necessários 2mg de hemitartarato.&lt;/li&gt;
&lt;li&gt;Usar preferencialmente em cateter venoso central.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;mecanismo&#34;&gt;Mecanismo&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Receptores alfa-1 adrenérgicos.&lt;/li&gt;
&lt;li&gt;Receptores beta-1 adrenérgicos.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;efeitos-adversos&#34;&gt;Efeitos adversos&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Efeito paradoxal de bradicardia reflexa.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagem&#34;&gt;Dosagem&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;0,01 a 3,3 mcg/kg/min.&lt;/li&gt;
&lt;li&gt;Apresenta pouco benefício acima de 2 mcg/kg/min.&lt;/li&gt;
&lt;li&gt;Acima de 0,5 mcg/kg/min no choque refratário.&lt;/li&gt;
&lt;li&gt;Acima de 1 mcg/kg/min está associado a taxa de mortalidade de 90%.&lt;/li&gt;
&lt;li&gt;Pode ser diluída em soro a 0,9% ou soro glicosado a 5%.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;prescrição-sugerida&#34;&gt;Prescrição sugerida&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;4 ampolas e 250mL de soro glicosado, iniciando a 5ml/h.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;vasopressina&#34;&gt;Vasopressina&lt;/h3&gt;
&lt;h4 id=&#34;indicação-1&#34;&gt;Indicação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Choque séptico refratário.&lt;/li&gt;
&lt;li&gt;Não é recomendada como agente único no tratamento do choque, trata-se de uma droga de associação.&lt;/li&gt;
&lt;li&gt;O efeito da vasopressina não é reduzido pela acidose, diferentemente das catecolaminas.&lt;/li&gt;
&lt;li&gt;Usar preferencialmente em cateter venoso central.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;apresentação&#34;&gt;Apresentação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Vasopressina 20U/ml.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;mecanismo-1&#34;&gt;Mecanismo&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;É um hormônio sintetizado no hipotálamo, também chamado hormônio anti-diurético (ADH).&lt;/li&gt;
&lt;li&gt;Ação V1 de vasoconstrição por contração de musculatura lisa vascular e sinergismo com catecolaminas.&lt;/li&gt;
&lt;li&gt;Inibe produção de óxido nítrico.&lt;/li&gt;
&lt;li&gt;Ação V2 de retenção de água no ducto coletor por fechamento de aquaporinas.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;efeitos-adversos-1&#34;&gt;Efeitos adversos&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Pode ocorrer isquemia mesentérica, isquemia digital, diminuição do débito cardíaco e hiponatremia.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagem-1&#34;&gt;Dosagem&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Habitualmente de 0,01 A 0,04 U/min.&lt;/li&gt;
&lt;li&gt;Evitar doses maiores do que 0,04 u/min, pois estão associadas a mais eventos isquêmicos.&lt;/li&gt;
&lt;li&gt;Pode ser diluída em soro a 0,9% ou soro glicosado a 5%.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;prescrição-sugerida-1&#34;&gt;Prescrição sugerida&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;1 ampola e 100mL de soro glicosado, iniciar a 5mL/h.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;adrenalina&#34;&gt;Adrenalina&lt;/h3&gt;
&lt;h4 id=&#34;indicações&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Parada cardiorrespiratória, anafilaxia e bradiarrtimias instáveis.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;apresentação-1&#34;&gt;Apresentação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Adrenalina ou epinefrina a 1mg/mL.&lt;/li&gt;
&lt;li&gt;Usar preferencialmente em cateter venoso central.&lt;/li&gt;
&lt;li&gt;Uso intravenoso ou intramuscular.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;mecanismo-2&#34;&gt;Mecanismo&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Meia vida curta de 2min.&lt;/li&gt;
&lt;li&gt;Receptores adrenérgicos alfa 1, beta1 e beta2.&lt;/li&gt;
&lt;li&gt;Droga catecolaminérgica não seletiva, armazenada e liberada pelas células cromoafins da medula adrenal.&lt;/li&gt;
&lt;li&gt;Pode ser útil em pacientes que permanecem hipotensos após infusão dos demais vasopressores.&lt;/li&gt;
&lt;li&gt;Droga de escolha no &lt;mark&gt;choque anafilático&lt;/mark&gt;, pcr e bradiarritmias instáveis.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagens&#34;&gt;Dosagens&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;2-10 mcg/min que é bem variável na literatura.&lt;/li&gt;
&lt;li&gt;Em doses mais baixas prevalece ação beta nas mais altas a ação alfa&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;prescrição-sugerida-2&#34;&gt;Prescrição sugerida&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;16 ampolas e 250mL de soro glicosado, inicar a 2mL/h.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;efeitos-adversos-2&#34;&gt;Efeitos adversos&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Aumento do índice cardíaco e da resistência vascular sistêmica em menor grau, com aumento da pressão arterial.&lt;/li&gt;
&lt;li&gt;Hiperlactatemia com acidose metabólica, além de disritmias, isquemia e hipoglicemia.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;dopamina&#34;&gt;Dopamina&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Precursora natural da noradrenalina e adrenalina.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;indicações-1&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Segunda linha em bradiarritmias instáveis.&lt;/li&gt;
&lt;li&gt;Não é mais recomendada para pacientes com choque. Seu uso se restringe ao tratamento emergencial de bradicardias instáveis.&lt;/li&gt;
&lt;li&gt;Via endovenosa.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagens-1&#34;&gt;Dosagens&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Dopamina 50mg/10mL.&lt;/li&gt;
&lt;li&gt;Seus efeitos são dose-dependentes.&lt;/li&gt;
&lt;li&gt;Predomina ação sobre receptores dopaminérgicos a doses abaixo de 5 mcg/kg/min, sobre Receptores beta-1 adrenérgicos entre 5 a 10 mcg/kg/min e sobre receptores alfa-1 adrenérgicos entre 10 a 20 mcg/kg/min.&lt;/li&gt;
&lt;li&gt;Pode ser diluída em soro a 0,9% ou soro glicosado a 5%.&lt;/li&gt;
&lt;li&gt;Usar preferencialmente em cateter venoso central.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;prescrição-sugerida-3&#34;&gt;Prescrição sugerida&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;5 ampolas e 250mL de soro glicosado, iniciar a 25mL/h.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;dobutamina&#34;&gt;Dobutamina&lt;/h3&gt;
&lt;h4 id=&#34;indicações-2&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Choque cardiogênico.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;apresentação-2&#34;&gt;Apresentação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Dobutamina 250 mg/20mL.&lt;/li&gt;
&lt;li&gt;Via endovenosa.&lt;/li&gt;
&lt;li&gt;Usar preferencialmente em cateter venoso central.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;indicações-3&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Pode ser usada em casos selecionados de choque sétpico com débito cardíaco muito reduzido, índice cardíaco abaixo de 2,5l/min/m2.&lt;/li&gt;
&lt;li&gt;É &lt;strong&gt;contra-indicada&lt;/strong&gt; em pacientes com fibrilação atrial, estenose aórtica grave e cardiomiopatias obstrutivas.&lt;/li&gt;
&lt;li&gt;Efeitos colaterais incluem taquicardia e arritmias (infarto miocárdico tipo 2).&lt;/li&gt;
&lt;li&gt;Pode ter o efeito anulado em usuários de beta-bloqueadores.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagens-2&#34;&gt;Dosagens&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;2 a 20 mcg/Kg/min e titular de acordo com a resposta desejada, sem aumentar frequência cardíaca acima de 10% do basal.&lt;/li&gt;
&lt;li&gt;Atua principalmente em receptores beta-1, produzindo uma ação inotrópica potente.&lt;/li&gt;
&lt;li&gt;Interage de maneira fraca com receptores beta-2, o que pode levar a uma queda da pressão arterial por efeito vasodilatador.&lt;/li&gt;
&lt;li&gt;Doses entre 5 e 15 mcg/kg/min apresenta efeito inotrópico maior que cronotrópico.&lt;/li&gt;
&lt;li&gt;Pode ser diluída em soro a 0,9% ou soro glicosado a 5%.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;prescrição-sugerida-4&#34;&gt;Prescrição sugerida&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;2 ampolas e 250mL de soro glicosado, inicar a 5mL/h.&lt;/li&gt;
&lt;li&gt;Monitorar o tempo de enchimento capilar.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;milrinona&#34;&gt;Milrinona&lt;/h3&gt;
&lt;h4 id=&#34;apresentações-1&#34;&gt;Apresentações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;20 mg/20mL.&lt;/li&gt;
&lt;li&gt;Efeitos hemodinâmicos semelhantes à dobutamina.&lt;/li&gt;
&lt;li&gt;Inibe a fosfodiesterase-3 que impede a degradação intracelular de AmpC.&lt;/li&gt;
&lt;li&gt;Betabloqueadores &lt;mark&gt;não revertem&lt;/mark&gt; suas manifestações inotrópicas.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagens-3&#34;&gt;Dosagens&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Ataque de 50 mcg/kg em 10 min.&lt;/li&gt;
&lt;li&gt;Manutenção de 0,25 a 0,75mcg/kg/min.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;indicações-4&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Insuficiência cardíaca grave insensível ao tratamento padrão&lt;/li&gt;
&lt;li&gt;Disfunção do ventrículo direito associado a hipertensão pulmonar.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Contra-indicado em cardiomiopatia hipertrófica obstrutiva&lt;/strong&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;levosimendana&#34;&gt;Levosimendana&lt;/h3&gt;
&lt;h4 id=&#34;apresentação-3&#34;&gt;Apresentação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;12,5 mg/5mL endovenosa.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;indicações-5&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Insuficiência cardíaca após infarto agudo do miocárdio.&lt;/li&gt;
&lt;li&gt;Melhora a contratilidade do miocárdio sem aumentar a demanda de oxigênio.&lt;/li&gt;
&lt;li&gt;Produz metabólitos ativos de meia vida longa com efeitos hemodinâmicos por dias após a suspensão.&lt;/li&gt;
&lt;li&gt;Faltam evidências para sustentar o uso dessa droga no choque cardiogênico.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagens-4&#34;&gt;Dosagens&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Ataque de 12 a 24mcg/Kg em 10min.&lt;/li&gt;
&lt;li&gt;Manutenção de 0,05 a 0,2 mcg/kg/min.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;terlipressina&#34;&gt;Terlipressina&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Análogo da vasopressina.&lt;/li&gt;
&lt;li&gt;Vasoconstrictor esplâncnico.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;indicações-6&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Hemorragia digestiva alta varicosa e na terapia crítica do hepatopata.&lt;/li&gt;
&lt;li&gt;Ataque de 2mg, de 4/4h por 48 horas.&lt;/li&gt;
&lt;li&gt;Manutenção de 1 mg de 4/4 horas por mais 24 a 72 horas.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;nitroprussiato-de-sódio--nipride&#34;&gt;Nitroprussiato de sódio &amp;mdash; Nipride&lt;/h3&gt;
&lt;h4 id=&#34;apresentação-4&#34;&gt;Apresentação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Nitroprussiato de sódio 50mg/2mL.&lt;/li&gt;
&lt;li&gt;Via endovenosa.&lt;/li&gt;
&lt;li&gt;Usar preferencialmente em cateter venoso central.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;indicações-7&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Emergências hipertensivas.
-AÇÃO DIRETA NA MUSCULATURA ARTERIOLAR, DIMINUINDO A RESISTÊNCIA VASCULAR PERIFÉRICA.
-VASODILATADOR ARTERIAL E VENOSO&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Efeitos adversos&lt;/strong&gt;: intoxicação por cianeto cursando com acidose metabólica, hipoxemia, bradicardia, convulsões. Também podem ocorrer náuseas, vômitos e roubo de fluxo coronariano&lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagens-5&#34;&gt;Dosagens&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;0,3 a 10mcg/kg/min.&lt;/li&gt;
&lt;li&gt;Pode ser diluída em soro a 0,9% de sal ou soro glicosado à 5%.&lt;/li&gt;
&lt;li&gt;Deve ser infundido com equipo &lt;mark&gt;fotoprotetor&lt;/mark&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;prescrição-sugerida-5&#34;&gt;Prescrição sugerida&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;1 ampola e 250 mL de soro glicosado, iniciar a 5 mL/h.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;nitroglicerina--tridil&#34;&gt;Nitroglicerina &amp;mdash; Tridil&lt;/h3&gt;
&lt;h4 id=&#34;indicações-8&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Emergências hipertensivas.&lt;/li&gt;
&lt;li&gt;Potente vasodilatador venoso e coronariano, promovendo controle álgico.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Efeitos adversos&lt;/strong&gt;: cefaléia, hipotensão e taquicardia. Após 24h, frequentemente ocorre taquifilaxia, necessitando doses crescentes para atingir o mesmo efeito desejado. Causa perda da capacidade contrátil da musculatura lisa por aumentar o óxido nítrico.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;apresentação-5&#34;&gt;Apresentação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Nitroglicerina 50 mg/10ml.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagem-2&#34;&gt;Dosagem&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;5 a 20mcg/kg/min.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;prescrição-sugerida-6&#34;&gt;Prescrição sugerida&lt;/h4&gt;
&lt;p&gt;1 ampola e 240 mL de soro glicosado, iniciar a 5 mL/h.&lt;/p&gt;
&lt;h3 id=&#34;hidralazina&#34;&gt;Hidralazina&lt;/h3&gt;
&lt;h4 id=&#34;indicações-9&#34;&gt;Indicações&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Emergências hipertensivas principalmente em gestantes com pré-eclâmpsia.&lt;/li&gt;
&lt;li&gt;Atua sobre as artérias e arteríolas.&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Efeitos adversos&lt;/strong&gt;: causa taquicardia reflexa e pode apresentar efeito hipotensivo retardado após o uso.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;apresentação-6&#34;&gt;Apresentação&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Hidralazina 20 mg/mL.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;dosagem-3&#34;&gt;Dosagem&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;5mg a cada 10min até dose máxima de 20mg/paciente.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;prescrição-sugerida-7&#34;&gt;Prescrição sugerida&lt;/h4&gt;
&lt;p&gt;1 ampola e 20mL de soro a 0,9% de Na. Administrar bolo de 5mL a cada 10min.
&lt;br&gt;&lt;/p&gt;
&lt;h2 id=&#34;fluxograma-de-manejo-das-vasodisplasias-agudas&#34;&gt;Fluxograma de manejo das vasodisplasias agudas&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD
A(Hipotensão) --&gt; B(Desidratação&lt;br&gt;Sedação&lt;br&gt;Anti-hipertensivos&lt;br&gt;Infecção&lt;br&gt;Alergia) --&gt; Z(Tratamento específico&lt;br&gt;para cada etiologia);
A --&gt; C(Sinais de choque);
Sim(Sim);
C --&gt; Sim --&gt; T(Enchimento&lt;br&gt;capilar);
Sim --&gt; U(Turgência&lt;br&gt;jugular);
Sim --&gt; V(Estertores&lt;br&gt;crepitantes);
T -- Normal --&gt; Dist(Choque&lt;br&gt;distributivo) --&gt; FimTEC(Noradrenalina&lt;br&gt;com vasopressina&lt;br&gt;se necessário);
T -- Lento --&gt; Hip(Choque&lt;br&gt;hipodinâmico) --&gt; Z;
U -- Presente --&gt; CC(Choque obstrutivo&lt;br&gt;ou cardiogênico) --&gt; Z
U -- Ausente --&gt; CD(Choque hipovolêmico&lt;br&gt;ou distributivo) --&gt; end1(Exapnsão volêmica&lt;br&gt;ou noradrenalina);
V -- Presentes --&gt; CCC(Choque cardiogênico) --&gt; end2(Dobutamina);
V -- Ausentes --&gt; CDD(Não-cardiogênico) --&gt; Z;
&lt;/pre&gt;

&lt;h2 id=&#34;análise-de-artigos&#34;&gt;Análise de artigos&lt;/h2&gt;
&lt;h3 id=&#34;dez-dicas-sobre-vasopressores&#34;&gt;Dez dicas sobre vasopressores &lt;sup id=&#34;fnref:3&#34;&gt;&lt;a href=&#34;#fn:3&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;3&lt;/a&gt;&lt;/sup&gt;&lt;/h3&gt;
&lt;h4 id=&#34;1-set-goals-of-mean-or-diastolic-blood-pressures&#34;&gt;1. Set goals of mean or diastolic blood pressures&lt;/h4&gt;
&lt;h4 id=&#34;2-individualize-the-arterial-pressure-targets-goals&#34;&gt;2. Individualize the arterial pressure targets goals&lt;/h4&gt;
&lt;p&gt;Tente definir um alvo de pressão arterial média para o paciente e revisá-lo e redefini-lo a cada 6/8h.
Calculadora &lt;a href=&#34;../../medicina/hemodinamica/&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;A hipertensão arterial sistêmica prévia não justifica maiores médias.&lt;/p&gt;
&lt;p&gt;Permita maiores médias pressóricas para manter perfusão periférica e diurese.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h4 id=&#34;3-vasopressors-induce-an-endogenous-fluid-recruitment-and-may-limit-positive-fluid-balance&#34;&gt;3. Vasopressors induce an endogenous fluid recruitment and may limit positive fluid balance&lt;/h4&gt;
&lt;p&gt;A vasoconstricção periférica mobiliza fluidos para circulação central, provocando sobrecarga adicional a dos fluidos exógenos.&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;Realize desafio de fluidos monitorando o paciente antes da administração continuada.&lt;/p&gt;
&lt;p&gt;A exceção é para hipotensão grave, com pressão arterial média menores que 55mmHg.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h4 id=&#34;4-reassess-fluid-status-and-cardiac-output-after-initiation-of-vasopressors&#34;&gt;4. Reassess fluid status and cardiac output after initiation of vasopressors&lt;/h4&gt;
&lt;p&gt;As drogas vasoativas podem preciptar eventos oclusivos de coronárias e artéria mesentérica, portanto reavalie o paciente após administração.&lt;/p&gt;
&lt;h4 id=&#34;5-consider-agents-with-a-different-mechanism-of-action-as-a-second-line-agent&#34;&gt;5. Consider agents with a different mechanism of action as a second line agent&lt;/h4&gt;
&lt;h4 id=&#34;6-consider-adding-hydrocortisone-in-patients-on-high-doses-of-vasopressors&#34;&gt;6. Consider adding hydrocortisone in patients on high doses of vasopressors&lt;/h4&gt;
&lt;blockquote&gt;
&lt;p&gt;Estudos mostram que hidrocortisona e fludrocortisona diminuem a necessidade de altas doses de vasopressores.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h4 id=&#34;7-vasopressin-in-patients-with-right-ventricular-failure&#34;&gt;7. Vasopressin in patients with right ventricular failure&lt;/h4&gt;
&lt;p&gt;O leito vascular pulmonar não apresenta receptores V1 e, assim, não provocam aumento de resistência vascular pulmonar, o que é benéfico para falência ventricular direita.&lt;/p&gt;
&lt;h4 id=&#34;8-there-is-no-maximal-dose-of-vasopressors&#34;&gt;8. There is no maximal dose of vasopressors&lt;/h4&gt;
&lt;p&gt;Limitar o uso de doses altas de vasopressores pode resultar em menor sucesso de sobrevida.&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;É um erro associar maior morbidade às altas doses de drovas vasoativas. Na verdade, trata-se de um &lt;a href=&#34;../../vieses/#vi%C3%A9s-de-confus%C3%A3o-das-vari%C3%A1veis&#34;&gt;viés de confusão entre variáveis&lt;/a&gt; porque os pacientes mais graves usam maiores doses.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h4 id=&#34;9-enteral-tube-feeding-can-be-initiated-while-under-vasopressors&#34;&gt;9. Enteral tube feeding can be initiated while under vasopressors&lt;/h4&gt;
&lt;p&gt;A vigência de terapia vasoativa não justifica atraso na passagem de sonda entérica.&lt;/p&gt;
&lt;blockquote&gt;
&lt;p&gt;A melhora da circulação enteral é um aspecto positivo e favorece a indicação de dieta por sondas entéricas.&lt;/p&gt;
&lt;/blockquote&gt;
&lt;h4 id=&#34;10-vasopressors-can-be-safely-administered-through-a-peripheral-catheter&#34;&gt;10. Vasopressors can be safely administered through a peripheral catheter&lt;/h4&gt;
&lt;p&gt;A falta de acesso vascular central não impede prescrição de droga vasoativa.&lt;/p&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Droga&lt;/th&gt;
          &lt;th&gt;Dose&lt;/th&gt;
          &lt;th&gt;Receptores&lt;/th&gt;
          &lt;th&gt;Colaterais&lt;/th&gt;
          &lt;th&gt;Comentários&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;Norepinephrine&lt;/td&gt;
          &lt;td&gt;0.01-1 µg/kg/min&lt;/td&gt;
          &lt;td&gt;α1 &amp;gt; β1 &amp;gt; β2&lt;/td&gt;
          &lt;td&gt;- Tachyarrhythmias&lt;br&gt;- Increased pulmonary vascular resistance&lt;br&gt;- Peripheral (digital) ischemia&lt;/td&gt;
          &lt;td&gt;- First-line vasopressor in septic and cardiogenic shock&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Epinephrine&lt;/td&gt;
          &lt;td&gt;0.01-0.3 µg/kg/min&lt;/td&gt;
          &lt;td&gt;α1 = β1 &amp;gt; β2&lt;/td&gt;
          &lt;td&gt;- Tachyarrhythmias, cardiac ischemia &lt;br&gt;- Splanchnic vasoconstriction leading to abdominal organ ischemia &lt;br&gt;- Hyperlactemia and hyperglycemia&lt;/td&gt;
          &lt;td&gt;- First-line vasopressor in anaphylactic shock and cardiac arrest &lt;br&gt;- Hyperlactemia makes lactate a less reliable measure of end-organ perfusion&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Dopamine&lt;/td&gt;
          &lt;td&gt;2-20 µg/kg/min&lt;/td&gt;
          &lt;td&gt;aDA1&amp;gt;β1 &amp;gt; α1&lt;/td&gt;
          &lt;td&gt;- Tachyarrhythmias&lt;br&gt;- Cardiac ischemia&lt;/td&gt;
          &lt;td&gt;- Second-line inotrope in adults &lt;br&gt;- Used in select patients with low risk of tachyarrhythmias and bradycardia&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Phenylephrine&lt;/td&gt;
          &lt;td&gt;0.1-1 µg/kg/min&lt;/td&gt;
          &lt;td&gt;α1&lt;/td&gt;
          &lt;td&gt;- Reﬂex bradycardia &lt;br&gt;- Severe peripheral ischemia&lt;/td&gt;
          &lt;td&gt;- Useful for tachyarrhythmias, or in patients with adequate cardiac output and persistently low blood pressure&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Vasopressin&lt;/td&gt;
          &lt;td&gt;0.01-0.06 units/min&lt;/td&gt;
          &lt;td&gt;V1&lt;/td&gt;
          &lt;td&gt;- Possible gastrointestinal hypoperfusion due to splanchnic vasoconstriction&lt;/td&gt;
          &lt;td&gt;- Usually used as an adjunct to norepinephrine in septic shock &lt;br&gt;- Does not increase pulmonary vascular resistance&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Dobutamine&lt;/td&gt;
          &lt;td&gt;2-10 µg/kg/min&lt;/td&gt;
          &lt;td&gt;β1 &amp;gt; β2 &amp;gt; α1&lt;/td&gt;
          &lt;td&gt;- Hypotension &lt;br&gt;- Tachyarrhythmias&lt;br&gt;- Tachyphylaxis (infusions greater than 72 hours)&lt;/td&gt;
          &lt;td&gt;- First-line inotrope for most forms of shock &lt;br&gt;- Quick onset of action&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Milrinone&lt;/td&gt;
          &lt;td&gt;0.1-0.5 µg/kg/min&lt;/td&gt;
          &lt;td&gt;Phosphodiesterase-3 inhibitor&lt;/td&gt;
          &lt;td&gt;- Hypotension (causes greater vasodilation than DOB)&lt;br&gt;- Tachyarrhythmias &lt;br&gt;- Torsades de pointes&lt;/td&gt;
          &lt;td&gt;- Useful inotrope in patients with signiﬁcant pulmonary vascular resistance&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Azul de metileno&lt;/td&gt;
          &lt;td&gt;0.25-1.2mg/kg/h&lt;/td&gt;
          &lt;td&gt;GABA-A&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Angiotensina II&lt;/td&gt;
          &lt;td&gt;Bolo de 2mg/Kg e 5-200ng/kg/min&lt;/td&gt;
          &lt;td&gt;Receptor de angiotensina II&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Desmopressina&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;V2&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;Diabetes insipidus, sangramentos&amp;hellip;&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Ornipressina&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;V1&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;Vasoconstrictor na miomectomia&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Selepressina&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;V1&lt;/td&gt;
          &lt;td&gt;&lt;span style=&#34;color:red;bakcground:black&#34;&gt;NÃO APROVADA PARA USO CLÍNICO&lt;/span&gt;&lt;/td&gt;
          &lt;td&gt;Choque séptico&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;Terlipressina&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;V1&lt;/td&gt;
          &lt;td&gt;&lt;/td&gt;
          &lt;td&gt;Hipertensão portal, varizes esofágicas e choque séptico&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;sup&gt;*&lt;/sup&gt;Adaptado de MERGOUM et. al.&lt;sup id=&#34;fnref:4&#34;&gt;&lt;a href=&#34;#fn:4&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;4&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Ações beta de receptores adrenérgicos: cronotropismo e inotropismo.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;O uso de nitroprussiato em síndromes coronarianas agudas promove dilatação das coronárias sadias e da periferia, diminuindo a disponibilidade para a coronária obstruída, causando piora no quadro isquêmico.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:3&#34;&gt;
&lt;p&gt;Legrand, M., Zarbock, A. &lt;strong&gt;Ten tips to optimize vasopressors use in the critically ill patient with hypotension&lt;/strong&gt;. Intensive Care Med 48, 736–739 (2022). &lt;a href=&#34;https://doi.org/10.1007/s00134-022-06708-y&#34;&gt;https://doi.org/10.1007/s00134-022-06708-y&lt;/a&gt;&amp;#160;&lt;a href=&#34;#fnref:3&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:4&#34;&gt;
&lt;p&gt;Mergoum AM, Rhone AR, Larson NJ, Dries DJ, Blondeau B, Rogers FB. &lt;strong&gt;A Guide to the Use of Vasopressors and Inotropes for Patients in Shock&lt;/strong&gt;. J Intensive Care Med. 2024 Apr 13:8850666241246230. doi: 10.1177/08850666241246230. Epub ahead of print. PMID: 38613381.&amp;#160;&lt;a href=&#34;#fnref:4&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
	</item>
	
	<item>
		<title>Taquiarritimias: visão geral</title>
		<link>https://www.aesclepius.com.br/taquicardias/</link>
		<pubDate>Sat, 30 Dec 2023 04:08:57 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/taquicardias/</guid>
		<description>&lt;h2 id=&#34;a-taquiarritmia-é-derivada&#34;&gt;A taquiarritmia é derivada?&lt;/h2&gt;
&lt;p&gt;Às vezes, como na sepse, a taquiarritmia é decorrente da condição clínica do paciente e resolvê-la &lt;em&gt;per si&lt;/em&gt; pouco ajuda.&lt;/p&gt;
&lt;p&gt;Para distinguir de forma prática, utilize o corte de Karvonen¹:&lt;/p&gt;
&lt;p&gt;$$ FC_{corte} = 220 - idade $$&lt;/p&gt;
&lt;p&gt;Se a FC atual do paciente é maior que o previsto na equação, muito provavelmente a taquiarritmia é a causa da instabilidade clínica. Se menor, é derivada de outra patologia.&lt;/p&gt;
&lt;h2 id=&#34;conduta-&#34;&gt;Conduta² ³&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
    inicio(Hemodinâmica) -- estável --&gt; i(Descartar &lt;br&gt;intoxicação digitálica) --&gt; estavel(Monitorização completa)
    estavel -- Taqui sinusal --&gt; fimTsinu(ansiólise e.g. &lt;br&gt;Midazolam 5mg)
    estavel -- Taqui supra --&gt; Ts(Massagem carotídea) -- persiste --&gt; fimTs(adenosina 6mg) -- persiste --&gt; fimTs2(adenosina 12mg) --&gt; fimTs3(Cardioversão&lt;br&gt;elétrica)
    estavel -- Taqui ventricular --&gt; Tq(amiodarona&lt;br&gt;5 a 10 mg/kg&lt;br&gt;OU&lt;br&gt;Lidocaína &lt;br&gt;1 a 1.5mg/Kg em 3min) -- persiste --&gt; fimTq(Cardioversão&lt;br&gt;elétrica)
    Tq -- Se lidocaína&lt;br&gt;com resolução --&gt; fimTq2(Manter infusão&lt;br&gt;1 a 4mg/Kg)
    inicio -- instável --&gt; instavel(Conferir pulso)
    instavel -- Sem pulso --&gt; fimInsta(Algoritmo de PCR)
    instavel -- Com pulso --&gt; fimInsta2(Medidas de estabilização hemodinâmica) --&gt; inicio
&lt;/pre&gt;

&lt;h2 id=&#34;alternativas&#34;&gt;Alternativas&lt;/h2&gt;
&lt;p&gt;Verapamil 5mg/IV e associação de diltiazém 120mg e propranolol 80mg por VO também podem ser utilizados para cardioversão química das taquicardias que dependem da junção AV.&lt;/p&gt;
&lt;h2 id=&#34;massagem-carotídea&#34;&gt;Massagem carotídea&lt;/h2&gt;
&lt;p&gt;Em detalhes &lt;a href=&#34;../../medicina/massagem-carotidea/index.html&#34;&gt;aqui&lt;/a&gt;.&lt;/p&gt;
&lt;h2 id=&#34;pill-in-the-pocket&#34;&gt;Pill-in-the-pocket⁴&lt;/h2&gt;
&lt;p&gt;Para pacientes sem cardiopatia estrutural ou distúrbios de condução e que já conhecem o diagnóstico de FA é possível adotar a seguinte estratégia:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;600 mg de propafenona ou 450 mg se massa corporal menor que 70 kg.&lt;/li&gt;
&lt;li&gt;300mg de flecainida ou 200mg se massa corporal menor que 70kg.&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;Ambas necessitam de repouso por 4 horas após a administração. Na segunda hora há resolução dos sintomas em 84% dos pacientes.&lt;/p&gt;
&lt;p&gt;Uma vez realizada com sucesso e sem reações adversas em regime hospitalar, faça a prescrição para uso emergencial-doméstico.&lt;/p&gt;
&lt;h2 id=&#34;mais-em-breve&#34;&gt;Mais em breve&amp;hellip;&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Detalhes da cardioversão elétrica&lt;/li&gt;
&lt;li&gt;Como realizar manobras&lt;/li&gt;
&lt;li&gt;Guia rápido de preparo medicamentoso com ampolas usadas no Brasil&lt;/li&gt;
&lt;li&gt;mais&amp;hellip;&lt;/li&gt;
&lt;/ol&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Karvonen JJ, Kentala E, Mustala O. &lt;strong&gt;The effects of training on heart rate: a “longitudinal” study&lt;/strong&gt;. Ann Med Exp Biol Fenn. 1957; 35: 307-15.&lt;/li&gt;
&lt;li&gt;Brugada P, Brugada J, Lluis M, Smeets J, Andries EW. &lt;strong&gt;A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex&lt;/strong&gt;. Circulation. 1991;83:1649-1659.&lt;/li&gt;
&lt;li&gt;VELASCO, Irineu Tadeu et al. &lt;strong&gt;Medicina de emergência: abordagem prática 16ed. - 2022&lt;/strong&gt;. Manole. Santana do Parnaíba - SP. Brasil. 2022.&lt;/li&gt;
&lt;li&gt;ALBONI, Paolo et al. &lt;strong&gt;Outpatient treatment of recent-onset atrial fibrillation with the “pill-in-the-pocket” approach&lt;/strong&gt;. New England Journal of Medicine, v. 351, n. 23, p. 2384-2391, 2004.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Analgesias</title>
		<link>https://www.aesclepius.com.br/analgesias/</link>
		<pubDate>Fri, 29 Dec 2023 12:25:50 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/analgesias/</guid>
		<description>&lt;h2 id=&#34;a-maior-falha-da-formação-médica&#34;&gt;A maior falha da formação médica&lt;/h2&gt;



&lt;div class=&#34;mediaframe&#34;&gt;
  &lt;img src=&#34;../../pix/medicina/dr-stupid.webp&#34;&gt;
  &lt;figcaption&gt;É só uma picadinha!&lt;/figcaption&gt;
  &lt;/img&gt;
&lt;/div&gt;
&lt;p&gt;Entre as pessoas leigas há um consenso: &lt;strong&gt;médicos são pessoas capazes de reduzir o sofrimento físico e, a depender, até mesmo emocional das pessoas.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Será?!&lt;/p&gt;
&lt;p&gt;Durante a formação acadêmica em medicina, uma das maiores, senão a maior lacuna é o aprendizado da correta analgesia e o conhecimento da dor associada aos procedimentos quotidianos.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;A seguir, vamos solucionar alguns destes problemas comumente encontrados no dia-a-dia médico&lt;/strong&gt;.&lt;/p&gt;
&lt;h2 id=&#34;benzetacil&#34;&gt;Benzetacil&lt;/h2&gt;
&lt;p&gt;No preparo da diluição dos 2.4 milhões de UI de penincilina benzatina, substitua 0.5ml da água destilada por lidocaína a 2%³ ⁴.&lt;/p&gt;
&lt;p&gt;Aplique usando agulha 30x8 sem fricção local. Não seja a tia da vacinação, não faça &amp;ldquo;morrinho&amp;rdquo; de músculo nem aperte o sítio.&lt;/p&gt;
&lt;p&gt;Quanto mais lenta a injeção, menos intensa a dor da aplição, porém mais durável o desconforto.&lt;/p&gt;
&lt;h2 id=&#34;botões-anestésicos&#34;&gt;Botões anestésicos&lt;/h2&gt;
&lt;p&gt;A base Cochrane já recomenda o ajuste de pH dos anestésicos locais a algum tempo⁶. Porém, sua adoção é muito restrita a centros de excelência. Na verdade, a lidocaína e.g. é 1mil vezes mais ácida que o tecido subcutâneo⁷.&lt;/p&gt;
&lt;p&gt;O preparo ideal é de 1ml de $ HCO_{3}^- $ a 8.4% para cada 10ml de anestésico com vasopressor⁷.&lt;/p&gt;
&lt;p&gt;Porém, é possível ajustes intermediários sem cálculos complexos, tendo em vista que qualquer atenuação da acidez é melhor que nenhuma.&lt;/p&gt;
&lt;h2 id=&#34;acesso-venoso-intraósseo&#34;&gt;Acesso venoso intraósseo&lt;/h2&gt;
&lt;p&gt;Este procedimento pertence ao departamento da emergência e da medicina pré-hospitalar, portanto, seu problema maior não é a instalação imediata, na cena, e sim o correr do fluido nos minutos e horas que se seguem. Novamente, a lidocaína apresenta boa aplicação neste caso porque seu início de ação e duração são compatíveis com o &lt;em&gt;onset&lt;/em&gt; associado ao acesso intraósseo.&lt;/p&gt;
&lt;p&gt;Prepare 40mg para adultos e 0.5mg/Kg para crianças de lidocaína em seringa separada.&lt;/p&gt;
&lt;p&gt;Faça lentamente antes da administração de fluidos, aguardando 2min se possível⁵.&lt;/p&gt;
&lt;h2 id=&#34;-mais-em-breve&#34;&gt;&amp;hellip; mais em breve!&lt;/h2&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I. &lt;strong&gt;Lidocaine as a diluent for administration of benzathine penicillin&lt;/strong&gt;. G. Pediatr Infect Dis J. 1998 Oct; 17 (10): 890-3. Disponível em: &lt;a href=&#34;https://journals.lww.com/pidj/Abstract/1998/10000/Lidocaine_as_a_diluent_for_administration_of.8.aspx&#34;&gt;https://journals.lww.com/pidj/Abstract/1998/10000/Lidocaine_as_a_diluent_for_administration_of.8.aspx&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;Zeydi AE, Khezri HD. &lt;strong&gt;Can lidocaine be safely used to reduce pain caused by intramuscular penicillin injections? A short literature review&lt;/strong&gt;. Oman Med J. 2012 Jul; 27(4): 337. Disponível em: &lt;a href=&#34;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464756/pdf/OMJ-D-12-00111.pdf&#34;&gt;https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464756/pdf/OMJ-D-12-00111.pdf&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;Brasil. Sociedade Brasileira de Cardiologia. &lt;strong&gt;Diretrizes brasileiras para o diagnóstico, tratamento e prevenção da febre reumática.&lt;/strong&gt; Arq Bras Cardiol 2009; 93(3 supl.4): 1-18. Disponível em: &lt;a href=&#34;http://publicacoes.cardiol.br/consenso/2009/diretriz_febrereumatica_93supl04.pdf&#34;&gt;http://publicacoes.cardiol.br/consenso/2009/diretriz_febrereumatica_93supl04.pdf&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;Prefeitura Municipal de Campinas. Secretaria de Saúde. Departamento de Saúde. Departamento de Vigilância em Saúde. Nota técnica  Nº 001-2017 – SMS. &lt;strong&gt;Ref: Orientações para uso de penicilina benzatina associada a lidocaína 2% para gestantes com sífilis e seus parceiros&lt;/strong&gt;. junho, 2017: 4p. Disponível em: &lt;a href=&#34;http://saude.campinas.sp.gov.br/saude/programas/protocolos/protocolo_mulher/2017/Nota_Tecnica_001_2017_Protocolo_de_Uso_de_Penicilina_Benzatina_associada_a_Lidocaina_para_Gestantes_com_Sifilis_e_Parceiros.pdf&#34;&gt;http://saude.campinas.sp.gov.br/saude/programas/protocolos/protocolo_mulher/2017/Nota_Tecnica_001_2017_Protocolo_de_Uso_de_Penicilina_Benzatina_associada_a_Lidocaina_para_Gestantes_com_Sifilis_e_Parceiros.pdf&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;Ilicki J, Scholander J. &lt;strong&gt;Lidocaine can reduce the pain of intra-osseous fluid infusion&lt;/strong&gt;. Crit Care. 2016 Jun 20;20(1):192. doi: 10.1186/s13054-016-1359-5. PMID: 27320792; PMCID: PMC4913427.&lt;/li&gt;
&lt;li&gt;CEPEDA, M. Soledad et al. &lt;strong&gt;Adjusting the pH of lidocaine for reducing pain on injection&lt;/strong&gt;. Cochrane Database of Systematic Reviews, n. 12, 2010.&lt;/li&gt;
&lt;li&gt;Frank SG, Lalonde DH. &lt;strong&gt;How acidic is the lidocaine we are injecting, and how much bicarbonate should we add?&lt;/strong&gt;. Can J Plast Surg. 2012 Summer;20(2):71-3. doi: 10.1177/229255031202000207. PMID: 23730153; PMCID: PMC3383550.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Arquivos</title>
		<link>https://www.aesclepius.com.br/files/</link>
		<pubDate>Sat, 23 Dec 2023 20:13:59 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/files/</guid>
		<description>&lt;p&gt;&lt;input type=&#34;text&#34; id=&#34;search&#34; placeholder=&#34;ex. pediatria&#34;&gt;&lt;/input&gt;&lt;/p&gt;
&lt;script src=&#34;../../files.js&#34;&gt;&lt;/script&gt;
&lt;ul id=&#34;files&#34;&gt;&lt;/ul&gt;
</description>
	</item>
	
	<item>
		<title>LLMedica: inteligência artificial para medicina</title>
		<link>https://www.aesclepius.com.br/ia-medica/llmedica/</link>
		<pubDate>Sat, 23 Dec 2023 20:04:39 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/ia-medica/llmedica/</guid>
		<description>&lt;h2 id=&#34;gestão-de-prontuário-médico-com-ia-treinada-em-medicina&#34;&gt;Gestão de Prontuário Médico com IA Treinada em Medicina&lt;/h2&gt;
&lt;p&gt;Este projeto visa integrar uma Inteligência Artificial baseada em LLM (Large Language Model) treinada especificamente em medicina para auxiliar na gestão de prontuários médicos.&lt;/p&gt;
&lt;h2 id=&#34;descrição&#34;&gt;Descrição&lt;/h2&gt;
&lt;p&gt;O objetivo principal desta solução é utilizar a inteligência artificial para:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Analisar e compreender informações contidas nos prontuários médicos.&lt;/li&gt;
&lt;li&gt;Auxiliar profissionais de saúde na interpretação e tomada de decisões com base nas informações encontradas.&lt;/li&gt;
&lt;li&gt;Oferecer insights e sugestões baseadas no contexto médico para melhorar a gestão dos prontuários.&lt;/li&gt;
&lt;li&gt;Alertar sobre possíveis erros de condutas ou prescrições.&lt;/li&gt;
&lt;li&gt;Melhor compreensão holística do paciente.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;funcionalidades&#34;&gt;Funcionalidades&lt;/h2&gt;
&lt;p&gt;O projeto buscará as seguintes funcionalidades:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Análise e interpretação de textos médicos.&lt;/li&gt;
&lt;li&gt;Construção de um tipo de arquivo independente para cada paciente, grupo de pacientes, enfermaria, unidade de saúde, hospital etc.&lt;/li&gt;
&lt;li&gt;Identificação de padrões, tendências e informações relevantes nos prontuários.&lt;/li&gt;
&lt;li&gt;Recomendações contextuais baseadas em informações médicas.&lt;/li&gt;
&lt;li&gt;Interação livre com o profissional de saúde, nunca assumindo o controle sobre as condutas mas sempre disponível.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;alvo-tecnológico&#34;&gt;Alvo tecnológico&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Linguagem de Programação: priorizar a construção de softwares em linguagens modernas e seguras como Rust, implementando bindings para os modelos open-source mais utilizados.&lt;/li&gt;
&lt;li&gt;Modelos de IA: LLMs de código livre e treino em databases médicas diversas, bem como literaturas¹.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;metas&#34;&gt;Metas&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;&lt;input checked=&#34;&#34; disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Repositório básico da ideia.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Síntese de evidências que favoreçam o uso de IA neste contexto.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Pesquisa de público alvo comercial e não-comercial.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Implementar demo.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Lançar codebase.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Instituir teste realístico em centro de saúde não-comercial ou comercial.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Lançar beta.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Instituir a startup/enterprise empresarial.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Fundar a marca.&lt;/li&gt;
&lt;li&gt;&lt;input disabled=&#34;&#34; type=&#34;checkbox&#34;&gt; Venda comercial do suporte e da integração.&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li&gt;As referências bibliográficas precisarão de consultoria jurídica/autoral para implementação.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Bulário</title>
		<link>https://www.aesclepius.com.br/bulario/</link>
		<pubDate>Sun, 17 Dec 2023 21:31:36 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/bulario/</guid>
		<description>&lt;p&gt;Este é um bulário médico profissional, &lt;strong&gt;não serve a pacientes&lt;/strong&gt;.&lt;/p&gt;


&lt;style&gt;
  #resultado{
    font-size: 80%;
    overflow-wrap: normal;
    min-height: 100vw;
  }
  #resultado div{
    font-weight: normal;
    width: fit-content;
    max-width: 60vw;
    display: none;
    margin-bottom: 0.5em;
    border: var(--stdBorder);
    border-radius: var(--borderRadius);
    background-color: var(--vidro);
  }

  .obsTopic {
    margin-bottom = 5px;
  }

  .nome{
    font-size: 140%;
    margin-left: 0em;
    /*
    background-image: var(--corH2-gradiente); 
    -webkit-background-clip: text; 
    */
    color: var(--corH2); 
    font-weight: bold;
    width: fit-content;
  }
  #resultado div .nomeComercial{
    color: var(--corLinks);
  }
  div#divAtb {
    display: block;
  }
  div#divAtb p{
    margin: 5px;
  }
  hr { 
    width: 20vw;
  }
&lt;/style&gt;

&lt;div class=&#34;search&#34; style=&#34;position: relative;&#34;&gt;
  &lt;input type=&#34;text&#34; id=&#34;search&#34; placeholder=&#34; ex. midazolam&#34;&gt;&lt;/input&gt;
&lt;/div&gt;
&lt;br&gt;
&lt;div id=&#34;resultado&#34;&gt;&lt;/div&gt;
&lt;script src=&#34;../../bulario.js&#34;&gt;
&lt;/script&gt;


</description>
	</item>
	
	<item>
		<title>Imunológicos e vacinas</title>
		<link>https://www.aesclepius.com.br/vacinas/</link>
		<pubDate>Tue, 12 Dec 2023 08:54:05 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/vacinas/</guid>
		<description>&lt;h2 id=&#34;termos&#34;&gt;Termos&lt;/h2&gt;
&lt;h3 id=&#34;heterólogo&#34;&gt;Heterólogo&lt;/h3&gt;
&lt;p&gt;Termo confuso na medicina e na biologia. Na imunologia, &lt;strong&gt;esquema heterólogo&lt;/strong&gt; significa utilizar uma vacina diferente daquela do esquema inicial. Coloquialmente chamado de booster.&lt;/p&gt;
&lt;h3 id=&#34;vírus-vivo&#34;&gt;Vírus vivo&lt;/h3&gt;
&lt;p&gt;Forma de vacina em que o vírus ofertado é vivo e não enfraquecido, apenas selecionado para causar um efeito específico sobre a resposta imune. Pode causar doenças.&lt;/p&gt;
&lt;h3 id=&#34;atenuada&#34;&gt;Atenuada&lt;/h3&gt;
&lt;p&gt;Trata-se de patógeno vivo, enfraquecido estratégicamente via técnicas genéticas ou laboratoriais diversas. Pode causar doenças e tem contraindicações mais voltadas aos imunossuprimidos.&lt;/p&gt;
&lt;h3 id=&#34;conjugada&#34;&gt;Conjugada&lt;/h3&gt;
&lt;p&gt;Significa que a vacina foi associada a um outro antígeno conhecido por sua imunogenicidade maior, por exemplo, as proteínas tifoides ou tetânicas, que possuem poder de provocar maior avidez no carreamento sérico. É uma forma de potencialização imunogênica.&lt;/p&gt;
&lt;h2 id=&#34;virais&#34;&gt;Virais&lt;/h2&gt;
&lt;h3 id=&#34;hepatite&#34;&gt;Hepatite&lt;/h3&gt;
&lt;h2 id=&#34;bacterianas&#34;&gt;Bacterianas&lt;/h2&gt;
&lt;h3 id=&#34;bcg&#34;&gt;BCG&lt;/h3&gt;
&lt;p&gt;A vacina bacilo Calmette-Guérin é um &lt;strong&gt;Mycobaterium bovis&lt;/strong&gt; atenuado, vivo, capaz de induzir imunidade contra a tuberculose (&lt;em&gt;M. tuberculosis&lt;/em&gt;) e hanseníase (&lt;em&gt;M. leprae&lt;/em&gt;).&lt;/p&gt;
&lt;p&gt;Deve ser aplicada, preferencialmente, ao nascer.&lt;/p&gt;
&lt;p&gt;Sua aplicação deixa uma cicatriz encrustada, de alto relevo, &lt;strong&gt;porém não necessária&lt;/strong&gt;.&lt;/p&gt;
&lt;h3 id=&#34;meningocóccica&#34;&gt;Meningocóccica&lt;/h3&gt;
&lt;p&gt;A meningite é um problema de saúde grave. Após a identificação da bactéria mais comumente responsável pelos surtos de infecção meníngea, os esforços para se criar uma vacina iniciaram.&lt;/p&gt;
&lt;p&gt;Existem quatro subtipos principais de &lt;em&gt;Neissera meningitidis&lt;/em&gt;: A, C, W e Y.&lt;/p&gt;
&lt;p&gt;Durante muito tempo a vacina mais aplicada foi a MenB, contra o subtipo B.&lt;/p&gt;
&lt;p&gt;Atualmente, há aplicação em larga escala e em serviços públicos da MeningoACWY, cobrindo todos subtipos.&lt;/p&gt;
&lt;p&gt;Idealmente, deve ser aplicada a MenC aos 5 meses com reforço aos 12 meses e, para maiores de 12 anos a MenACWY.&lt;/p&gt;
&lt;h3 id=&#34;dt-dtpa-e-dtpa&#34;&gt;dT, dTpa e DTPA&lt;/h3&gt;
&lt;p&gt;A vacina dTpa é uma associação de toxóide diftérico, toxóide tetânico e componentes purificados dos antígenos da &lt;em&gt;Bordetella pertussis&lt;/em&gt; – toxina pertussis, tendo o hidróxido e o fosfato de alumínio como adjuvantes.&lt;/p&gt;
&lt;p&gt;Normalmente é indicada para a gestante em 3 doses separadas por 60 (mínimo de 30) dias de preferência entre a 20° e 36° semanas de gestação, porém pode ser aplicada até 45 dias depois do parto, seja por perda das doses ou para completar o esquema.&lt;/p&gt;
&lt;div style=&#34;display:flex; align-content:center&#34;&gt;
  &lt;span class=&#34;etiqueta&#34;&gt;
dT é a denominação genérica das vacinas para difteria e tétano.&lt;br&gt;
dTPA é a oficial infantil, até os 7 anos, feita com componentes acelulares.&lt;br&gt;
dTpa é a tríplice adulta, também usada como reforço infantil.&lt;br&gt;
A primeira imunização infantil ao tétano idealmente deve ser feita com Penta e Hexa.
 &lt;/span&gt;
&lt;/div&gt;


&lt;p&gt;Também deve ser administrada em profissionais de saúde com reforços a cada 10 anos.&lt;/p&gt;
&lt;p&gt;Pode ser feita como reforço da DTPA (infantil) a partir dos 7 anos de idade.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;O esquema nunca deve ser reiniciado&lt;/strong&gt;.&lt;/p&gt;
&lt;h3 id=&#34;hib&#34;&gt;Hib&lt;/h3&gt;
&lt;p&gt;Haemophilus influenzae bacteria.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;BRASIL. &lt;strong&gt;Manual de Normas e Procedimentos para Vacinação Ministério da Saúde&lt;/strong&gt;. Secretaria de Vigilância em Saúde. Departamento de Vigilância das Doenças Transmissíveis. Ministério da Saúde. Brasília. 2014. ISBN 978-85-334-2164-6&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Dicionário</title>
		<link>https://www.aesclepius.com.br/dicionario/</link>
		<pubDate>Wed, 06 Dec 2023 22:08:46 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/dicionario/</guid>
		<description>&lt;p&gt;&lt;input type=&#34;text&#34; id=&#34;search&#34; placeholder=&#34;procure aqui&#34;&gt;&lt;/input&gt;&lt;/p&gt;
&lt;script src=&#34;../../dicionario.js&#34;&gt;&lt;/script&gt;
&lt;ul id=&#34;search-output&#34;&gt;&lt;/ul&gt;
</description>
	</item>
	
	<item>
		<title>Hemodinâmica</title>
		<link>https://www.aesclepius.com.br/hemodinamica/</link>
		<pubDate>Mon, 27 Nov 2023 11:02:22 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/hemodinamica/</guid>
		<description>&lt;h2 id=&#34;valores-normais&#34;&gt;Valores normais&lt;/h2&gt;
&lt;h3 id=&#34;frequência-cardíaca&#34;&gt;Frequência cardíaca¹&lt;/h3&gt;
&lt;p&gt;$$
50bpm \leq FC_{normal} \leq 100bpm
$$&lt;/p&gt;
&lt;h3 id=&#34;delta-de-pressão&#34;&gt;Delta de pressão&lt;/h3&gt;
&lt;p&gt;$$
\delta = PAS - PAD
$$&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Se $\delta \leq 30mmHg $ a pressão arterial é convergente; e&lt;/li&gt;
&lt;li&gt;Se $\delta \geq 60mmHg $ a pressão arterial é divergente.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;pressão-arterial-média&#34;&gt;Pressão arterial média&lt;/h2&gt;
&lt;p&gt;$$
PAM = \frac{PAS + 2 * PAD}{3}
$$&lt;/p&gt;
&lt;h2 id=&#34;média-da-pressão-arterial&#34;&gt;Média da pressão arterial&lt;/h2&gt;
&lt;p&gt;$$
\bar{\mu}= PA[média] = \frac{PAS + PAD}{2}
$$&lt;/p&gt;
&lt;h3 id=&#34;calculadora-de-médias&#34;&gt;Calculadora de médias&lt;/h3&gt;


&lt;div class=&#34;calculadoras&#34;&gt;
&lt;label for=&#34;pas&#34;&gt;Pressão sistólica:&lt;/label&gt;
&lt;br&gt;
&lt;input id=&#34;pas&#34; placeholder=&#34;mmHg&#34; type=&#34;number&#34;&gt;&lt;/input&gt;
&lt;br&gt;
&lt;label for=&#34;pad&#34;&gt;Pressão diastólica:&lt;/label&gt;
&lt;br&gt;
&lt;input id=&#34;pad&#34; placeholder=&#34;mmHg&#34; type=&#34;number&#34;&gt;&lt;/input&gt;
&lt;br&gt;
&lt;br&gt;
&lt;button id=&#34;calc-pam&#34; onclick=&#34;pamedia()&#34;&gt;Calcular&lt;/button&gt;
&lt;p id=&#34;resultado&#34;&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script&gt;
    function pamedia() {
        let pad = parseFloat(document.getElementById(&#34;pad&#34;).value);
        let pas = parseFloat(document.getElementById(&#34;pas&#34;).value);

        let delta = pas - pad;

        let pam = (pas + (2 * pad)) / 3;
        let pm = (pas + pad) / 2;

        if (!(pad &gt; 0 &amp;&amp; pas &gt; 0) || isNaN(pam) || isNaN(pm) || delta &lt; 5 ) {
            document.getElementById(&#34;resultado&#34;).innerText = &#34;Confira os dados!&#34;;
            return
        }

        document.getElementById(&#34;resultado&#34;).innerHTML = pam.toFixed(1)+&#34;mmHg de pressão arterial média.&lt;br&gt;&#34;+pad.toFixed(1)+&#34;mmHg de média da pressão arterial&#34;;

        if (delta &lt; 30) {
            document.getElementById(&#34;resultado&#34;).innerHTML += &#34;&lt;br&gt;A pressão está convergente!&#34;;
        } else if (delta &gt; 60) {
            document.getElementById(&#34;resultado&#34;).innerHTML += &#34;&lt;br&gt;A pressão está divergente!&#34;;
        } 
    }
&lt;/script&gt;

&lt;h2 id=&#34;pressão-normal-de-tecidos-não-fluidos&#34;&gt;Pressão normal de tecidos não-fluidos&lt;/h2&gt;
&lt;p&gt;$$
0mmHg \leq PA_{tissue} \leq 8mmHg
$$
$$
\Delta P_{tissue} = PA_{dias} - PA_{tissue}
$$&lt;/p&gt;
&lt;p&gt;O $\Delta P_{tissue}$ é crítico se &lt;strong&gt;menor que 30mmHg&lt;/strong&gt;. Se zero, a isquemia é presumida.&lt;/p&gt;
&lt;h2 id=&#34;choque&#34;&gt;Choque&lt;/h2&gt;
&lt;h3 id=&#34;classificação&#34;&gt;Classificação&lt;/h3&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Classe&lt;/th&gt;
          &lt;th&gt;Pulso(bpm)&lt;/th&gt;
          &lt;th&gt;Pressão&lt;/th&gt;
          &lt;th&gt;Reperfusão&lt;/th&gt;
          &lt;th&gt;Incursẽos respiratórias por min&lt;/th&gt;
          &lt;th&gt;Perda sanguínea(%)&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;I&lt;/td&gt;
          &lt;td&gt;&amp;lt; 100&lt;/td&gt;
          &lt;td&gt;Normal&lt;/td&gt;
          &lt;td&gt;Normal&lt;/td&gt;
          &lt;td&gt;14-20&lt;/td&gt;
          &lt;td&gt;≤16&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;II&lt;/td&gt;
          &lt;td&gt;100-120&lt;/td&gt;
          &lt;td&gt;Normal&lt;/td&gt;
          &lt;td&gt;Atrasada&lt;/td&gt;
          &lt;td&gt;20-30&lt;/td&gt;
          &lt;td&gt;15-30&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;III&lt;/td&gt;
          &lt;td&gt;120-140&lt;/td&gt;
          &lt;td&gt;Baixa&lt;/td&gt;
          &lt;td&gt;Atrasada&lt;/td&gt;
          &lt;td&gt;30-40&lt;/td&gt;
          &lt;td&gt;30-40&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;IV&lt;/td&gt;
          &lt;td&gt;&amp;gt;140&lt;/td&gt;
          &lt;td&gt;Baixa&lt;/td&gt;
          &lt;td&gt;Atrasada&lt;/td&gt;
          &lt;td&gt;&amp;gt;35&lt;/td&gt;
          &lt;td&gt;&amp;gt;40&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;acessos-vasculares&#34;&gt;Acessos vasculares&lt;/h2&gt;
&lt;h3 id=&#34;acesso-venoso-femoral&#34;&gt;Acesso venoso femoral&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Indicado quando obstruída a cava superior, para poupar comprometimento de vias aéreas, facilitar a pronagem e para evitar a manipulação excessiva pelo paciente com desordem psiquiátrica[2];&lt;/li&gt;
&lt;li&gt;Deve ser realizado, preferencialmente, guiado por ultrassonografia[2];&lt;/li&gt;
&lt;li&gt;A maioria das punções inserem cateters comerciais com menos de 20cm e, portanto, não alcançam a cava inferior e devem ser tratados como periférico de grosso calibre[2].&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;manejo-hemodinâmico&#34;&gt;Manejo hemodinâmico&lt;/h2&gt;
&lt;h3 id=&#34;evidências&#34;&gt;Evidências&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Among adults with septic shock, &lt;mark&gt;vasopressin initiation&lt;/mark&gt; when low-dose NE was used was associated with an improvement in 28-day mortality[3].&lt;/li&gt;
&lt;li&gt;For the clinician caring for patients with sepsis today, the initial administration of &lt;mark&gt;20 mL/kg&lt;/mark&gt; of intravenous balanced crystalloid, followed by consideration of the risks and benefits of subsequent fluid administration represents a reasonable approach [4].&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;radioscopia&#34;&gt;Radioscopia&lt;/h2&gt;
&lt;h3 id=&#34;interpretação-de-sequência-de-imagens-ou-videocoronariografias&#34;&gt;Interpretação de sequência de imagens ou videocoronariografias&lt;/h3&gt;
&lt;p&gt;Este fluxograma é de minha autoria e serve como auxílio a imagens não laudadas que precisam ser interpretadas pelo médico não especialista.&lt;/p&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
1(Identificar se está visualizando:&lt;br&gt;1. O óstio da coronária esquerda&lt;br&gt;OU&lt;br&gt;2. O tronco de coronária direita) -- artéria em forma de C --&gt; n(Coronária&lt;br&gt;direita) --&gt; 2(Observar ramos e possível dominância) --&gt; 8(Observar calibres);
1 -- coronária&lt;br&gt;esquerda --&gt; 3(Identificar a a descendente anterior) --&gt; 4(As perforantes são visualizadas?);
4 -- Sim --&gt; 5(Tratam-se de&lt;br&gt;artérias septais) --&gt; 8;
4 -- Não --&gt; 6(Seguir observando calibre até a ponta);
6 -- Ramos craniais --&gt; 7(Identificar a circunflexa);
6 -- Ramos caudais --&gt; 8;
7 --&gt; 8;
&lt;/pre&gt;

&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;MASON, Jay W. et al. &lt;strong&gt;Electrocardiographic reference ranges derived from 79,743 ambulatory subjects&lt;/strong&gt;. Journal of electrocardiology, v. 40, n. 3, p. 228-234. e8, 2007.&lt;/li&gt;
&lt;li&gt;ANNETTA, Maria Giuseppina et al. &lt;strong&gt;Femoral venous access: State of the art and future perspectives&lt;/strong&gt;. The Journal of Vascular Access, p. 11297298231209253, 2023.&lt;/li&gt;
&lt;li&gt;Xu, J., Cai, H. &amp;amp; Zheng, X. &lt;strong&gt;Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.&lt;/strong&gt; BMC Infect Dis 23, 199 (2023). &lt;a href=&#34;https://doi.org/10.1186/s12879-023-08147-6&#34;&gt;https://doi.org/10.1186/s12879-023-08147-6&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;BROWN, Ryan M.; SEMLER, Matthew W. &lt;strong&gt;Fluid management in sepsis.&lt;/strong&gt; Journal of intensive care medicine, v. 34, n. 5, p. 364-373, 2019.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Calculadoras para pacientes queimados</title>
		<link>https://www.aesclepius.com.br/queimados/</link>
		<pubDate>Tue, 21 Nov 2023 01:34:54 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/queimados/</guid>
		<description>&lt;h2 id=&#34;grandes-queimados&#34;&gt;Grandes queimados&lt;/h2&gt;
&lt;h3 id=&#34;calculadora-de-parkland-via-regra-dos-nove-de-pulaski-e-tennisson&#34;&gt;Calculadora de Parkland via regra dos nove de Pulaski e Tennisson&lt;/h3&gt;
&lt;p&gt;

&lt;div class=&#34;calculadoras&#34;&gt; 
&lt;form id=&#34;formElementos&#34;&gt;
  &lt;label for=&#34;elementos&#34;&gt;Adicione as partes queimadas:&lt;/label&gt;
  &lt;br&gt;
 &lt;select id=&#34;elementos&#34;&gt;
    &lt;option value=&#34;meiacabeca&#34;&gt;Cabeça - anterior&lt;/option&gt;
    &lt;option value=&#34;meiacabeca&#34;&gt;Cabeça - posterior&lt;/option&gt;
    &lt;option value=&#34;pescoco&#34;&gt;Pescoço&lt;/option&gt;
    &lt;option value=&#34;meiobraco&#34;&gt;Braço direito - anterior&lt;/option&gt;
    &lt;option value=&#34;meiobraco&#34;&gt;Braço direito - posterior&lt;/option&gt;
    &lt;option value=&#34;meiobraco&#34;&gt;Braço esquerdo - anterior&lt;/option&gt;
    &lt;option value=&#34;meiobraco&#34;&gt;Braço esquerdo - posterior&lt;/option&gt;
    &lt;option value=&#34;torax&#34;&gt;Tronco anterior&lt;/option&gt;
    &lt;option value=&#34;dorso&#34;&gt;Tronco posterior&lt;/option&gt;
    &lt;option value=&#34;nadega&#34;&gt;Nádega direita&lt;/option&gt;
    &lt;option value=&#34;nadega&#34;&gt;Nádega esquerda&lt;/option&gt;
    &lt;option value=&#34;genitalia&#34;&gt;Genitália&lt;/option&gt;
    &lt;option value=&#34;meiaperna&#34;&gt;Perna direita - anterior&lt;/option&gt;
    &lt;option value=&#34;meiaperna&#34;&gt;Perna direita - posterior&lt;/option&gt;
    &lt;option value=&#34;meiaperna&#34;&gt;Perna esquerda - anterior&lt;/option&gt;
    &lt;option value=&#34;meiaperna&#34;&gt;Perna esquerda - posterior&lt;/option&gt;
    &lt;option value=&#34;palma&#34;&gt;Palma (1%)&lt;/option&gt;
  &lt;/select&gt;
&lt;/form&gt;
&lt;br&gt;
&lt;div&gt;
  &lt;button onclick=&#34;adicionarElemento()&#34;&gt;Adicionar&lt;/button&gt;
  &lt;p&gt;Elementos adicionados:&lt;/p&gt;
    &lt;ul class=&#34;left&#34; id=&#34;elementosSelecionados&#34;&gt;&lt;/ul&gt;
  &lt;br&gt;
  &lt;label for=&#34;idade&#34;&gt;Idade:&lt;/label&gt;
  &lt;br&gt;
  &lt;input id=&#34;idade&#34; placeholder=&#34;anos&#34; type=&#34;number&#34;&gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;label for=&#34;peso&#34;&gt;Massa corporal:&lt;/label&gt;
  &lt;br&gt;
  &lt;input id=&#34;peso&#34; placeholder=&#34;Kg&#34;  type=&#34;number&#34;&gt;&lt;/input&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;input id=&#34;eletrica&#34; type=&#34;checkbox&#34;&gt;&lt;/input&gt;
  &lt;label for=&#34;eletrica&#34;&gt;Queimadura elétrica&lt;/label&gt;
  &lt;br&gt;
  &lt;br&gt;
  &lt;button onclick=&#34;calcular()&#34;&gt;Calcular&lt;/button&gt;
  &lt;br&gt;
  &lt;p id=&#34;resultado&#34;&gt;Adicione os elementos queimados, idade, peso e clique em Calcular.&lt;/p&gt;
&lt;/div&gt;
&lt;/div&gt;
&lt;script src=&#34;../../queimados.js&#34;&gt;&lt;/script&gt;

&lt;br&gt;
&lt;br&gt;
&lt;br&gt;&lt;/p&gt;
&lt;h3 id=&#34;queimadura-elétrica&#34;&gt;Queimadura elétrica&lt;/h3&gt;
&lt;h4 id=&#34;como-a-eletricidade-pode-matar&#34;&gt;Como a eletricidade pode matar&lt;/h4&gt;
&lt;h5 id=&#34;tetania&#34;&gt;Tetania&lt;/h5&gt;
&lt;p&gt;A contração persistente do diafragma como resultado da passagem da corrente elétrica pode causar asfixia.&lt;/p&gt;
&lt;h5 id=&#34;fibrilação-ventricular&#34;&gt;Fibrilação ventricular&lt;/h5&gt;
&lt;p&gt;A corrente elétrica pode priorizar o surgimento de ritmo desordenado ventricular, causando predominância desta origem, levando a FV e, consequentemente, à morte.&lt;/p&gt;
&lt;h5 id=&#34;morte-cerebral&#34;&gt;Morte cerebral&lt;/h5&gt;
&lt;p&gt;Normalmente, a corrente elétrica ao atravessar o líquor provoca hemorragia meníngea, muitas vezes maciça.&lt;/p&gt;
&lt;p&gt;Pela natureza eletroquímica do funcionamento de neurônios, a corrente elétrica também é capaz de danificar a maioria dos nervos e do sistema nervoso central pode levar a morte.&lt;/p&gt;
&lt;h5 id=&#34;efeito-joule&#34;&gt;Efeito Joule&lt;/h5&gt;
&lt;p&gt;Em grandes tensões e em fontes com capacidade elétrica suficiente, o funciona como resistência convertendo energia elétrica em calor e promove o cozimento, fritura e queimadura dos diversos tecidos, levando a morte.&lt;/p&gt;
&lt;h5 id=&#34;quedas&#34;&gt;Quedas&lt;/h5&gt;
&lt;p&gt;Ao ser eletrocutado, o corpo pode perder o equilíbrio ou ser ejetado pelo grande diferencial de potencial, levando a queda e trauma grave.&lt;/p&gt;
&lt;h3 id=&#34;geladuras&#34;&gt;Geladuras&lt;/h3&gt;
&lt;p&gt;Hoffmann também propôs que as queimaduras de frio se classificam por graus, como as de alta temperatura:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;1° - palidez cutânea, pode ou não ser dolorosa.&lt;/li&gt;
&lt;li&gt;2° - eritema doloroso.&lt;/li&gt;
&lt;li&gt;3° - necrose de tecido epidérmico e dérmico.&lt;/li&gt;
&lt;li&gt;4° - gangrena.&lt;/li&gt;
&lt;/ul&gt;
&lt;h2 id=&#34;classificações&#34;&gt;Classificações&lt;/h2&gt;
&lt;ul&gt;
&lt;li&gt;Simples: queimaduras decorrentes de agentes causadores líquidos ou vapores, líquidos densos e sólidos aquecidos, substâncias inflamáveis, contato direto com chama, radiações não-ionizantes e frio.&lt;/li&gt;
&lt;li&gt;Complexas: decorre de agentes causadores como a fricção mecânica, a eletricidade, as radiações ionizantes como raios X, alfa, beta, gama, e produtos químicos.&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;bibliografia&#34;&gt;Bibliografia&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;LOURDES, Carolina de; ROCHA, J. V.. &lt;strong&gt;Histofisiologia e classificação das queimaduras: consequencias locais e sistêmicas das perdas teciduais em pacientes queimados&lt;/strong&gt;. Revista Interdisciplinar de Estudos Experimentais, v. 1, n. 3, p. 140 - 147, 2009.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Convulsões e grande mal</title>
		<link>https://www.aesclepius.com.br/convulsoes/</link>
		<pubDate>Sun, 19 Nov 2023 15:45:49 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/convulsoes/</guid>
		<description>&lt;h2 id=&#34;lactente-ou-neonato&#34;&gt;Lactente ou neonato&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
G(Instalar o EEG se disponível) --&gt; A(Fenobarbital em 20-30mg/Kg) -- Resolução --&gt;B(Manter 5-6mg/Kg/dia)
A -- Persistência --&gt; D(Repetir 20-30mg/Kg) -- Opção 1 --&gt; E(Fenitoína 21mg/Kg + manutenção 5-8mg/Kg)
D -- Opção 2 --&gt; F(Midazolam 0.15mg/Kg + manutenção 0.1mcg/Kg/min)
F -- Persistência --&gt; Z(Sedação e intubação)
E -- Persistência --&gt;Z
&lt;/pre&gt;

&lt;h2 id=&#34;estado-de-mal-epilético-pelo-purple-book1&#34;&gt;Estado de mal epilético pelo Purple Book[1]&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Fase&lt;/th&gt;
          &lt;th&gt;Tipo do EME&lt;/th&gt;
          &lt;th&gt;Duração&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;I&lt;/td&gt;
          &lt;td&gt;Preliminar ou iminente&lt;/td&gt;
          &lt;td&gt;5 a 30min&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;II&lt;/td&gt;
          &lt;td&gt;Estabelecido&lt;/td&gt;
          &lt;td&gt;&amp;gt; 30min&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;III&lt;/td&gt;
          &lt;td&gt;Refratário&lt;sup&gt;1&lt;/sup&gt;&lt;/td&gt;
          &lt;td&gt;&amp;gt; 60min ou falha das fases I/II&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;IV&lt;/td&gt;
          &lt;td&gt;Super-refratário&lt;sup&gt;2&lt;/sup&gt;&lt;/td&gt;
          &lt;td&gt;-&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;ol&gt;
&lt;li&gt;Persiste apesar do tratamento estabelecido na fase I e II com estado de mal sutil, comatoso ou não convulsivo.&lt;/li&gt;
&lt;li&gt;Persiste apesar do tratamento anestésico por mais de 24h.&lt;/li&gt;
&lt;/ol&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
inicio(Reconhecimento do EME) -- Adolescente ou adulto&lt;br&gt;de 13 a 40kg &lt;br&gt;e idosos --&gt; ate40kg(Midazolam 5mg IM&lt;br&gt; repetir se necessário&lt;br&gt;OU&lt;br&gt;Diazepam 10mg&lt;br&gt;repetir até 2x);
inicio -- Adolescente ou adulto&lt;br&gt;acima de 40kg --&gt; adulto(Midazolam 10mg IM&lt;br&gt;OU&lt;br&gt;Diazepam IV 10mg);
inicio -- Crianças --&gt; crianca(Midazolam 0.2mg/Kg IM&lt;br&gt;repetir em 5min se necessário&lt;br&gt;OU&lt;br&gt;Diazepam 0.5mg/Kg&lt;br&gt;repetir até 2x);
adulto --&gt; rep(Repetições em 5min:&lt;br&gt;Diazepam uma vez&lt;br&gt;Midazolam duas vezes.) --&gt; fim(Fenitoína 20mg/Kg - manutenção em 6h&lt;br&gt;&lt;b&gt;OU&lt;/b&gt;&lt;br&gt;Fenobarbital 20mg/Kg - manutenção em 12h);
ate40kg --&gt; fim;
crianca --&gt; fim;
fim -- Sedação em UTI --&gt; sedacao(Quetamina, midazolam, propofol e tiopental contínuos);
sedacao -- Mantém crise via EEG ou clínica --&gt; Fiim(Super-refratário se +24h);
sedacao --&gt; reajuste(Reajustar fármacos&lt;br&gt;antiepiléticos e sedação);
&lt;/pre&gt;

&lt;h3 id=&#34;quetamina&#34;&gt;Quetamina&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Criança: bolus inicial de 2 a 3mg/Kg até duas vezes IV e infusão contínua de no máximo 3.6mg/Kg/h.&lt;/li&gt;
&lt;li&gt;Adultos: bolus inicial de até 5mg/Kg IV e infusão contínua de no máximo 15mg/Kg/h.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;propofol&#34;&gt;Propofol&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Bolus IV de 2-3mg/Kg e manutenção com bolus de até 2mg/Kg a cada 3-5min;&lt;/li&gt;
&lt;li&gt;Manutenção de até 10mg/Kg/h;&lt;/li&gt;
&lt;li&gt;Evitar o uso por mais de 48h por risco de síndrome da infusão de propofol.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;midazolam&#34;&gt;Midazolam&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Bolus inicial de 0.2mg/Kg e manutenção de 0.05 a 0.4mg/Kg/h.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;tiopental&#34;&gt;Tiopental&lt;/h3&gt;
&lt;ul&gt;
&lt;li&gt;Bolus de 3-5mg/Kg e bolus de 1-2mg/Kg a cada 3-5min em diluição até fim da crise. Mantenção de 3-7mg/Kg/h.&lt;/li&gt;
&lt;li&gt;Existe a administração por manutenção em EEG.&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;super-refratário&#34;&gt;Super-refratário&lt;/h3&gt;
&lt;h4 id=&#34;topiramato&#34;&gt;Topiramato&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Criança: 10 a 30mg/Kg/dia&lt;/li&gt;
&lt;li&gt;Adulto: 200-500mg duas vezes ao dia.&lt;/li&gt;
&lt;/ul&gt;
&lt;h4 id=&#34;clobazam&#34;&gt;Clobazam&lt;/h4&gt;
&lt;ul&gt;
&lt;li&gt;Criança: 0.5-1mg/Kg/dia.&lt;/li&gt;
&lt;li&gt;Adulto: iniciar com 10mg/dia podendo chegar a 60mg/dia. Pode ser feito em 2 tomadas por dia, dividindo-se a dose.&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;YACUBIAN, Elza Márcia Targas; MANREZA, Maria Luiza; TERRA, Vera Cristina.&lt;strong&gt;Purple book : guia prático para o tratamento de
epilepsias : recomendações para tratamento de crises e síndromes epiléticas de um grupo de especialistas brasileiros 2ed&lt;/strong&gt;. Planmark. São Paulo - Brasil. 2020. ISBN 978-85-9525-037-6&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Dor torácica</title>
		<link>https://www.aesclepius.com.br/dor-toracica/</link>
		<pubDate>Sat, 18 Nov 2023 13:00:42 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/dor-toracica/</guid>
		<description>&lt;h2 id=&#34;sempre-descarte-a-dissecação-de-aorta&#34;&gt;Sempre descarte a dissecação de aorta!&lt;/h2&gt;
&lt;p&gt;A dissecação de aorta é um diagnóstico muito improvável, mesmo no contexto de dor torácica.&lt;/p&gt;
&lt;p&gt;Porém, sua fatalidade e necessidade de alta desconfiança diagnóstica exige que sempre a descartemos como diferencial o mais cedo possível!&lt;/p&gt;
&lt;p&gt;Para isso, a ferramenta mais atualizada é o chamado &lt;strong&gt;ADD-Risk Score&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Sua lógica se baseia no descarte do diferencial de imediato ou, na dúvida, tentar um segundo descarte por D-dímero, como foi sugerido posteriormente pelo estudo ADvISED[1]. Em toda lesão de leito vascular o valor de D-dímero se alterará e o estudo considerou o corte de 500ng/ml como valor superior de descarte.&lt;/p&gt;
&lt;p&gt;De forma prática, utilize a calculadora abaixo.&lt;/p&gt;
&lt;h3 id=&#34;calculadora-add-rs-12&#34;&gt;Calculadora ADD-RS [1][2]&lt;/h3&gt;
&lt;br&gt;
&lt;div class=calculadoras &gt;
    &lt;label for=historia&gt;História pessoal e familiar&lt;/label&gt;
    &lt;br&gt;
    &lt;select id=historia&gt;
        &lt;option value=0&gt;Sem história relevante&lt;/option&gt;
        &lt;option value=1&gt;Histórico familiar de doença aortica&lt;/option&gt;
        &lt;option value=1&gt;Doença valvar cardíaca conhecida&lt;/option&gt;
        &lt;option value=1&gt;Manipulação recente da aorta&lt;/option&gt;
        &lt;option value=1&gt;Síndrome de Marfan&lt;/option&gt;
        &lt;option value=1&gt;Aneurisma torácico conhecido&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=dor&gt;Dor posterior, torácica ou abdominal&lt;/label&gt;
    &lt;br&gt;
    &lt;select id=dor&gt;
        &lt;option value=0&gt;Sem dor&lt;/option&gt;
        &lt;option value=1&gt;Dor de início abrupto&lt;/option&gt;
        &lt;option value=1&gt;Dor severa&lt;/option&gt;
        &lt;option value=1&gt;Sensação de rasgo ou facada&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;label for=dor&gt;Dor posterior, torácica ou abdominal&lt;/label&gt;
    &lt;br&gt;
    &lt;select id=exame&gt;
        &lt;option value=0&gt;Exame normal&lt;/option&gt;
        &lt;option value=1&gt;Gradiente de MMSS de sistólica maior de 10mmHg&lt;/option&gt;
        &lt;option value=1&gt;Déficit de pulso&lt;/option&gt;
        &lt;option value=1&gt;Déficit neurológico focal com dor&lt;/option&gt;
        &lt;option value=1&gt;Murmúrio aortico e dor&lt;/option&gt;
        &lt;option value=1&gt;Hipotensão ou choque&lt;/option&gt;
    &lt;/select&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;button onclick=&#34;riscoAddrs()&#34;&gt;Calcule&lt;/button&gt;
    &lt;br&gt;
    &lt;br&gt;
    &lt;div id=resultado&gt;
    &lt;/div&gt;
    &lt;br&gt;
&lt;/div&gt;
&lt;script src=../../addrs.js&gt;&lt;/script&gt;
&lt;h2 id=&#34;tipos-de-infarto&#34;&gt;Tipos de infarto&lt;/h2&gt;
&lt;table&gt;
  &lt;thead&gt;
      &lt;tr&gt;
          &lt;th&gt;Tipo&lt;/th&gt;
          &lt;th&gt;Descrição&lt;/th&gt;
      &lt;/tr&gt;
  &lt;/thead&gt;
  &lt;tbody&gt;
      &lt;tr&gt;
          &lt;td&gt;1&lt;/td&gt;
          &lt;td&gt;placa causando obstrução da passagem do sangue por uma coronária.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;2&lt;/td&gt;
          &lt;td&gt;hipóxia miocárdica por eventos graves, e.g. crise hipertensiva, que eleva a demanda por oxigênio de modo abrupto, espasmos das artérias, pressão baixa e arritmias.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;3 ou fulminante&lt;/td&gt;
          &lt;td&gt;hipóxia miocárdica massiva ou arritmias graves.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;4&lt;/td&gt;
          &lt;td&gt;reúne os casos de infarto pós angioplastia coronária logo depois ou em decorrência de nova obstrução por cima do stent.&lt;/td&gt;
      &lt;/tr&gt;
      &lt;tr&gt;
          &lt;td&gt;5&lt;/td&gt;
          &lt;td&gt;identificado quando existe relação entre o infarto e a revascularização cirúrgica de coronárias.&lt;/td&gt;
      &lt;/tr&gt;
  &lt;/tbody&gt;
&lt;/table&gt;
&lt;h2 id=&#34;escore-grace-3&#34;&gt;Escore GRACE [3]&lt;/h2&gt;
&lt;p&gt;Em breve.&lt;/p&gt;
&lt;!--
&lt;div class=calculadoras&gt;
    &lt;label for=&#34;idade&#34;&gt;Idade:&lt;/label&gt;
    &lt;input type=&#34;number&#34; id=&#34;idade&#34; name=&#34;idade&#34; required&gt;&lt;br&gt;
    &lt;label for=&#34;pas&#34;&gt;Pressão Arterial Sistólica (mmHg):&lt;/label&gt;
    &lt;input type=&#34;number&#34; id=&#34;pas&#34; name=&#34;pas&#34; required&gt;&lt;br&gt;
    &lt;label for=&#34;fc&#34;&gt;Frequência Cardíaca (bpm):&lt;/label&gt;
    &lt;input type=&#34;number&#34; id=&#34;fc&#34; name=&#34;fc&#34; required&gt;&lt;br&gt;
    &lt;label for=&#34;creatinina&#34;&gt;Creatinina (mg/dL):&lt;/label&gt;
    &lt;input type=&#34;number&#34; id=&#34;creatinina&#34; name=&#34;creatinina&#34; required&gt;&lt;br&gt;
    &lt;label for=&#34;killip&#34;&gt;Classe de Killip:&lt;/label&gt;
    &lt;select id=&#34;killip&#34; name=&#34;killip&#34; required&gt;
      &lt;option value=&#34;1&#34;&gt;Killip I&lt;/option&gt;
      &lt;option value=&#34;2&#34;&gt;Killip II&lt;/option&gt;
      &lt;option value=&#34;3&#34;&gt;Killip III&lt;/option&gt;
      &lt;option value=&#34;4&#34;&gt;Killip IV&lt;/option&gt;
    &lt;/select&gt;&lt;br&gt;
    &lt;label for=&#34;parada&#34;&gt;Parada Cardíaca Antes da Admissão:&lt;/label&gt;
    &lt;select id=&#34;parada&#34; name=&#34;parada&#34; required&gt;
      &lt;option value=&#34;0&#34;&gt;Não&lt;/option&gt;
      &lt;option value=&#34;1&#34;&gt;Sim&lt;/option&gt;
    &lt;/select&gt;&lt;br&gt;
    &lt;input type=checkbox id=st&gt;Alterações no segmento ST&lt;/input&gt;
    &lt;br&gt;
    &lt;input type=checkbox id=&#34;enzimas&#34; name=&#34;enzimas&#34;&gt;Enzimas Cardíacas Elevadas&lt;/input&gt;
    &lt;br&gt;
    &lt;input type=checkbox id=&#34;icc-c&#34; name=&#34;icc-c&#34;&gt;História de insuficiência cardíaca congestiva&lt;/label&gt;&lt;/input&gt;
    &lt;br&gt;
    &lt;button onclick=grace()&gt;Calcular&lt;/button&gt;
  &lt;p id=&#34;resultadoGRACE&#34;&gt;&lt;/p&gt;&lt;/div&gt;
&lt;/div&gt;
&lt;script src=../../grace.js&gt;&lt;/script&gt;

melhora dor
ecg supra menor 50%
arritmia reperfusao
pico precoce de troponina (troponina circula mais quando revasculariza)

ecg 10min 
trombolise 12h 
porta-agulha 30min  trombolise
porta-balao 120min transf 90min 
angio de resgate apos trombolise
angio primaria 
--&gt;
&lt;h2 id=&#34;fluxogramas&#34;&gt;Fluxogramas&lt;/h2&gt;

 
&lt;div class=&#34;carousel&#34;&gt;
  &lt;div class=&#34;button-container&#34;&gt;
    &lt;button type=&#34;button&#34; id=&#34;anterior&#34;&gt;Anterior&lt;/button&gt;
    &lt;button type=&#34;button&#34; id=&#34;proximo&#34;&gt;Próxima&lt;/button&gt;
  &lt;/div&gt;
  &lt;div class=&#34;conteudo&#34;&gt;
  
    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;TINOCA vs MINOCA&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/tinoca.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;

    
    
    
    &lt;div class=&#34;legend&#34;&gt;
      &lt;p&gt;Fluxo da análise de troponina&lt;/p&gt;
    &lt;/div&gt;
    &lt;div class=&#34;slide&#34;&gt;
      
      &lt;img src=&#34;../../pix/medicina/fluxo-troponina.png&#34;&gt;&lt;/img&gt;
      
    &lt;/div&gt;


  
  &lt;/div&gt;
&lt;/div&gt;
&lt;script&gt;
(function() {
  let currentSlide = 0;
  let slides = document.querySelectorAll(&#34;.carousel .slide&#34;);
  let legends = document.querySelectorAll(&#34;.carousel .legend&#34;);
  let totalSlides = slides.length;
  let anterior = document.getElementById(&#34;anterior&#34;);
  let proximo = document.getElementById(&#34;proximo&#34;);

  function showSlide(n) {
    currentSlide = (n + totalSlides) % totalSlides;
    for (let i = 0; i &lt; totalSlides; i++) {
      slides[i].style.display = &#34;none&#34;;
      legends[i].style.display = &#34;none&#34;;
    }
    slides[currentSlide].style.display = &#34;block&#34;;
    legends[currentSlide].style.display = &#34;block&#34;;
  }
  
  showSlide(currentSlide);
  
  
  
  
  proximo.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide + 1);
  })
  anterior.addEventListener(&#34;click&#34;, () =&gt; {
    showSlide(currentSlide - 1);
  })
  
  
  
  
  
  
  
  
})();
  &lt;/script&gt;


&lt;h2 id=&#34;manejo-da-angina-crônica&#34;&gt;Manejo da angina crônica&lt;/h2&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
n{{Nitrato&lt;br&gt;em S.O.S}} &lt;--&gt; 1;
1(IECA/BRA&lt;br&gt;AAS&lt;br&gt;Estatinas&lt;br&gt;Betabloqueadores) --&gt; 2(Fração de ejeção?) -- maior que 70% --&gt; 3(Aumentar&lt;br&gt;betabloqueador) --&gt; 10(Fração de&lt;br&gt;ejeção em queda?) -- Sim --&gt; 4(Ritmo sinusal?) -- Sim --&gt; 5(Ivabradina);
4 -- Não --&gt; 6(Digoxina);
10 -- Não --&gt; 16(Bloqueadores&lt;br&gt;de canal de cálcio);
5 --&gt; 13(Fração de ejeção&lt;br&gt;continua em queda?) --&gt; 2;
6 --&gt; 13;
2 -- menor que 70% --&gt; 12(Trimetadizidina e/ou&lt;br&gt;Bloqueadores de canal de cálcio) --&gt; 14(Propatilnitrato de horário) --&gt; 15(Alopurinol em&lt;br&gt;dose antianginosa);
&lt;/pre&gt;

&lt;p&gt;1 &amp;ndash; 7(FE &amp;lt; 70) &amp;ndash;&amp;gt; 9(ate alupurinol);&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Nazerian P, Mueller C, Soeiro AM, et al. &lt;strong&gt;Diagnostic Accuracy of the Aortic Dissection Detection Risk Score Plus D-Dimer for Acute Aortic Syndromes: The ADvISED Prospective Multicenter Study&lt;/strong&gt;. Circulation. 2018;137(3):250-258.&lt;/li&gt;
&lt;li&gt;Rogers AM, Hermann LK, Booher AM, et al. &lt;strong&gt;Sensitivity of the aortic dissection detection risk score, a novel guideline-based tool for identification of acute aortic dissection at initial presentation: results from the international registry of acute aortic dissection&lt;/strong&gt;. Circulation. 2011;123(20):2213-8.&lt;/li&gt;
&lt;li&gt;Eagle KA, Lim MJ, Dabbous OH, et al. &lt;strong&gt;A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.&lt;/strong&gt; JAMA. 2004;291(22):2727-2733.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Massagem Carotídea: mitos e verdades</title>
		<link>https://www.aesclepius.com.br/massagem-carotidea/</link>
		<pubDate>Wed, 15 Nov 2023 22:42:02 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/massagem-carotidea/</guid>
		<description>&lt;h2 id=&#34;o-que-é&#34;&gt;O que é&lt;/h2&gt;
&lt;p&gt;A massagem do seio carotídeo constitui-se no emprego de preensão manual do seio carotídeo do paciente por cerca de 10s para averiguar se a frequência cardíaca é reduzida como resposta ao aumento de pressão arterial local com consequente sinalizacão via barorreceptores que provocam estimulação parassimpática vagal.&lt;/p&gt;
&lt;p&gt;Seu emprego também é terapêutico nos casos de taquiarritmias supraventriculares.&lt;/p&gt;
&lt;p&gt;Reporta-se uma baixíssima taxa de complicações, mesmo quando praticada por profissionais menos treinados. Seu baixo custo e independência de preparo a tornam uma das mais famosas &lt;strong&gt;mágicas atitudes médicas a beira-leito&lt;/strong&gt;.&lt;/p&gt;
&lt;h2 id=&#34;o-mito-da-tromboembolia-cerebral-como-complicação&#34;&gt;O mito da tromboembolia cerebral como complicação&lt;/h2&gt;
&lt;p&gt;É comum que em cursos de emergência, os instrutores ou professores contraindiquem o procedimento em idosos e/ou por mais de 10s, sob a argumentação de que uma complicação possível é o despreendimento de placa carotídea com consequente efeito embólico nos finos vasos cerebrais.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Isto não procede &lt;em&gt;estatisticamente&lt;/em&gt;&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Em um estudo transversal, Lacerda &lt;em&gt;et al&lt;/em&gt; demonstraram que apenas 0.4% de um grupo de 502 pacientes &lt;strong&gt;de alto risco&lt;/strong&gt; apresentaram complicações do tipo déficit neurológico agudo após serem submetidos a massagem carotídea¹.&lt;/p&gt;
&lt;p&gt;Tal constatação joga por terra a teoria do fácil deslocamento de placas carotídeas, tendo em vista que foram selecionados pacientes de alta prevalência de doença aterosclerótica e de cardiopatia, já em acompanhamento ambulatorial. Por extrapolação estatística (neste caso mais que autorizada), podemos inferir que a incidência é ainda menor na população em geral, provavelmente zero.&lt;/p&gt;
&lt;p&gt;Na verdade, a plausibilidade biológica do despreendimento de placa carotídea pela massagem revelaria uma delicadeza excessiva da estrutura aterial, sendo possível, até mesmo no curso de movimentos bruscos, tal complicação. Aliás, tromboembolismos ocorreriam por todo o corpo sob movimentos. Em quase todos cenários de traumas veríamos tromboembolismos decorrentes de agitação mecânica, pelo menos nos pequenos vasos ocorreriam de forma abundante.&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Non sequitur&lt;/em&gt;.&lt;/p&gt;
&lt;p&gt;Por outro lado, a excessiva manipulação do sítio carotídeo pode, e é documentada, como causa de AVCi, como demonstrado por Hyo &lt;em&gt;et al&lt;/em&gt; quando uma paciente de 50 anos cursou com múltiplas isquemias cerebrais após longo período de carotidínea e excessiva manipulação do pescoço na tentativa de compensar a dor².&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;O que ocorre é o tradicional hábito de superestimação de incidências raras na medicina&lt;/strong&gt;. &lt;a href=&#34;../../vieses/&#34;&gt;Trata-se de um viés&lt;/a&gt;. Nossos vícios de percepção estatística são amplificados por casos específicos e raros, como Bastulli &lt;em&gt;et all&lt;/em&gt; demonstraram de um paciente de 77 anos pós-cirúrgico que cursa com AVCi embólico³. Como se pode observar no estudo, a recomendação de evitarmos o procedimento foi extrapolada para todos idosos, inclusive entre aqueles sem indicativos de doença aterosclerótica. &lt;strong&gt;Absurdo&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;A culpa de tais artigos atingirem o grande público recai sobre as bancas avaliadoras e a nossa fantástica fábrica de publicações. Assuma, você só escreveu aquele artigo na faculdade pra somar pontos na residência, né? 🤣&lt;/p&gt;
&lt;p&gt;&lt;em&gt;Quod erat demonstrandum&lt;/em&gt;.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Lacerda G de C, Pedrosa RC, Lacerda RC de, Santos MC dos, Brasil AT, Siqueira-Filho AG de. &lt;strong&gt;Incidência de complicações relacionadas à massagem do seio carotídeo em 502 pacientes ambulatoriais&lt;/strong&gt;. Arq Bras Cardiol [Internet]. 2009Feb;92(2):82–7. Available from: &lt;a href=&#34;https://doi.org/10.1590/S0066-782X2009000200002&#34;&gt;https://doi.org/10.1590/S0066-782X2009000200002&lt;/a&gt;&lt;/li&gt;
&lt;li&gt;KWAK, Hyo Sung et al. &lt;strong&gt;Carotidynia presenting with acute ischemic stroke after carotid sinus massage&lt;/strong&gt;. Annals of Clinical Neurophysiology, v. 19, n. 1, p. 46-49, 2017.&lt;/li&gt;
&lt;li&gt;Bastulli JA, Orlowski JP. &lt;strong&gt;Stroke as a complication of carotid sinus massage&lt;/strong&gt;. Crit Care Med. 1985 Oct;13(10):869. doi: 10.1097/00003246-198510000-00022. PMID: 4028760.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Banco de questões</title>
		<link>https://www.aesclepius.com.br/banco-de-questoes/</link>
		<pubDate>Mon, 13 Nov 2023 11:41:15 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/banco-de-questoes/</guid>
		<description>&lt;div class=calculadoras id=&#34;aviso&#34;&gt;
 &lt;div style=&#34;display:flex; align-content:center&#34;&gt;
  &lt;span class=&#34;etiqueta&#34;&gt;
   Infelizmente, a maior parte dos bancos de questões estãos protegidos por &lt;em&gt;paywalls&lt;/em&gt;. 
   &lt;br&gt;
   Isto seria facilmente superado por um esforço coletivo para produzir um banco de livre acesso.
   &lt;br&gt;
   &lt;br&gt;
   &lt;strong&gt;Para provar meu ponto, criei este protótipo.&lt;/strong&gt;
   &lt;br&gt;
   A adição de novas questões demora um pouco porque faço quando posso. 
   &lt;br&gt;
   Entre em contato se deseja adicionar questões.
   &lt;br&gt;
   &lt;span style=&#34;color: var(--termo)&#34;&gt;Clique em &lt;em&gt;Gerar nova questão&lt;/em&gt; e boa prática! &lt;/span&gt;
  &lt;/span&gt;
&lt;/div&gt;


&lt;br&gt;
 &lt;button id=&#34;close&#34; onclick=&#34;fechardialogo()&#34;&gt;
    Fechar aviso!
 &lt;/button&gt;
&lt;/div&gt;
&lt;br&gt;


&lt;div id=&#34;counter&#34;&gt;&lt;/div&gt;
&lt;div id=&#34;question-container&#34;&gt;&lt;/div&gt;
&lt;div id=&#34;info-question&#34;&gt;
  &lt;button style=&#34;margin-left: 5vw; margin-right: auto; margin-top: 5px;&#34; onclick=&#34;generateRandomQuestion()&#34;&gt;Gerar nova questão&lt;/button&gt;
&lt;/div&gt;
&lt;br&gt;
&lt;script src=&#34;../../bancoquestoes.js&#34;&gt;&lt;/script&gt;
&lt;script&gt;
function fechardialogo() {
  let aviso = document.getElementById(&#34;aviso&#34;);
  aviso.style.display = &#39;none&#39;
};
&lt;/script&gt;

</description>
	</item>
	
	<item>
		<title>Colecistite aguda</title>
		<link>https://www.aesclepius.com.br/tokyo-guideline/</link>
		<pubDate>Wed, 08 Nov 2023 00:00:00 +0000</pubDate>
		
		<guid>https://www.aesclepius.com.br/tokyo-guideline/</guid>
		<description>&lt;style&gt;
	h4 {
		padding: 0px;
		padding-top: 1rem;
		margin: 0px;
	}
&lt;/style&gt;
&lt;h2 id=&#34;tokyo-guideline1&#34;&gt;Tokyo Guideline[1]&lt;/h2&gt;


&lt;div class=calculadoras&gt;
      &lt;h4&gt;Exame do abdome&lt;/h4&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;suspeita&#34;&gt;
      &lt;label&gt;Murphy positivo, palpação dolorosa ou de massa.&lt;/label&gt;
      &lt;br&gt;
      &lt;h4&gt;Inflamação sistêmica&lt;/h4&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;inflamacao&#34;&gt;
      &lt;label&gt;Febre ou calafrios.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;inflamacao&#34;&gt;
      &lt;label&gt;Proteína C reativa elevada ou leucocitose.&lt;/label&gt;
      &lt;br&gt;
      &lt;h4&gt;Imagem&lt;/h4&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;imagem&#34;&gt;
      &lt;label&gt;Dilatação biliar.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;imagem&#34;&gt;
      &lt;label&gt;Constricção constatada (estenose, cálculo etc).&lt;/label&gt;
      &lt;h4&gt;Colestase&lt;/h4&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;colestase&#34;&gt;
      &lt;label&gt;Icterícia ou bilirrubina de pelo menos 2mg/dL.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;colestase&#34;&gt;
      &lt;label&gt;Transaminemia ou enzimas canaliculares de pelo menos 1.5x o normal.&lt;/label&gt;
      &lt;h4&gt;Gravidade&lt;/h4&gt;
      &lt;label&gt;Idade:&lt;/label&gt;
      &lt;input type=&#34;number&#34; placeholder=&#34;anos&#34; id=&#34;idade&#34;&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;disfuncao_cardiovascular&#34;&gt;
      &lt;label&gt;Necessidade de epinefrina em qualquer dose ou pelo menos 5ug/Kg de dopamina.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;disfuncao_neurologica&#34;&gt;
      &lt;label&gt;Qualquer aleração de consciência.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;disfuncao_respiratoria&#34;&gt;
      &lt;label&gt;PaO2/FiO2 menor que 3.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;disfuncao_renal&#34;&gt;
      &lt;label&gt;Oliguria, anúria ou Cr de pelo menos 2mg/dL&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;disfuncao_hematologica&#34;&gt;
      &lt;label&gt;Plaquetopenia de 100.000/mm³ ou menos.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;leocicitose_12_leucopenia&#34;&gt;
      &lt;label&gt;Leucocitose de 12.000/mm³ ou leucopenia de pelo menos 4.000/mm³.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;febre_alta&#34;&gt;
      &lt;label&gt;Febre acima de 39°C.&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;bilirrubina&#34;&gt;
      &lt;label&gt;Bilirrubina de pelo menos 5mg/dL&lt;/label&gt;
      &lt;br&gt;
      &lt;input type=&#34;checkbox&#34; id=&#34;albumina&#34;&gt;
      &lt;label&gt;Albumina menor que 70% do limite superior laboratorial.&lt;/label&gt;
       &lt;br&gt;
&lt;br&gt;
&lt;button onclick=&#34;updateResult()&#34;&gt;Calcule!&lt;/button&gt;
&lt;br&gt;
&lt;p id=&#34;result&#34; style=&#34;text-indent: 0&#34;&gt;&lt;/p&gt;
&lt;/div&gt;
&lt;script&gt;
function updateResult() {
	var suspeita = document.getElementById(&#34;suspeita&#34;).checked;
	var colestase = document.getElementById(&#34;colestase&#34;).checked;
	var inflamacao = 
		document.getElementById(&#34;inflamacao&#34;).checked || 
		document.getElementById(&#34;febre_alta&#34;).checked;
	var imagem = document.getElementById(&#34;imagem&#34;).checked;
	var idade = false ;
	if ( document.getElementById(&#34;idade&#34;).value &gt; 74) { 
		idade = true
	};
	var grau2 = [
		document.getElementById(&#34;leocicitose_12_leucopenia&#34;).checked,
		document.getElementById(&#34;febre_alta&#34;).checked,
		document.getElementById(&#34;bilirrubina&#34;).checked,
		document.getElementById(&#34;albumina&#34;).checked,
		idade
	];

	var diagnostico = &#34;verifique o exame do abdome!&#34;;
	var grau = &#34;sem graduação&#34;;

	// diagnostico
	if (suspeita === true ) {
		diagnostico = &#34;suspeita&#34;;
		if (inflamacao === true ) {
			if (colestase === true &amp;&amp; imagem === true ) {
				diagnostico = &#34;confirmada&#34;;
				console.log(&#34;local 1&#34;)
				grau = &#34;I&#34;;
			}
		}
	} else {
      // suspeita falsa
      diagnostico = &#34;sem exame do abdome não se faz Tokyo!&#34;
    };
		// gradação
		conta_grau = 0 ;
		grau2.forEach(function(value) {
			if (value === true) {
    	    conta_grau++; 
    	}
		});

		if ( diagnostico === &#34;confirmada&#34; &amp;&amp; conta_grau &gt; 1 ) {
			grau = &#34;II&#34;	
		}

		if ( 
			document.getElementById(&#34;disfuncao_neurologica&#34;).checked === true ||
			document.getElementById(&#34;disfuncao_hematologica&#34;).checked === true ||
			document.getElementById(&#34;disfuncao_respiratoria&#34;).checked === true ||
			document.getElementById(&#34;disfuncao_cardiovascular&#34;).checked === true ||
			document.getElementById(&#34;disfuncao_renal&#34;).checked === true 
		) {
			diagnostico = &#34;confirmada&#34;;
            grau = &#34;III&#34;;
		}

	let result = document.getElementById(&#34;result&#34;);
	result.innerHTML = &#34;Colangite &#34; + diagnostico + &#34;&lt;br&gt;Grau &#34; +grau;
}
&lt;/script&gt;

&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;YOKOE, Masamichi et al. &lt;strong&gt;Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos)&lt;/strong&gt;. Journal of Hepato‐biliary‐pancreatic Sciences, v. 25, n. 1, p. 41-54, 2018.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Distúrbios do pH e gasometria arterial</title>
		<link>https://www.aesclepius.com.br/gasometria-arterial/</link>
		<pubDate>Tue, 07 Nov 2023 20:55:26 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/gasometria-arterial/</guid>
		<description>&lt;h2 id=&#34;acidez-e-basicidade-sérica&#34;&gt;Acidez e basicidade sérica&lt;/h2&gt;
&lt;p&gt;O pH sanguíneo deve sempre estar entre 7.35 e 7.45.&lt;/p&gt;
&lt;p&gt;Valores abaixo deste intervalo são chamados de acidemia. Acima, alcalemia.&lt;/p&gt;
&lt;p&gt;Para este controle, um sistema tampão surgiu evolutivamente nos mamíferos:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;A respiração provoca retirada do dióxido de carbono diluído no soro; e&lt;/li&gt;
&lt;li&gt;Os rins regulam a excreção de bicarbonato.&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;Este sistema é o principal sistema tampão sérico. Existem outros, como o sistema proteico (bases), principalmente via albumina.&lt;/p&gt;
&lt;h3 id=&#34;regulação&#34;&gt;Regulação&lt;/h3&gt;
&lt;p&gt;Sempre que o pH se altera, o sistema tampão tentará manter fixa a seguinte relação matemática:&lt;/p&gt;
&lt;p&gt;$$
pH \propto \frac{pCO2}{[HCO3⁻]}
$$&lt;/p&gt;
&lt;p&gt;Onde pCO2 é a pressão parcial de CO2 no soro e [HCO3⁻] é a concentração sanguínea de bicarbonato.&lt;/p&gt;
&lt;p&gt;Aqui, alguns livros de medicina pecam em afirmar que esta fórmula é uma &amp;ldquo;igualdade&amp;rdquo;. O símbolo matemático correto é a &amp;ldquo;proporcionalidade&amp;rdquo;.&lt;/p&gt;
&lt;p&gt;O cálcuo do pH depende, na verdade, de inúmeros fatores. Até mesmo a temperatura corporal influencia a autoionização da água e, portanto, o pH. Nesse sentido, a única forma de estimar matemáticamente o pH é por regressões numéricas. Historicamente, usa-se a estimativa de Henderson-Hasselbach:&lt;/p&gt;
&lt;p&gt;$$
pH = 6,10 + \frac{log[HCO3⁻]}{0,03} * pCO2
$$&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Portanto, quedas na pC02 são compensadas também com queda da [HCO3⁻].&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;O raciocínio inverso também é válido.&lt;/p&gt;
&lt;p&gt;Os processos que causam queda da pCO2 ou aumento da [HCO3⁻] são chamados de &lt;mark&gt;alcalose&lt;/mark&gt;.&lt;/p&gt;
&lt;p&gt;Os processos que causam aumento da pCO2 ou queda da [HCO3⁻] são chamados de &lt;mark&gt;acidose&lt;/mark&gt;.&lt;/p&gt;
&lt;p&gt;Observe que na fórmula de Henderson-Hasselbach existe um valor constante de 6,10 acrescido de um valor dado pela fração do logarítmo de bicarbonato multiplicado pela pCO2 dividido por 0,03. Esta fração é justamente o sistema tampão do bicarbonato. Regressões numéricas mais sofisticadas adicionam outros tampões a este cálculo. Teríamos:&lt;/p&gt;
&lt;p&gt;$$
pH = 6,1 + \sum_{1}^{i} tampão_i
$$&lt;/p&gt;
&lt;p&gt;Onde, sendo $f(a,b)$ uma função genérica de parâmetros $a,b$, temos:&lt;/p&gt;
&lt;p&gt;$$
tampão_{HCO_3⁻} = f([HCO_3⁻], pCO2)
$$&lt;/p&gt;
&lt;p&gt;O valor de 6,10 é uma constante que reflete a composição sanguínea estática e a autodissociação da água, ou seja, é um determinístico do pH basal do sangue, sendo o principal fator a reação da água consigo mesma, produzindo íons hidrônio ($H_{3}O^{+}$):&lt;/p&gt;
&lt;p&gt;$$
H_{2}O + H_{2}O \rightarrow H_{3}O^{+}
$$&lt;/p&gt;
&lt;h2 id=&#34;interpretação-da-gasometria&#34;&gt;Interpretação da gasometria&lt;/h2&gt;
&lt;p&gt;O paciente terá sempre uma gasometria &lt;mark&gt;esperada&lt;/mark&gt;, pois a clínica do paciente deve ser entendida como o primeiro passo da interpretação de gasometria arterial.&lt;/p&gt;
&lt;p&gt;Exemplo:&lt;/p&gt;
&lt;p&gt;Um paciente com taquipneia, hiperglicêmico e com alterações do estado geral e de consciência no sentido de rebaixamento, sofre com uma provável &lt;strong&gt;acidose metabólica&lt;/strong&gt;. Assim, espera-se uma gasometria de acidemia.&lt;/p&gt;
&lt;p&gt;Normalmente, este é o curso de interpetação:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Clínica.&lt;/li&gt;
&lt;li&gt;Há acidemia ou alcalemia?&lt;/li&gt;
&lt;li&gt;Há acidose ou alcalose?&lt;/li&gt;
&lt;li&gt;Qual a resposta renal (bicarbonato)?&lt;/li&gt;
&lt;li&gt;Qual a resposta esperada respiratória (gás carbônico)?&lt;/li&gt;
&lt;li&gt;Hipóteses de acordo que expliquem a clínica.&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;Repare que os passos 4 e 5 podem ser invertidos, mas raramente faz sentido observar primeiro a resposta respiratória, já que esta é muito efêmera.&lt;/p&gt;
&lt;p&gt;Ao analisarmos os passos 4 e 5, será necessário conhecer as respostas fisiológicas a cada cenário, chamada de &lt;strong&gt;compensação esperada&lt;/strong&gt;.&lt;/p&gt;
&lt;p&gt;Após, deve se proceder a elucidação do mecanismo de acidose ou de alcalose e se, porventura, ambos concorrem, num processo conhecido como &lt;strong&gt;misto&lt;/strong&gt;.&lt;/p&gt;
&lt;h3 id=&#34;compensação-esperada&#34;&gt;Compensação esperada&lt;/h3&gt;
&lt;p&gt;Na acidose metabólica:&lt;/p&gt;
&lt;p&gt;O  esperado é dado pela proporção de 10 pontos de HCO&lt;sub&gt;3&lt;/sub&gt; para cada 4 pontos em pCO&lt;sub&gt;2&lt;/sub&gt;.&lt;/p&gt;
&lt;p&gt;Já na alcalose metábolica, é esperado:&lt;/p&gt;
&lt;p&gt;$$
pCO_{2} = HCO_{3}^{-} + 15
$$&lt;/p&gt;
&lt;h3 id=&#34;ânion-gap&#34;&gt;Ânion gap&lt;/h3&gt;
&lt;p&gt;Nos casos de acidemia por acidose metabólica, o bicarbonato pode ter sido diminuído pela presença de outros ânions, visto que há um equilibrío eletrostático no sangue. Matematicamente:&lt;/p&gt;
&lt;p&gt;$$
[H_{3}O⁺] + [Na⁺] - [HCO_{3}⁻] - [Cl⁻] - \sum_{}^{} ânions = 0
$$&lt;/p&gt;
&lt;p&gt;Desconsiderando o hidrônio, já que este se associa ao bicarbonato, e isolando para os demais ânions:&lt;/p&gt;
&lt;p&gt;$$
\sum_{}^{} ânions = \cancel{[H_{3}O⁺]} + [Na⁺] - [HCO_{3}⁻] - [Cl⁻]
$$&lt;/p&gt;
&lt;p&gt;Este somatório de outros íons negativos não medidos seria o &lt;mark&gt;ânion gap&lt;/mark&gt;.&lt;/p&gt;
&lt;p&gt;Porém, a albumina é uma proteína grande e, como toda proteína, tem carga eletrostática tendente a valores negativos. Assim, quando um ânion qualquer aumenta, também &lt;em&gt;empurra&lt;/em&gt; a albumina para menos e sua influência merece correção, dada empiricamente por:&lt;/p&gt;
&lt;p&gt;$$
\sum_{}^{} ânions = [Na⁺] - [HCO_{3}⁻] - [Cl⁻] + 2.5(\Delta{Albumina})
$$&lt;/p&gt;
&lt;p&gt;Onde:&lt;/p&gt;
&lt;p&gt;$$
\Delta{Albumina} = Albumina_{referência} - Abulina_{aferida}
$$&lt;/p&gt;
&lt;h3 id=&#34;delta-delta&#34;&gt;Delta delta&lt;/h3&gt;
&lt;p&gt;Como sei que mais de um processo (alcalose ou acidose) não ocorrem simultâneamente num contexto de gap aniônico alargado?&lt;/p&gt;
&lt;p&gt;Esta dúvida raramente fará sentido clínico, uma vez que o exame de gasometria é um teste complementar e &lt;a href=&#34;../../medicina/estatistica-diagnostica&#34;&gt;deve ser solicitado já com uma hipótese diagnóstica prévia&lt;/a&gt; reforçando ou enfraquecendo-a.&lt;/p&gt;
&lt;p&gt;Mas em casos obscuros, a seguinte lógica deve ser aplicada:&lt;/p&gt;
&lt;div style=&#34;display:flex; align-content:center&#34;&gt;
  &lt;span class=&#34;etiqueta&#34;&gt;
Se o ânion gap aumenta, o bicarbonato diminui na &lt;mark&gt;mesma proporção&lt;/mark&gt;.
 &lt;/span&gt;
&lt;/div&gt;


&lt;p&gt;Matematicamente:&lt;/p&gt;
&lt;p&gt;$$
\frac{\Delta{ânion gap}}{\Delta{HCO⁻_3}} \propto 1
$$&lt;/p&gt;
&lt;p&gt;Ou ainda:
$$
\frac{{ânion gap} – 10} {24 – [HCO3⁻]} \propto 1
$$&lt;/p&gt;
&lt;p&gt;Assim, esperamos que esta relação seja sempre próxima de 1.&lt;/p&gt;
&lt;p&gt;Quando menor que 1 significa que o ânion gap foi alargado por outro processo de acidose hiperclorêmica, já que o bicarbonato não foi deslocado tanto quanto o gap demonstra, havendo outro ânion com presença aumentada, o cloro.&lt;/p&gt;
&lt;p&gt;Quando maior que 1 significa que o bicarbonato está sendo retido por um processo além do compensatório, sendo portanto uma alcalose escondida.&lt;/p&gt;
&lt;p&gt;A interpretação da relação delta/delta só se justifica em contextos muito confusos e deve ser criteriosa.&lt;/p&gt;
&lt;h3 id=&#34;fluxograma-para-acidemia&#34;&gt;Fluxograma para acidemia&lt;/h3&gt;
&lt;pre class=&#34;mermaid&#34;&gt;graph TD;
    acidemia(acidemia&lt;br&gt;pH &lt; 7.35);
    acidemia -- HCO3⁻ &lt; 20 --&gt; acmet(acidose&lt;br&gt;metabólica);
    acmet --&gt; gapN(ânion gap normal) --&gt; clor(acidose hiperclorêmica); 
    acmet --&gt; gapLargo(ânion gap &gt; 12 );
    gapLargo -- dúvidas --&gt; delta(calcular&lt;br&gt;delta/delta);
    gapLargo --&gt; etio(cetoacidose diabética&lt;br&gt;intoxicação alcoólica&lt;br&gt;sepse);
    acidemia -- HCO3⁻ &gt; 26&lt;br&gt;pCO2 &lt; 35 --&gt; fimmetcomp(acidose respiratória&lt;br&gt;compensada) --&gt; cron(investigar processos de hipóxia crônica);
    acidemia -- HCO3⁻ normal&lt;br&gt;pCO2 &gt; 45 --&gt; resp1(acidose respiratória&lt;br&gt;recente não compensada) --&gt;hipox(hipóxia);
    hipox --&gt; etioH(edema pulmonar&lt;br&gt;DPOC descompensado&lt;br&gt;crise de asma);
&lt;/pre&gt;

&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;COPPOLA, Silvia et al. &lt;strong&gt;Sodium bicarbonate in different critically ill conditions: From physiology to clinical practice&lt;/strong&gt;. Anesthesiology, v. 134, n. 5, p. 774-783, 2021.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Tromboembolismo pulmonar</title>
		<link>https://www.aesclepius.com.br/wells-tep/</link>
		<pubDate>Sun, 05 Nov 2023 00:00:00 +0000</pubDate>
		
		<guid>https://www.aesclepius.com.br/wells-tep/</guid>
		<description>&lt;h2 id=&#34;escore-de-wells&#34;&gt;Escore de Wells&lt;/h2&gt;


&lt;!-- Falta incluir alguns elementos como ruptura de aneurisma etc --&gt;
&lt;div class=calculadoras&gt;
  &lt;input type=&#34;checkbox&#34; id=&#34;3&#34;&gt;
  &lt;label&gt;Não há outro diagnóstico mais provável.&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=&#34;checkbox&#34; id=&#34;3&#34;&gt;
  &lt;label&gt;Sinais clínicos de trombose venosa.&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=&#34;checkbox&#34; id=&#34;1.5&#34;&gt;
  &lt;label&gt;Cirurgia recente ou imobilização.&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=&#34;checkbox&#34; id=&#34;1.5&#34;&gt;
  &lt;label&gt;Tromboembolismos prévios.&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=&#34;checkbox&#34; id=&#34;1.5&#34;&gt;
  &lt;label&gt;Frequência cardíaca acima de 100bpm.&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=&#34;checkbox&#34; id=&#34;1&#34;&gt;
  &lt;label&gt;Hemoptise.&lt;/label&gt;
  &lt;br&gt;
  &lt;input type=&#34;checkbox&#34; id=&#34;1&#34;&gt;
  &lt;label&gt;Câncer.&lt;/label&gt;
&lt;br&gt;
&lt;br&gt;
&lt;button onclick=&#34;updateResult()&#34;&gt;Calcule!&lt;/button&gt;
&lt;br&gt;
&lt;p id=&#34;result&#34;&gt;&lt;/p&gt;

&lt;/div&gt;
&lt;script&gt;
function updateResult() {
  let um = document.querySelectorAll(&#39;input[id=&#34;1&#34;]:checked&#39;).length;
  let ummeio = (document.querySelectorAll(&#39;input[id=&#34;1.5&#34;]:checked&#39;).length * 1.5);
  let tres = (document.querySelectorAll(&#39;input[id=&#34;3&#34;]:checked&#39;).length * 3);
  let soma = um + ummeio + tres;
  let resposta = &#34;Valor preditivo baixo de &#34;+soma+&#34;.&lt;br&gt;Solicite D-dímero.&lt;br&gt;Se acima de 400ng/mL para pacientes de até 40 anos ou acima de 10 vezes a idade a partir dos 40 anos, considere positivo.&lt;br&gt;&lt;br&gt;D-dímero é contexto-dependente, portanto, avalie se outra causa não está positivando o exame!&#34;;
  if (soma &gt; 4) { 
    resposta = &#34;&lt;span style=&#39;color: red; font-weight: bold&#39;;&gt;Valor preditivo alto de &#34;+ soma+&#34;!&lt;/span&gt; &lt;br&gt;Realize angiotomografia de tórax e proceda a anticoagulaçao plena com 1.5mg/Kg de heparina de baixo peso molecular (Enoxaparina).&#34;
  };
  let result = document.getElementById(&#34;result&#34;);
  result.innerHTML = resposta
}
&lt;/script&gt;

&lt;hr&gt;
&lt;h2 id=&#34;referências&#34;&gt;Referências&lt;/h2&gt;
&lt;ol&gt;
&lt;li&gt;Wells PS, Anderson DR, Rodger M et al. &lt;strong&gt;Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer&lt;/strong&gt;. Thromb Haemost. 2000;83(3): 416-20.&lt;/li&gt;
&lt;/ol&gt;
</description>
	</item>
	
	<item>
		<title>Websites e páginas úteis</title>
		<link>https://www.aesclepius.com.br/sites-uteis/</link>
		<pubDate>Wed, 31 Dec 1969 21:33:44 -0300</pubDate>
		
		<guid>https://www.aesclepius.com.br/sites-uteis/</guid>
		<description>&lt;br&gt;
&lt;br&gt;
&lt;div class=&#34;search&#34; style=&#34;position: relative;&#34;&gt;
&lt;input type=&#34;text&#34; id=&#34;search&#34; placeholder=&#34;procure aqui&#34;&gt;
&lt;svg class=&#34;lupa&#34; xmlns=&#34;http://www.w3.org/2000/svg&#34; stroke-width=&#34;1.09&#34; enable-background=&#34;new 0 0 24 24&#34; height=&#34;14px&#34; viewBox=&#34;0 0 24 24&#34; width=&#34;4px&#34; focusable=&#34;false&#34;&gt;&lt;path d=&#34;m20.87 20.17-5.59-5.59C16.35 13.35 17 11.75 17 10c0-3.87-3.13-7-7-7s-7 3.13-7 7 3.13 7 7 7c1.75 0 3.35-.65 4.58-1.71l5.59 5.59.7-.71zM10 16c-3.31 0-6-2.69-6-6s2.69-6 6-6 6 2.69 6 6-2.69 6-6 6z&#34;&gt;&lt;/path&gt;&lt;/svg&gt;
&lt;/input&gt;
&lt;/div&gt;
&lt;script src=&#34;../../sites-uteis.js&#34;&gt;&lt;/script&gt;
&lt;ul id=&#34;search-output&#34;&gt;
&lt;/ul&gt;
</description>
	</item>
	
	</channel>
</rss>
